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ABSTRACT 
Ochratoxin A is a contaminant in wine and known to be immunosuppressive and 
possibly carcinogenic. Therefore, the development of a rapid and sensitive method for 
field analysis is required for risk assessment and management. The work presented in 
this thesis reports the construction of a sensor platform capable of fulfilling these 
requirements. As a sensor platform, screen-printed thick film electrodes and 
microelectrodes on a silicone support were investigated for sensor development. As 
biological recognition elements, an antibody specifically binding ochratoxin A and a 
peptide receptor that was designed using computational modelling were examined. 
 
A disposable immunosensor for ochratoxin A was developed based on screen-printing 
technology. An indirect competitive immunoassay format was used on bare screen 
printed gold electrode (SPGE). The performance of this sensor was compared to 
carboxmethylated dextran (CMD) modified SPGE. Detection was performed by 
chronoamperometry monitoring the reaction of tetramethylbenzidine and hydrogen 
peroxide catalysed by horseradish peroxidase. The SPGE-based immunosensor 
achieved a detection limit of 100 ng L-1 and the CMD-modified SPGE immunosensor 
10 ng L-1. The latter has been used for ochratoxin A determination in wine samples and 
was validated against standard HPLC and a commercial immunoassay test kit. Wine 
sample analysis involved the sample pre-treatment using immunoaffinity 
chromatography, electrochemical wine component characterisation and interference 
control. The immunosensor format was transferred to a gold microelectrode array based 
on a silicone support for the purpose of signal sensitivity enhancement and 
miniaturisation in the prospect of field analysis. Preliminary data showed the 
characterisation of the microelectrode array immunosensor construction and 
characterisation. Further optimisation is needed to establish a calibration curve with the 
required sensitivity. 
 
The second part of the work comprised the design of a peptide receptor for ochratoxin A 
using computational methods by screening de novo designed peptide libraries. An 
octapeptide (CSIVEDGL) and a 13-peptide (GPAGIDGPAGIRC) were selected for 
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synthesis and affinity characterised for ochratoxin A recognition using a surface 
plasmon resonance biosensor (BiacoreTM). The peptide receptors showed good 
sensitivity for ochratoxin A of 10 µg L-1. Preliminary affinity characterisation resulted 
in KA = 63 mM-1 for the 13-mer peptide and KA = 84 mM-1 for the octapeptide, which 
appears to be binding with higher strength to ochratoxin A. The affinity values 
correspond to the binding score (binding energy) calculated by computational 
modelling. This work shows the potential of designing peptide receptors for small 
molecules (e.g. ochratoxin A) and suggests their application in affinity sensors for 
detecting ochratoxin A contamination. 
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CHAPTER 1 : LITERATURE REVIEW 
1.1 Background 
Wine as a beverage has been known since 5000-6500 B.C., when the ancient Greeks 
made wine in their numerous colonies in Italy, southern France, and Spain. As of today, 
these countries are leading the world’s largest wine production and export. Wine has 
been praised by poets like Homer and Ovid and philosophers such as Plato and Socrates 
for its ability to induce relaxation, inspiring thoughts, new hopes and creativity.  
 
The roman encyclopedist and natural philosopher Pliny the Elder quoted “in vino 
sanitas”, which means “in wine there is health”. But is this really true?  
 
For some, wine is purely an alcoholic drink; others, however, regard wine not only as a 
beverage, but a uniquely complex beverage that is complex in terms of taste and also in 
environmental, historical and cultural factors influencing its production. From a 
scientist’s point of view, wine is very complex indeed, not only because it is made up of 
many different components, but also due to its controversy as health benefit and health 
hazard. The health benefit is known; moderate wine consumption, especially red wine, 
can reduce the risk of acute myocardial infarction or cancer by up to 34% [Gronbeck et 
al., 2000]; thanks to the generous amount of polyphenols in wine. Phenolic compounds 
favourably influence multiple biochemical systems, such as increased high-density 
lipoprotein cholesterol, antioxidant activity, decreased platelet aggregation and 
endothelial adhesion, or suppression of cancer cell growth [Lorimier, 2000]. With all 
things, there is a drawback, as wine also has negative health effects that do not have to 
be entirely related to alcohol, but to contaminants such as heavy metals, pesticides or 
carcinogens. The benefits and disadvantages of wine consumption in humans have been 
extensively reviewed by Tomera [1999]. One substance was not described in that 
review even though its toxicity has been known since 1965 [van der Merwe et al., 1965] 
and it has been related to wine contamination since 1996 [Zimmerli & Dick, 1996]. This 
contaminant is ochratoxin A.  
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Ochratoxin A is a mycotoxin, which is a group of molecules produced by certain fungi 
such as Aspergillus or Penicillium. These fungi can grow on grapes, which are 
processed predominantly into red wine and, due to the stable nature of ochratoxin A, it 
is processed alongside. As for every toxin, the dose is crucial and above a certain level 
of consumption, ochratoxin A can become a serious health risk, since it is 
immunosuppressive and genotoxic [Walker, 1999], but above all it has been classified 
as possibly carcinogenic. The International Agency for Research on Cancer (IARC) 
categorises it as a possibly carcinogenic substance into category ‘group 2B’, which is 
used for substances when there is inadequate evidence of carcinogenicity in humans, but 
there is sufficient evidence of carcinogenicity in animal experiments [IARC, 1993]. Just 
recently, the EU has established the maximum acceptable level of ochratoxin A 
contamination in wine that is 2 μg L-1 (Commission Regulation – EC No. 123/2005). It 
was found that wine consumption can contribute up to 10–13% of total ochratoxin A 
intake (whereas the main intake of 40–50% is due to cereals) [Jorgensen, 2005].  
 
A study conducted by Altieri et al. [2004] related alcohol and particularly wine 
consumption to cancer occurrence. The authors concluded that alcohol concentration 
per se, rather than specific contaminants, is a major risk factor for oral cancer, but also 
admitted that this conclusion remains speculative. The study indicated that in 
populations with frequent wine consumption, wine can strongly increase the risk of e.g. 
oral cancer. 
 
In Britain the wine consumption has risen 60 % in the last decade and currently an 
average of 20 litres of wine is consumed per capita each year. In comparison, the 
average per capita consumption in France and Italy is close to 60 litres a year [IWSR, 
2007]. The IWSR (International Wine and Spirit Record) also predicts that world wine 
consumption will grow by 4.8% between 2005 and 2010 to a total volume of 238,825 
million hectolitres. 
 
One could argue that many people do not drink alcohol or wine and thus are not 
affected. However, ochratoxin A is also present in grapes and grape juice, cereals and 
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coffee, to mention a few sources [Adams, 1995]. Ochratoxin A basically contaminates 
every food commodity where ochratoxin A producing fungi grow. 
 
The thesis reports the development of an affinity sensor for ochratoxin A for 
determination in wine samples. Comprising the required elements of specificity, 
sensitivity, time and cost-effectiveness, the biosensor has to be carefully assembled. 
Two kinds of recognition element were investigated; one was an antibody specifically 
binding ochratoxin A and the other a peptide receptor for ochratoxin A that is designed 
using computational modelling. Peptides have various advantages in terms of molecular 
stability and availability, compared to antibodies, which are being more commonly used 
in immunosensors. Also, the production of antibodies for a specific molecule can be 
time and cost-consuming and generally requires animal resources.  
 
The first stage of the biosensor development involved the parallel execution of 
computational design of peptide receptors for ochratoxin A and the consecutive 
characterisation of both the antibody and peptide recognition elements using binding 
assays. 
 
The second stage comprised the construction of the transducer component of the 
biosensor for both types of recognition elements. The transducer relates the biological 
signal (as a result of a binding interaction) via a detector towards an electronic data 
output. Electrochemical detection was chosen using an electrode as transducer. C 
Complexity of wine plays a significant role as the components of wine have to be 
considered for achieving interference-free and sensitive detection. 
1.2 Mycotoxins  
Fungi are everywhere and come in many forms: as mushrooms, yeasts and filamentous 
moulds, to name a few. Moulds grow naturally in many agricultural crops. This occurs 
both in the field, after harvest and during storage, and later when processed into food 
and animal feed. Moulds are microscopic, filamentous fungi that grow as multi-cellular 
filaments called hyphae forming a mycelium [Adams, 1995]. These species of fungi 
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produce mycotoxins as secondary metabolites, whose specific function is yet 
undetermined, but who, together with hydrolytic enzymes, inhibit the growth of 
competing microorganisms. Mycotoxins are considered secondary metabolites as they 
not required for the growth of the producing fungus and therefore. The major difference 
of toxic metabolites associated with food poisoning from fungi versus the toxins 
produced by bacteria is that mycotoxins are generally small in molecular weight (300-
400 Daltons), whereas bacterial toxins are often macromolecules such as polypeptides, 
proteins or lipopolysaccharides [Adams, 1995].  
 
Mycotoxins are produced by several biosynthesis pathways in fungi:  
 
• polyketide route (e.g. patulin; ochratoxin1), 
• terpene route (e.g. trichothecenes), 
• amino acid route (e.g. aflatoxins), and  
• tricarboxylic route (e.g. rubratoxin).  
 
In relation to their pathway, mycotoxins show significant diversity in their chemical 
structures and biological activity [Bhatnagar et al., 2001]. The three genera Aspergillus, 
Penicillium and Fusarium comprise the largest number of mycotoxin-producing species, 
but not all species within these genera produce toxins. Production is often depended on 
temperature and water activity. Different genera grow under distinct conditions. For 
example, Aspergillus prefers high humidity and temperature found in tropical and 
subtropical climates [EMAN, 2004] whereas Penicillium verrucosum grows only at 
temperatures below 30°C and at a lower water activity, but can be also found at 
temperatures as low as 5°C [WHO, 1990]. Generally, fungal growth can occur over a 
wide range of these environmental factors [Bhatnagar et al., 2001]. 
 
Mycotoxicoses (poisoning resulting from exposure to fungal toxins) occurs when fungal 
toxins are ingested by animals or humans, and affects various organs, most commonly 
liver, kidney and lungs and the nervous, endocrine and immune system. The effect of a 
                                                 
1 Biosynthesis pathway for ochratoxin A has not yet been established, but there are indications it derives 
from the shikimate pathway (phenylalanine moiety) and the pentaketide pathway (dihydroisocoumarin) 
[Ringot et al., 2006]. 
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mycotoxin depends on the affected species and intra-species susceptibility, which is 
age, sex, nutritional status and the condition of the immune system [Bhatnagar et al., 
2001].  
 
The liver and kidney have a high capacity to bind many mycotoxins while other 
mycotoxins are highly lipophilic and can accumulate in body fat. A toxic response will be 
critically influenced by the rate of adsorption (gastrointestinal tract, lungs, and skin), 
distribution through the blood stream, enzymatic degradation (hydroxylation of 
ochratoxin A by e.g. proteases results in ochratoxin α) or excretion [Smith, 1991]. 
 
Because of their diversity of chemical structures and differing physical properties, 
mycotoxins exhibit a wide array of biological effects on mammalian systems. Hence, 
they can be genotoxic, mutagenic, carcinogenic (e.g. Aflatoxin), potent renal 
carcinogenic, nephrotoxic (e.g. Ochratoxin), or embryogenic, teratogenic or oestrogenic 
(e.g. Zearalenone) [Smith, 1991]. Furthermore, some of the mycotoxins show 
immunosuppressive activity by inhibiting protein biosynthesis, which can occur in 
different ways such as: (1) inhibition of transcription (e.g. aflatoxin), (2) inhibition of 
the phenylalanine tRNA synthetase (e.g. ochratoxin) or (3) inhibition of the translation 
through binding to the eukaryote ribosome (e.g. T-2 toxin) [Adams, 1995]. Selected 
mycotoxins are described briefly in the following paragraph. 
Aflatoxin is the best known and one of the most potent carcinogens and has been linked 
to a wide variety of human health problems. Primarily, Aspergillus flavus, Aspergillus 
parasiticus, and Aspergillus nomius produce aflatoxins. The Food and Drug 
Administration (FDA) has established maximum allowable levels of total aflatoxin in 
most food commodities at 20 µg kg-1. The maximum level for milk products is even 
lower at 0.5 µg L-1.  
T-2 Toxin is a trichothecene produced by Fusarium species and can cause permanent 
damage to the digestive tract. In 2000 the European Commission (EC) proposed 
maximum levels for trichothecenes in food at 500 µg kg-1 on an advisory base.  
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Vomitoxin, chemically known as Deoxynivalenol, is produced by several species of 
Fusarium. Vomitoxin has been associated with outbreaks of acute gastrointestinal 
illness in humans. The FDA advisory level for vomitoxin for human consumption is 1 
mg kg-1. 
Zearalenone is also a mycotoxin produced by Fusarium species. Zearalenone toxin is 
similar in chemical structure to the female sex hormone estrogen and targets the 
reproductive organs. Maximum levels for zearalenone in e.g. cereals have not yet been 
set by the EC, although maximum tolerable levels in food (mainly cereals) is about 1 
mg kg-1 are advised by the FDA. 
1.2.1 Legislation 
Mycotoxin contamination in food, feeds and beverages has received much attention in 
the past decade based on their unfavourable impact on human health and economic 
effects. The food and feed industry encountered considerable losses in life stock animals 
such as poultry and swine due to contamination of animal feeds with mycotoxins such 
as aflatoxin, fumonisin and zearalenone. This resulted in the reduction of agricultural 
food export, which has resulted in considerable economic losses for the producing 
countries. 
 
The EU has set limits for 40 mycotoxin–food combinations; according to the European 
Commission Regulation (EC) No 123/2005 of 26 January 2005 (amending Regulation 
(EC) No. 466/2001). The regulations involved are increasingly based on scientific 
opinions of regulatory authorities such as the Joint Expert Committee on Food 
Additives of the United Nations (JECFA) and the European Food Safety Authority 
(EFSA). This has a significant impact on mycotoxin regulations; regarding the rapid 
alert system for food and feed and the creation of an EU Community reference 
laboratory for mycotoxin analysis. Large European research and networking projects 
such as ‘BioCop’, ‘MoniQA’ or ‘GoodFood’ (funded by the EC’s 6th Framework 
Program) do also have an impact [Van Egmond et al., 2007] on regulations. 
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To ensure that these regulations are followed, monitoring schemes have been 
introduced. It needs to be ensured that the results from food and feed monitoring fulfil 
the requirements of the legislation. Therefore, any analytical method that is used for 
monitoring must meet established and accepted performance criteria. This is important 
in terms of legal actions and trade specifications (e.g. rejection of imports due to 
contamination), as well as monitoring and risk assessment studies. Both rapid and 
reliable screening and confirmatory methods must be available to fulfil regulations in 
daily practice. Official methods in mycotoxin legislation comprise approximately 45 
analytical methods for determination of mycotoxins in a few dozen countries [FAO, 
2004; AOAC, 2005]. 
 
At a world wide level, international inquiries were held regularly in recent decades 
[1981, 1987, 1995, and 2003] and regulations published for mycotoxins in food and 
feed [Schuller et al., 1983; Van Egmond, 1989; FAO, 1997 & 2004]. The most recent 
enquiry in 2003 was conducted by the National Institute for Public Health and the 
Environment, under contract to the Food and Agricultural Organization (FAO). At least 
99 countries had mycotoxin regulations for food and/or feed in 2003, an increase of 
approximately 30% compared to 1995 [van Egmond et al., 2007]. 
1.3 Ochratoxin A 
Ochratoxin (Figure 1.1) was discovered by van der Merwe et al in 1965. In cool and 
temperate regions, ochratoxin A is mainly produced by Penicillium verrucosum, which 
is a known contaminant of cereals like barley, wheat and rye. Ochratoxin can be also 
produced by Aspergillus ochraceus that contaminates mostly food from (sub)-tropical 
origin like maize, coffee beans, cocoa, soy beans, spices and dried fruits [Adams, 1995]. 
Ochratoxin is found in wine and grape-derived juices as well as in other beverages such 
as beer (malt barley) [Walker, 1999]. The wide variety of contamination is a result of 
fungal infection under favourable environmental conditions in the field during growth, 
at harvest, in storage or in shipment. 
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Figure 1.1: The ochratoxin structure. 
The ochratoxin family consist of ochratoxin - A; - B; - C; - A-methyl ester; - B-methyl 
ester; - B-ethyl ester; - α ;- β; and - 4-Hydroxyochratoxin A [Chu, 1998] as listed in 
Table 1.1. Ochratoxin A and ochratoxin esters are the toxic members of the group 
[Betina, 1985]. 
Table 1.1: The molecular family of ochratoxins. 
R1 R2 R3 R4 R5 Trivial name 
Phenylalanyl Cl H H H Ochratoxin A 
Phenylalanyl H H H H Ochratoxin B 
Phenylalanyl ethyl ester Cl H H H Ochratoxin C (ethyl ester) 
Phenylalanyl methyl ester Cl H H H Ochratoxin A methyl ester 
Phenylalanyl methyl ester H H H H Ochratoxin B methyl  ester 
Phenylalanyl ethyl ester H H H H Ochratoxin B ethyl  
OH Cl H H H Ochratoxin α 
OH H H H H Ochratoxin β 
Phenylalanyl Cl H OH H 4R-Hydroxyochratoxin A 
Phenylalanyl Cl OH H H 4S-Hydroxyochratoxin A 
Phenylalanyl Cl H H OH 10-Hydroxyochratoxin A 
The ochratoxin A structure is composed of a 3,4- dihydro-3-methyl-isocoumarin moiety 
linked via the 7-carboxy group to L-β-phenylalanine by an amide bond. Its molecular 
weight is 403.8 Dalton. The molecular formula is C20H18ClNO6. 
Contributing to the understanding of the pathway of ochratoxin biosynthesis, Mantle 
and Harris [2001] suggested fermentation dynamics of the ochratoxin producing fungi 
Aspergillus ochraceus and found that ochratoxin A and B production is growth-
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associated and that ochratoxin α seems to be a precursor of ochratoxin A. Structure 
activity studies indicate that the toxicity of ochratoxin A is attributable to its 
isocoumarin moiety and that the lactone carbonyl group (in the lactone-opened form 
OP-ochratoxin A) may be involved [Xiao et al., 1996. Neither the dissociation of the 
phenolic hydroxyl group nor the iron-chelating properties of ochratoxin A were directly 
related to its toxicity [Xiao et al., 1996]. The molecule is highly hydrophobic and 
anionic with metal-chelating properties. It shows non-specific protein interactions due 
to these and other properties. Therefore, acidic form of ochratoxin A is soluble in 
organic solvents (IARC, 1993), whereas the sodium salt is soluble in water. Ochratoxin 
A is generally a very stable compound that can only be completely hydrolyzed to 
ochratoxin α by heating under reflux for 48 hours in 6 M hydrochloric acid [Van der 
Merwe et al., 1965].  
1.3.1 Toxicity 
Upon ingestion, ochratoxin A is absorbed from the stomach as a result of its acidic 
properties and the gastrointestinal tract. Accumulation occurs in blood and kidney and 
at lower concentrations in the liver, muscle and fat. Metabolism of ochratoxin A has not 
been elucidated in details and at present, data regarding biotransformation in kidney and 
liver are controversial as a significant proportion of ochratoxin A is excreted unchanged 
[Galtier, 1978; Ringot, 2006]. Elimination of ochratoxin A in humans is extremely 
slow, since the toxin is exhibiting unusual toxico-kinetics, with a half-life in blood of 
840 hours (=35 days) after oral ingestion [Schlatter et al., 1996]. This is partly 
explained, by the fact that 99 % ochratoxin A is bound to serum proteins, which 
facilitates its passive absorption [Chu, 1971 & 1974]. 
 
Effects of acute poisoning have been reported following single dose administration. 
Examples are haemorrhages in various organs and fibrin thrombi in the spleen, brain, 
liver, kidney and heart. Nephrosis, hepatic and lymphoid necrosis, and enteritis with 
villous atrophy have also been observed in the test species [Albassam et al., 1987; 
JECFA, 2001]. Ochratoxin A toxicity tests in rat have shown LD50 value (50% Lethal 
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Dose) of 20 µg kg-1 [Pittet, 1998]. As of May 2006, there are no documented cases of 
acute toxicity reported in humans. 
In humans, the subchronic and chronic effects of ochratoxin A are of greatest concern 
[FEHD, 2005]. Ochratoxin A has been shown to be mutagenic, nephrotoxic, genotoxic, 
teratogenic and immunotoxic to several species of animals. Ochratoxin A-mediated 
mutagenicity requires additional processing of cytochrome P450-derived metabolism [De 
Groene et al., 1996]. The genotoxic effect remains rather unclear as most short-term 
assays for gene-mutations were negative and assays for unscheduled DNA synthesis 
(UDS), sister chromatid exchange (SCE) and chromosomal aberrations in CHO cells 
(cell line derived from chinese hamster ovary cells) were similarly negative or 
equivocal. However, ochratoxin A has been reported to cause DNA single strand breaks 
in mouse spleen cells in vitro and in kidney, liver and spleen cells in vivo [Walker, 
1999]. Ochratoxin A is an immunosuppressive agent [Muller et al., 1995 and 1999] and 
leads to inhibition of immune responses transmitted by B- and T-lymphocytes 
[Petzinger, 2002]. In relation to the humoral immunity, ochratoxin A induces a 
regression of IgG-, IgA-, and IgM- immunoglobulines [Muller et al., 1995]. It is also a 
potent competitive inhibitor for the phenylalanine hydrolase, phenylalanine tRNA 
synthetase, and other enzymes that use phenylalanine as substrate. The inhibitory effect 
is based on its structural homology, since its chemical structure is composed of a 
phenylalanine group. The daily administration of a medium dose (50 µg kg-1 ochratoxin 
A) produces an inhibitory effect that could be diminished by competitive action of 
phenylalanine [Zanic-Grubisic et al., 2000]. 
The main target site of ochratoxin A toxicity in human is the renal proximal tubule, 
where it exerts cytotoxic and carcinogenic effects. Dietary exposure to ochratoxin A in 
parts of Bulgaria, Romania and the former Yugoslavia may have association with 
‘Balkan Endemic Nephropathy’, which is a chronic kidney disease that is characterised 
by progressive hypercreatinaemia, uraemia, hypertension and oedema [JECFA, 2002]. 
 
Human exposure, as demonstrated by the occurrence of ochratoxin A in blood and 
human milk, has been observed in various countries in Europe. In central European 
countries, ochratoxin A is probably the most ubiquitous mycotoxin, which can be 
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detected at levels greater than 0.1 µg kg-1 in more than 90% of human blood samples 
[Petzinger, 2002]. Ochratoxin A was found more frequently and at high concentrations 
in blood samples obtained from people living in regions where the disease ‘Balkan 
Endemic Nephropathy’ occurs [JECFA, 2002]. However, the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) concluded in 2001 that the epidemiological and 
clinical data available do not provide a basis for carcinogenic potency in human and that 
‘Balkan Endemic Nephropathy’ may involve other nephrotoxic agents [Creppy et al., 
1984]. 
In 1993, the International Agency for Research on Cancer (IARC) classified ochratoxin 
A as possible human carcinogen (Group 2B) and concluded that there was sufficient 
evidence in animal experiments (causing tumours of the kidney and liver of mice and 
rats) for carcinogenicity of ochratoxin A but inadequate evidence in humans [IARC, 
1993]. 
1.3.2 Regulations of daily intake and permissible limits in food 
During the past few years, levels of contamination in foods sampled in Europe ranged in 
wine from 0.01-7.0 µg L-1 and in rye 0.05-121 µg kg-1. In 2006, the EFSA Panel on 
Contaminants in the Food Chain (CONTAM) of the European Food Safety Authority 
(EFSA) has published a tolerable daily intake of 17 ng kg-1 per body weight for 
ochratoxin A. Further reduction of the limits set may be required in the future, 
particularly in commodities such as dried wine fruit, wine and grape juice [EFSA, 
2006]. Regarding the legal limits of ochratoxin A in food commodities such as cereals 
and cereal products, dried vine fruits, roasted and soluble coffee, wine, grape juice, and 
foods for infants and children, permissible limits have been set by the European 
Commission under EC regulation 466/2001 [2001] , 472/2002 [2002], and 123/2005 
[2005]. The latter introduced the current permissible limit of ochratoxin A in wine and 
grape containing beverages of 2 μg L-1. 
1.4 Sample extraction and clean-up 
Mycotoxin determination is a complex process. The mycotoxin concentration of a bulk 
lot is usually estimated by taking a sample of the whole and measuring the mycotoxin 
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concentration, inferring the bulk to contain as much as the sample [Whitaker, 2004]. 
The determination procedure involves sampling of possibly mycotoxin contaminated 
food or feed, preparing the sample (i.e. grinding and homogenisation, extraction, 
filtration, and dilution) for clean-up. Clean-up removes interfering substances such as 
lipids, carbohydrates and proteins. Figure 1.2 shows a typical procedure for processing 
mycotoxins in solid samples according to the European Mycotoxin Awareness Network 
(EMAN) compared to liquid sample treatment as described by Visconti et al. [1999].  
 
Sampling
Filtration
Extraction
Grinding & Homogenisation
Clean-up
Separation of matrix from 
analyte
Preparation for analysis
Preconcentration
Analysis
Sampling
Dilution
Filtration
Ultrasonication
Clean-up
Separation of bulk 
solution from analyte
Preparation for analysis
Preconcentration
Analysis  
Figure 1.2: Procedure for determination of mycotoxins in solid samples (left) and liquid 
samples (right) Visconti et al. [1999]. 
Solid samples are grinded to get a uniform composition out of a coarse sample, then 
extracting the analyte of interest and filtering to remove unwanted particles. Liquid 
samples, such as fizzy drinks (e.g. beer or some wines), are ultrasonicated to remove 
bubbles, followed by filtration to remove interfering particles, which is also aided by 
dilution. Dilution is also used to set the pH and ionic strength of the sample solution. 
The following subchapters describe the main steps of the mycotoxin determination from 
sampling to analysis and will give a more detailed overview on liquid sample treatment.  
1.4.1 Sampling 
The sampling procedure specifies how the sample will be selected and how much will 
be taken from the bulk lot [Whitaker, 2004]. Sampling error can be the greatest source 
of variance in the analytical procedure due to uneven distribution of the contaminated 
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samples or physical characteristics of the sample (e.g. uneven particle size). It also 
occurs that the mycotoxin contamination is not related to the amount of mould present 
and it can come to further mould or mycotoxin development during lengthy transit to 
the laboratory and in storage [Ratcliff, 2002]. One method of sampling is to use a probe 
sampler on recently blended lots of grain, since mould growth usually occurs in spots in 
a bulk lot.  
 
Another method is to collect small samples from a continuous stream of material 
[Woloshuk, 2001]. However, due to the variability associated with each step of such 
sampling procedures, the real mycotoxin concentration of a bulk lot cannot be 
determined with 100% certainty. Difficulties arise due to variation in coarse material 
particle size. The sample size to be taken should be related to size of the specific 
particles and level of homogeneity.  Increasing sample size will result in more reliable 
analytical results, thus larger samples should be taken according to particle size, i.e. 
peanuts > corn > wheat > rice > milled products. Fluids and well-mixed process 
products such as wine, beer or milk and milk products do not normally present such 
sampling problems [Smith, 2001] due to their homogeneous nature. A review published 
by Coker et al. [1995] describes the complex design of efficient sampling procedures 
for mycotoxins.  
1.4.2 Extraction from wine and clean-up 
Clean-up procedures are performed to extract mycotoxins from contaminated material 
and remove possible interferences. The Association of Official Agricultural Chemists 
(AOAC) publishes official methods of extraction for mycotoxins in food and feeds 
[Scott, 1997]. However, a number of the official methods of analysis were adopted 
AOAC some 20–35 years ago and might be outdated as no performance parameters are 
given or only recoveries for the methods (by spiking) and coefficients of variation 
(CVs) are reported, which do not relate information on precision, systematic error, 
interference, or in-depth statistical analyses.  
 
Such one method is based on liquid-liquid partitioning, which involves the separation of 
analyte between immiscible solvents until equilibrium. Since liquid-liquid partitioning 
Chapter 1: Literature Review  
14 
is a batch method and can not be automated, the method is now often replaced by less 
labour intensive and economical techniques such as Solid Phase Extraction (SPE). 
Furthermore, Ion Exchange Chromatography (IEC) can be applied if the mycotoxin is 
present in its ionic state [EMAN, 2004]. A frequently used method is immunoaffinity 
chromatography (IAC) (Figure 1.3), which is based on the binding interaction of 
mycotoxin-specific antibodies and thus depends on their availability [Dietrich et al., 
1995]. IAC has several advantages over other clean-up methods as it is more analyte-
specific, uses less solvent, can be automated and columns reused [Scott, 1997]. 
Immunoaffinity columns can be both used for mycotoxin clean-up and detection when 
incorporated into a HPLC system. The clean-up procedure for ochratoxin A involves 
generally IAC, SPE or IEC [EMAN, 2004]. Immunoaffinity clean-up has been set as 
European Standard (prEN 14133) for ochratoxin A analysis in wine and beer according 
to the work published by Visconti et al. [1999]. 
 
Bead
Ochratoxin A + Ochratoxin
A antibody
 
Figure 1.3: Immunoaffinity column design containing solid extraction phase made from 
antibody-modified support beads binding ochratoxin A. 
With ochratoxin A clean-up in beverages such as wine or beer, the possible 
interferences of ethanol and sugars are of great importance since they are making up a 
large part of the sample. Ratola et al. [2004] observed that most studies on ochratoxin A 
contamination in beverages do not comprise records about the possible interference of 
ethanol or sugar content in the clean up process and established experimentally that 
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there seems to be no interference of such parameters in the process of ochratoxin A 
clean-up when using immunoaffinity chromatography. 
1.5 Antibodies as Immunochemical Reagents 
Antibodies as immunological entities were not recognized in connection with chemistry 
until 1907, when Arrhenius published a series of his lectures entitled 
“Immunochemistry: The Application of the Principles of Physical Chemistry to the 
Study of Biological Antibodies”. The importance of this publication was in the 
mathematical approach with which (as established in physical chemistry) Arrhenius 
explained various in vivo and in vitro occurrences in relation to antibody-antigen 
complex formation. Hence, Arrhenius was the founder of the term ‘immunochemistry’ 
[Arrhenius, 1907]. 
1.5.1 Antibody structure and function 
Antibodies or immunoglobulines (Ig) are glycoproteins that are found in serum and 
tissue fluids. An antibody consists of two identical heavy polypeptide chains (50-65 
kDa) and two identical light chains (25 kDa), which are connected via disulfide bridges 
and non-covalent interactions. There are five distinct antibody classes: IgG, IgM, IgA, 
IgE and IgD. The heavy chain of the antibody is built by four (IgG, IgA and IgD) or five 
(IgM and IgE) domains which are termed the variable domains (VH) and constant 
domains (CH1, CH2 and CH3). The light chain consists of two domains, VL and CL. 
Antibodies can be subdivided into two Fab-fragments and one Fc-fragment. The Fab-
fragment (antigen binding site) consists of a light chain and two N-terminal domains of 
the heavy chain, connected via disulfide bridges. The Fc-fragment (crystallisable 
fraction) consists of the remaining C-terminal domains of the heavy chain. To obtain the 
fragments, it is possible to enzymatically digest the antibody molecule using the enzyme 
papain. Each antibody class can be further subdivided into five chain-classes regarding 
five different constant regions [Janeway & Travers, 2004]. In contrast to polyclonal 
antibodies, monoclonals are produced by one B lymphocyte clone only. To produce 
monoclonal antibodies, spleen cells producing specific antibodies and immortal 
myeloma cells are fused. The spleen cells are obtained by immunization of an animal 
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species (e.g. mouse), which in turn generates specific antibody-producing cells. Since 
those cells are mortal, they are fused with immortal myeloma cells using PEG 
(polyethylene glycol). The fusion produces a hybrid cell line that is named hybridoma. 
Those hybridoma cells, which are producing the desired antibody, are cloned from one 
single cell. This cell line is producing the same, monoclonal antibody molecule [Ducey, 
1997].  
1.5.2 The principle of antibody recognition 
Antibody recognition was further unravelled by Carl Landsteiner, who, in 1930, 
investigated many of the fundamental principles of this field using a molecular approach 
(immunoprecipitation). Landsteiner observed that small molecules (later termed 
haptens), in contrast to larger protein molecules, were not immunogenic; that is being 
capable of inducing an immune response by themselves. He also found that small 
molecules could be attached to a carrier protein to facilitate an immune response, called 
hapten-carrier conjugates. Antibody recognition is mediated by a versatile binding site 
(known as paratope) composed variable domains of the heavy (VH) and light chains 
(VL). Those domains contain highly variable loops called complementary determining 
region (CDR), which are capable of virtually recognizing any specific molecular 
structure [Day, 1990; Nezlin, 1994]. The paratopes of immunoglobulins recognize in the 
complementary antigen a 3-dimensional array of closely placed atoms, together known 
as the epitope [Van Regenmortel, 1998]. This explains antibodies are being capable of 
discriminating minor differences in molecular structures and exhibit region-selective 
properties with molecular isomers i.e. the ability of one antibody to bind one and not 
another member of a family of chemically related substances. In the immune system, 
specific signals lead to the elimination of pathogens, whereas noise occurs as a result of 
a non-specific input, where the immune system eliminates the host (autoimmunity). 
Effectively, the immune system has to differentiate between self and non-self; this is the 
basis of specific selection [Langman, 2000].  
 
As pointed out by Berzofsky and Schechter [1981], the concept of specificity of 
antibodies is complementary to the concept of cross-reactivity. One type of cross-
reactivity arises when a particular antibody recognizes the same epitope in two different 
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proteins. Another type when the antibody recognizes an epitope on a heterologous 
antigen (e.g. isomer) that is different but structurally related to the epitope of the antigen 
(antigen used to raise the antibody). Generally, the antibody’s paratope will bind with 
higher affinity to the homologous epitope [Underwood, 1985]. 
1.5.3 The difference between affinity and avidity 
Affinity describes the binding strength of a monovalent binding interaction of an 
antibody with an antigen (e.g. binding of a Fab-fragment to one epitope on an antigen) 
[Karush, 1978] while avidity describes the total binding strength of a polyvalent binding 
interaction depending on the number of paratopes and epitopes [Goldblatt, 1997].  
 
The binding interaction is described as equilibrium between association and dissociation 
of the antibody-antigen complex and is illustrated as follows: 
  
      ka    
Ab + Ag           Ab-Ag    Equation I 
kd    
 
ka = association rate constant 
kd = dissociation rate constant 
 
The equilibrium is described by the affinity constant KA: 
 
KA = ka / kd         Equation II 
 
The time taken to reach equilibrium is dependent on the rate of diffusion and the affinity 
of the antibody for the antigen, and can vary widely. The affinity constant for antibody-
antigen binding can span a wide range, extending from below 105 M-1 to above 1012 M-1 
and can be affected by temperature, pH and solvent. Affinity constants can be 
determined for monoclonal antibodies, but not for polyclonal antibodies, as multiple 
binding interactions take place between polyclonal antibodies and their antigens. 
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Increased specificity does not necessarily correlate with greater affinity of antibodies in 
terms of better stereochemical complementarity with their antigens. Antibodies with 
lower affinity may discriminate better between two heterologous antigens (isomers) 
[Underwood, 1985; van Regenmortel, 1998].  
1.6 Immunoassays 
Immunoassays (IA) use antibodies for determination of sample components [Hage, 
1999] mostly on solid state polystyrene microtitre plates (MTP). The method is based 
on the selective nature of an antibody which is binding specifically to its antigen. Some 
examples are the radioimmunoassay (RIA) that use radio-labelled analytes, 
fluorescence-immunoassay (FIA) using fluorescent labels such as o-phthalaldehyde 
[Jones, 1983], chemiluminescence immunoassay (CIA) with chemiluminescent labels 
such as luminol [Zhuang, 2000] and enzyme-immunoassay (EIA) with enzyme labels 
like horseradish peroxidase (HRP) [Al-Kaissi, 1983] or alkaline phosphatase. A 
common immunoassay technique is the enzyme-linked immunosorbent assay (ELISA) 
[Janeway & Travers, 1999]. Immunoassays are rapid, simple and portable. Both 
threshold (visually) and quantitative (spectrophotometric) determination is available. 
Immunoassays can be extremely specific and sensitive, often in the ng to µg L-1 range 
[Trucksess, 1997]. 
1.6.1 How to develop an immunoassay 
The goals in developing an immunoassay include (1) achieving the best signal/noise 
ratio for the sensitivity level desired; (2) to have a robust reproducible assay for the 
sample being tested; and (3) to be able to measure the antigen over a biological relevant 
assay range (dynamic range). Therefore, ideal concentrations of each assay reagent must 
be established empirically.  
 
The signal generated by a sample containing analyte, relative to the signal of the same 
sample without analyte, is the signal/noise ratio. As the signal/noise ratio increases, the 
assay becomes better at measuring small amount of antigen. To establish the optimal 
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dilutions of reagent concentrations, a checkerboard titration is performed, which is a 
single experiment in which the concentration of two components is varied. 
1.6.1.1 Immobilisation (coating) 
The amount of antibody or antigen bound to the microtitre well is critical to the assay 
sensitivity and has to be carefully controlled. Molecular orientation of the bound 
substance is random and may reduce the number of potential binding sites for the 
analyte trough sterical hindrance [ThermoCorp, 2004].  
 
When considering the binding capacity of adsorbent plastic surfaces for biomolecules, 
one must distinguish between the total amount of molecules that can be bound to the 
surface and the amount that can be bound and still remain biologically active. Both 
quantities are very much dependent on the properties of the biomolecules 
(concentration, size, and hydrophobicity), the character of the surface, coating time, 
temperature, pH, ionic strength of buffer). Coating stability is determining the 
sensitivity and precision of the assay and can be affected by the microtitre plate surface, 
size and hydrophobicity of the compound to be coated or long-term storage conditions 
[ThermoCorp, 2004]. Microtitre plates commonly used are MaxiSorbTM or PolySorbTM 
from Nuncbrand®. While PolySorp™ predominantly presents hydrophobic groups; 
MaxiSorp™ has in addition many hydrophilic groups, which results in a fine patchwork 
of hydrophobic and hydrophilic binding sites. On a MaxiSorpTM surface, adsorption of 
hydrophilic macromolecules will be greatly facilitated binding the macromolecules by 
hydrogen bonds [Esser, 1988].  
 
There are several other points to consider when coating on a microtitre plate. It is 
important to ensure that the coating buffer is free of detergent, since they often compete 
for binding and cause low and uneven binding. Smaller molecules such as peptides 
require chemically-activated microtitre plates such as amine-functionalised plates to 
achieve covalent attachment to the plate surface [Piercenet, 2007]. Static supports and 
coupling methods for immunoassays are factors to be considered in immunoassay 
design.  
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Table 1.2 lists three selected methods for immobilisation [Hermanson et al., 1992; 
Eggins, 2002]. 
Table 1.2: Immobilisation techniques for biomolecules. 
Immobilisation Method description Positive and Negative Features 
Physical 
adsorption 
Weak electrostatic or van der 
Waals interaction or 
Hydrogen bonds (–OH, =O,  
–NH2, =NH, ≡N) 
 
+ High coupling yields 
- Desorption, random orientation 
Cross-linking Chemically bondage using 
bifunctional reagents  
(e.g. Glutaraldehyde) 
+ Stabilization of adsorbed material 
- Biomaterial might be inactive 
Covalent bonding Establishment of a chemical bond 
between a functional in the 
biomaterial and the support. 
+ Stable bond 
+ High coupling yield 
- Random orientation 
For antibodies, proteins, and peptides different immobilisation techniques are 
recommended for different supports. Proteins can be immobilized using all mentioned 
techniques, depending on the particular application. Biomolecules may undergo 
conformational changes (e.g. denaturation) during passive adsorption on synthetic 
surfaces and thereby lose their biological activity [Butler et al., 1992].  
Enzymes in particular are to be immobilized covalently and the active site should be 
protected during the procedure to keep enzyme-activity. Peptides are recommended to 
be covalently immobilized via reactive amines-, thiol- or carboxyl-groups. Site-directed 
immobilisation techniques are considered to enhance the orientation of peptides 
[Hermanson, 1992] and antibodies [Kooyman & Lechuga, 1996]. With capture 
antibodies there is the risk of steric hindrance due to saturated surface adsorption [Esser, 
1988]. Surface adsorption of molecules is non-specific; therefore it is a well known 
possibility that any substance can adsorb to the microtitre plate surface at any stage of 
the assay. It is important to block unoccupied sites on the plate surface to reduce the 
amount of non-specific binding of protein during subsequent steps of the assay.  
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1.6.1.2 Blocking reagents and detergents 
A blocking interval step should improve the sensitivity of the assay by reducing 
background interference. The proper choice of blocking reagent depends on the antigen 
itself and on the type of enzyme conjugate to be used. Examples of blocking reagent 
include bovine serum albumin (BSA), non-fat milk powder, gelatine, casein or in recent 
years, polymers have been used as a new class of blocking agents in immunoassays. In 
this context, polymers such as polyvinyl alcohol (PVA) [Rodda & Yamaraki, 1994] 
have significant blocking abilities and do not interfere with specific binding. In addition, 
PVA has been shown to stabilize the immuno-reactive activities of proteins [Boyd, 
1995; Raghuvanshi et al., 1998]. Rodda and Yamazaki [1994] also demonstrated a 
significant improvement in the specificity of the secondary antibody reaction using 
PVA with enzyme-labelled rabbit IgG compared with the specificity obtained using 
traditional blocking agents. It has been shown that blocking agents can be added to the 
buffer solutions of all assay steps to enhance the effect. 
 
A detergent is usually used in ELISA for washing off loosely or non-specifically bound 
reactants eliminating steric hindrance caused by reactant accumulation on the surface. It 
may also be used for blocking excess surface (e.g. polystyrene) after coating with one 
reactant to avoid unspecific immobilisation of subsequent reactants. Detergents are 
molecules consisting of a distinct hydrophobic and hydrophilic part (e.g. Tween, 
Triton). They disperse hydrophobic molecules in aqueous medium and the blocking 
effect is based on the ability to compete with other molecules for both hydrophobic and 
hydrophilic binding sites. If no other blocking agent is used, detergent must be present 
during incubation in all reaction steps to avoid unspecific adsorption [Esser, 1989]. 
1.6.1.3 Enzyme labels in immunoassays 
Enzyme labels are used when the detecting molecule does not comprise any 
physicochemical properties that can be directly measured. In immunoassays, the 
primary antibody can be directly conjugated to an enzyme label, which is used for 
detection. An alternative to the direct method is the use of a peroxidase-labelled 
secondary antibody that recognises the primary antibody in its Fc fragment according to 
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the species it was raised in (e.g. anti-rabbit antibody). The choice of method depends 
upon the availability of the primary antibody, its enzyme conjugate and the sensitivity 
level required. Enzyme labelled biomolecules can be used in a variety of detection 
methods such as colorimetry, fluorescence or chemiluminescence, depending on 
substrate and detection setup. In many applications, colorimetric substrates provide a 
sufficient level of sensitivity and dynamic range [Piercenet, 2007]. 
 
Colorimetric detection is highly depended on the enzyme label and the substrate used. 
Differences in stabilities of both enzyme and substrate as well as the turn-over rate of 
the enzyme are having an impact on the sensitivity of the assay. Peroxidases, such as the 
horseradish peroxidase (HRP), catalyse the reaction of hydrogenperoxide with a number 
of chromogenic substrates (e.g. ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic 
acid); OPD (o-phenylenediamine; and TMB (3.3',5,5'-tetramethylbenzidine)).  
Chromogen + H2O2                Product(ox) + 2 H2O   Equation III 
The reaction is resulting in a coloured or fluorescent product or with the release of light 
as a by-product (chemiluminescent). Peroxidases are found in multiple isoenzyme forms 
and show high sensitivity and for their substrates. The availability of a variety of 
substrates (colorimetric, fluorescent or chemiluminescent) and its high turnover rate 
makes horseradish peroxidase (MW 40 kDa) the enzyme of choice for many 
applications. HRP-antibody conjugates are superior to e.g. alkaline phosphatase and ß-
galactosidase-conjugates due to their higher specific enzyme activity (more HRP 
molecules/mole of antibody) and immunological reactivity (less steric hindrance 
because of the size of HRP) as well as molecular stability [Piercenet, 2007].  
 
Alkaline phosphatase catalyses the conversion of phosphate esters and is widely 
distributed in a large number of species and tissues.  
Phosphate ester + 2 H2O  Alcohol + o-phosphate   Equation IV 
When used as a label, calf intestinal alkaline phosphatase (MW 140,000) offers several 
distinct advantages over other enzymes. Because reaction rates remain linear, sensitivity 
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can be improved by allowing the reaction to proceed for longer periods of time 
[Piercenet, 2004].  
1.6.2 Competitive enzyme linked immunoassays 
Non-competitive immunoassays involve the use of two antibodies for two different 
epitopes on the antigen such as the sandwich ELISA. However, small haptens do not 
usually comprise two distinct epitopes and thus competitive assays are generally used 
for small hapten determination. Direct competitive immunoassays (Figure 1.4) involve 
the immobilisation of specific antibody to a microtitre plate. Unlabelled sample antigen 
(e.g. ochratoxin A) and enzyme-labelled antigen (e.g. ochratoxin A-HRP) is competing 
for the antibody binding sites.  
HRP
HRP
HRP
HRP HRP
Ochratoxin antibody
Ochratoxin A
Unbound ligand
washed off
TMB A 450 nm
 
Figure 1.4: Direct competitive enzyme immunoassay format. 
The amount of antibody-bound labelled antigen (e.g. ochratoxin A-HRP) is quantified 
colorimetrically, where the colour intensity is inversely proportional to the amount of 
free antigen (e.g.ochratoxin A) in the sample.  
 
Alternatively, the indirect competitive immunoassay (Figure 1.5) involves 
immobilisation of e.g. ochratoxin A-BSA to the microtitre plate. Free antigen (e.g. 
ochratoxin A) sample is added to the microtitre well premixed with a known amount of 
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specific antibody. Immobilized ochratoxin A-BSA and the ochratoxin A-sample 
compete for antibody binding sites.  
Ochratoxin A antibody
BSA BSA
TMB
BSABSA BSA
TMB A 450 nm
HRP
 
Figure 1.5: Indirect competitive enzyme immunoassay format. 
The ochratoxin A-BSA-bound antibody is quantified indirectly by addition of an 
enzyme-labelled secondary antibody and determined colorimetrically. The colour 
intensity is inversely proportional to the amount of free antigen (e.g. ochratoxin A) in 
the sample [Wiley Encyclopaedia, 1999]. 
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1.7 Chromatography based techniques  
Analysis of mycotoxins in food often requires trace analytical techniques because 
mycotoxins are typically present in agricultural commodities at levels ranging from ng 
kg-1 to µg kg-1. Mycotoxins vary greatly in their structural, and thus also their physical 
properties. Consequently, it is impossible to develop methods that are applicable to all 
mycotoxins [Wiley Encyclopaedia, 1999]. Thus, the choice of analytical method used to 
separate, detect, and quantify mycotoxins depends on its physicochemical properties. 
Early studies used biological methods, such as microbial, animal, and plant toxicity 
assays, to detect the presence of mycotoxins. Antimicrobial properties of mycotoxins 
have been applied for the detection of aflatoxin-B1, patulin, and ochratoxin A. In animal 
toxicity, mice and rats have been successfully used to detect aflatoxins and chickens 
have been used for the detection of ochratoxin A. However, with the development of 
sophisticated instrumentation, chemical techniques became the methods of choice. 
1.7.1 High Performance Liquid Chromatography 
High performance liquid chromatography (HPLC) offers improved resolution, increased 
sensitivity, improved accuracy and precision. The ability to automate also makes it 
useful for large-scale analysis. Reverse-phase (RP) liquid chromatography is being 
increasingly used for many mycotoxins [Bhatnagar et al., 2001]. Columns used for 
mycotoxin separation are e.g. RP-C18 used for detection of Fusarium mycotoxins such 
as deoxynivalenol (DON), or nivalenol (NIV), which can also be detected 
simultaneously. Fumonisins, aflatoxins and ochratoxins are also separated by RP-C18 
columns differing in the mobile phase composition. HPLC allows ultra-trace analysis at 
the ng or even the pg level. It allows for analysis of thermally labile, poorly volatile, 
polar, and ionic compounds.  
 
Common HPLC detectors used in mycotoxin analysis are the diode array detector 
(DAD), the fluorescence detector (FD) or secondary detection via mass-spectrometry 
(MS) [Wiley Encyclopaedia, 1999]. However, disadvantages of HPLC are that samples 
are required to be highly processed regarding clean-up to achieve sensitive detection 
limits. HPLC also lacks a sensitive universal detector for all mycotoxins. Only one 
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sample can be analyzed at any given time, the running costs are high, trained personal is 
normally required to operate the equipment and interpret the results; and also 
measurements and washing intervals are time-consuming [ Smith, 2001]. Most 
mycotoxins can be detected visually as they contain a chromophore and thus high molar 
absorbtivity and/or fluorescent properties such as for ochratoxin, aflatoxins, or 
zearalenone (Table 1.3) or by colour development after spraying with a 
chromatographic reagent such as Ninhydrin [Coker, 1997].  
Table 1.3: Summary of fluorescing mycotoxins using a RP-C18 column (MycotoxTM) 
in a mobile phase of acetonitrile/methanol/phosphate buffer (pH 3.3) [Pickering et al., 
2004]. 
Mycotoxin Extinction (nm) Emission (nm) 
Ochratoxin A 335nm 455nm 
Aflatoxin 365nm 455nm 
Zearalenone 275nm 455nm 
Alternatively, non- absorbing/fluorescing mycotoxins can be analyzed directly by gas 
chromatography-mass spectrometry (GC-MS) or liquid-chromatography-mass 
spectrometry (LC-MS). However, interfering compounds can be present despite of 
clean-up procedures, which can have an effect on the outcome of the measurement. The 
two main techniques to confirm the identity of mycotoxins are chemical derivatisation 
(into e.g. ochratoxin α) and mass-spectrometry [Wiley Encyclopaedia, 1999].  
 
1.7.2 Thin layer chromatography and Gas chromatography 
Thin Layer Chromatography (TLC) is a semi-quantitative technique, which requires 
intense sample clean-up. Some mycotoxins naturally fluoresce or absorb in the far UV 
region, so TLC is easy to perform [Wiley Encyclopaedia, 1999]. Mycotoxins are 
quantified by comparing visually the intensity of the fluorescence/absorbance of the 
sample spot with a series of standards. More accurate quantification is achieved 
instrumentally with a densitometer. Detection limits for TLC on e.g. silica gel plates are 
in the range of ng kg-1 to µg kg-1, depending on the analyte, source of contamination, 
and clean-up method [Lin et al., 1998]. In contrast to HPLC, TLC allows greater 
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versatility and is more suitable for the analysis of complex organic materials such as 
cereals [Smith, 2001]. TLC is rapid and in most instances an inexpensive separation 
technique. Special applications of TLC deal with multi-mycotoxin analyses and of 
structurally related mycotoxins [Betina, 1985]. 
Gas chromatography (GC) is the method of choice for some mycotoxins that exhibit 
little or no UV absorption or fluorescence. Most mycotoxins are not volatile at GC 
temperatures (30 – 350 °C), and must be derivatised to a volatile form. GC’s advantage, 
compared to HPLC, is that it has effective detectors for mycotoxin analysis, such as the 
flame ionization detector (FID), the electron capture detector (ECD), and also the mass 
spectrometer (MS) [Wiley Encyclopaedia, 1999]. 
 
More specialized and thus rare methods are supercritical fluid chromatography (SFC) or 
capillary electrophoresis (CE). SFC uses a mobile phase with the solvating properties of 
a liquid and the diffusivity and viscosity of a gas to separate non-volatile or thermally 
labile compounds, e.g. trichothecenes [Roach et al., 1989]. CE is capable of separating 
several charged and water-soluble molecules in a single run and has been used to 
separate and quantify aflatoxins and ochratoxins [Wiley Encyclopaedia, 1999]. 
 
A selection of current research in ochratoxin analysis in various media using HPLC and 
other chromatographic techniques is summarized in Table 1.4. 
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Table 1.4: Chromatography based techniques for ochratoxin A determination. 
Method Food Sensitivity Reference 
GC-MS using 
SPE/derivatisation Variety of food samples 0.1 µg kg
-1 [Jiao et al., 1992] 
HPLC-FLD using IAC clean-up Blood, serum and milk  5-10 ng L-1 [Zimmerli et al., 1995] 
HPLC-FLD usig solvent 
extraction and IAC clean-up  Wheat and oats 0.8 µg kg
-1 [Solfrizzo et al., 1998] 
HPLC-FLD using IAC clean-up Wine 0.01 µg L-1 [Visconti et al. 1999] 
HPLC-FLD using IAC clean-up Coffee 0.2 µg kg-1 [Leoni et al., 2000] 
HPLC-FLD using IAC clean-up Beer 0.01 µg L-1 [Visconti et al. 2000] 
GC-MS and electronic nose 
using no clean-up (collection of 
volatile compounds at increased 
temperature) 
Barley grain  5 µg kg-1 [Olsson et al., 2001] 
HPLC with ESI, MS-MS, and 
FLD detection and SPE clean-
up 
Wine 1 µg L-1 [Leitner et al., 2002] 
TLC using IAC clean-up Green coffee. 10 µg kg-1 [Pittet et al., 2002] 
HPLC-MS using IAC clean-up Raisins 0.5-1.4 µg kg-1 [Lindenmeier et al., 2004] 
LC-FLD using solid-phase 
extraction (SPE) Must, wine and beer 0.1-1.0 µg L
-1 [Saez et al., 2004] 
LC- FLD using liquid-phase 
microextraction (LPME) Wine  0.2 µg L
-1 [Gonzalez-Penas et al., 2004] 
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1.7.3 Immunoaffinity Chromatography (IAC) 
Affinity chromatography is a type of chromatography where the separation of molecules 
is not based on chemicophysical properties but on a molecular binding interaction. 
Affinity chromatography is generally used to separate an antibody mixture (e.g. 
antiserum) using a specific antigen (e.g. protein A is specific for IgG) which is 
immobilized in the stationary phase of the affinity column. Unbound molecules are 
washed off the column whereas bound molecules are eluted using e.g. low pH solutions. 
The term immunoaffinity chromatography describes a type of affinity chromatography 
where the stationary phase contains antibodies or antibody-like molecules. It is possible 
to integrate an immunoaffinity column into an HPLC system. Both techniques have 
their distinctive strength and drawbacks. Immunoassays are fast, inexpensive and 
sensitive. Although a group of analytes can be determined, multi-analyte analysis is not 
possible with immunoassays. Standard chromatography however, shows very high 
performance for quantitative analysis. The drawbacks are high costs per sample and 
often sufficient sensitivity can only be obtained sample pre-concentration. Furthermore, 
setup, calibration, sample concentration and clean-up are time-inefficient. Combination 
of immunoassays with chromatographic techniques is highly complementary and 
effective as the data generally do not interfere [Weller, 2000]. 
1.7.4 Current Research using Immunoassays 
Three kinds of immunoassays have been developed for mycotoxin analysis including 
the radioimmunoassay (RIA), and the enzyme linked immunosorbent assay (ELISA). 
The RIA and ELISA analyses are mainly based on the competition of unlabelled 
mycotoxin in the sample and labelled (either radio- or enzyme-label) mycotoxin 
standard, binding to its specific antibody. IAC involves the use of antibody columns that 
specifically bind the mycotoxin which is subsequently eluted and quantified [Wiley 
Encyclopaedia, 1999].  
 
Initially, the radioimmunoassay was a common application [Aalund et al., 1975; 
Rousseau et al, 1985] for ochratoxin A analysis. One of the first reporting an enzyme-
linked immunosorbent assay for ochratoxin A was Petska et al. [1981]. This was 
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followed by a report on ochratoxin A ELISA in barley [Morgan et al., 1983] and wheat 
[Lee & Chu, 1984].  
 
Since then, the ochratoxin A analysis has shifted more towards chromatography 
applications such as TLC and HPLC and more recent LC-MS combinations [Reinsch et 
al., 2007]. Generally, the research focus is to develop more sensitive methods, to 
improve sample clean-up and detection. The method(s) that received the widest 
acceptance has been collaboratively studied by the Association of Official Analytical 
Chemists (AOAC) and subsequently adopted by that organization as an official method 
[Helrich, 1990]. 
 
Current research on ochratoxin A using immunoassays can be found [Thirumala-Devi et 
al., 2000], however is often based around antibody production and characterisation [Chu 
et al., 1976; Candlish et al., 1986; Gyongyosi-Horvath et al., 1996]. It is also common 
to use commercial available kits for antibody characterisation [de Saeger et al., 2002; 
Koeller et al., 2006] as a time-effective alternative. However, current interests in 
immunoassay research are in immunoaffinity column applications [Goryacheva et al., 
2006] or multi-analyte and multi-component analysis [Saha et al., 2007]. 
 
Over the last years a number of immunochemical methods have been developed. These 
are very sensitive, specific and rapid. Some of these methods have been incorporated 
into test kits and are commercially available (Table 1.5). 
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Table 1.5: List of Immunoassay-based commercially available test kits for Ochratoxin A. 
Company Product Reference Format  Sensitivity  
[µg L-1] 
Range 
 [µg L-1] 
R-Biopharm Rhône 
Ltd/UK 
Ridascreen® 
Ochratoxin A 
www.r-biopharmrhone.com Direct Competitive EIA (OTA-HRP 
conjugate) 
0.025-0.625 0.025 - 2 
Eurodiagnostica/ NL Ochratoxin-A EIA www.eurodiagnostica.com Direct Competitive EIA (OTA-HRP 
conjugate) 
0.5 0.25 - 8 
DiffChamb/ SWE Transia® Plate 
Ochratoxin A 
www.diffchamb.com/ Indirect competitive ELISA 3 - 
TecnaLab/ Italy Immunoscreen 
OCHRA® 
www.tecnalab.com/home Direct competitive EIA 
 
0.1 0.1 - 10 
Neogen/ USA Veratox® for OT www.neogen.com/ Direct competitive ELISA 1 2 - 25  
Tepnel Biosystems/ 
UK 
BioKits ®Ochratoxin 
A Assay Kit 
www.tepnelbiosystems.com/ Indirect competitive ELISA (biotin-
labelled OTA, avidin-HRP-conjugate) 
<0.3 
 
NA 
Romer Labs/ 
Singapore 
AgraQuant® 
Ochratoxin Assay 
www.romerlabs.com Direct competitive ELISA (OTA-HRP-
conjugate) 
2 2 - 40 
Helica/ USA MycoMonitor® 
Ochratoxin A Assay 
www.accuratechemical.com Competitive ELISA 2  NA 
Vicam/ USA OchraTest®-Affinity 
Columns 
www.vicam.com/ Anti-OTA-antibody columns; detection 
of eluted OTA via HPLC or Fluorimeter  
1 (FL) 
 
0.25 (HPLC) 
1 - 100 
 
0.25 - 100 
Toxi-Test/Belgium 
 
Flow-trough ELISA 
Kit for OTA 
www.toxi-test.com/ 
 
-Enzyme-linked immuno-filtration assay 
for rapid screening of OTA in cereals  
4 (cereals) 
8 (coffee) 
NA 
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Though most accurate and reliable, sending mycotoxin samples for analysis is often 
cost and time consuming. Because of the need for fast determination of mycotoxin 
levels, a variety of mycotoxin tests are sold that are easy to use and relatively 
inexpensive. The information derived from these kits is basically of two types: 
quantification or threshold levels. The advantages of the immunochemical methods 
are their ease of use and the short time required for the analysis. For determining 
threshold levels of the toxin, immunochemical test kits are probably the method of 
choice [Woloshuk, 2001].  
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1.8 Electroanalytical methods and applications 
Electroanalytical chemistry is a group of quantitative and analytical methods based 
upon the electrical properties of an analyte solution as part of an electrochemical cell. 
Electrochemical methods comprise many advantages, such as being analyte specific and 
can give sensitive information about analyte activity and concentration [Bard & 
Faulkner, 1980; Kissinger & Heinman, 1996].  
1.8.1 Cyclic voltammetry 
Cyclic voltammetry is the measurement of current response over a range of electrode 
potentials (potential window). The same potential window is scanned in the opposite 
direction (hence the term cyclic). By plotting the current versus the voltage of the 
electrode potential one obtains a cyclic voltammogram (CV). Electroactive species 
formed by oxidation on the first (forward) scan can be reduced on the second (reverse) 
scan, if the reaction is reversible. Cyclic voltammetry can be used to study the 
electrochemical properties of substances in solution as well as at the 
electrode/electrolyte interface. One can obtain information about the cathodic and 
anodic peak potential (Epc; Epa) and the cathodic and anodic peak current (Ipc, Ipa). It can 
also be used to determine the electrode potential required for the oxidation or reduction 
of different redox species (e.g. mediators). This involves cycling a dilute mediator 
solution between two fixed potentials versus Ag/AgCl at a desired scan rate. During 
oxidation and reduction, the mediator shows a peak on the cyclic voltammogram, 
depending on whether the redox reaction is reversible. The determined peak potential 
can be used as working potential during e.g. amperometric measurements [Evans et al., 
1983; Kissinger et al., 1983]. 
1.8.2 Chronoamperometry 
By applying an analyte-specific electrochemical potential on a working electrode, 
submersed in analyte solution, a redox analyte is oxidised at the anode or reduced at the 
cathode. The measured current is a function of the concentration of this redox analyte. 
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Amperometric detection is based on the measurement of current between a working and 
a counter electrode with respect to the reference electrode (e.g. Ag/AgCl).  
 
In all electrochemical methods, the rate of oxidation and reduction depend on: 
1) redox reaction rate & mass transport 
2) electrode kinetics (electron transfer at the electrode) which depend on: 
a) characteristics of the reaction 
b) characteristics of electrode surface 
c) temperature 
 
Mass transport or mass transfer can be described by diffusion, which is the movement 
of particles due to a concentration gradient. If an electrochemical reaction depletes (or 
produces) some species at the electrode surface, then a concentration gradient develops 
and the electroactive species will tend to diffuse from the bulk solution to the electrode 
(or from the electrode out into the bulk solution). In contrast, within a flow cell or 
environment where the solution around the electrode is stirred, a stable diffusion profile 
is observed at the electrode surface and hence the establishment of a steady unchanging 
current [Bird et al., 2002]. 
 
In case of a planar electrode placed in an unstirred solution, which contains excess 
electrolyte and a small amount of electro-active material, one speaks of non-equilibrium 
conditions. Upon the application of a suitable potential (potential at which the 
electroactive component is electrolysed completely), at t = 0, the concentration (C) of 
the electroactive component at the electrode surface is reduced to zero ([C] = 0) 
instantly.  Thus, a concentration gradient will be established; down which material will 
flow from solution to the electrode surface. With progressing time, the diffusion layer 
grows; stretching further into the bulk solution.  Thus, the slope of the diffusion 
gradient will also change with time resulting in a non-steady state current. The flux of 
components to the electrode surface changes as a function of time.  This is described 
appropriately by the Cottrell equation [Cottrell, 1902]: 
Chapter 1: Literature Review  
35 
I = nFACD½π-½t -½ or  I= nFAC √(D/π t)   Equation V 
I = Current [Ampere] 
n = number of electrons transferred/molecule 
F = Faraday's constant [96,500 C mol-1] 
A = electrode area [cm2] 
D = diffusion coefficient [cm2 s-1] 
C = concentration [mol cm-3] 
 
Regarding the applied potentials in chronoamperometry, the current response to a 
positive potential is a current 'spike' towards more positive values followed by a time-
dependent decay. At applied negative potentials, however, the current ‘spikes’ towards 
more negative values with a ‘reverse’ decay towards more positive values. Generally, 
one can state that the diffusion-controlled current ‘decays’ towards zero ampere. The 
integration of the Cottrell equation for determination of the electro-active surface area is 
described by Brett & Brett [1993]. The Cottrell equation is valid for linear diffusion 
models; in case of radial diffusion, which can occur with micro-or nano-electrode 
arrays, the establishment of the real geometry of the working electrode becomes more 
complex. 
1.8.3 Hydrogen peroxide detection 
Hydrogen peroxide (H2O2) is often utilised in biosensor detection since it is a substrate 
for the enzyme horseradish peroxidase (HRP), which catalyses the oxidation of a 
number of (chromogenic) hydrogen donors by H2O2 [Pütter & Becker, 1983]. 
Horseradish peroxidase is widely used as enzyme label in immunological reactions 
enabling the reaction be monitored electrochemically or colorimetrically (section 
1.6.1.2). Since H2O2 can be detected by both oxidation and reduction, it is used to 
monitor reactions as either a consumed reactant or increasing product. However, direct 
electrochemical detection of H2O2 requires high potentials (oxidation of H2O2 occurs at 
+ 650 mV vs Ag/AgCl) where interferences (from sample components) become more 
prominent and the signal response becomes unstable over time. This can be overcome 
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by deposition of noble metals (Pt, Pd, Au) on e.g. carbon electrodes to reduce 
interferences [Cass et al., 1984].  
1.8.4 Redox mediators 
Mediators are implemented in the sensor design to decrease interference effects from 
the sample matrix [Cagnini et al., 1995; Ricci et al., 2003]. The use of redox mediators 
or electrochemical substrates such as TMB [McKimm-Breschkin, 1990] is applied to 
shuttle electrons from H2O2 to the electrode surface and thus decreases the high 
overpotential needed for H2O2 oxidation [Thenmozhi et al., 2007]. The catalytic 
mechanism of HRP in solution is based on the formation of several intermediates and 
was proposed by Chance [1949].  The hydrogen donor can be also referred to as 
mediator, which is generally a low molecular weight substance that acts as intermediate 
electron acceptor at low electrochemical potentials. The catalytic reaction of HRP with 
H2O2 and the hydrogen donor are as follows.  
 
HRP catalysed 
H2O2 + Mediator(H2)   2 H2O + Mediator(ox)  Equation VI 
 
Mediator(ox)    Mediator(red) + ne-   Equation VII 
 
By transferring the electrons from H2O2 to the mediator, the latter is electrochemically 
oxidised by acting as electron acceptor and subsequentially reduced by releasing the 
electrons at the electrode and thus producing a current.  
 
Table 1.6 lists some examples of mediators that act as either one or two electron 
acceptors/donors. 
Table 1.6: Examples of 1 e- and 2 e- acceptor/donors. 
1 e- acceptor/donor 2 e- acceptor/donor 
Hexacyanoferrate Anthraquinone 
Ferrocence Hydroquinone 
Methyl viologen TMB 
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The characteristics of a 1 e- acceptor/donor are as follows:  
? The potential [E] does not change with pH of the solution since H+ does not 
participate 
? No radical intermediates 
? Moderate reaction rates with peroxidases 
 
Whereas the characteristics of a 2 e- acceptor/donor are:  
? The potential [E] varies with pH 
? Radical intermediates can be present 
? High reaction rates with peroxidases 
 
 
The drawback of the use of mediators is that the mediator itself is not specific for any 
enzyme and therefore the reaction can be subject to non-specific interferences. The 
advantage is that this allows substitution of a variety of mediators.   
 
One example is the use of TMB (3,3′,5,5′-tetramethylbenzidine), which is used as a 
sensitive chromogen for horseradish peroxidas [Liem et al., 1979] in enzyme-linked 
binding assays. Generally, benzidine-related compounds are well known substrates for 
HRP-catalysed H2O2 reaction. The two step reaction forms initially a charge-transfer 
complex of the parent diamine and the diimine oxidation product (in equilibrium with 
its free radical). Addition of equimolar hydrogen peroxide to TMB yields the yellow 
diimine, which is stable at acid pH [Josephy et al., 1982]. The overall reaction results in 
2 electrons as depicted in Figure 1.6. 
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Figure 1.6: Chemical structures of 3,3′,5,5′-tetramethylbenzidine (TMB) and its 
oxidation states according to Josephy et al. [1982]. 
The use of TMB as electrochemical mediator has been widely applied [He et al., 1997a, 
1997b; Compagnone et al., 1998]. TMB was found to be a sensitive substrate for 
electrochemical detection using low levels of HRP, as compared to hydroquinone 
[Volpe et al., 1998]. The most suitable electrochemical method of monitoring the 
oxidised TMB species is considered chronoamperometry, since only the signal from 
oxidised TMB is required and this should be readily achieved by applying a negative 
working potential. This is not feasible using cyclic voltammetry owing to the fact that 
any reduced TMB would be electrochemically oxidised at the initial potential, which 
would give an erroneous measurement for the resulting reduction peak [Crew et al., 
2007]. 
1.8.5 The classic three-electrode system 
The construction of an electrochemical cell requires only two electrodes measuring the 
potential of the working electrode relative to a reference electrode, whose potential is 
constant. This is sufficient for potentiometric measurements, since there is no current 
flowing trough the cell (potential difference at zero current). When monitoring the 
change of current, such as in amperometry, an external constant potential is applied, one 
requires the precise control over that potential. This is given by using a three-electrode 
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system, in which the potential of the working electrode (fixed) is controlled relative to 
the reference electrode. During the electrochemical reaction the current produced is 
measured between the working electrode and a counter electrode. A good reference 
electrode needs to have a potential that is stable with time and temperature, and that is 
not altered by passing a small current. An example is the silver/silver chloride 
(Ag/AgCl) electrode, which is immersed in an electrolyte solution containing Cl- ions 
[Bott, 1995]. Particularily, the choice of working electrode can be crucial for a specific 
measurement. Generally, a working electrode acts as a donor or acceptor of electrons in 
exchange with molecules in close proximity of the electrode surface. The electrode 
material must be conductive and electrochemically inert over a wide potential range. 
Commonly used working electrode materials for e.g. voltammetry include platinum, 
gold, mercury, and glassy carbon. The choice of material depends upon the potential 
window required as well as the rate of electron transfer, which can vary considerably 
from one material to another. Gold is more conductive than carbon [Barbalace, 2007] 
and thereby increases the rate of electron transfer ensuring reversible redox behaviour of 
the electrochemical system. Gold is also more chemically inert, belonging to the class of 
noble metals.  
 
Screen printed electrodes (SPE) come as planar carbon, gold, or platinum working 
electrode including a Ag/AgCl reference electrode and a counter electrode, all of them 
printed subsequentially on plastic, silicone or ceramic support. The three-electrode 
design of a screen printed electrode can be considered as a disposable electrochemical 
cell onto which the sample droplet is placed. Another advantage is the applied low 
reagent volume, which is in the micro-litre range. The great versatility presented by the 
screen printed electrodes lies in the wide range of ways in which the electrodes may be 
modified. The composition of the printing inks may be altered by the addition of very 
different substances such as metals, enzymes, polymers, complexing agents, etc. There 
is also the possibility of post-modifying the manufactured electrodes by means of 
depositing various substances on the surface of the electrodes such as metal films, 
polymers, or enzymes [Eggins, 2002].  
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In current applications, graphite materials are preferred for electrodes due to their 
simple technological processing and low-cost, although other materials such as gold and 
silver-based inks are also used for analysis and determination of various elements. Thus, 
Mascini and co-workers performed the determination of lead and other environmentally 
hazardous metals such as Cu, Hg and Cd on gold-based SPEs [2006]. Screen-printed 
gold electrodes have also been also applied to the determination of lead in wastewater 
and soil extracts by Noh et al. [2006].  
1.8.6 Miniaturization and electrode arrays 
Micro- and nano-technology allows for the production of microelectrodes and 
microelectrode arrays. Microelectrodes (1-20 µm) offer many advantages over 
conventional macroelectrodes in electroanalytical applications. These include high 
current density, high signal:noise ratio, dominance of radial diffusion, low ohmic drop, 
chemical concentration measurements in a microsecond time under appropriate 
conditions, and low dependence from hydrodynamics [Bond, 1994].  
 
One of the benefits of miniaturization is that the current density (Ampere per area) 
increases with decreasing electrode size. This is substantial at electrode width below 20 
micrometer and quasi-exponentially at below 10 micrometers. This has been explained 
through diffusion processes, which are the rate limiting factor in static systems. The 
smaller the electrode area the faster is the diffusion from solution to the electrode 
surface and the less mass transport limitations. Diffusion can be linear (1-D) or radial 
(3-D) depending on the ion transfer. Radial, or 3-D diffusion, is illustrated by a 
sigmoidal voltammogram, whereas linear (1-D) diffusion shows the characteristic 
peaks-shaped voltammograms [Sandison et al., 2002].  
 
Microelectrode arrays are an alternative to their macroelectrodes counterparts due to 
their ability to produce a voltammetric response of similar or raised magnitude [Beni et 
al., 2006], showing less background current [Wightman and Wipf, 1989; Amatore et al., 
1995; Fletcher and Horne, 1999]. A microelectrode or ultra-microelectrode may be 
viewed as any electrode in which the electrode is smaller in magnitude than the 
diffusion layer [Arrigan, 2004]. Maximum current density is achieved when each 
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electrode in the array acts as an individual microelectrode with no overlapping diffusion 
layers. In this case, radial diffusion dominates the mass transport of the reactant, leading 
to larger mass transport coefficients compared to planar diffusion [Wightman and Wipf, 
1989]. 
 
A series of different electrochemical cell designs have been fabricated in the Tyndall 
National Institute using photolithography (microelectrode arrays and cell-on-a-chip) and 
ion-beam lithography (has been investigated for the fabrication of nanopore electrode 
arrays).The microelectrodes used in this thesis were described by Lanyon et al. [2007] 
and a schematic view of a microelectrode arrays (used as working electrodes) is seen in 
Figure 1.7. 
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Figure 1.7: Micro square electrode arrays (single nanopore electrodes displayed as 5x5 
array) developed by Tyndall National Institute, Cork, Ireland. 
The microelectrodes shown here (Figure 1.7) have been characterized using cyclic 
voltammetry to determine the charging current or the electrode area; SEM images of a 
single nanopore electrode and nanopore electrode arrays were recently published 
[Lanyon et al., 2007]. This array electrode setup allows for multi-sample and multi-
component determination using sample volumes in the 1-10 μl range.  
1.8.7 Electrode modification  
Modification of electrode surfaces provides an effective means of enhancing the power 
of voltammetric sensors [Murray et al., 1987]. The terminology and definition of 
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chemically modified electrodes was updated by Durst et al. [1997] by reviewing the 
distinguishing features of a chemically modified electrode (CME) compared with other 
electrode concepts in electrochemistry. Electrodes can be modified using a number of 
biologically or chemically reagents that have desirable properties and thus the modified 
electrodes can display these properties [Arrigan, 1994].  
 
Furthermore, electrodes can be modified by biological reagents such as proteins and 
thus referred to as biologically modified electrodes (BME). Methods of immobilisation 
include adsorption, entrapment or covalent binding to the electrode surface. Adsorption 
is experimentally simple and can be performed on numerous supports, from polystyrene 
over silica to gold. It is regarded a mild coupling method that preserves protein activity 
[Kenndey and Cabral, 1983]. However, it can be reversible; moreover, it does not 
provide as high surface loading of protein as covalent coupling [Ulbrich et al., 1991]. 
Lower surface loading implies a decreased initial sensitivity relative to a sensor with 
covalent immobilisation; desorption would further reduce the sensitivity over time.  
 
The use of chemically and biologically modified electrodes has been reviewed by 
Gilmartin et al. [1995]. Most of the biological components are either immobilised via a 
functional group or by physical adsorption. However, Moulton et al. [2003] found that 
the adsorbed protein layer had the effect of blocking the electron transfer. The degree of 
electron blocking correlated with the amount of adsorbed protein: the greater the 
adsorption, the larger the blocking effect. It has already been known that the adsorption 
of proteins onto electrode surfaces disturbs electrochemical analysis of clinical samples 
[Guo et al., 1996]. Generally, the more distant the electron producing reaction from the 
surface the more the reaction is diffusion controlled and has to overcome several 
(protein)-barriers.  
 
Carboxymethylated dextran (CMD) modification of gold surfaces is commonly known 
in BiacoreTM technology [Loefas et al., 1990; Johnsson et al., 1991] where the CMD- 
modified gold chip is used for binding interaction analysis using the optical detection 
method surface plasmon resonance. The main concept of CMD modification is to 
control the amount of immobilised reagent and to reduce non-specific binding and also 
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in terms of reproducibility and durability of the coated layer. The CMD modified gold 
surfaces have been also applied in quartz crystal microbalance (QCM) [Rickert et al., 
1997; Storri et al., 1998; Tombelli et al., 2000]. To date, little work has been reported 
on the use of CMD-modified gold electrodes. Pallarola et al. [2006] reports the 
application of CMD to avoid non-specific adsorption of proteins on gold electrodes. The 
only electrochemical assay described using carboxymethylated gold electrodes has just 
recently been reported by Priano et al. [2007], which is based on a three-electrode 
system. This is used for monitoring a current that is generated by the addition of 
hydrogen peroxide and a redox mediator to determine lipopolysaccharides from 
Salmonella minnesota at concentrations as low as 0.1 µg L−1 (0.1 ppb). Surprisingly, 
even though the technique of chemically modified electrodes (CME) has been long 
known, the use of carboxymethylated dextran is new. 
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1.8.8 Wine electrochemistry 
Wine is a complex matrix containing redoxactive species including organic acids, 
polyphenols, and anthocyanins [Kilmartin et al., 2001 and 2002, Zou et al., 2002]. In 
electrochemical wine analysis electroactive species in the wine sample may react 
directly at the electrode surface [Zhao et al., 2004]. Wines are generally containing up 
to 3.5 g L-1 phenolic compounds (commonly expressed as gallic acid). The ideal 
potential range for amperometric determination is considered to be from -150 to 0 mV 
versus SCE where electrochemical interferences are minimal. It was furthermore found 
that gallic acid can be oxidised at low potentials in the range of -100 mV versus SCE 
[Avramescu et al., 2001]. The change in the applied potential to -150 mV versus 
pseudo-Ag/AgCl [Avramescu et al., 2002] contributed not only to the decrease of 
electrochemical interferences, but also to a reduction in sensitivity as the coefficient of 
variation increased 5 fold. 
 
Selecting a potential that results in low interference from wine components is one 
solution. Another is to reduce or remove the concentration of one or more undesirable 
components. This is known as ‘wine fining’. Fining agents are commonly adsorptive or 
reactive substances that can be grouped according to their chemical nature and mode of 
action: 
 
? Bentonite (electrostatic; removes proteins) 
? Proteins: gelatin, isinglass (collagen), casein, albumen (remove e.g. tannins) 
? Carbons (non-specific adsorbtive agent, smaller polyphenols) 
? Synthetic polymers: PVPP (polyphenols, phenols) 
? Others, including chelators and enzymes (e.g. tyrosinase) 
 
Since polyphenols are the main source of electrochemical interferences and electrode 
fouling [Siebert and Lynn, 1997], the polymer polyvinyl polypyrrolidone (PVPP) can be 
most successfully applied to remove polyphenols from wine samples [Zoecklein et al., 
1990; Morris and Main, 1995]. 
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1.9 Biosensors 
Above all, an ideal analytical method should be specific. This means it should be able to 
measure the amount of a specific substance accurately, no matter what other substances, 
and to what extent, present in the sample. In practice, only a few analytical methods 
achieve this aim, but many are selective, meaning they can detect a small group of 
molecules in a crude mixture. The need for an analytical method that is capable of 
specifically detecting a single substance was early recognised. It became clear that no 
chemical analysis could be ever as specific as nature itself. Biomolecules such as 
enzymes or antibodies were not only selective but also highly specific for a single 
biomolecular group in any crude mixture. The idea was to combine chemical analysis 
with biomolecules initiating the rise of bioanalysis and biosensors.  
 
Entering the term ‘biosensor + definition’ into an internet search engine one stumbles 
upon more than a quarter of a million entries covering a broad range of terms to 
describe a biosensor. The simplest way of describing a biosensor to non-scientific 
persons is that ‘a biosensor is an analytical device which converts a specific biological 
response into an electrical signal’. However, reality is not as simple a matter. 
 
Initially, Turner et al. [1987] defined a biosensor as ‘a compact analytical device 
incorporating a biological or biologically-derived sensing element either integrated 
within or intimately associated with a physicochemical transducer. The usual aim of a 
biosensor is to produce either discrete or continuous digital electronic signals which are 
proportional to a single analyte or a related group of analytes’.  
 
In 1996, the following proposal for a biosensor definition was offered: ‘A biosensor is a 
self-contained integrated device, which is capable of providing specific quantitative or 
semi-quantitative analytical information using a biological recognition element 
(biochemical receptor) which is retained in direct spatial contact with a transduction 
element. Because of their ability to be repeatedly calibrated, we recommend that a 
biosensor should be clearly distinguished from a bioanalytical system, which requires 
additional processing steps, such as reagent addition’ [Thevenot et al., 1996]. This 
proposal was later on accepted as official definition by the IUPAC published in 1999. 
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However, Scheller et al. [1997] had pointed out, that ‘owing to the rapid technological 
progress essential parts of it [...the definition...] appear ambiguous. Thus, in the light of 
the ability of miniaturized bioreactors to interact with transducers (without additional 
sample processing elements) on single chip the term, “direct spatial contact" of the 
elements is amenable to different interpretations. Furthermore, the borderline between 
recognition tools that are biological in nature and synthetic (organic) receptor molecules 
is no longer well definable; these two classes of recognition elements are merging. This 
is especially true for enzyme models, polymers imprinted by biomolecules, and, 
although to a lesser extent, (synthetic) oligonucleotides and ionophores, which mimic 
the function of channels. Although at present routine application of biosensor 
technology is more or less restricted to enzyme electrodes, optical immunosensors, and 
whole cell-based receptor assays, the forefront of biosensor research exploits results and 
principles of molecular biotechnology and nanotechnology for creating qualitatively 
new molecular sensors’. 
 
So, where do we stand today? With the ever growing market in biosensors [Newman & 
Turner, 2005] and development of new applications in the field of biomimetic sensors 
such as molecular imprinted polymers [Haupt and Mosbach, 1998; Piletsky, 1999], 
aptamers [Tombelli, 2005], and synthetic receptors [Allender, 2006], it is hard to 
distinguish what is a biosensor by definition. For example what is ‘bio’ and what is not 
and should there not be a common nomenclature for a common concept?  
 
Historically, the biosensor concept was initiated by Clark and Lyons in 1962 when they 
coupled the enzyme glucose oxidase to a platinum electrode [Clark and Lyons, 1962]. 
Further biosensors did arise due to the demand of functional characteristics such as 
sensitivity, cost, selectivity, versatility, range, availability, future adaptability and 
simplicity, which were/are not provided by conventional analytical methods. 
Electrochemical biosensors are favoured, often comprising all those characteristics; 
closely followed by optical sensors, which differ only in their costs and availability. 
Other sensors such as piezoelectric sensors are showing viewer functional 
characteristics (expensive, low availability) and are thus lower rated [Cunnigham, 
1998]. 
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1.9.1 Electrochemical biosensors 
Electrochemical biosensors can be divided into conductimetric, potentiometric and 
amperometric biosensors depending on the electrochemical property to be measured. 
Conductimetric biosensors monitor the changes in conductance/impedance using noble 
metal electrodes, whereas potentiometric biosensors measure the potential difference 
between the working electrode and a reference electrode at zero current. Amperometric 
biosensors measure the currents resulting from the electrochemical oxidation or 
reduction of an electroactive species at a constant potential. 
 
Commercial biosensors are commonly amperometric biosensors, which have been 
divided into three generations. The first-generation biosensors were proposed by Clark 
and Lyons and implemented by Updike and Hicks, who coined the term enzyme 
electrode [Clark and Lyons, 1962; Updike and Hicks, 1967]. Typically, an oxidase (e.g. 
glucose oxidase) is immobilized behind a dialysis membrane at the surface of a 
platinum electrode. The enzyme's function is to selectively oxidize an analyte by the 
reduction of O2 [Durst et al., 1997]. Second-generation biosensors use mediators, which 
replace O2 as the electron shuttle and use other redox enzymes in addition to oxidases as 
O2 can result in high interferences. Third-generation sensors are co-immobilising 
enzyme and mediator (in contrast to free diffusion of O2 or mediator) at an electrode 
surface, making the recognition element an integral part of the electrode transducer. 
Parallel immobilisation of enzyme and mediator can be accomplished by (1) mediator-
labelling of the enzyme followed by enzyme immobilisation, (2) enzyme 
immobilisation entrapped in a redox polymer (redoxpolymer is the mediator), or (3) 
enzyme and mediator co-immobilisation in a conducting polymer. The most known 
amperometric biosensor is the glucose biosensor, which has been successfully 
commercialized for blood glucose monitoring [Newman & Turner, 2005]. 
 
Enzyme-based biosensors primarily rely on two mechanisms. The first involves the 
catalytic transformation of an analyte (substrate) into a detectable product or co-product. 
The second mechanism involves the detection of an analyte that inhibits or mediates the 
enzyme’s activity. Although very selective and sensitive, inherent limitations for this 
type of biosensor are primarily those imposed by the nature of the enzyme itself and 
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include the limited number of analytes that happen to be substrates/inhibitors for the 
enzyme. The detection limits for these sensors are determined by the enzyme’s catalytic 
properties and are defined by kinetic constants, such as the Michaelis Menten constant 
KM and the Vmax value [Rogers, 1998]. One of the first enzyme sensors on screen-
printed carbon electrodes (SPCE) was developed by Newman et al. [1992] and further 
investigated in terms of catalytic  materials and membranes [Newman et al., 1995]. 
Enzymatic sensors constructed with SPEs present a great number of applications, such 
as the determination of hydrogen peroxide using SPEs with immobilized horseradish 
peroxidase [Ledru et al. 2006], the construction of a glucose biosensor with flow-
injection analysis [White et al., 1996] or monitoring microbial fermentation [Tothill et 
al., 1997]. 
 
Instead of enzymes, antibodies can be used as recognition element. Bioaffinity-based 
biosensors primarily depend on the use of antibodies directed towards a wide range of 
analytes and the antibody’s relative affinity and selectivity for a particular compound or 
closely related group of compounds [Rogers, 1998]. Interestingly, immunosensors do 
not fit the official definition of biosensors, which states that biosensors should operate 
reversibly and in real-time. The antigen-antibody reaction, which is the basis of 
immunosensors, can be irreversible and usually requires the addition of labelled 
compounds, which only allow the indirect determination of the concentration of 
antigen-antibody complexes. Consequently, immunoanalytical procedures, including 
immunosensor systems, are based on multi-step assays and deliver a signal some time 
after the introduction of the analyte [Bilitewski, 2000]. Most of the electrochemical 
immunosensors are based on the enzyme-linked immunosorbent assay (ELISA) 
principle, where either antibody or antigen is immobilised to the transducer. 
Electrochemical immunosensing requires labelling of either antigen or antibody, since 
their binding interaction is accompanied by only small physico-chemical changes 
[Warsinke et al., 2000; Darain et al., 2003], which can not be electrochemically 
detected. Peroxidases, phosphatases, ureases and glucose oxidases proofed to be best-
suited enzyme labels [Darain et al., 2003; Moore et al., 2003]. Several immunosensors 
have been reported for the detection of hormones, where Butler and Guilbault [2006] 
describe an amperometric immunosensor, based on disposable SPCE, for the 
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determination of 17-β estradiol in water, or seafood toxins such as in the case of domoic 
acid [Micheli et al., 2004]. The measurement principle of indirect competitive detection 
was employed by Lu et al. [2002] who fabricated immunosensors by immobilizing a 
boldenone–BSA conjugate on the surface of SPCEs, followed by the competition 
between the free boldenone for the corresponding antibody. A secondary anti-species 
IgG–HRP conjugate determines the degree of competition. The electrochemical 
technique chosen in this case was chronoamperometry. This technique was also 
employed for the determination of testosterone in bovine urine [Coneely et al., 2007]. 
 
Immunochemical assays for food contaminant analysis [Tothill, 2003] and the 
application of biosensors in food analysis [Tothill et al., 2001; Tothill and Turner, 2003] 
has been discussed. Electrochemical immunosensors for mycotoxins using differential 
pulse voltammetry (DVP) with SPCEs based on an indirect competitive assay format 
has been described [Ammida et al., 2004 & 2006; Pemberton et al., 2006]. Micheli et 
al. [2005] described an electrochemical immunosensors based on the immobilisation of 
antibodies on SPCEs and direct competition between free aflatoxin M1 and aflatoxin 
M1-HRP. An indirect competitive format was presented for simple and fast 
measurement of aflatoxin B1 in barley using DPV and SPCEs [Ammida et al., 2004 & 
2006].  Alarcon et al. described an indirect [2004] and direct [2006] competitive 
immunoassay for ochratoxin A using polyclonal antibodies on SPCEs. The 
immunosensor appears to be suitable for ochratoxin A screening in wheat. 
Electrochemical detection of mycotoxins can be either monitored by direct 
electrochemistry, or by following the binding interaction of a mycotoxin with an 
immobilized recognition element [Logrieco et al., 2005]. Direct electrochemistry of 
mycotoxins has been reported by Calcutt et al. [2001] for the electrochemical oxidation 
of ochratoxin A. Electrochemical monitoring of mycotoxin interaction was also studied 
using a DNA based electrochemical biosensors capable of detecting compounds able to 
intercalate within the DNA chains [Mascini et al., 2001 & 2001]. The intercalating 
compound, such as aflatoxin B1, is influencing the oxidation signal of the guanine 
moieties of the DNA. Investigations were made on alternative biosensing principles; 
using supported bilayer lipid membranes (s-BLM), which showed an increased ion 
current following application of aflatoxin M1 [Siontorou et al., 1998]. Those 
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phospholipids bilayers were also used for immobilisation of oligonucleotides or 
antibodies and biospecific interactions of the e.g. aflatoxin M1 could be detected by 
electrochemical impedance spectroscopy [Vagin et al., 2003]. 
1.9.2 Surface plasmon resonance-based optical biosensors 
Surface plasmon resonance (SPR) is a phenomenon that occurs upon a metal (Au) 
interface between an optical dense medium (n1) and an optical rare one (n2). Polarized 
light is totally internal reflected when the angle of reflection is larger than the critical 
angle of incidence. An evanescent wave is generated at the reflecting surface, which 
penetrates several hundred nanometers (nm) in the surrounding medium [Otto, 1968].  
Biacore technology utilises the natural phenomenon of surface plasmon resonance 
(SPR), where detection is carried out with a diode array detector (DAD) that measures 
the shift in angle of incidence (change in refractive index (n) caused by mass changes 
on the sensor surface. Association and dissociation of molecules to the sensor surface 
can be followed by converting the shift in angle of incidence into resonance units (RU) 
and monitoring in a sensorgram (resonance units (RU) versus time (min)). The Biacore 
system is using SPR to perform label-free direct immunoassays in a flow-through 
format. This can be utilized to screen kinetics and affinities of biomolecules [Malmquist 
& Karlsson, 1997; Markey, 1999].  
Figure 1.8 below describes the detection principle incorporated into any Biacore device 
currently on the market. 
 
Figure 1.8: Biacore detection utilising surface plasmon resonance [Biacore™]. 
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The device can be used for many applications such as concentration analysis [Karlsson 
et al., 1993] or epitope mapping [De La Lastra et al., 1999]. Biospecific interaction 
analysis (BIA) is consistently used to establish kinetic rates and affinities of binding 
interactions by assessing the kinetic rate constants for association and dissociation of an 
analyte to an immobilised ligand [Malmquist, 1993]. The observed binding interactions 
can be simple protein-protein interactions, antibody-antigen, or DNA hybridisation. 
More specialised interactions such as peptide-protein or lectin-carbohydrate require 
more sensitive modifications.  
 
Optical biosensor development for mycotoxins is commonly based on 
immunoanalytical methods. Polyclonal antibodies were used in a surface plasmon 
resonance-based immunoassay for aflatoxin B1 [Daly et al., 2000]. Deoxynivalenol 
sensing by SPR-based immunoassays using polyclonal antibodies has been reported by 
Schnerr et al. [2002]. An SPR-based inhibition assay was developed for deoxynivalenol, 
using monoclonal antibodies as recognition elements [Tudos et al., 2003]. A biosensor 
for multiple mycotoxin analysis was also investigated by van der Gaag et al. [2002], 
where an immunochemical biosensor assay for the detection of multiple mycotoxin (i.e. 
aflatoxin, zearalenone, deoxynivalenol, and ochratoxin A) was described. An SPR 
immunosensor with real-time measurement and flow-trough format (Biacore) was also 
introduced by van der Gaag et al. [2003] for the detection of mycotoxins in food and 
feed. Whole cell recognition elements were used in a biosensor for the mycotoxins 
patulin, diacetoxyscirpenol, roquefortine, and T-2 toxin by Benitez et al. [1994]. 
Thompson and Maragos [1999] designed a fibre-optic immunosensor that has the 
potential for screening corn for fumonisins with a detection limit of 10 µg L-1. Scheper 
et al. [1994] presented a paper on optical sensors for biotechnology applications, where 
two fibre optic based immunosensor are described for mycotoxins. 
1.10 Biomimetics 
To date, many analytical methods are based on natural recognition elements, such as 
antibodies, enzymes, and protein receptors. Although of fundamental importance, these 
methods sometimes suffer from features such as low stability and high production costs. 
Nevertheless, new and more specific stationary phases are needed for analytical 
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methods like high-performance liquid chromatography (HPLC). Thus, alternative 
techniques to produce materials for separation chemistry are therefore of great interest 
and value. One of nature's most important results of evolution is a system capable of 
distinguishing one molecule from another. Molecular recognition is the basis for most 
biological processes, such as ligand-receptor binding or substrate-enzyme reactions and 
is therefore of universal interest. If nature can produce enzymes, receptors and 
antibodies by evolution, molecular engineers should be able to develop materials with 
similar properties by design. Some common biomimetic recognition elements are 
described in the following section. 
 
Biomimetic recognition elements such as molecular imprinted polymers (MIP) offer 
several applications in areas such as analysis, sensing, extraction, or pre-concentration 
of components [Haupt, 2002]. It is possible to design and produce tailor-made, stable 
recognition matrices for a wide range of analytes that can be employed in a multitude of 
analytical formats [Ramstrom, 2001]. The construction and operation of fibre-optic 
sensing devices based on molecularly imprinted polymers and the advantages of using 
molecularly imprinted polymers as artificial recognition systems in sensor technology 
were discussed by Kritz et al. [1995] and Haupt and Mosbach [2000]. MIPs were also 
used as recognition element in a surface plasmon resonance sensor [Lotierzo et al., 
2004]. Molecular imprinted polymers for mycotoxins were discussed by Mahony et al. 
[2005] being applied as stationary phase recognition matrix in HPLC and SPE. A MIP 
that recognized ochratoxin A was produced by Turner et al. [2004]. Other MIPs towards 
ochratoxin A for solid-phase extraction and sample clean-up from red wine are 
described by Lindner et al. [2002 and 2004], Jodlbauer et al. [2002] and Maier  et al. 
[2004].  
 
Other biomimetic recognition elements are aptamers, which are single-stranded 
oligonucleotide that assumes a specific, sequence-dependent shape and bind to a target 
molecule based on a key-lock fit. Aptamers are screened using SELEX (Systematic 
Evolution of Ligands by EXponential amplification), which is an in vitro combinatorial 
chemistry process used to identify aptamers to a target from large pools of diverse 
oligonucleotides [Wilson and Szostak, 1998]. Aptamers possess numerous advantages 
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that make them preferred candidates for drug development such as better stability (pH, 
temperature) than proteins [Mascini, 2003]. 
Peptides are also used as recognition elements. Molecular recognition by peptides is 
known for a number of biochemical processes, such as signal transduction (e.g. 
neuropeptides), metabolism (e.g. hormones), cell growth (e.g. Ras-protein, p53), and 
immune defense (e.g. MHC-receptors) [Schmuck, 2001]. Peptide receptors are 
relatively small enough to offer uncomplicated and fully understood structures, while 
being sufficiently complex to offer unique binding sites. The molecular recognition by 
peptides is based on several non-covalent interactions, such as (1) H-bridge-bonding, 
(2) salt-bridges, (3) hydrophobic and (4) van der Waals interactions (Table 1.7). 
Table 1.7: Types of intermolecular forces [Selassie et al., 2003]. 
Bond type  
Bond strength (bond enthalpie) 
[kJ/mol] 
Covalent 40-140 
Ionic (Electrostatic) 5 
Hydrogen 1-10 
Dipole-Dipole 1 
Van der Waals 0.5-1 
Hydrophobic 1 
Artificial peptides can be designed to interact specifically with a target molecule. 
Combinatorial libraries of up to a million synthetic peptides are screened for ligands 
with improved selectivity for a specific target analyte [Schmuck, 2001]. 
1.10.1 Peptide structure and synthesis 
The primary structure of a peptide is the sequence of its monomer units (amino acid 
residues). The secondary structure is the spatial arrangement of the peptide chain under 
the influence of hydrogen bonding between the various amino acid residues. The 
secondary structure can be rationalized in terms of the rules formulated by Linus 
Pauling and Robert Corey. The essential feature of the Pauling and Corey rules is the 
stabilization of structures by hydrogen bonds involving the planar amide bond. The 
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amide bond can act both as a donor of the H-atom (the NH- part) and as an acceptor (the 
CO- part).  
 
 
A peptide bond (Figure 1.9) is a covalent bond between a carboxyl- and an amino-group 
formed in a condensation reaction. 
 
Figure 1.9: Peptide bond formation from amino acid monomers. 
To abide by the rules, hydrogen bonding occurs between peptide links of the same chain 
in the α-helix or links different chains as is the β-pleated sheet [Atkins, 1996]. The fact 
that peptides fold spontaneously, implies that all the information required specifying the 
structure is inherent in the sequence. The three methods of secondary structure 
prediction are those of Lim [1974], Chou and Fasman [1978], and Robson et al. [1978]. 
None gives predictions consistently more than 55 percent correct in assigning amino 
acids to three states: helix, sheet, and turn.  
Peptide formation occurs naturally as condensation between the α-COOH group of one 
amino acid and the α-NH group of another forming an amide. In peptide synthesis, 
coupling of amino acids is done by the (1) azide-, (2) carbodiimide- and (3) active ester- 
method. To meet the solubility problems posed by the minimal nature of the protection 
in synthesis, polar, but chemically uncreative, substituents are employed as protecting 
groups. Furthermore, there are –SH, imidazole-, and guanido- protection methods. The 
various coupling and protection reagents can be deployed in practice in either of two 
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ways. In ‘stepwise synthesis’ one starts with the terminal residue and adds the others in 
the correct order, one by one, until the molecule is finished. Almost all coupling 
methods involve the activation of the α–COOH group and begin with the carboxyl-
terminal (opposite direction of biosynthesis). In “fragment condensation” synthesis 
separate portions of the sequence are assembled in a series of independent stepwise 
syntheses. These portions are then combined into larger fragments until all are joined in 
the final molecule [Offord, 1980]. 
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1.11 Computational chemistry 
Computational (bio)-chemistry is dealing with all of the three aspects of (bio)chemistry, 
namely: structure, reaction and function. Molecular modelling (computational 
modelling) can be defined as the application of computers to generate, manipulate, 
calculate and predict realistic molecular structures and associated properties. Molecular 
modelling can be also used as computer-aided rational drug design tool [Cramer, 1983]. 
In contrast to the combinatorial chemistry approach, computational modelling employs 
structure-based design. Molecular structures are represented numerically by simulating 
molecule behaviour with quantum equations and classical physics. Computational 
modelling programs generate and present molecular data including geometries (bond 
lengths, bond angles, torsion angles), energies (heat of formation, activation energy, 
etc.), electronic properties (moments, charges, ionization potential, electron affinity), 
spectroscopic properties (vibrational modes, chemical shifts) and bulk properties 
(volumes, surface areas, diffusion, viscosity) [Richon et al., 1994]. This can be a 
powerful tool for conformational studies of molecules, such as drugs, proteins and other 
macromolecules [Tsai, 2002]. 
1.11.1 Force Fields 
Force fields (molecular mechanics) are functions that associate energy with a given 
nuclear conformation and thus rely on the Born-Oppenheimer approximation. The 
calculation of the structure and energy of molecules is based on nuclear motions. 
Electrons are not considered explicitly, but rather it is assumed that they will find their 
optimum distribution once the positions of the nuclei are known. This assumption is 
based on the Born-Oppenheimer [1927] approximation of the Schroedinger equation 
[1926]: 
        Equation VIII 
The energy of the system E is relative to a system, in which all atomic particles are 
separated to infinite distances. Psi is the wave function, which defines the Cartesian and 
spin coordinates of the atomic particles and H is the Hamiltonian operator which 
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includes terms for both potential and kinetic energy. However, the Schroedinger 
equation can be solved only for very small molecules such as hydrogen or helium. 
Approximations must be introduced in order to extend the utility of the method to 
polyatomic systems. One approximation attempts to differentiate nuclei and electrons. 
The Born-Oppenheimer approximation states that nuclei are much heavier and much 
more slowly than electrons. Thus, nuclear motions, vibrations and rotions can be studied 
separately from electrons; the electrons are assumed to move fast enough to adjust to 
any movement of the nuclei [Richon, 1994]. Two types of force fields are known for 
both small and macromolecules: 
Class I force field: 
? Parameterized primarily from experimental data and mostly based on small 
molecule model systems 
? 10 - 100 parameters  
? Emphasis on thermodynamic properties in the condensed phase 
? Condensed phase implicitly taken into account in parameterization 
Examples: MM1/MM2 [Allinger et al., 1989], CHARMM [Brooks et al., 
1983], OPLS [Jorgensen and Tirado-Rivers, 1988], AMBER [Weiner et al., 
1984], and SYBYL [Clark et al., 1989] 
? Evolution: mid-1960's to present 
Class II force field: 
? Accounts for properties of more diverse systems such as isolated molecules 
in the gas phase, molecules in condensed phases, and macromolecular 
systems  
? Emphasis on high precision reproduction of geometries and dipole moments 
? Extensive parameterization for many different classes of organic molecules;  
? >100 parameters  
? MM3 and MM4 [Allinger et al., 1989 & 1996]  
? Evolution: mid-1980's to present  
 
These two classes of force fields are increasingly merging as macromolecular force 
fields increasingly include arbitrary small molecules, e.g. for protein-ligand simulations 
[Jacobson, 2003].  
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The forces holding atoms together (bond length, bond angles, or non-bonded 
interactions) can be described by potential energy functions of structural characteristics 
and the combination is referred to as the force field. Atoms can be considered as spheres 
and bonds as springs. The mathematics of spring deformation can be used to describe 
the ability of bonds to stretch, bend, and twist as shown in Figure 1.10 [Steinbach, 
2005]. 
 
Figure 1.10: A molecule is viewed as a collection of points (atoms) connected by rods 
(bonds) with different elasticity (force constants) [Steinbach, 1996]. 
Non-bonded atoms (greater than two bonds apart) interact through van der Waals 
attraction, steric repulsion, and electrostatic attraction/repulsion. These properties are 
easiest to describe mathematically when atoms are considered as spheres of 
characteristic radii. Molecular mechanics predicts the energy associated with a given 
conformation of a molecule. The calculated energy can not be given absolute but 
relative quantities, since the energy zero is arbitrary. One can only compare energies 
calculated for different (two or more) configurations of chemically identical systems 
[Steinbach, 2005]. The molecular energy is calculated term by term, comparing bond 
parameter values that are taken from either experimental data or from ab initio 
(quantum mechanics) calculations.  
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A simple molecular mechanics energy equation including parameters that are 
contributing to the prediction of energies by molecular mechanics is given by Steinbach 
[1996]:  
Energy [E] = EStretching + EBending + ETorsion + ENon-Bonded Intact          Equation IX 
Engler et al. [1973] initially found that relative energies are determined more reliably 
than absolute enthalpy calculations and now supports Allinger’s [1989] conclusion that 
the molecular mechanics method, in principle, must be considered to be competitive 
with experimental determination of the structures and enthalpies of molecules. In that 
context, Apostolakis and Caflisch [1999] discussed the estimation of (relative) binding 
affinities, which is from a theoretical point of view, the most challenging part of ligand 
design. In their paper, they reviewed three methods for the estimation of binding 
energies: (1) quantitative structure-activity relationships (QSAR); (2) empirical energy 
functions and (3) free energy calculations based on molecular dynamics simulations.  
 
The optimal force field is context-depended as there have been numerous reviews on 
comparing different force fields [Engler et al., 1973; Clark et al., 1989; Roterman et al., 
1989; and Apostolakis & Caflisch, 1999]. Furthermore, revisions within a single force 
field and the choice of solvent model for each application make the choice difficult.  
1.11.2 Minimisation 
As part of a force field, energy minimisation results in geometry optimisation of the 
molecular structure [Tsai, 2002]. The most stable conformation of a molecule can be 
found by minimising its free energy. Energy is a function of the atomic coordinates and 
force constant definitions as described in section 1.11.1. Based on the force constants 
and associated parameters the computational program generates a set of atomic 
coordinates which correspond to a minimum of energy. This is accomplished by a 
minimisation procedure that is an iterative method in which the atomic coordinates are 
modified from one iteration to the next in order to decrease energy. 
A minimisation method is for instance molecular mechanics ‘MM3’ developed by 
Allinger et al. [1989]. MAXIMIN2 is the standard minimisation program applied in 
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SYBYL and uses the TRIPOS force field parameters. MAXIMIN is describing that 
energy can be minimised while maintaining specified geometric relationships within 
and/or among given sets of atoms [Labanowski et al., 1986].  
The goal of energy minimisation is to find a route (consisting of variation of the 
intramolecular degrees of freedom) from an initial conformation to the nearest 
minimum energy conformation using the smallest number of calculations possible. With 
molecular modelling of proteins, the molecule is placed in an imaginary box and 
periodic boundary conditions are set at a dielectric constant of 1(vacuum) – 80 (water) 
[Joergensen, 1983]. The setting of the dielectric constant in minimisation procedures is 
crucial to the outcome of the entire model. The relationship between an initial and 
minimum energy conformation is shown in the following hypothetical energy surface 
(Figure 1.11): 
 
Figure 1.11: The energy minimisation principle [Steinbach, 1996]. P (●) is the initial 
point on the energy surface. The energy minimum (●) can be characterized by a small 
change in energy and/or a zero gradient between steps towards a minimum. At a 
minimum of the potential energy surface, the net force on each atom vanishes, therefore 
the stable configuration [Tsai, 2002].  
The inclusion of electrostatic interactions can play a critically important role in 
molecules where H-bonding and other electrostatic interactions are involved. Therefore, 
a number of applications used in SYBYL calculate partial charges in molecules, such as 
Pullman- or Gasteiger-Hueckel-charges [Tripos bookshelf, 2002]. Solvation can also 
have a strong effect on the energies of different conformations. It influences the H-
bonding pattern, solute surface area, and hydrophilic/hyrdrophobic group exposures of 
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protein molecules. Empirical potential energy functions for proteins may be used to 
study protein stability and motion. However, it is difficult to evaluate these functions 
because most protein crystal structures are not accurate enough to act as test cases. 
Whitlow and Teeter [1986] empirically examined how well potential energy 
minimisation can model the high resolution crystal structure of the hydrophobic protein 
Crambin [Hendrickson & Teeter, 1981] and found that, empirically, the best overall 
conditions for minimisation are employing Jorgensen's van der Waals radii [1981]. 
1.11.3 Simulated annealing 
Another optimisation technique is known as simulated annealing, which was introduced 
by Kirkpatrick et al. [1983] as similar to evolutionary algorithms. Simulated annealing 
locates local minima (low-energy state) by annealing in a multivariate objective 
function [Donelly, 1986]. To simplify, the idea comes from the industrial process of 
annealing in which a material is heated to above a critical point to soften it, then 
gradually cooled in order to erase defects in its crystalline structure by producing a more 
stable and regular lattice arrangement of atoms [Haupt & Haupt, 1998]. The annealing 
function is using constant temperature simulations on molecules to explore the 
conformational space available to a molecular system. This is done by simulating 
motions at a very high temperature, where nearly all conformations are energetically 
accessible. Thus, energetic barriers can be exceeded to find conformations with energies 
lower than the local minimum energy found by energy minimisation. [Steinbach & 
Brooks, 1994]. Then, the molecule is slowly cooled down to room temperature or below 
and settles into a natural conformation at that temperature.  
 
Annealing can be repeated many times to explore all possible conformations 
energetically attainable at a given temperature. That way, several different low energy 
conformations of a single molecule or different low energy configurations of a system 
of molecules (e.g ligand docked to a receptor) are obtained. The conformations obtained 
by simulated annealing are further minimised to ensure that the system is truly in a low 
energy state [Tripos bookshelf, 2002]. Practically, a molecular conformation is 
minimised using MAXMIN, then annealed and again minimised. 
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1.11.4 Introduction to SYBYL and the Tripos force field  
Tripos’ program SYBYL applies a genetic algorithm, which is a programming 
technique that is used for solving problems and modelling evolutionary systems 
[Forrest, 1993; Mitchell, 1996]. SYBYL provides the fundamental components for 
understanding molecular structure and properties with an emphasis on the discovery of 
lead candidates [Van Opdenbosch et al., 1985]. Geometry optimisation (minimisation) 
is performed via molecular mechanics or quantum mechanical methods to produce high 
quality models [Blanco, 1991]. SYBYL offers a variety of force fields as well as several 
options for computing or importing atomic charges. Several algorithms are available for 
generating solvent models. The force fields in SYBYL have been extensively tested and 
validated against the literature. The validation of the Tripos force field 5.2 was based 
upon crystal structures of small molecules and peptides [Clark et al., 1989]. SYBYL 
also includes implementations of the ‘Amber united-atom and all-atom’ force fields 
[Cornell et al., 1995; Weiner et al., 1984 & 1986; Singh and Kollmann, 1984] as well as 
MMFF947-9 and MM2 [ Halgren, 1990, 1996 & 1999; Burkert and Allinger, 1982].  
1.11.5 Introduction to Leapfrog 
Structure-based virtual screening has emerged as a reliable, cost-effective and time-
saving technique for the discovery of lead compounds. LeapFrog is an example of a 
software design tool as part of SYBYL (Tripos Inc.) which generates a virtual library of 
functional monomers containing electrostatic, hydrophobic, and dipole-dipole 
interactions as well as van der Waals forces or reversible covalent bonds. A molecular 
model of the template molecule is prepared (charges of each atom are calculated and the 
structure is refined using molecular mechanics methods). Each of the monomers from 
the virtual library is probed around the template molecule to investigate possible 
interactions. A new, potentially active receptor molecule is designed by repeatedly 
making small structural changes, rapidly evaluating the binding energy of the new 
compound, and keeping or discarding the changes based on the results [Dixon et al., 
1993; Payne et al., 1993]. Unlike other methods, LeapFrog does not require an 
experimentally known receptor site; it can generate receptor-site models directly from 
CoMFA (Comparative Molecular Field Analysis) or other models [Cramer et al., 1988]. 
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The generation of new compounds begins with a pool of potential monomers (e.g. 
amino acids) and a cavity (shown as a box) in which to place them with the target 
molecule (e.g. ochratoxin A). In each step of this virtual screening process called 
‘electrostatic screening’ (Figure 1.12), an existing monomer and a particular atom are 
randomly selected. Each stage of polymer growth is evaluated according to a molecular 
mechanics-based energy function, which considers van der Waals interactions, internal 
strain energy of the lengthening polymer and desolvation of the overall structure [Moon 
et al., 1991]. 
 
Figure 1.12: Leapfrog electrostatic screening displaying all possible site points for the 
interactions of a molecular template with suitable monomers [Chianella et al., 2002]. 
Molecules grown by this procedure are subjected to follow-up evaluation in which an 
approximate binding enthalpy is determined. Therefore, LeapFrog samples the 
environment surrounding the polymer and determines three major components of 
binding energy. The direct enthalpies ΔH of binding (electrostatic, steric and H-bonding 
enthalpies) are always calculated. Cavity desolvation energy and polymer desolvation 
energies are optionally included. An estimate of synthetic difficulty can also be 
calculated [Goodford, 1985]. The scoring function calculates the binding energy (kcal 
mol-1) of the resulting structure and if low enough, the new polymer is added to the pool 
of molecules available for the next move. Over a large number of such moves, the 
average binding energy of the pool improves [Tripos bookshelf, 2002]. An alternative 
scoring function that can be used in de novo ligand design estimates the binding energy 
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for a given molecular complex of known 3D structure [Boehm, 1993]. The program 
LUDI, designed by Boehm [1992] is similar in its application and function to LeapFrog. 
1.11.6 Docking with FlexiDock 
In vivo, a detailed description of for example ligand–receptor association leads to a 
delicate balance between van der Waals and electrostatic interactions, hydrogen 
bonding, solvation effects, and conformational entropy, all of which are difficult to 
compute accurately [Janin, 1995; Gilson et al., 1997]. Tingjun and Xiaojie [2004] have 
discussed the basic ideas and computational tools for virtual screening and scoring 
functions in molecular docking. Docking procedures aim to identify the energetically 
most favourable docking structures to predict the affinity between the ligand and 
receptor. Thus, the goal of molecular docking is to search for the structure and stability 
of the molecular complex with the global minimum energy, as opposed to minimisation 
and annealing search for local minima. Molecular docking requires a target receptor 
structure with or without a bound ligand, the molecules of interest or a database 
containing existing or virtual compounds for the docking process. A computational 
framework allows the implementation of the desired docking and scoring procedures. 
The three-dimensional structure of the receptor-ligand complex has to be detailed at 
atomic resolution. Since molecules are dynamic, flexibility and motion are clearly 
important to the biological functioning of proteins and peptides. However, most docking 
algorithms assume the receptor to be rigid (as flexibility is difficult to compute) whereas 
the conformation of the ligand is mostly regarded as flexible [Krovat et al., 2005]. 
Further discussion on recent progressions in molecular docking has been reviewed by 
Krovat et al. [2005] and the computational concepts that have been extended from rigid-
body to flexible docking, as well as important strategies for flexible docking and design 
were reviewed by Rosenfeld et al. [1995]. Alberts et al. [2005] presented an algorithm 
for integrating protein binding-site flexibility into de novo ligand design and docking 
processes. The approach allows dynamic rearrangement of for example amino acid side 
chains during the docking and design simulations. In addition, molecular dynamics 
simulations, computing the motion of atoms in the molecule according to Newton’s law 
of motion, are applied to calculate the forces acting on the atoms, and thus provide 
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information about possible conformations, thermodynamic properties, and dynamic 
behaviour of molecules according to Newton’s mechanics. 
 
Scoring of docking processes is still regarded as one of the major challenges in the field 
of molecular docking. The purpose of the scoring procedure is the identification of the 
correct binding pose by its lowest energy value, and the ranking of receptor-ligand 
complexes according to their binding affinities [Muegge and Rarey, 2001]. Genetic 
algorithm-based Flexible Docking (FlexiDock) provides a means of docking ligands 
into protein active sites [Tripos bookshelf, 2002]. 
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1.11.7 Current research in peptide modelling 
SYBYL’s ligand-based design techniques use information about one or several known 
templates (ligands) as a basis for the design of lead compounds (e.g. peptide receptors). 
Research performed using SYBYL among other force fields for peptide design include 
peptide ligand-receptor interactions [Singh et al., 1991], or peptide design with enzyme 
characteristics [Hahn et al., 1990]. Further studies are summarized in Table 1.8. 
Table 1.8: Research on peptide receptors and synthetic peptides [TriposTM]. 
Title Application Reference 
A novel method for the modelling of peptide 
ligands to their receptors.  
 
Computer model of a bovine type I collagen 
microfibril. 
 
 
Development of a unique 3D interaction model 
of endogenous and synthetic peripheral 
benzodiazepine receptor ligands. 
 
 
Conformational restriction of the phenylalanine 
residue in a cyclic opioid peptide analogue: 
effects on receptor selectivity and 
stereospecificity. 
 
Role of the conformational element in peptide-
receptor interactions. Studies with cyclic opioid 
peptide analogs. 
 
The use of a proline ring as a conformational 
restraint in CCK-B receptor "dipeptoids." 
 
CoMFA investigations on two series of artificial 
peptide inhibitors of the serine protease 
thermitase. Synthesis of an inhibitor of predicted 
greater potency. 
 
Computer design of bioactive molecules: a 
method for receptor-based de novo ligand design. 
 
The computer program LUDI: A new method for 
the de novo design of enzyme inhibitors," 
SYBYL 
 
 
SYBYL 
 
 
 
Structure-Based 
Design 
 
 
 
SYBYL 
 
 
 
 
/ 
 
 
 
Molecular 
Mechanics 
 
 
CoMFA, Peptides 
Proteins, QSAR 
 
 
Docking, LeapFrog 
 
 
LUDI 
 
Singh et al. [1991] 
 
 
Erickson et al. [1997] 
 
 
 
Cinone et al. [2000] 
 
 
 
 
Schiller et al. [1991.] 
 
 
 
 
Schiller et al.  [1988] 
 
 
 
Fincham et al. [1992] 
 
 
 
Brandt et al. [1995] 
 
 
 
Moon et al. [1991] 
 
 
Böhm et al. [1992] 
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Peptides represent a difficulty because of their great conformational flexibility. The 
design of peptides, amides and peptidomimetics using amino acids as building blocks is 
described by Boehm [1996] using the computer program LUDI as de novo design tool. 
Current research using LeapFrog as de novo design tool includes the structure-based 
design of enzyme inhibitors [Jordan et al., 2001] using the LeapFrog program to 
develop a docking model for interaction of ligands with the active site of an enzyme. 
Modelling of enzyme-peptide inhibitor complexes was performed by Singh et al. 
[1991], whereas other investigations included the structure-based design of protein-
binding ligands [Dong et al., 2006]. The successful design of a molecular imprinted 
polymer for microcystin-LR using a computational approach (SYBYL, LeapFrog) has 
been shown by Chianella et al. [2002]. The de novo designed MIP was later on 
implemented into a MIP-based sensor using a solid phase extraction cartridge 
[Chianella et al., 2003]. 
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1.12 Aims and Objectives 
The aim of this thesis was to develop an affinity sensor for ochratoxin A for 
determination in wine samples. Comprising the required elements of specificity, 
sensitivity, time and cost-effectiveness, the biosensor has to be carefully assembled.  
 
Two types of recognition elements were considered; one is a commercially available 
antibody specifically binding ochratoxin A and the other a synthetic peptide receptor for 
ochratoxin A, which is designed in this research project using computational modelling. 
Peptides have various advantages in terms of molecular stability and availability, 
compared to antibodies, which are being more commonly used in immunosensors. Also, 
the production of antibodies for a specific molecule can be time and cost-consuming 
and generally requires animal resources.  
 
The first stage of the biosensor development involves the parallel execution of 
computational design of peptide receptors for ochratoxin A and the consecutive 
characterisation of both the antibody and peptide recognition elements using binding 
assays.  
 
The second stage comprises the construction of the transducer component of the 
biosensor for both types of recognition elements. The transducer relates the biological 
signal (as a result of a binding interaction) via a detector towards an electronic data 
output. Electrochemical detection was chosen using an electrode as transducer. The 
proposed sensor format was a mediated amperometric immunosensor using screen- 
printed electrodes directly transducing the current response arising from an indirect 
competitive enzyme-linked immunoassay. The screen printed electrode sensor is 
compared to a microelectrode array platform in the context of miniaturisation and 
portability of the sensor device. 
 
Complexity of wine plays a significant role as all the components of wine have to be 
considered for achieving interference-free and sensitive detection. The proposed 
biosensor shall be used to monitor ochratoxin A contamination (possibly on-site the 
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wine yard) and prevent wine samples that show ochratoxins A contamination above the 
permissible limit to reach the consumer. That way, the health risk imposed by 
ochratoxin A consumption may be decreased significantly. The required objectives of 
the project were carried out as follows: 
I. Reagent preparation 
• Immunoaffinity purification of selected antibodies for ochratoxin A 
• Conjugation of ochratoxin A to horseradish peroxidase 
II. Enzyme immunoassay development and affinity characterisation of antibodies 
• Incorporation of immuno-reagents into a colorimetric enzyme 
immunoassay using solid phase microtitre plate supports 
• Optimisation of assay parameters (time, temperature and reagent 
concentration and composition) 
• Characterisation of antibody suitability for immunosensor analysis 
• Immunoassay format design 
• Affinity characterisation of antibodies and cross-reactivity 
III. Immunosensor development incorporating the developed immunoassay format 
• Fabrication of screen printed electrodes and assembly of the 
immunosensor 
• Electrochemical characterisation of produced sensor supports and 
incorporated electro-active reagents 
• Transfer of the selected antibody and competitive immunoassay format 
to the electrochemical sensor support 
• Optimisation of the amperometric signal sensitivity for enzyme 
immunoassay transduction 
• Determination and optimisation of ochratoxin A standards using the 
assembled immunosensor 
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IV. Immunosensor application to wine samples 
• Characterisation of the effects from wine sample components on sensor 
performance 
• Establishment of a calibration curve using the immunosensor in wine 
matrix 
• Application of the sensor to determine ochratoxin A contamination in 
real wine samples 
V. Validation against standard methods 
• Compare the immunosensor performance to HPLC standard analysis and 
a commercially available immunoassay test kit. 
VI. Computational modelling of peptide recognition elements 
• De novo design of peptide receptors for ochratoxin A and synthetic 
peptide library construction 
• Characterisation of peptide sequences in silico using ligand-receptor 
docking algorithms 
VII. Binding assay and affinity characterisation if peptides 
• Synthesis of selected lead peptide sequences for in vitro analysis 
• Characterisation of peptide suitability for immunosensor analysis using 
binding assays 
• Affinity characterisation of peptide recognition elements 
 
An outline of the consecutive milestones carried out in this thesis is illustrated in the 
flow chart in Figure 1.13. 
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INTRODUCTION AND LITERATURE REVIEW
CONLCUSIONS AND FUTURE WORK
Bibliography and Appendices
IMMUNOASSAY DEVELOPMENT FOR OCHRATOXIN A:
Immuno-reagent selection, purification and conjugation
Microtitre enzyme immunoassay development and optimisation
SURFACE PLASMON RESONANCE ANALYSIS OF OCHRATOXIN A ANTIBODIES:
Affinity characterisation of ochratoxin A antibodies
Investigation of immunoassay format
Selection of suitable antibody and immunoassay format for immunosensor application
SCREEN PRINTED ELECTRODE BASED IMMUNOSENSOR FOR OCHRATOXIN A:
Fabrication and characterisation of screen-printed electrode sensors and 
transfer of the developed microtitre enzyme immunoassay to the sensor platform 
using the selected antibody
Development and optimisation of amperometric transduction system
Evaluation of immunosensor characteristics
COMPUTATIONAL MODELLING OF PEPTIDE RECEPTORS:
In sillico design and characterisation of peptide receptor library
Selection of lead peptide sequences and synthesis for in vitro analysis
Affinity characterisation and application of peptide binding assays
Chapter 4
Chapter 5 & 6
Chapter 3
Chapter 2
 
Figure 1.13 : Flowchart outlining the consecutive milestones carried out in this thesis. 
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CHAPTER 2 : IMMUNOASSAY DEVELOPMENT FOR 
OCHRATOXIN A 
2.1 Introduction 
Antibodies are commonly used as recognition elements in binding assays since they can 
display great selectivity and sensitivity for their antigen. Binding assays involving 
antibodies are known as immunoassays. When the detection is based on the use of an 
enzyme label, the method is know as enzyme linked immunosorbent assay. This 
technique was used in this work to characterise a commercially available polyclonal 
anti-ochratoxin A antibody (Biogenesis Ltd., UK). The antibody had been raised against 
ochratoxin A conjugated to the carrier-protein bovine serum albumin (BSA). The 
manufacturer stated that the specific antibody recognition for ochratoxin A was 100% 
and cross-reactivity for BSA (adsorbed) was < 0.1%.  
 
In this work, an ELISA test based on the reagents available was developed. By 
characterising antibody binding and optimising assay conditions, the assay can be 
specifically tailored to achieve lower detection limits and sensitivity, a wider dynamic 
range and higher signal:noise ratio. The limit of detection (LOD) regarding the direct 
and indirect competitive detection format is compared. Furthermore, the possibility to 
circumvent the need for sample clean-up and pre-concentration is part of the 
investigation. 
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2. 2 Materials 
2.2.1 Chemicals and Immunoreagents 
All the chemicals used were of analytical grade and these are listed in Table 2.1. 
Table 2.1: List of chemicals and supplier. 
Trivial name Chemical name Source 
BSA Bovine serum albumin  Sigma-Aldrich,UK 
Casein Casein from bovine milk Sigma-Aldrich,UK 
C6H8O7 Citric acid Merck, Germany 
EDAC N-Ethyl-N′-(3dimethylaminopropyl) carbodiimide hydrochloride Sigma-Aldrich, UK 
H2O2  Hydrogenperoxide solution 30% Sigma-Aldrich,UK 
HRP Peroxidase from horseradish, Type VI-A Sigma-Aldrich, UK 
OPD o-Phenylenediamine dihydrochloride  Sigma-Aldrich,UK 
NaH2PO4 Sodiumdihydrogenphosphate Merck, Germany 
Na2CO3 di-Sodiumcarbonate Merck, Germany 
NaHCO3 Sodiumhydrogencarbonate Merck, Germany 
Na2HPO4 di-Sodiumhydrogenphosphate Fluka, UK 
NHS N-Hydroxysulfosuccinimide sodium  Sigma-Aldrich, UK 
TMB 3,3′,5,5′-Tetramethylbenzidine Sigma-Aldrich, UK 
Tween 20 Polyethylene glycol sorbitan monolaurate Sigma-Aldrich, UK 
Ochratoxin A 
(R)-N-[(5-chloro-3,4-dihydro-8-hydroxy-3-
methyl-1-oxo-1H-2-benzopyran-7-yl) carbonyl]-
L-phenylalanine (Aspergillus ochraceus) 
Sigma-Aldrich, UK 
Ochratoxin A-
BSA 
Ochratoxin A (Aspergillus ochraceus) 
conjugated 3 mol per mol bovine serum albumin Sigma-Aldrich, UK 
ochratoxin A-
polyclonal 
antibody 
Class: IgG-purified; Species: rabbit; antigen: 
ochratoxin A-BSA, Concentration: 1 mg ml-1 
Biogenesis Ltd, Poole, 
UK 
α rabbit IgG-
HRP 
Class: IgG; Species: goat; antigen: rabbit-Fc, 
Concentration: 1mg ml-1 Dako,Kopenhagen,DK
Due to the potentially carcinogenic properties of ochratoxin A, safety precautions were 
applied, such as wearing gloves, protection glasses and a mask when handling the 
powder. The powder was generally dissolved in ethanol or buffer upon arrival and 
stored in a locked fridge for toxic reagents according to safety instructions.  
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2.2.2 Equipment 
The material and equipment used in this work were dialysis cassette Slide-A-Lyzer® 
10K (Pierce, Rockford, IL, USA), microtitre plates MaxiSorbTM (Nunc Brand products, 
DK), FLUOstar Galaxy plate reader (BMG Labtechnologies Inc, US) and Micro titre 
plate Incubator/ Shaker HT (Labsystems iEMS, USA). 
2.2.3 Buffer solutions 
The compositions of the buffers used are listed below: 
 
Coupling buffer (CB):         
 
0.05 M Carbonate buffer (pH 9.6) 
 
2.65 g NaHCO3 
3.5 g Na2CO3  
dissolved in 1l H2O. pH adjusted to 9.6. 
 
Coating buffer (PBS):         
0.1 Phosphate buffered Saline ( pH 7.4) 
 
2.96 g NaH2PO4 
11.5 g Na2HPO4 
8.4 g NaCl 
dissolved in 1l H2O. pH adjusted to 7.4. 
 
Washing buffer (PBST):         
 
0.1 M Phosphate buffered saline with Tween (pH 7.4) 
 
2.96 g NaH2PO4 
11.5 g Na2HPO4 
5.84 g NaCl  
0.05% (= 0.5 ml) Tween20 
dissolved in 1l H2O. pH adjusted to 7.4. 
 
Substrate buffer:          
 
44 mM PCB (pH 5.5) 
   
4.6 g Citric acid (mono- hydrate)  
7.1 g Na2HPO4    
dissolved in 1l H2O. pH adjusted to 5.5.
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Blocking solution:          
 
1mg ml-1 BSA (dissolved in PBS, pH 7.4) 
1mg ml-1 casein (dissolved in PBS, pH 7.4) 
 
Substrate solution:          
 
22 mg ml-1 OPD  
5µl 30 % H2O2  
dissolved in PCB, pH 5.5. 
2.3 Methods 
2.3.1 Immunoaffinity purification of antibody with BSA 
The polyclonal antibody from Biogenesis Ltd was BSA-purified to prevent cross-
reacting with BSA. This is done by immobilising a saturating BSA concentration (100 
mg L-1) to the polystyrene surface of a microtitre plate. The polyclonal ochratoxin A 
antibody (1 mg ml-1) was added (200 µl/well) and left to incubate at room temperature 
for 2 hours. Cross-reacting polyclonal antibody is bound to the surface-adsorbed BSA, 
whereas the unbound IgG is removed from the well. BSA-bound antibody is discarded. 
2.3.2 Ochratoxin A-BSA coating procedure 
Distinct concentrations of ochratoxin A-BSA were immobilised on the polystyrene 
surface of a microtitre plate (MaxiSorbTM) by physical adsorption according to Nunc 
Bulletin No.1 (2) [Nuncbrand, DK]. The polyclonal ochratoxin A-antibody (Biogenesis 
Ltd., UK) had been IgG-purified by the manufacturer, so no further purification was 
necessary. The secondary anti-rabbit-IgG antibody labelled with horse radish peroxidase 
(Dako Denmark A/S) is recognizing species-specific the Fc fragment of the applied 
antibody.  
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Ochratoxin A-BSA concentrations were coated by adding 100 µl/ well solution to the 
microtitre plate according to Table 2.2. 
Table 2.2: Ochratoxin A-BSA coating concentrations. 
MTP 
(row) Ochratoxin A-BSA [µg L
-1] 
1A 50,000 100,000 750 
1B 25,000 10,000 100 
1C 10,000 1,000 10 
1D 7,500 100 1 
1E 5,000 10 
1F 1,000 1 
1G 750 0.1 
1H 500 0 
2A 100 
2B 50 
2C 10 
2D 5 
2E 1 
2F 0.5 
2G 0.1 
2H 0 
 
 
Coating was performed (if not stated otherwise*1) in coating buffer (100 mM Carbonate 
buffer, pH 9.6) for 16 hours at 4˚C, followed by washing the plates three times (150 µl/ 
well) using phosphate buffered saline containing Tween 20 (PBST, pH 7.4). Free 
binding sites on the polystyrene surface were blocked using 1% (w/v) BSA in PBS (pH 
7.4) using a volume of 100 µl/well) and incubated at 4°C for 2-6 hours, followed by 
washing. A dilution of 1/200 from 1 mg ml-1 stock solution (unless stated otherwise*2) 
anti-ochratoxin A antibody solution (PBS, pH 7.4) was applied (100 µl/well) and 
incubated at 4°C for about 18 hours followed by washing. Finally, a dilution of 1/2000 
anti-rabbit–IgG-HRP was added (100 µl/well) and incubated at 4°C for 1.5 hours. 
Before adding the substrate solution, the plate was washed again three times (150 
µl/well) with PBST. The o-phenylenediamine (OPD) was prepared in substrate buffer 
(pH 5.5), whereas H2O2 was added just before adding the solution to the microtitre plate 
(100 µl/well). Incubation was performed at room temperature (RT) for 5 minutes before 
measuring the absorbance at 492 nm (or alternatively 450 nm when using TMB/H2SO4 
system) in a plate reader. 
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*1 Influence of ochratoxin A-BSA coating concentrations ( Table 2.2, column 3) and 
time was examined at incubation times of the coating step varying from 0.5; 2; 4; 16 
and 48 hours to determine the optimal coating time.  
 
*2 Antibody dilution of 1/1000 – 1/10.000 was used when investigating the effect of 
antibody dilution. 
2.3.3 Temperature, antibody concentration and blocking reagent 
addition to the coating buffer 
Ochratoxin A-BSA (30 mg L-1) was added to the wells (100 µl/well) of a microtitre 
plate. Incubation was performed at 4°C for 18 hours, followed by washing three times 
150µl/ well with phosphate buffered saline containing Tween 20 (PBST). Free binding 
sites on the polystyrene surface were blocked with either 1% (w/v) casein or 1% (w/v) 
BSA blocking solution (100 µl/well) and incubated at 4°C for 2 hours, followed by 
washing. Ochratoxin A-BSA coating (Table 2.3, column 2) was investigated at three 
different temperatures: 4°C; room temperature (RT), and 37°C. Two different blocking 
agents, bovine serum albumin (BSA) and casein were investigated and the addition of 
casein (0.1 % w/v) to the coating buffer.  
Table 2.3: Antibody dilutions for indirect immunoassay. 
MTP 
(row) Ochratoxin A-antibody (0.95 mg ml
-1) 
1A 1/100 1/100 
1B 1/500 1/200 
1C 1/1000 1/500 
1D 1/2000 1/1000 
1E 1/4000 1/2000 
1F 1/5000 1/5000 
1G 1/10000 1/10000 
1H 0 Blank 
All antibody dilutions (Table 2.3, column 1) deposited at a volume of 100 µl/well were 
incubated for 4 hours at 4°C, room temperature (RT) and 37°C, respectively. The 
incubation was followed by washing the wells three times (150 µl/ well) with PBST. A 
dilution of 1/2000 HRP-labelled secondary antibody was added (100 µl/well) and 
incubated at 4°C for 1.5 hours and then unbound material washed off. The o-
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phenylenediamine (OPD) and H2O2 substrate solution was added (100 µl/well) and 
incubated at room temperature (RT) for 5 minutes before measuring the absorbance at 
492 nm in a plate reader. 
 
The addition of casein (0.1 % w/v) to the coating buffer was investigated for two fixed 
ochratoxin A-BSA coating concentrations (25 and 50 mg L-1) and a dilution series of 
anti-ochratoxin A-antibody concentrations (Table 2.3, column 2). Secondary antibody 
and substrate detection was performed as described above. 
2.3.4 Indirect non-competitive ochratoxin A immunoassay 
Free ochratoxin A (Table 2.4) was coated (100 µl/well) onto the microtitre plate at 4°C 
for about 18 hours, followed by washing three times 150µl/ well with phosphate 
buffered saline containing Tween 20 (PBST). Free binding sites on the polystyrene 
surface were blocked with 1% (w/v) casein blocking solution (100 µl/ well) and 
incubated at 4°C for 2 hours, followed by washing. Each antibody concentration (100 
µl/well) was incubated at 4°C, room temperature (RT) and 37°C for 4 hours (Table 2.4, 
column 1).  
Table 2.4: Ochratoxin A concentrations adsorbed onto a polystyrene surface. 
MTP (row) Ochratoxin A [µg L-1] 
1A 10,000 
1B 5,000 
1C 1,000 
1D 10 
1E 1 
1F 0 
The incubation was followed by washing and addition of 1/2000 HRP-labelled 
secondary antibody (100 µl/ well) that was incubated at 4°C for 1.5 hours. The o-
phenylenediamine (OPD)/ H2O2 substrate solution was added (100 µl/well) and 
incubated at room temperature (RT) for 5 minutes before measuring the absorbance at 
492 nm in a plate reader. 
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2.3.5 Indirect competitive ochratoxin A (-BSA) immunoassay 
The competitive format allows ochratoxin A or ochratoxin A-BSA to compete for anti-
ochratoxin A-antibody binding sites with immobilized ochratoxin A-BSA. The 
concentration of the immobilised ochratoxin A-BSA was 30,000 µg L-1 to reach surface 
saturation and the antibody (2500 µg L-1) was pre-mixed with each competitor 
concentration, respectively. The concentration range for competing ochratoxin A-BSA 
was 0.1 to 30,000 µg L-1 and for competing un-conjugated ochratoxin A was 1 to 
10,000 µg L-1 (Table 2.5).  
Table 2.5: Competitor concentrations pre-mixed with ochratoxin A-antibody. 
Standard Ochratoxin A [µg L-1] Ochratoxin A-BSA [µg L-1] 
1A 10,000 30,000 
1B 5,000 10,000 
1C 1,000 1,000 
1D 100 100 
1E 1 10 
1F 0.1 1 
1G 0 0 
Ochratoxin A-BSA (30,000 µg L-1) was coated onto each well (150 µl/well) at 37°C on 
a plate shaker (400 rpm) for 1.5 hours. Washing was performed three times (150 µl/ 
well) with PBST. Free binding sites on the polystyrene surface was blocked with 1% 
w/v casein (150 µl/well) at 4°C for 2 hours and subsequently washed. Pre-incubation of 
1/400 diluted ochratoxin A-antibody with distinct competitor concentrations was 
performed for 0.5 hours and then added to the microtitre plate (150µl/well). Incubation 
was done at room temperature (RT) on a plate shaker (400 rpm) for about 16 hours. 
After washing with PBST, the secondary (1/2000) was added (150µl/well) and 
incubated at RT for 1.5 hours. The plate was washed and the o-phenylenediamine 
(OPD)/ H2O2 substrate solution was added (100 µl/well) and incubated at room 
temperature (RT) for 5 minutes before measuring the absorbance at 492 nm in a plate 
reader. 
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2.3.6 Production of ochratoxin A-HRP conjugate 
The conjugation method was adapted from Chu et al. [1976]. Ochratoxin A (2 mg) was 
suspended in 400 µl ethanol (98%) and mixed with 463 µl of 32.5 mg ml-1 EDAC and 
862 µl of 8.7 mg ml-1 NHS (PBS, pH 7.4). The solution was stirred for 12 hours at room 
temperature, then horseradish peroxidase (4 mg dissolved in 1ml PBS, pH 6.5) was 
added to the solution and stirred for another 12 hours at room temperature adding up to 
a total reaction volume of 2.72 ml. The conjugate was dialysed against PBS, pH 7.4 for 
48 hours at room temperature using a dialysis cassette with a MWCO of 10,000 Da. The 
A280 for HRP was determined 1.043, which corresponds to a concentration of 43 mmol 
L-1 and Em 335 nm for ochratoxin A of 0.441, which corresponds to 66 mmol L-1. The 
approximate HRP/ochratoxin A ratio is 1.5 which corresponds to 1-2 molecules of 
ochratoxin A bound to each molecule HRP. 
2.3.7 Activity characterisation of ochratoxin A-HRP conjugate 
A dilution series of ochratoxin A-HRP was prepared in PBS, pH 7.4 (1/1; 1/10; 1/50; 
1/100; 1/200; 1/500 and 1/1000 from stock solution of 1.9 mg mL-1). Each microtitre 
plate well contained 100 µl; then the tetramethylbenzidine (TMB)/H2O2 substrate 
solution was added (100 µl/ well) and incubated at room temperature (RT) for 5 minutes 
before stopping the reaction using 10% H2SO4 and measuring the absorbance at 450 nm 
in a plate reader. 
2.3.8 Direct non-competitive ochratoxin A-HRP immunoassay 
Protein A (100 µg L-1) was coated to a microtitre plate by adsorption for 18 hours at 
4°C, the non-adsorbed part removed by washing three times with PBST (150 µl/well). 
Anti-ochratoxin A-antibody concentration (2.5 µg L-1) was incubated with adsorbed 
protein A for 2 hours at room temperature and the unbound material removed by 
washing three times with PBST (150 µl/well). The surface was blocked with 1% w/v 
casein (150 µl/well) at 4°C for 2 hours. A dilution of 1/100 ochratoxin A-HRP (1.9 mg 
ml-1) was added to incubate with the immobilised antibody for 2 hours at room 
temperature. The plate was then removed by washing three times with PBST, 
tetramethylbenzidine (TMB)/H2O2 substrate solution added (100 µl/well) and incubated 
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at room temperature for 5 minutes before adding 10% H2SO4 and measuring the 
absorbance at 450 nm in a plate reader. 
2.3.9 Wine sample analysis 
2.3.9.1 Indirect competitive immunoassay for wine analysis 
Ochratoxin A-BSA (30,000 µg L-1) was coated onto each well (150 µl/well) at 37°C 
using a plate shaker (400 rpm) for 1.5 hours. Washing was performed three times (150 
µl/ well) with PBST. Free binding sites on the polystyrene surface were blocked with 
1% casein (150 µl/well) at 4°C for 2 hours. A volume of 50 µl wine sample was diluted 
1:2 with dilution buffer (5% w/v NaHCO3 and 1% w/v PEG). The diluted wine sample 
was pre-incubated with 1/400 dilution ochratoxin A-antibody (1 mg ml-1) for 0.5 hours 
and then added (150µl/ well) to the microtitre plate (Table 2.6). 
Table 2.6: Wine samples pre-mixed with ochratoxin A-antibody 
MTP Sample ID and standards 
A red01 red09 white06 Standard 0 ng L-1 
B red02 red10 white07 Standard 25 ng L-1 
C red03 red11 white08 Standard 75 ng L-1 
D red04 white01 white09 Standard 225 ng L-1 
E red05 white02  Standard 675 ng L-1 
F red06 white03  Standard 2025 ng L-1 
G red07 white04   
H red08 white05   
Incubation was done at room temperature (RT) on a plate shaker (400 rpm) for about 16 
hours. After washing three times (150 µl/well) with PBST, the secondary IgG-HRP 
(1/2000) was added to each well (150µl/well) and incubated at RT at 400 rpm for 1.5 
hours. The plate was the washed three times (150 µl/well) with PBST and the 
tetramethylbenzidine (TMB)/H2O2 substrate solution (100 µl/well) incubated at room 
temperature (RT) for 5 minutes before stopping the reaction using 10% H2SO4 and 
measuring the absorbance at 450 nm in a plate reader. 
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2.3.9.2 Wine analysis using an immunoassay test kit (Ridascreen) 
Wine samples were prepared following two protocolls. The first method performs 
sample clean-up and pre-concentration according to the OchraTest™ (Vicam Ltd., UK) 
procedure as follows: A volume of 5 ml wine was added to 5 ml of diluting solution 
(5% NaHCO3 +1% PEG, pH 8.3) and mixed. The Ochratest™ immunoaffinity column 
was connected to a pumpstand and 10 ml diluted sample solution was passed through 
the column at a flow rate of 1-2 drops/second using a syringe. The column was washed 
with 5 ml washing solution (2.5% NaCl + 0.5% NaHCO3) at a flow rate of 1-2 
drops/second and then dried. Ochratoxin A was eluted by passing 2 ml methanol, at a 
flow rate of 1 drop/second, trough the column. The methanol eluat was evaporated to 
dryness at 50°C under Nitrogen atmosphere and re-dissolved immediately in 250 μL 
PBS, pH 7.4. The second method applies dilution to reduce possible interferences as a 
simple alternative to extensive sample clean-up procedures. All wine samples were 
diluted 1:2 in dilution buffer (5% NaHCO3 and 1% PEG) and processed by taking 50 µl 
of either immunoaffinity-treated or diluted wine sample and adding it to the microtitre 
plate (coated with adsorbed ochratoxin A-antibodies) of the ochratoxin A test kit 
(Ridascreen®). A volume of 100 µl/well of 1/500 diluted ochratoxin A-HRP conjugate 
(test kit) was added and incubation performed at room temperature for 2 hours. The 
plate was washed three times using a spray water bottle and the TMB chromogen (50µl) 
and substrate (50µl) solution was added immediately and incubated for up to 10 minutes 
before stopping the reaction using 10 % H2SO4 and reading the absorbance at 450 nm in 
a plate reader.  
2.3.9.3 Wine analysis using HPLC 
Wine samples were prepared according to the OchraTest™ AOAC HPLC procedure for 
wine and beer as follows. A wine sample (5 ml) was diluted 1:1 with dilution buffer 
(1% PEG + 5% NaHCO3, pH 8.3) and mixed vigorously. The Ochratest™ 
immunoaffinity column was connected to a column stand and 10 ml sample dilution 
was added to the column reservoir. The solution was manually passed through the 
column at a flow rate of 1-2 drops/second using a syringe (according to OchraTestTM 
manual instructions). The column was washed with 5 ml washing solution (2.5% NaCl 
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+ 0.5% NaHCO3) and then dried by passing air through the column. Ochratoxin A was 
eluted by passing 2 mL 99% methanol at the same flow rate. The eluate was evaporated 
to dryness at 50 0C under Nitrogen. The eluate was re-dissolved immediately in 250 μL 
HBS buffer, pH 7.4 for the immunoassay test kit application and in HPLC mobile 
phase, water: acetonitrile: glacial acetic acid (51:47:2), pH 3.2, for HPLC analysis The 
HPLC system used consisted of a Millipore Water 600E system controller, a Millipore 
712 WISP autosampler and a Millipore Waters 470 scanning fluorescence detector 
(Millipore Corporation, MA, USA) with excitation at 330 nm and emission at 460 nm). 
The samples were separated using a C18 Luna Spherisorb ODS2 column (150 x 4.6 
mm, 5 mm) (Phenomenex, Macclesfield, U.K.), with a guard column of the same 
material. Run time for samples was 15 min with OTA being detected at about 5.75 min. 
The flow rate of the mobile phase was 1 ml min-1 and the injection volume per sample 
50 μl. Standards used were 50–1200 ng ml-1. 
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2.4 Results and Discussion 
To achieve a good signal:noise ratio and low detection limits as well as reproducibility 
and a relevant dynamic range, ideal concentrations of each assay reagent are established 
empirically. To establish the optimal dilutions checkerboard titrations are performed, by 
varying the concentrations of two components of the assay. That way, optimal 
ochratoxin A-BSA coating concentration and antibody concentration were established. 
Blocking reagents BSA and casein were validated. By varying incubation times and 
temperatures, the optimal assay parameters were characterised. For detection, the 
enzyme label horseradish peroxidise was chosen as it is commonly used in colorimetric 
assays as it is stable, has a relatively high turnover rate and can be used with many 
chromogenic substrates. A direct and indirect immunoassay format developed in this 
work is compared against each other and the literature. 
2.4.1 Ochratoxin A-BSA coating concentration  
Preliminary ochratoxin A-BSA coating concentration and the anti-ochratoxin A-
antibody concentration were determined using a titration assay. Primarily, the 
polyclonal antibody was BSA-purified to reduce cross-reaction with the BSA-conjugate. 
Ochratoxin A-BSA adsorption was chosen as the BSA-conjugate is easily adsorbed to 
the polystyrene surface of a micro titre plate and the passive immobilisation does not 
nessecarily affect the ochratoxin A epitope. A broad concentration range of 0.1 – 50,000 
µg L-1 ochratoxin A-BSA was immobilised to establish the dynamic range of the assay. 
Figure 2.1 describes three saturation curves for increasing ochratoxin A-BSA coating 
concentrations, where each curve depicts a distinct dilution of polyclonal anti-
ochratoxin A-antibody used for the binding interaction (Figure 2.1).  
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Figure 2.1: Serial dilution curve of adsorbed ochratoxin A-BSA. The ochratoxin A-
antibody is binding at three distinct dilutions (■ 1/2000; ● 1/4000, and ▲ 1/6000) 
diluted from stock solution of 1 mg ml-1. Absorbance was at 492 nm by monitoring the 
catalysis of OPD with H2O2 by HRP. Each error bar represents standard deviation of 
three replicates. The curves were fitted using a 4-parameter fit. 
The absorbance increased (Figure 2.1) with the antibody concentration (reduced 
dilution) and also with the increasing ochratoxin A-BSA concentration confirming 
interaction of antibody with ochratoxin A-BSA. All antibody dilutions reached 
saturation at an ochratoxin A-BSA coating concentration of 750 µg L-1.  
 
The dynamic range of the assay is the linear part of the binding curve. In the following 
plot (Figure 2.2), the dynamic range was fitted by linear regression.  
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Figure 2.2: Logarithmic scale of the dynamic working range showing three anti-
ochratoxin A-antibody dilutions (■ 1/2000; ● 1/4000, and ▲ 1/6000) made from stock 
solution of 1 mg ml-1. Absorbance was at 492 nm by monitoring the catalysis of OPD 
with H2O2 by HRP. Each error bar represents standard deviation of three replicates. 
Linear regression depicts corresponding equations and R-squared values. 
The dynamic range depicted in Figure 2.2 covers an ochratoxin A-BSA concentration 
range from 5-750 µg L-1. The widest dynamic range was observed at an antibody 
dilution of 1/2000 (500 µg L-1). The best signal/noise ratio of this assay was also 
observed with 1/2000 antibody dilution.  
 
The limit of detection (LOD) is the lowest quantity of a substance that can be 
distinguished from the blank value within a stated confidence limit [Currie, 1997]. The 
detection limit for this assay was determined as 10 % absorbance signal distinction from 
the blank absorbance (0.07) and was calculated to be about 5-10 µg L-1 ochratoxin A-
BSA for all antibody concentrations. 
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2.4.2 Increased dynamic range of the assay 
To decrease the limit of detection, ochratoxin A-antibody dilutions were further 
optimised in order to establish, if higher dilutions can be used while reaching a 
sufficient binding interaction. To increase the sensitivity of the assay, ochratoxin A-
BSA coating concentration was increased to 100,000 µg L-1 to increase the binding 
capacity when using more diluted antibody concentrations (Figure 2.3). 
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Figure 2.3: Serial dilution curve of ochratoxin A-BSA adsorbed to the wells of a 
microtitre plate. The anti-ochratoxin-antibody is shown binding at four distinct dilutions 
(■ 1/1000; ● 1/2000, ▲ 1/5000, and ◊ 1/10,000) from stock solution 1 mg ml-1.The 
highest antibody concentration 1/1000 achieved saturation which indicates its molecular 
excess on the microtitre plate. Absorbance was determined at 492 nm by monitoring the 
catalysis of OPD with H2O2. Each error bar represents standard deviation of two 
replicates. The curves were fitted using a 4-parameter fit. 
The blank absorbance was 0.06±0.006 (0.1 or lower is recommended), which confirmed 
the absence of unspecific binding. The signal:noise ratio was best for the antibody 
dilutions 1/1000 (1000 µg L-1) and 1/2000 (500 µg L-1). The dynamic range covers an 
ochratoxin A-BSA concentration range from 100 – 10.000 µg L-1 for the antibody 
dilutions 1/1000 (1000 µg L-1) to 1/2000 (500 µg L-1) showing an expansion of the 
dynamic range towards higher ochratoxin A-BSA concentrations as compared to Figure 
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2.2. The detection limit for this assay is >10µg L-1. Also, the absorbance signal for 
similar ochratoxin A-BSA coating concentrations was lower as compared to Figure 2.1, 
which becomes particularily obvious with an antibody dilution of 1/2000. A a 
concentration of 100 ug L-1 ochratoxin A-BSA, the absorbance results in 1.06 as seen 
in Figure 2.1, whereas the same coating concentration in Figure 2.3 results in an 
absorbance signal of 0.22. This shows that the assay in Figure 2.1 shows the better 
sensitivity of the two assays and that higher coating concentrations are not improving 
the sensitivity or the dynamic range of the assay. 
 
Higher antibody dilutions (1/5000 1/10,000) are also not recommended as the 
signal:noise ratio decreases substantially and saturation is not reached. The optimal 
antibody dilution of 1/2000 (500 µg L-1) is 5 - 20 times higher than the dilution 
recommended by the manufacturer Biogenesis Ltd which is 1/100-1/400 (stock 
concentration 1 mg ml-1). The A50 value (signal at 50% absorbance) indicated an 
optimal coating concentration for ochratoxin A-BSA of about 700 µg L-1 at an antibody 
dilution of 1/2000 (500 µg L-1).  
2.4.3 Ochratoxin A-BSA coating incubation time 
A range of four ochratoxin A-BSA coating concentrations (1-750 µg L-1) were selected 
from the linear portion of the dynamic range shown in Figure 2.2 covering the optimal 
coating concentration A50 (established in Section 2.4.2, Fig. 2.3). Incubation times of 
the coating step varied from 0.5 to 48 hours to determine the optimal coating incubation 
time. A 5 fold excess of the optimal ochratoxin A antibody dilution of 1/2000 (500 µg 
L-1), that is 1/200 (5000 µg L-1), was used to reach saturation. Saturation was performed 
to ensure that the incubation time is the only parameter influencing the binding 
interaction.  
 
Also, higher concentrations of specific antibodies allow for the shortening of the 
incubation time and thus will allow determination of the shortest possible incubation 
time under these conditions. An incubation temperature of 4°C was applied to diminish 
the effect of possible non-specific interactions that are more likely to arise with higher 
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temperatures. The binding capacity dependence on incubation time is shown in Figure 
2.4. 
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Figure 2.4: Different concentrations of adsorbed ochratoxin A-BSA is shown as a 
function of coating time. Ochratoxin A-BSA was adsorbed to the wells of a microtitre 
plate at coating concentrations (■ 750 µg L-1; ● 100 µg L-1; ▲ 10 µg L-1 and ◊ 1 µg L-
1). The anti-ochratoxin-antibody was added at 1/200 dilution made from stock solution 1 
mg L-1 and incubated overnight at 4°C. Absorbance was determined at 492 nm 
monitoring the catalysis of OPD with H2O2. Each error bar represents standard 
deviation of two replicates. 
Figure 2.4 illustrates the distinct increase in signal with increasing ochratoxin A-BSA 
coating concentrations for the two highest coating concentrations 100 and 750 µg L-1. 
Using a coating concentration of 750 µg L-1 ochratoxin A-BSA, 4 hours coating was 
necessary to ensure maximum adsorption. Coating times above 24 hours (24 – 48 hours 
incubation) showed a significant decrease in signal by about 19 % (decrease from 100 
% at maximum absorbance signal at 4-24 hours) to 81 % decrease in absorbance signal 
at 48 hours incubation.  
 
There is a strong possibility of denaturation when biomaterials are incubated for longer 
periods of time and even more when using high temperatures. It was shown that 
ochratoxin A-BSA physically adsorbed to the plate did not desorb during 24 hours of 
incubation for coating concentrations 100 and 750 µg L-1. Coating concentration below 
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1-10 µg L-1 showed no significant signal increase which leads to the conclusion that 
these concentrations are too low using the given antibody concentrations.  
2.4.4 Antibody incubation time, temperature and blocking reagent 
Equilibrium in antigen-antibody reactions is often reached more quickly at 37°C 
compared to room temperature or lower temperatures. As binding interaction reaches 
equilibrium faster, an increase in incubation temperature allows for a greater dilution of 
the antibody or a shortened incubation time, which would be both advanteous. 
However, high incubation temperatures can result in denaturation of biomaterials. In 
this experiment, the influence of temperature was determined. In addition, the antibody 
incubation time was varied for each temperature as to investigate how temperature and 
time relate for the antibody binding interaction.  
 
Coating was performed with the established range of ochratoxin A-BSA coating 
concentrations (1 - 750 µg L-1). The assay was performed at three different 
temperatures: 4°C; room temperature (RT), and 37°C to characterise temperature 
influence on ochratoxin A-BSA coating and antibody-ochratoxin A binding interaction.  
 
The incubation times for ochratoxin A-antibody were in the range of 0.5 - 48 hours. The 
influence of antibody incubation time at 4°C incubation temperature for BSA (A) and 
casein (B) blocking is shown in Figure 2.5. 
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Figure 2.5: Serial dilution curve of ochratoxin A-BSA at 4ºC incubation temperature 
versus incubation time (■ 0.5, ● 2; ▲ 4, ◊ 16, and ○ 24 hours) of anti-ochratoxin A-
antibody. The anti-ochratoxin-antibody was added at 1/200 dilution made from stock 
solution 1 mg L-1 and incubated overnight at 4°C Blocking reagent was bovine serum 
albumin (A) and casein (B). Absorbance was determined at 492 nm monitoring the 
catalysis of OPD with H2O2. Double measurements were performed and the standard 
deviation is depicted as error bars. 
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At an incubation temperature of 4°C (Figure 2.5), the absorbance signal ranged between 
0.05 – 0.25 absorbance units, which is compared to previous curves of the same assay 
design, relatively low und probably a result of experimental error in the microplate 
assay design. However, a signal increase for a range of increasing antibody incubation 
times (depicted as curves) was observed for increasing ochratoxin A-BSA 
concentrations. At 4°C incubation temperature, there is a significant increase antibody 
incubation time above 0.5 hours for both BSA and casein blocking (Figure 2.5). As the 
signal reaches a plateau as shown in Figure 2.5A, equilibrium (antibody binding 500 µg 
L-1 ochratoxin A-BSA) is reached after 4 hours as the signal does not change much with 
higher incubation times.  
 
Figure 2.5B depicts that equilibrium was not reached before an incubation time of four 
hours and required higher coating concentrations to reach a signal plateau. Generally, 
the signal did not seem to decrease thereby suggesting a low dissociation rate of the 
antigen-antibody complex. However, the signal curve at 16 hours (Figure 2.5B) showed 
less binding than at 2, 4, and 24 hours, which is likely due to an experimental error. 
 
Figure 2.6 illustrates the binding at room temperature (RT) showing a signal range of 
0.05 – 0.3 OD. An increase in signal with increasing antibody incubation time was also 
observed. A major characteristic compared to incubation at 4°C is a clearer distinction 
of curves for every incubation time. When blocking with BSA, the signal reached a 
plateau at 4 hours at a coating concentration of 500 µg l-1 ochratoxin A-BSA. Lower 
incubation times showed a significantly lower signal. However, a signal decrease was 
observed at incubation times 16-24 hours (Figure 2.6 A). When blocking with casein, 
the signal increased from 0.5 to 4 hours and then stabilised. An incubation of 16 hours 
showed again a drop in signal. No plateau was reached at 24 hours (Figure 2.6 B). 
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Figure 2.6: Serial dilution curve of ochratoxin A-BSA at room temperature versus 
incubation time (■ 0.5, ● 2; ▲ 4, ◊ 16, and ○ 24 hours) of anti-ochratoxin A-antibody. 
The anti-ochratoxin-antibody was added at 1/200 dilution made from stock solution 1 
mg L-1. Blocking reagent was bovine serum albumin (A) and casein (B). Absorbance 
was determined at 492 nm monitoring the catalysis of OPD with H2O2. Double 
measurements were performed and the standard deviation is depicted as error bars. 
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Figure 2.6 confirms that incubation at room temperature allows for a more reliable 
distinction between incubation times. It is also shown that the standard deviation seems 
to be generally lower for casein blocking. Generally, an incubation time of 0.5 - 2 hours 
would be sufficient to result in significant binding, however, to reach a binding 
equilibrium, higher incubation times are of advantage. Although at incubation times 
above 24 hours, desporption of the coated ochratoxin A-BSA may occur. 
 
The Figure below shows the binding curves at 37°C (Figure 2.7). The signal ranged 
between 0.05 – 0.25 absorbance units which is a further increase in binding capacity. 
Both graphs showed an increase in signal with increasing incubation time 0.5 to 4 hours. 
Thus, Figure 2.7 confirms the data obtained at room temperature (Figure 2.6A), which 
is an optimal incubation time of 4 hours when using the BSA block. It also becomes 
evident, that at 37°C, incubation times from 16-24 hours result in a decrease in overall 
signal.  
 
Overall, the standard deviations increases with increasing temperature, whereas BSA 
blocking shower higher standard deviation values than casein at 4°C and room 
temperature, whereas at 37°C incubation, the standard deviation between BSA and 
casein seem to be similar. Incubation at room temperature and 37°C resulted in an 
optimal antibody incubation time of four hours. Incubation at 4°C showed lower signal 
values, but an optimal incubation time of 2 hours.  
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Figure 2.7: Serial dilution curve of ochratoxin A-BSA at 37°C incubation temperature 
versus incubation time (■ 0.5, ● 2; ▲ 4, ◊ 16, and ○ 24 hours) of anti-ochratoxin A-
antibody. The anti-ochratoxin-antibody was added at 1/200 dilution made from stock 
solution 1 mg L-1. Blocking reagent was bovine serum albumin (A) and casein (B). 
Absorbance was determined at 492 nm monitoring the catalysis of OPD with H2O2. 
Double measurements were performed and the standard deviation is depicted as error 
bars. 
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Overall, binding equilibrium (signal plateau) 4°C, to a lesser extend at room 
temperature, but was not reached at 37°C. It is not known whether temperature 
promotes the antigen-antibody reaction selectively rather than the various reactions that 
give rise to background noise. Here, the lowest temperature seems to promote the 
antigen-antibody interaction better than higher temperatures. Also, regarding the 
blocking reagents, BSA blocking generally seems to assist the equilibrium, whereas 
with casein blocking a plateau is only reached at 4°C. As the standard deviation of BSA 
is clearly larger at 4°C and room temperature incubation, the casein block seems to be 
better for this application. The effect of temperature on antigen-antibody binding 
interaction shows that the binding capacity is increased with increasing temperature; 
however, binding equilibrium decreases with increasing temperature. Therefore, it was 
concluded that future binding assays will be performed at optimal incubation 
temperature of 4°C (or for maximum binding capacity at room temperature) using 
casein blocking and an incubation time of ochratoxin A-antibody of 4 hours. 
2.4.5 Calculation of the functional affinity constant  
The term ‘functional affinity’ describes the interaction of an immobilised antigen with 
its corresponding antibody without the influence of multi-valence. Introducing a solid 
phase such as a microtitre plate (for the immobilisation of one of the reactants) 
complicates the determination of affinity [Underwood et al., 1993]. Diffusion effects 
play an important role in heterogeneous binding by slowing down the association and 
dissociation rate, thus affecting the attainment and/or the position of the equilibrium. 
Moreover, surface effects such as antigen-density dependent steric hindrance and 
bivalent antibody binding can influence the estimation of the affinity constant [Nygren 
and Stenberg, 1989, Underwood, 1993]. The method developed by Beatty et al. [1987] 
belongs to the class of solid phase affinity measurements which directly estimates the 
affinity constant from solid-phase binding of the antibody. This method uses serial 
dilution of both antigen (coated to the plate) and antibody for measuring affinity 
constants using the ‘Law of Mass Action’.  
 
However, Beatty et al. [1987] assume that the reaction reaches equilibrium and 
therefore justifying the use of the Law of Mass Action. According to Loomans et al. 
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[1995], these assumptions are theoretical questionable and developed an improved 
method to determine the functional affinity constant by the coating conditions, and not 
by any other limiting experimental conditions such as multi-valent binding, steric 
hindrance or severe diffusion effects. Figure 2.8 depicts absorbance change for serial 
dilution of antibody binding to seven decreasing ochratoxin A-BSA coating 
concentrations. 
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Figure 2.8: Experimental signal curve for anti-ochratoxin A antibody at 7 different 
ochratoxin A-BSA coating concentrations (■ 0, ● 0.1, ▲1, □ 10 ○ 100, △ 1000,◆ 
10.000, and ◇100.000 μg L-1). Absorbance was determined at 492 nm monitoring the 
catalysis of OPD with H2O2. The curves were fitted using a 4-parameter fit. 
From Figure 2.8, the functional affinity constant (Kaff) was calculated by selecting the 
antibody dilution, which was necessary to achieve 50% of the maximum absorbance 
value (A50). This antibody dilution was used in the following equation, derived from the 
Beatty formula [Beatty et al., 1987]: 
 
Kaff = (n-1) / 2(n [Ab’]-[Ab]      Equation X 
 
The terms [Ab] and [Ab’] equal the antibody concentration at A50% each corresponding 
for [Ag] and [Ag’], respectively; and n = [Ag] / [Ag’]. [Ag] is the varying ochratoxin A-
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BSA concentration; [Ab] is the varying antibody concentration. Here, the terms [Ag] 
and [Ag’] equal 1000 and 10,000 μg L-1 ochratoxin A-BSA, since an approximate A100% 
was observed. The calculated functional affinity for this interaction, assuming a 
molecular weight of the antibody at 150 kD, was calculated 1.66*1011 M-1. It was noted 
that the affinity value is about 2-3 magnitudes higher than expected for a common 
antibody-antigen interaction. For solid-phase measurements, as compared to liquid-
phase equilibrium measurements, some authors report higher affinity values [Pellequer 
and van Regenmortel, 1993]. These differences have been primarily explained by 
differences in kinetic rates as a result of diffusion limitations [Nygren and Stenberg, 
1992]. It also needs to be pointed out that the Beatty equation was developed for 
monoclonal antibody interaction. Since polyclonal antibodies display a mixture of 
affinities, one can only estimate an average avidity for the polyclonal antibody mixture.  
2.4.6 Ohratoxin A coating to solid phase support 
The preceding experiments were all performed using the ochratoxin A-BSA conjugate 
since it is easy to immobilise by simple physical adsorption. Nevertheless, the attempt 
was made to immobilise ochratoxin A to polystyrene. In contrast to the adsorption of 
high molecular weight proteins, the immobilisation of small low molecular weight 
molecules is quite a challenge.  
 
Physical adsorption is depended on van der Waals forces which are determined by the 
dipole moment of a molecule which in return is dependent on the molecules polarity, 
size, and length. Ochratoxin A possesses a much lower dipole moment, than for 
example aflatoxin B1 (low polar, non-ionisable), due to its low polar, ionisable nature 
[Dakovic et al., 2005]. In the following experiment, the adsorption of ochratoxin A to a 
microtitre plate surface and its non-competitive interaction with anti-ochratoxin A-
antibody was investigated (Figure 2.9). 
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Figure 2.9: Signal curve of increasing ochratoxin A coating concentration (■). The 
signal curve depicts signal – background (blank reference). Absorbance is measured at 
492 nm monitoring the catalysis of OPD with H2O2. Double measurements were 
performed and the standard deviation is depicted as error bars. 
Figure 2.9 shows that the adsorption of ochratoxin A on polystyrene at basic pH 
occurred to a much lesser extend than with using its BSA conjugate. With increasing 
ochratoxin A coating concentration, the signal increased as well (Figure 2.10) at a fixed 
antibody concentration. This indicates a certain amount of physical adsorption taking 
place and confirms that the anti-ochratoxin A-antibody is binding to adsorbed 
ochratoxin A.  
 
However, the absorbance signal ranged only between 0.03 – 0.12 absorbance signal and 
can be barely distinguished from the background. An explanation for the low signal 
range could be that the antigen-antibody binding interaction is prone to steric hindrance. 
However, the small signal range can also be directly related to the amount of adsorbed 
ochratoxin A and that the interacting part of the ochratoxin A molecule is not accessible 
to the antibody caused by establishment of a surface assembled monolayer which could 
hinder antibodies from recognizing the antigenic epitope (e.g. ochratoxin A) that may 
became buried during immobilisation of a tightly packed monolayer [Butler et al, 2000]. 
Summarizing, the physical adsorption of unconjugated ochratoxin A, however desirable 
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in terms of monovalent antigen-antibody interaction, is not recommended due to its low 
immobilisation yield and increased steric hindrance of the interaction.  
2.4.7 Indirect competitive immunoassay using ochratoxin A (- BSA) 
A competitive assay approach is used in combination particularly with small haptens 
which only display one epitope; this format should yield more specific and sensitive 
results. The indirect detection approach via a secondary antibody is used to increase 
detection signal and sensitivity of the antigen-antibody interaction determination 
[O’Shannessy, and Faegerstam, 1993]. 
 
The competitive immunoassay format promotes competition of ochratoxin A (-BSA), 
for anti-ochratoxin A-antibody binding sites with immobilized ochratoxin A-BSA.  The 
concentration of the immobilised ochratoxin A-BSA was 30 mg L-1 to reach surface 
saturation and the antibody concentration 2.5 mg L-1 (1/400) was pre-mixed with each 
ochratoxin A-BSA competitor concentration, respectively. The concentration range for 
competing ochratoxin A-BSA was 0.1 to 30,000 µg L-1 (Figure 2.10) and for competing 
un-conjugated ochratoxin A was 1 to 10,000 µg L-1 as shown in Figure 2.11. 
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Figure 2.10: Signal curve (blank corrected) shows increasing concentrations of 
ochratoxin A-BSA competitor (■). Absorbance is measured at 492 monitoring the 
catalysis of OPD with H2O2 nm. Standard deviation is depicted as error bars. 
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Figure 2.11 illustrates the absorbance signal increase with decreasing ochratoxin A-
BSA competitor concentration and ranging between 0.6 – 1.3 absorbance units. The 
high background is directly related to the high amount of ochratoxin A-BSA adsorbed 
to the surface. BSA is prone to non-specifically interact with other biomolecules. To 
improve the signal background, a coating concentration of 0.1-5 mg L-1 should be 
chosen instead. The detection limit was determined 1-10 µg L-1 ochratoxin A-BSA 
(10% above blank signal).  
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Figure 2.11: Signal curve (blank corrected) shows increasing concentrations of 
ochratoxin competitor (●). Absorbance is measured at 492 nm monitoring the catalysis 
of OPD with H2O2. Standard deviation is depicted as error bars. 
As seen in Figure 2.11, the absorbance signal is increasing with decreasing ochratoxin 
A competitor concentration and rangingbetween 0.27 – 0.49 absorbance units, which is 
significantly less than observed with ochratoxin A-BSA competitor in Figure 2.11. 
Nevertheless, the lowest detectable signal is 1 µg L-1 ochratoxin A (10% above blank 
signal). The slope of the signal curve showed a steeper increase with lower ochratoxin 
A concentrations (Figure 2.11) than with ochratoxin A-BSA (Figure 2.10), indicating 
that even lower ochratoxin A competitor concentrations could be measured and a LOD 
below 1 µg L-1 can be expected for ochratoxin A. To establish the appropriate 
immunoreagent concentration a two-dimensional checkerboard titration needs to be 
performed to determine optimal coating concentration of ochratoxin A-BSA and 
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antibody concentration. In a competitive assay, saturating concentrations are less 
favourable, thus an antibody concentration that shows a signal of around 1.0 absorbance 
units and an antigen concentration at 70% saturation is optimal. 
2.4.8 Direct non-competitive ochratoxin A-HRP immunoassay 
The indirect assay format resulted in detection limits for ochratoxin A at about 1 µg L-1. 
A direct approach can enhance the detection signal, since it is less prone to non-specific 
binding as there are fewer steps in the assay. Here, a direct immunoassay for ochratoxin 
A was performed using ochratoxin A-HRP as label. As ochratoxin A-HRP is not 
commercially available, the conjugate was prepared in-house as described in Section 
2.3.6. The conjugate was tested for its enzyme activity using UV spectroscopy at 492 
nm by adding a fixed substrate/chromogen solution to increasing HRP-conjugate 
concentrations (Figure 2.12). 
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Figure 2.12: Spectrophotometric investigation of ochratoxin A-HRP activity upon 
substrate addition [■]. Absorbance was determined at 450 nm monitoring the catalysis 
of TMB with H2O2.and plotted against ochratoxin A-HRP dilution factor.  
Upon enzyme substrate/chromogen addition, an increase of signal was observed in 
Figure 2.12 corresponding to increasing HRP-conjugate concentration. The enzyme 
activity is defined by the reaction velocity/enzyme volume at constant total solution 
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volume. At excess substrate concentration, the enzyme activity should be constant 
showing a linear increase of enzyme reaction velocity with the enzyme concentration as 
seen in Figure 2.12. This indicates that the enzyme activity was retained trough the 
conjugation process. A clear distinction of signal could be observed at a dilution larger 
than 1/50.  
 
Ochratoxin A antibody immobilisation to the microtitre plate via, a) physical adsorption 
and b) site-directed immobilisation to adsorbed Protein A, was investigated. Site-
directed immobilisation can enhance sensitivity of a direct assay by making the antigen 
binding sites more approachable. The comparison resulted in a stable signal increase 
over a wide range of ochratoxin A-HRP concentrations when using protein A. 
Therefore, one can assume that an antibody immobilisation approach via protein A 
generally results in a more sensitive signal. A series of ochratoxin A-HRP conjugate 
diltutions was tested in a direct approach with 2.5 μg L-1 (1/500 dilution) antibody 
immobilised via protein A (Figure 2.13). 
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Figure 2.13: Signal curve of immobilised ochratoxin A-antibody (2.5 µg L-1) via protein 
A (■) and passive adsorption (●) interacting directly with increasing ochratoxin A-HRP 
concentration. Absorbance was determined at 450 nm monitoring the catalysis of TMB 
with H2O2. 
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The signal curve in Figure 2.13 describes a linear correlation of increasing ochratoxin 
A-HRP concentration (decreasing dilution factor) binding directly to ochratoxin A 
antibody. The signal ranged from 0.2 - 0.8 absorbance units. The ochratoxin A-HRP 
dilution 1/100 is the limit of detection (absorbance signal 10% above the blank signal). 
To specifically determine how strongly the ochratoxin A-HRP conjugate binds to the 
antibody the affinity of the interaction has to be determined using Biacore analysis.  
2.4.9 Analysis of wine samples using an indirect enzyme 
immunoassay 
The indirect assay format was chosen over the direct format for preliminary wine 
sample analysis. A standard curve was produced using ochratoxin A standards (Figure 
2.14) included in the test kit (RidascreenTM). The same ochratoxin A standards were 
used for the indirect immunoassay format and in the Ridascreen test kit immunoassay. 
The ochratoxin A standards from the test kit are specifically made for standard analysis 
alongside various sample matrices. However, those sample matrices are expected to be 
pre-treated and in the case of wine, diluted and clean-up by IAC. 
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Figure 2.14: Standard curve of ochratoxin A using the indirect competitive assay for 
wine sample analysis. Ochratoxin A standard concentrations (0, 25, 75, 225, 675 and 
2025 ng L-1) were obtained from the Ridascreen test kit. Absorbance was monitored at 
450 nm using TMB/H2O2. 
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As the applied wine samples were simply diluted buffer, the standard curve lacks 
comparison to standards which are prepared in wine to determine the matrix effect.  
The following results were obtained when comparing to the standard curve (Figure 
2.14). For the indirect competitive immunoassay analysis, wine samples were diluted 
1:2 in sodium carbonate buffer, pH 9.6, whereas the Ridascreen assay was performed 
with pre-concentrated samples subjected to immunoaffinity clean-up as suggested by 
the manufacturer. Concentration of ochratoxin A in the wine samples are summarised in 
Table 2.7.  
Table 2.7: Wine samples analysed with indirect competitive assay and commercial 
immunoassay kit (Ridascreen) compared to HPLC data as verification method. 
Wine sample HPLC  
Ridascreen 
kit   
Indirect 
competitive 
immunoassay 
White Wine Ochratoxin A [ug L-1] 
Canti Catarratto Chardonnay, Italy-
Sicily 2005 (batch 1) 1.337 0.398 0.39 
Canti-Chardonnay Pinot Grigio, Italy 
2005 (batch 1) 1.629 0.411 0.42 
Canti Catarratto Chardonnay, Italy-
Sicily 2005 (batch 2 1.338 0.410 0.41 
Bordeaux, France 2005 0.998 0.405 0.43 
Soave, Italy-Verona 2005 1.094 0.409 0.39 
Pinot Grigio, Italy 2005 0.813 0.385 0.56 
Canti-Chardonnay Pinot Grigio, Italy 
2005 (batch 2) 0.020 0.397 0.54 
Canti-Chardonnay Pinot Grigio, Italy 
2005 (batch 3) 0.536 0.392 0.45 
Soave Classico, Italy 2005 1.260 0.392 0.43 
Red wine 
France, 2001 0.572 0.389  
Canti, Italy, 2006 0.379 0.4 0.56 
Cabernet Sauvignon, Chile, 2005 0.439 0.328 0.56 
Italy, 2006 0.556 * * 
Bordeaux, France, 2005 0.321 0.375 0.47 
Cru,S 0.138 0.403 0.46 
Mon,France, 2005 0.213 0.379 0.76 
South Africa, 2006 0.354 0.314 0.64 
unknown origin 0.722 0.396 0.59 
-*- depicts a signal below the detection limit 
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This suggests that the two immunoassay methods show data within the methods 
standard error. This supports the hypothesis that the indirect competitive assay 
developed throughout this thesis is as sensitive as the direct assay format used in the test 
kit. Also, the sample dilution could be increased 5 fold and still achieve sensitive 
detection. Thus, the indirect competitive format is being implemented into 
immunosensor development. However, the variation compared to the HPLC data is, 
especially with white wine samples, is very high. Higher values suggest that ochratoxin 
A is determined more sensitively using HPLC with fluorescence detection than 
colorimetric solid state immunoassays. Regarding the pre-concentration and clean-up 
procedure, one can assume that clean-up by dilution and immunoaffinity 
chromatography perform both similarily good (regarding the data correlation) and bad 
(regarding the comparison to HPLC data). 
2.5 Concluding remarks 
The coating concentration for ochratoxin A-BSA was established in Figure 2.1 and 2.2 
and resulted in a preliminary LOD of 5-10 µg L-1 ochratoxin A-BSA coating over a 
dynamic range of 5-750 µg L-1. The antibody dilution range was further decreased over 
a wider dynamic range of coating concentration (100-10,000 µg L-1 ochratoxin A-BSA), 
however, resulted in lower sensitivity (LOD > 10 µg L-1). Optimal coating time aws 
established as 4 hours for a coating concentration of 750 (50+/-) µg L-1 whereas >24 
hours incubation will lead to signal decrease and sensitivity loss (Figure 2.3). The 
indirect competitive assay, using a coating concentration of 30 mg L-1 ochratoxin A-
BSA when testing with an antibody solution of 2.5 mg L-1 showed improved sensitivity 
when of 1-10 μg L-1 ochratoxin A-BSA and indicating <1 μg L-1 ochratoxin A 
competitor. However, the signal noise in the competitive assays was comparitatively 
high (Figure 2.10), possibly as a result of non-specific interactions involving the BSA 
conjugate, whereas the signal noise was less when applying ochratoxin A only (Figure 
2.11). The choice of blocking agent is also of vital importance for the signal/noise ratio, 
thus casein block generally resulted in better signal/noise ratio than BSA. Therefore, it 
was concluded that future binding assays will be performed at optimal incubation 
temperature of 4°C (or for maximum binding capacity at room temperature) using 
casein blocking and an incubation time of ochratoxin A-antibody of 4 hours. 
Chapter 2: Immunoassay development for ochratoxin A 
107 
Furthermore, the affinity of the interaction of immobilised ochratoxin A-BSA with a 
range of antibody concentrations could be established using a solid-phase immunoassay 
without steady-state equilibrium. The affinity constant was 1.66x1011 M-1. 
 
This work can be directly compared to the work published by Alarcon et al. [2004], 
who also using the polyclonal antibody from Biogenesis for ochratoxin A detection. The 
paper discusses interference resulting from the antibody cross-reacting with BSA as a 
standard curve for a competitive assay was not achievable. The indirect immunoassay 
was repeated with BSA-purified antibody but it was not possible to achieve the required 
sensitivity. They also encountered low reproducibility and non-specific binding (high 
blank values). The indirect assay presented in this work, however, using the same BSA-
purified ochratoxin A antibody (while also applying the same method of BSA-
purification) shows comparably good reproducibility and sensitivity (Figure 2.11, 2.12). 
Alarcon et al. [2004] proposed a direct immunoassay instead with a limit of detection of 
0.18 μg L-1 ochratoxin A applying the parameters 20 mg L-1 anti-IgG capture antibody, 
26 mg L-1 ochratoxin A antibody (Biogenesis) using an ochratoxin A-AP conjugate. The 
detection limit of the direct immunoassay is lower than the detection limit for the 
indirect assay presented in this work for an indirect assay (<1 μg L-1 ochratoxin A). 
 
Detection limits of immunoassay based test kits range from 0.1 – 3 μg L-1, where the 
direct binding format falls in the detection range of 0.1-2 μg L-1 (Immunoscreen®Ochra, 
Tecna Lab, It; MycoMonitor®, Helica USA) and the indirect immunoassay format of 
0.3 – 3 μg L-1 ochratoxin A (Transia®Plate, DiffChamb AB; Biokits®Ochratoxin A 
Assay kit, Tepnel Biosystems Ltd.). The test kit from Ridascreen that was used in this 
work for comparison states a detection limit of 0.025 – 0.625 μg L-1. This shows that the 
indirect immunoassay based methods generally show a smaller detection range and less 
sensitivity for ochratoxin A. The indirect assay developed in this work showed that a 
LOD of μg L-1 can be achieved and therefore places the hereby developed assay 
alongside the commercial test kits. 
 
Also, detection of ochratoxin A in chillies was performed using a polyclonal detection 
antibody and an indirect competitive ELISA format, thereby achieving a detection limit 
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of 0.1 μg L-1[Thirumala-Devi et al., 2000]. The polyclonal antibody used was raised 
against ochratoxin A-BSA, which, according to the authors did not increase non-
specific binding. Another indirect competitive ELISA used of monoclonal antibodies 
and resulted in a less sensitive detection limit of 3.75 μg kg-1 ochratoxin A in green 
coffee [Fujii et al., 2006]. This is compared to an ELISA also using monoclonal 
antibodies, but in a direct competitive format, resulting in a detection limit of 0.01-0.1 
μg L-1 in coffee extract [Ueno et al., 1999]. Recently, Yu et al. [2005] developed a 
direct competitive ELISA with a detection limit of 0.90 μg L-1 for ochratoxin A in 
various agricultural commodities, which shows the potential of polyclonal antibodies 
being used in a sensitive direct assay format. This shows that the use of polyclonal or 
monoclonal antibodies does not nessecarily have an affect on assay sensitivity, as both 
the indirect and direct ELISA, when using either antibody, show similar sensitivity. 
Also, generally, the indirect ELISA does show the same sensitivity as the direct format 
and one can summarise that the lowest detection limits for immunoasays for ochratoxin 
A detection using either polyclonal or monoclonal antibodies is about 0.1 μg L-1. 
Another test kit designed to detect ochratoxin A by a membrane-based flow-through 
enzyme immunoassay using monoclonal antibodies were studied by screening cereals 
(wheat, rye, maize and barley) and resulted in a limit of detection for ochratoxin A of 4 
μg kg−1 [De Saeger et al., 2002], which is in the range of commercial immunoassay 
based kits and was marketed as a flow-through ELISA kit for ochratoxin A by Toxi-
Test (Belgium). In comparison, a direct competitive enzyme immunoassay for 
ochratoxin A in chillies developed by Saha et al [2007] showed a detection limit for 
ochratoxin A of only 10 μg kg−1, which is comparitatively high for a direct 
immunoassay format. They have also determined ochratoxin A in wine and coffee with 
a detection limit in wine of 1 μg L-1 and coffee of 2.5 μg kg-1 [Saha et al., 2006]. The 
method itself, based on focused absorption of a sample and reagents through an aqueous 
network of capillary channels formed between a nitrocellulose membrane and a wetted 
absorbent body, could cause the relatively high detection limit or the method of 
detection which is based on densitometric analysis. The latter has been extensively used 
for TLC analysis of ochratoxin A and has been show limits in terms of sensitivity and 
selectively, thus it could also result in a high background noise. Saha et al. [2006] also 
points out that the quality of the immobilized antigen or antibody spots on the 
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membranes is highly operator-dependent and spotting by conventional methods often 
leads to heterogeneous spot morphologies and deposition inconsistencies. It can be 
summarised that membrane-based immunoassays generally show higher detection limits 
than conventional ones. 
 
Current research in ochratoxin A using immunoassays is often based around antibody 
production and characterisation [Chu et al., 1976; Candlish et al., 1986; Gyongyosi-
Horvath et al., 1996], or in immunoaffinity column applications [Goryacheva et al., 
2006] and multi-analyte analysis [Saha et al., 2007] and some specialised application 
include the application of colloidal gold direct competitive immunoassay with a 
detection limit of 1.0 μg L-1 [Wang et al., 2007] and a gel-based direct competitive 
ELISA for ochratoxin A in beer resulting in a detection limit of 0.2 μg L-1.  
 
This research shows that the immunoassay developed in this work has the potential of 
improving its detection limit below 1 μg L-1 and that both direct and indirect format 
using both polyclonal and monoclonal antibodies are capable of achieving a very 
sensitive detection limit in various sample commodities. 
 
Furthermore, throughout the immunoassay development in this work, it became 
apparent that there was a need for comparison with another ochratoxin A antibody, 
particularly one that has no likelihood of cross-reacting with BSA. Even though, a 
cross-reaction with BSA could not be positively confirmed, especially results from 
Section 2.4.4 indicated the involvement of BSA in high standard deviation of the signal. 
Therefore, a more accurate method to characterise antibody binding to ochratoxin A 
was needed. Biospecific interaction analysis such as surface plasmon based Biacore 
technology can be used for monitoring binding interaction, kinetic rates and cross-
reactivity towards BSA. Affinity data for one or more antibodies can be quickly 
obtained and compared to the solid phase immunoassay data. As the solid phase 
immunoassay was developed to optimise the ochratoxin A binding assay for eventual 
sensor development, the Biacore analysis can be used to compare antibody affinities and 
cross-reactivity to screen the optimal antibody to be used as recognition element in 
sensor construction. 
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CHAPTER 3 : SURFACE PLASMON RESONANCE 
ANALYSIS OF OCHRATOXIN A ANTIBODIES 
3.1 Introduction 
Different ochratoxin A antibodies available commercially allow for optimal sensor 
development by selecting the best antibody to be implemented as recognition element in 
the immunosensor. Therefore, antibodies need to be characterised for their binding 
ability for ochratoxin A. To investigate the effect of ligand immobilisation in a direct 
and indirect binding format, a number of antibody receptors can be screened for 
common characteristics such as binding recognition of ochratoxin A and the strength of 
the interaction. Different antibodies can bind an analyte with the same affinity even 
though the kinetic rates are different. Binding interaction analysis was performed using 
surface plasmon resonance to investigate the affinity and kinetics of several antibodies 
interacting with ochratoxin A. The surface plasmon resonance phenomenon and its use 
in binding interaction analysis have been described by Johnsson et al., [1991]. Sensors 
based on surface plasmon resonance (SPR) have been reviewed by Homola et al. [1999] 
and the use of a SPR biosensor for mycotoxin analysis binding to specific antibodies 
was described by van der Gaag et al. [2003] and will be discussed in this chapter.  
The objective of this work was the development of a binding assay for ochratoxin A 
detection using a commercial biosensor based on surface plasmon resonance (Biacore). 
In the process, the affinity of anti-ochratoxin A antibodies B (Biogenesis Ltd) and 
antibody A (Acris GmBH) for immobilised ochratoxin A-BSA conjugate is monitored. 
Upon antibody immobilisation while using ochratoxin A-BSA as analyte, the difference 
in affinity is compared. A competitive binding assay was developed on the SPR sensor 
and investigated whether the SPR biosensor can be used for wine analysis. 
 
As both antibodies are polyclonal (subject to availability), the affinity measured will be 
a combination of affinities and thus the results will display avidity. The immobilisation 
of ochratoxin A-BSA conjugate compared to antibody immobilisation should show a 
variation in affinity as the immobilisation will especially affect the antibody binding 
capacity. By testing different antibodies and different formats of binding, the resulting 
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data will allow estimation about which binding assay format will be optimal for the 
proposed sensor and also which antibody should be used as recognition element. 
 
The affinity of the antibodies is also expected to be high for the ochratoxin A-BSA 
conjugate since it has 3-6 mol ochratoxin A per molecule of BSA (Sigma-Alrdich Ltd., 
UK) that can lead to enhanced avidity as a result of the increased number of binding 
sites. Multiple binding sites are also likely to cause a problem when analysing the 
kinetics and affinity using standard binding models. 
3.2 Experimental 
The ochratoxin A-BSA conjugate, ochratoxin A and BSA, acetate buffer and glycine 
was purchased from Sigma Aldrich Ltd., UK. The CM5 sensor chips, HEPES buffered 
saline (HBS-EP), 1 M ethanolamine, pH 8.5, 0.4 M EDC (N-(3-dimethylaminopropyl)-
N'-ethylcarbodiimide) and 0.1 M NHS (N-hydroxysuccinimide) as well as the BIAcore 
3000™ used for the analysis were from BIAcore (Uppsala, Sweden). The ochratoxin A-
antibodies were from Biogenesis Ltd. (UK) and Acris GmbH (Germany) and are 
hereafter referred to as ochratoxin A antibody B (Biogenesis) and A (Acris). 
3.3 Methods 
3.3.1 Amine coupling of ochratoxin A-BSA to the CM5 sensor chip 
The binding interaction analysis of ochratoxin-BSA with the anti-ochratoxin antibodies 
(Biogenesis Ltd. (now known as MorphoSys UK Ltd.) & Acris GmBH) were carried 
out on a CM5 (carboxymethylated dextran on gold) sensor chip. HBS (0.01 M HEPES 
pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% Surfactant P20) was used as running and 
dilution buffer. The CM5 surface was activated using 0.4 M N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) and 0.1 M N-hydroxysuccinimide 
(NHS), according to BIAcore instruction manual, applying amine coupling. Amine 
coupling involves the activation of carboxy-groups present on the sensor surface by a 
mixture of NHS and EDC to give reactive succinimide esters. Ligands passed over the 
surface react with their primary amines with the succinimide esters and link the ligand 
covalently to the carboxymethylated dextran surface. In brief, a 1:1 mixture of 
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EDC/NHS was passed over the surface for 6 minutes at a flow rate of 5 μl min-1. The 
ligand ochratoxin A-BSA was diluted in 10 mM acetate buffer, pH 4.5 to a 
concentration of 100 μg ml-1. The injection volume was 75 μl at a flow rate of 5 μl per 
minute for 15 minutes. Every flow cell of a sensor chip was immobilised separately. 
Non-bound binding sites were subsequently deactivated by injecting 35 μl 1M 
ethanolamine-HCl, pH 8.5 for 7 minutes. Calibration was executed at a flow rate of 5 μl 
min-1 and regeneration was performed of the surface using 15 μl 20 mM Glycine-HCl, 
pH 2.0 for 3 minutes. Antibody A and B analytes were injected at a volume of 50 μl at a 
flow of 5 μl per minute. This was followed by a dissocication phase of about 7 minutes, 
regeneration by 15 μl 20 mM Glycine-HCl plus 2 minutes to stabilise the baseline 
before another injection. 
 
The immunogen used for the production of the polyclonal antibody from Acris GmbH is 
a synthetic peptide corresponding to part of the native molecule conjugated to bovine 
serum albumin, whereas the immunogen used for the antibody manufactured by 
Biogenesis Ltd. is a BSA conjugate of ochratoxin A. The specificity of the antibody was 
determined by the manufacturer as for ochratoxin A 100%, ochratoxin B 1%, BSA 
(absorbed) <0.1% for both antibodies. Both antibodies were Ig purified. There has been 
a report of the Biogenesis antibody to be showing cross-reaction with BSA [Alarcon et 
al., 2004]. Therefore, BSA was co-immobilised on a reference flow cell as negative 
control for both antibodies, thus allowing subtraction of any cross-interaction of BSA 
from the specific binding event. 
3.3.2 Amine coupling of ochratoxin A antibody to the CM5 sensor 
chip 
Ochratoxin A antibody B was immobilised using amine coupling using the procedure 
described for ochratoxin A-BSA. The analyte (ochratoxin A-BSA and ochratoxin A-
HRP) were injected at a volume of 25 μl at a flow rate of 5 μl per minutes. Competitive 
reactions were performed by pre-incubation of a fixed ochratoxin A- antibody 
concentration (5 mg L-1) with varying ochratoxin A concentrations (0.1; 1; 10; 50 and 
100 μg ml-1) for 15 minutes and then injected a volume of 50 μl at a flow rate of 5 μl per 
minutes. The kinetic parameters of the binding reactions were determined using 
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BIAevaluation 3.2 software (Karlsson et al., 1994) and statistically validated using the 
chi-square distribution (also chi-squared or χ2 distribution), which is one of the most 
widely used theoretical probability distributions in inferential statistics, i.e. in statistical 
significance tests. The resonance signal is displayed in resonance units (RU) that can be 
directly related to a specific biomolecule mass on the sensor chip surface. 
 
A binding interaction is comprised of the analyte transfer from the bulk solution onto 
the surface and the subsequential binding of the analyte to the surface bound ligand. The 
analyte transfer from the bulk solution onto the surface is termed mass transfer and is 
dependent on diffusion and convection (in a flow system). The mass transfer depends on 
the flow cell dimensions, the diffusion coefficient of the analyte and the flow rate, 
whereas the rate of the binding interaction depends on the association and dissociation 
constants of the analyte, the concentration of the analyte on the surface and the surface 
binding capacity [Glaser, 1993]. Checking for mass transfer limitations is done by 
injecting the analyte at different flow rates. The association and dissociation rate 
constants should be the same between different flow rates when mass transfer 
limitations are not present. 
3.3.2.1 Production of Ochratoxin A-HRP conjugate 
The ochratoxin A-HRP conjugation method was adapted from the method according 
Chu et al. [1976]. Ochratoxin A (2 mg) was suspended in 400 µl ethanol (98%) with 15 
mg EDAC and 7.5 mg NHS (in PBS, pH 7.4) and stirred for 12 hours at room 
temperature. Horseradish peroxidase (4 mg, dissolved in PBS, pH 6.5) was added to the 
solution and stirred for another 12 hours at room temperature. The conjugate was 
dialysed against PBS, pH 7.4 for 48 hours at room temperature using a dialysis cassette 
with a MWCO of 10.000. 
3.3.2.2 Wine sample preparation 
All wine samples were purchased from major UK supermarkets within a price range of 
£3-5. The wine samples for Biacore analysis were pre-treated using immunoaffinity 
clean-up according to the “OchraTest™ AOAC HPLC procedure for wine and beer” in 
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accordance with the work published by Visconti et al. [1999]. Wine (5 ml) was added to 
5 ml of diluting solution (1% polyethylene glycol (PEG) + 5% NaHCO3, pH 8.3) and 
mixed vigorously. The Ochratest™ immunoaffinity column was connected to a 
pumpstand and 10 ml diluted sample solution was added to the column reservoir, 
whereas the solution was passed through the column at a flow rate of 1-2 drops/second 
using a syringe. The column was washed using 5 ml washing solution (2.5% NaCl + 
0.5% NaHCO3) and then dried. Ochratoxin A was eluted by passing 2 mL methanol, at 
a flow rate of 1 drop/second, trough the column and the eluate was evaporated to 
dryness at 50°C under Nitrogen. The eluate was re-dissolved immediately in 250 μl 
HEPES buffer, pH 7.4 for Biacore analysis. 
3.3.2.3 Control experiments 
To establish what type of binding model would fit the interaction; a linked reaction 
experiment is carried out. A fixed concentration of ochratoxin A-BSA analyte (10 mg 
L-1) is passed over a sensor surface with immobilised ochratoxin A antibody. The 
binding interaction is observed at different flow rates (1 and 5 μl min-1) resulting in 
different length of association and dissociation phase. The Biaevaluation software 3.2 
aligns both curves at the injection stop marker (end of association). The dissociation 
phase is analysed by observing if the dissociation phases overlay. A 1:1 binding or 
heterogenous ligand binding model will result in overlaying dissociation curves, 
whereas overlapping dissociation curves indicate a more complex binding model. 
 
The mass transfer control experiment involves both ochratoxin A antibodies being 
passed over a sensor surface with immobilised ochratoxin A-BSA. The binding 
interaction is observed at increasing flow rates (5, 15 and 75 μl min-1) and the 
association (ka) and dissociation constant (kd) of the resulting sensorgrams are obtained 
and plotted versus the flow rate. Mass transfer is flow rate-dependent and an increase in 
flow rate will result in increased ka and kd if mass transfer is involved in the interaction. 
 
BSA cross-reactivity was assessed by passing varying antibody concentrations over a 
sensor surface immobilised with BSA. The sensorgrams of the association and 
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dissociation were monitored and the binding interaction evaluated using Biaevaluation 
software 3.2. 
 
The immobilised biomolecule will be referred to as ligand, whereas the interacting 
partner free in solution will be referred to as analyte according to the definition used 
with Biacore. In the following section, the anti-ochratoxin A polyclonal antibody 
purchased from Acris Antibodies GmbH will be abbreviated as ‘antibody A’ and the 
one from Biogenesis Ltd. as ‘antibody B’. 
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3.4 Results and Discussion 
3.4.1 Immobilisation of Ligands 
The amount of biomolecule to be immobilised to the sensor chip surface depends on the 
molecular weight of the immobilised ligand and also of the analyte. According to the 
Biacore description, when using large molecular weight ligands and analytes (such as 
ochratoxin A-BSA and specific antibody), as much as possible of the ligand should be 
immobilised. High surface density allows rapid binding at low analyte concentrations, 
thereby improving sensitivity. When measuring kinetics, a lower amount of 
immobilised ligand is generally preferred to reduce adverse effects such as mass 
transport limitations of the analyte. The ligands used in this work and their respective 
immobilisation level (RU) on the CM5 chip surfaces is shown in Table 3.1. 
Table 3.1: Immobilisation levels of ligands immobilised on carboxymethylated gold 
surface via amine coupling. 
Ligand Immobilisation level [RU] Analyte 
Ochratoxin A-BSA 6460 RU Ochratoxin A antibody 
Ochratoxin A antibody B 5400 RU Ochratoxin A-BSA 
Ochratoxin A antibody A 2380 RU Ochratoxin A-BSA 
The immobilisation level can be calculated according to the estimation that 1 RU is 
about equal to 1 pg mm-2 of ligand immobilised [Biacore Evaluation Handbook, 1998]. 
The net surface plasmon resonance signal for immobilized ochratoxin A-BSA, with a 
MW ≈ 67211-68422 g mol-1 (3-6 mol ochratoxin A at MW 403.81 g mol-1 per mol BSA 
at MW 66000 g mol-1), was 6460 resonance units after completion of the chip 
regeneration cycle, which corresponds to 6.5 ng/mm2 (95-96 fmol/mm2). The net 
surface plasmon resonance signal for immobilized ochratoxin A-antibody B, with a MW 
≈ 150000-180000 g mol-1 was 5400 resonance units after completion of the chip 
regeneration cycle, which corresponds to 5.4 ng/mm2 (30-36 fmol/mm2). The net 
surface plasmon resonance signal for immobilized ochratoxin A-antibody A, with a 
MW ≈ 150000-180000 g mol-1 was 2380 resonance units after completion of the chip 
regeneration cycle, which corresponds to 2.38 ng/mm2 (13-15 fmol/mm2). 
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3.4.2 Binding interaction analysis of ochratoxin A antibodies 
Sensorgrams show binding interactions in real-time as a plot of time (seconds) versus 
response signal (RU). Kinetics and affinities are defined by the association rate constant 
ka [Ms-1], dissociation rate constant kd [s-1], the affinity constant KA [M-1] and the 
equilibrium dissociation constant KD [M].  
3.4.3 Immobilised ochratoxin A-BSA-conjugate 
The Figure below (Figure 3.1) illustrates the covalent immobilisation of the ochratoxin 
A-BSA ligand to the carboxymethylated dextran on the CM5 sensor chip surface. 
Ochratoxin A antibody
BSA BSA BSABSA BSA
C=O
NH
CM5 sensor chip
OTA
C=O
NH
C=O
NH
C=O
NH
C=O
NH
 
Figure 3.1: Covalently immobilised ochratoxin A-BSA is linked to the sensor chip 
surface trough a carbodiimide linker. The illustration represents amine coupling. The 
ochratoxin A antibody is passed over the surface at a set flow rate displaying association 
and dissociation from the immobilised ochratoxin A-BSA ligand. 
3.4.3.1 Ochratoxin A-BSA ligand with antibody B analyte 
To assess the binding interaction of antibody B to immobilized ochratoxin A-BSA, a 
range of antibody analyte concentrations was injected over the ochratoxin A-BSA 
ligand surface. Here, the reference is a blank surface that was blocked with 
ethanolamine. Any cross-reactivity of antibody B to BSA will be included in the 
response units of the curves shown in Figure 3.2.  
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Figure 3.2: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Biogenesis) to immobilized ochratoxin A-BSA. A medium 
concentration (10 μg ml-1) antibody was measured in duplicate to assess the 
reproducibility of the method. The ochratoxin A-antibody concentrations as displayed 
from top to bottom ranged from 100, 50, 10, 5, 2, 1 and 0 mg L-1. The zero 
concentration is equivalent to the same volume of buffer injected over the surface. All 
curves were substracted by a blank reference surface (ethanolamine blocked). 
Figure 3.2 shows that the response signal decreases according to the decreasing 
antibody concentration binding to the surface-bound ligand. Measurements are 
reproducible as indicated by the concentration duplicate (10 mg L-1 antibody B). High 
association and low dissociation rates were observed suggesting high affinity of the 
interaction. The sensitivity of the binding interaction was estimated at 2 mg L-1 antibody 
B with a response of 20 RU. The higher antibody concentrations had shown 
reproducible and distinct binding curves and were therefore selected in duplicate for the 
kinetic assessment (sensorgram not shown). For the kinetic evaluation, the reality of the 
binding cannot be truly assessed using the available fitting models. The kinetic model is 
complex since the immoblised ochratoxin A-BSA offers three or more binding sites 
whereas the antibody analyte suggests bivalent binding and the cross-reactivity towards 
BSA has to be included as well. The 1:1 Langmuir model was chosen as it shows the 
best chi2 value for the fit. The model is not displaying the true binding rates but suggests 
that the interaction is strong with an association rate constant of ka = 4.36x103 Ms-1 and 
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a dissociation rate constant of kd = 7.82x10-5 s-1 resulting in affinity of KA = 5.58x107 
M-1 and KD = 1.79x10-8 M.  
In the following experiment, immobilised BSA is used as reference and the response 
signal subtracted automatically by BIAevaluation from the specific binding event. Here, 
only the antibody binding to ochratoxin A will be included in the response units of the 
curves shown in Figure 3.3. 
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Figure 3.3: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Biogenesis) to immobilized ochratoxin A-BSA. A medium 
concentration (10 μg ml-1) antibody was measured in duplicate to assess the 
reproducibility of the method. The ochratoxin A-antibody concentrations as displayed 
from top to bottom ranged from 100, 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.05 and 0 mg L-1. 
The zero concentration is equivalent to the same volume of buffer injected over the 
surface. All curves were substracted by a blank reference surface (BSA blocked). 
Figure 3.3 illustrates the sensorgams showing a steeper, faster association rate and much 
slower dissociation, which indicates that the specific interaction has high affinity. The 
1:1 Langmuir model suggests that the interaction is quite strong with ka = 5.13x103 Ms-1 
and kd = 5.22x10-9 s-1 resulting in affinity of KA = 9.84x1011 M-1 and KD = 1.02x10-12 M. 
The evaluation confirms that the antibody binds very strongly and only dissociates very 
slowly from ochratoxin A. The affinity shows a 4 orders of magnitude increase 
compared to the binding event where a mixture of specific binding and cross-reaction 
with BSA is monitored (Figure 3.2). The LOD at a maximum response of 5 RU is 
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corresponding to an antibody concentration of 0.2 mg L-1, increasing the sensitivity ten 
fold. 
3.4.3.2 Ochratoxin A-BSA ligand with antibody A  
The same experiment was also performed with antibody A. Selected antibody 
concentrations were investigated on the same ochratoxin A-BSA surface and the 
reference is a blank surface that was blocked with ethanolamine. Any binding of the 
antibody to BSA will be included in the response units of the curves shown in Figure 
3.4.  
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Figure 3.4: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Acris) to immobilized ochratoxin A-BSA. All curves are 
reference subtracted. The ochratoxin A-antibody concentrations as displayed from top 
to bottom ranged from 10, 5, 2, 1, 0.5 mg L-1 and zero injection (PBS). The zero 
concentration is equivalent to the same volume of buffer injected over the surface. All 
curves were substracted by a blank reference surface (ethanolamine blocked). 
The sensorgram in Figure 3.4 illustrates the binding interaction of the antibody A with 
immobilized ochratoxin A-BSA at distinct concentrations. The lowest concentration of 
0.5 mg L-1 showed a maximum response of 17 RU, whereas the corresponding analysis 
of antibody B had shown a similar response (of 20 RU) at 2 mg L-1 suggesting that 
antibody A is more sensitive than B. The sensorgram also indicates a bulk refractive 
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index change (The refractive index change RI is seen as signal spike at injection start 
and end). The highest antibody concentration (10 mg L-1) displays a RI value of 60 RU, 
the lower concentrations range between 10-20 RU, thus confirming that the RI is 
concentration dependent. The kinetic evaluation, using the 1:1 Langmuir model as 
described earlier, suggests that the interaction is quite strong with ka = 2.07x104 Ms-1 
and kd = 8.59x10-5 s-1 resulting in affinity of KA = 2.41x108 M-1 and KD = 4.16x10-9 M.  
 
Having immobilised BSA as reference and the response signal subtracted automatically 
from the specific binding event the resulting sensorgram is shown in Figure 3.5. 
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Figure 3.5: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Acris) to immobilized ochratoxin A-BSA. All curves are BSA 
reference subtracted. The ochratoxin A-antibody concentrations as displayed from top 
to bottom ranged from 100, 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.05 and 0 mg L-1. The zero 
concentration is equivalent to the same volume of buffer injected over the surface. All 
curves were substracted by a blank reference surface (BSA blocked). 
Figure 3.5 shows sensorgrams displaying fast association and low dissociation rates, 
which are also observed in Figure 3.4 when using a blank surface as reference. The 1:1 
Langmuir model suggests that the interaction is strong with ka = 8.4x103 Ms-1 and kd = 
3.29x10-8 s-1 resulting in affinity of KA = 2.55x1011 M-1 and KD = 3.92x10-12 M 
confirming that the antibody has very high affinity and only dissociates very slowly 
from the ochratoxin A. The affinity shows a three orders of magnitude increase 
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compared to the binding event where a mixture of specific binding and cross-reaction 
with BSA is monitored (Figure 3.4). The LOD at a maximum response of 6 RU is 
corresponding to an antibody concentration of 0.1 mg L-1, which is a five fold increase 
in sensitivity in respect to the binding interaction, monitored using ethanolamine 
blocking as reference. 
 
Comparing Figure 3.2 to 3.4, antibody A shows a magnitude higher affinity and 4  
orders of magnitude better sensitivity than antibody B. Taking into account the cross-
reactivity of the antibodies towards BSA (Figure 3.3 and 3.5), antibody B shows slower 
dissociation rates resulting in three times higher affinity of antibody B for the 
immobilized ochratoxin A-conjugate than antibody A. However, antibody A shows 
better sensitivity in comparison (two fold more sensitive). This shows that the cross-
reactivity towards BSA has sufficient impact on the overall binding interaction to affect 
the overall affinity. For accurate kinetics and affinity, a BSA reference should be used at 
all time using this binding format. 
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3.4.4 Immobilised antibody 
As a comparison the antibody was immobilised and the ochratoxin A-BSA conjugate 
used as analyte as illustrated in Figure 3.6. Here, the influence of cross-reaction with 
BSA cannot be reference subtracted, as the conjugate is injected as analyte. Only 
immobilised ligands can be used as reference using the BIAevaluation software 3.2. 
This has to be taken into consideration when analysing affinity of the binding 
interactions. 
Ochratoxin A antibody
BSA
BSA
BSA
BSA
BSA
C=O
NH
CM5 sensor chip
C=O
NH
C=O
NH
C=O
NH
C=O
NH
 
Figure 3.6: Covalently immobilised ochratoxin A antibody is linked to the sensor chip 
surface trough a carbodiimide linker. The illustration represents amine coupling. The 
ochratoxin A-BSA analyte is passed over the surface at a set flow rate displaying 
association and dissociation from the immobilised ochratoxin A antibody ligand. 
3.4.4.1 Antibody B ligand with ochratoxin A-BSA analyte 
Anti-ochratoxin A antibody B itself was successfully immobilized onto a CM5 chip 
surface to investigate a direct assay format. The activity of an antibody could be 
decreased due to non-site-specific immobilisation which might hinder the access to its 
antigen-binding site; nevertheless the ochratoxin A-BSA analyte showed sensitive 
binding as seen in Figure 3.7. 
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Figure 3.7: Sensorgram of response unit versus time illustrating varying ochratoxin A-
BSA concentrations (top to bottom: 100, 10, 1, 0.1 and 0.01 mg L-1) binding 
immobilized anti-ochratoxin A antibody (Biogenesis). All curves are reference 
subtracted with non-specific IgG used as blank. 
The overall signal response shown in Figure 3.7 was clearly lower and the drifting 
baseline implies that the immobilised antibody is leaking off the surface due to 
insufficient covalent attachment. This assumption was made as the drift had been 
observed over several hours of flowing buffer over the surface, but did not stabilise. The 
low response unit can be a result of activity of the immobilised antibody and the 
decreasing surface coverage of the antibody as it is leaking off the surface over time. 
The curve displaying the highest ochratoxin A-BSA analyte concentration (red) might 
indicate a biphasic binding event as the association and dissociation curves seem to 
progress at two stages. This can be seen as the initial association progresses very 
quickly however does not proceed into a signal plateau as expected for a steady state 
reaction but progresses by further increase in signal, which indicates a second binding 
phase. This can be a result of multiple binding events as ochratoxin A-BSA has on 
average 3-6 epitopes, as a result of binding cooperativity and also as a result of the 
antibody cross-reacting with BSA at a different affinity. Analysing the data with 1:1 
binding kinetics, the average kinetics and affinity for antibody B binding immobilized 
ochratoxin A-BSA are: ka = 2x104 Ms-1, kd = 3x10-3 s-1 and KA = 6x104 M-1, KD = 3x10-6 
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M. The affinity of the binding interaction was about two to three magnitudes lower 
having the antibody immobilized instead of ochratoxin A-BSA, as compared to the 
binding interaction (blank reference) shown in Figure 3.2  as it also includes BSA cross-
reaction. The lower affinity is mainly due to the increase in dissociation rate, which 
indicates a slight activity loss of the immobilised antibody and thus a decrease in 
binding strength. The sensitivity of the binding interaction though was sufficiently low 
at a concentration of 1 mg L-1. 
3.4.4.2 Antibody A ligand with ochratoxin A-BSA analyte 
Antibody A was also immobilized onto a CM5 chip surface to investigate a direct assay 
format using ochratoxin A-conjugates. 
 
Figure 3.8 below shows a steady baseline and no signal drift indicating a stable 
immobilisation of antibody. This is also corresponding well with the overall signal 
response, which was lower than shown with antibody B (Figure 3.7). 
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Figure 3.8: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-BSA to immobilized ochratoxin A-antibody (Acris). All curves are 
reference subtracted with non-specific IgG used as blank. All conjugate concentrations 
were measured in duplicate to assess the reproducibility of the method. The ochratoxin 
A-BSA concentrations as displayed from top to bottom ranged from 100, 50, 20, 10, 5, 
2, 1, 0.5, 0.2, 0.1 and 0 mg L-1. 
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Figure 3.8 shows a reduced binding response at similar ochratoxin A-BSA analyte 
concentrations. This is probably a result of the activity loss upon non-site-directed 
immobilisation. Also, the immobilisation level of antibody A was only 2380 RU 
compared to 5400 RU for antibody B, indicating lower binding capacity. Fitting basic 
kinetic model 1:1 Langmuir binding to the curves results, the kinetics and affinity of the 
binding interaction are summarized as follows: ka = 1.41x105 M-1s-1, kd = 4.75x10-4 s-1 
and KA = 2.96x108 M-1, KD = 3.38x10-9 M. 
3.4.4.3 Antibody A ligand with ochratoxin A-HRP analyte 
A commercially available ochratoxin A-HRP conjugate is not available except for those 
being included in binding assay kits, which are generally expensive. As a cost-effective 
alternative, an in-house prepared ochratoxin A-HRP conjugate (as described in section 
3.3.2.1) has shown good enzyme activity containing a crude mixture of HRP and HRP-
conjugate. The ratio of ochratoxin A per mol horseradish peroxidase was not analysed 
and therefore is not known.  
 
To assess the composition of the conjugate, one has to employ for instance Matrix-
Assisted Laser Desorption/Ionisation (MALDI) Time-of-Flight (TOF) mass 
spectrometry. At this point, this method is not available. Therefore, the success of the 
conjugation with ochratoxin A was verified using binding analysis. Antibody A was 
chosen for this experiment (Figure 3.9) as it had previously shown higher sensitivity for 
the ochratoxin A-BSA conjugate.  
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Figure 3.9: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-HRP (Horseradish peroxidase) to immobilized ochratoxin A-antibody 
(Acris; amine coupling). All curves are reference subtracted with non-specific IgG used 
as blank. All conjugate concentrations were measured in duplicate to assess the 
reproducibility of the method. The ochratoxin A-BSA concentrations as displayed from 
top to bottom ranged from 100, 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1 and 0 mg L-1. 
The sensorgram (Figure 3.9) shows very little response with the highest ochratoxin A-
HRP concentrations resulting in about 5 RU (five fold less response than with 
ochratoxin A-BSA). The residuals analysis shows a variation in signal of +/-0.8 RU. It 
was assumed that ochratoxin A-HRP interacts with the immobilised antibody as a clear 
association phase that can be observed in contrast to the zero concentration (blank 
injection).  
 
Therefore, the sensorgrams were fitted to the kinetic model 1:1 Langmuir binding, 
which gives a Chi2 value of 1.01 as indicator of good statistical value. The kinetics of 
the binding interaction is ka = 0.0173 Ms-1 and kd = 1.01x10-5 s-1, KA = 1.71x103 M-1 
and 5.84x10-4 M. The affinity evaluation confirms very little affinity, as a result of very 
fast association and dissociation, of the conjugate for the immobilised antibody A. This 
indicates that the conjugation ratio of mol ochratoxin A to mol HRP is probably low 
suggesting that the conjugate should not be used in sensitive binding assays. 
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Due to the lack of a suitable reference cell, in retrospective, a simple injection of BSA 
alone could have been used as a reference to the injection of ochratoxin A-BSA and 
ochratoxin A-HRP by subtracting the sensorgram of the BSA injection from the signal 
curve. 
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3.4.5 Immobilised ochratoxin A-BSA with ochratoxin A competitor 
Competitive assays differ from direct binding analysis as the binding interaction is not 
entirely happening on the ligand surface (surface affinity) but also in the analyte 
solution (solution affinity) as illustrated in Figure 3.10. 
Premixed
Ochratoxin A antibody + OTA
BSA BSA BSABSA BSAOTA
C=O
NH
CM5 sensor chip
C=O
NH
C=O
NH
C=O
NH
C=O
NH
 
Figure 3.10: Covalently immobilised ochratoxin A-BSA is linked to the sensor chip 
surface via amine coupling. The ochratoxin A antibody is premixed with varying 
ochratoxin A concentrations and the solution is then passed over the sensor surface at a 
set flow rate illustrating the competitive reaction of premixed ochratoxin A and 
immobilised ochratoxin A-BSA ligand for antibody binding sites. 
3.4.5.1 Ochratoxin A-BSA ligand with antibody B and ochratoxin A competitor 
A competitive assay using ochratoxin A antibody B analyte and ochratoxin A as 
competitor is shown in Figure 3.11. 
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Figure 3.11: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Biogenesis) to ochratoxin A in solution competing with 
immobilized ochratoxin A-BSA. The measurement was performed in duplicate and the 
ochratoxin A concentrations in solution with the antibody are displayed in duplicate 
from top to bottom: 0, 0.0001; 0.001; 0.01; 0.1; 1; 10 and 100 mg L-1 ochratoxin A 
standard. 
The sensograms in Figure 3.11 illustrate that with the increase in ochratoxin A 
concentration, antibody B will predominantly bind the free analyte than to immobilized 
ochratoxin A-BSA surface resulting in a decrease in signal. The response signal drops 
with increase in ochratoxin A competitor in solution. However, no competition could be 
observed with ochratoxin A standard concentrations below 0.1 mg L-1. This could be 
due to the cross-reaction with immobilised BSA-conjugate as competitive standard 
curve with ochratoxin A-BSA could not be obtained. 
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3.4.5.2 Ochratoxin A-BSA ligand with antibody A and ochratoxin A competitor 
A competitive assay using the second ochratoxin A antibody (A) with ochratoxin A in 
solution as competitor is shown in Figure (Figure 3.12). 
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Figure 3.12: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Acris) to ochratoxin A in solution competing with immobilized 
ochratoxin A-BSA. The measurement was performed in duplicate and the ochratoxin A 
concentrations in solution with the antibody are displayed in duplicate from top to 
bottom: 0, 0.0001; 0.001; 0.01; 0.1; 1; 10 and 100 mg L-1 ochratoxin A standard. 
Figure 3.12 shows the response signal drop with increase in ochratoxin A competitor in 
solution indicating the competition of ochratoxin A with immobilised ochratoxin A-
BSA for antibody A binding sites. No competition was observed with lower ochratoxin 
A standard concentrations below 0.001 mg L-1.  This indirect competitive assay shows 
that both antibodies show some sensitivity for the ochratoxin A standard, particularly 
antibody A which shows a 100 times better sensitivity than antibody B. However, the 
influence of BSA cross-reactivity leads to a non-linear relationship of response signal 
versus ochratoxin A standard concentration when attempting a standard curve. 
Therefore, the competitive assay has to be improved by either affinity purifying the 
antibodies using a BSA-immunoaffinity column or by adding BSA to the buffer 
solutions used for binding interaction to reduce non-specific binding. 
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3.4.6 Wine sample analysis 
As antibody A had shown better sensitivity in the competitive assay (Figure 3.12) it was 
used when monitoring a number of standard ochratoxin A concentrations in a 
competitive format to establish a standard curve that can be used alongside wine 
analysis. The indirect competitive assay has been optimised regarding the cross-
reactivity with BSA by adding 10 mg L-1 BSA to antibody A solution before it was 
premixed with an ochratoxin A standards and injected over the immobilised ochratoxin 
A-BSA conjugate. The competitive binding interaction is shown in Figure 3.13. 
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Figure 3.13: Sensorgram of response unit versus time illustrating the binding of 
ochratoxin A-antibody (Acris) to ochratoxin A in solution competing with immobilized 
ochratoxin A-BSA. The reference surface is blocked with BSA and used as blank. The 
measurement was performed in duplicate and the ochratoxin A concentrations in 
solution with the antibody are displayed in duplicate from top to bottom: 0, 0.0001; 
0.001; 0.01; 0.1; 1; and 10 mg L-1 ochratoxin A standard (in HEPES buffer pH 7.4). 
The overall response signal is much lower shown in Figure 3.13 compared to the 
untreated (no BSA additive) assay shown in Figure 3.12. The optimised assay shows a 
much more refined decrease of response signal with increasing ochratoxin A standard 
concentration. The response signal at the end of the dissociation phase indicates the 
amount of analyte (antibody A) bound to the ligand surface (ochratoxin A-BSA). At the 
end of dissociation all loosely bound biomaterial is washed off and the response unit 
should directly correspond to the antibody concentration bound to the surface and thus 
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inversely to the ochratoxin A standard concentration. By plotting the RU values at the 
end of dissociation of each sensorgram against the respective ochratoxin A 
concentration, a standard curve is presented (Figure 3.14). 
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Figure 3.14: Standard curve displaying response signal [RU] versus ochratoxin A 
standard concentration: 0; 0.0001; 0.001; 0.1 and 10 mg L-1 in HBS, pH 7.4. 
The plot in Figure 3.14 shows the decrease of signal with increasing ochratoxin A 
competitor concentration. It appears that the sensitivity could be high for this method as 
there is a clear signal distinction between the 0.1 μg L-1 and zero concentration. To 
emphasize the linear decrease of the signal with concentration the data have been 
normalised by the response signal by the blank response and multiplied by 100 (Figure 
3.15).  
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Figure 3.15: Normalised response signal [RU] times 100 versus ochratoxin A standard 
concentration: 0; 0.0001; 0.001; 0.1 and 10 mg L-1. 
The blank response is the zero concentration for ochratoxin A, which should show 
maximum, non-competed binding of the antibody to ochratoxin A-BSA. Figure 3.15 
confirms the linear dependency of ochratoxin A concentration and response signal and 
illustrates the dynamic range of the binding assay of 0.1 μg L-1 to 10 mg L-1 with a 
sensitivity of below 0.1 μg L-1. The sensitivity of this assay is compared to a multi 
analyte biosensor for mycotoxins by van der Gaag et al. [2003], who describe a similar 
competitive binding assay for ochratoxin A, except for using a non-commercial 
monoclonal antibody and having an ochratoxin A-derivative immobilised on the sensor 
surface. The assay results in a sensitivity value of 0.1 μg L-1, which is in about the same 
range of magnitude as presented here. 
 
These standards were recorded along side a number of selected red wine samples that 
have been pre-treated using immunoaffinity chromatography and were re-dissolved in 
HEPES buffered saline, pH, 7.4. Wine samples were premixed with a fixed 
concentration of antibody A (2.5 μg L-1) and passed over the sensor surface. Any 
ochratoxin A present in a wine sample binds the antibody and is competing with 
immobilized ochratoxin A-BSA. The following sensorgram shows the competitive 
analysis of a number of wine samples (Figure 3.16). 
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Figure 3.16: Sensorgram of response unit versus time illustrating wine samples 
premixed with ochratoxin A antibody A passed over the sensor surface. Any ochratoxin 
A present in a wine sample binds the antibody and is competing with immobilized 
ochratoxin A-BSA. Signal spikes result from interfering substances present in wine. 
This (Figure 3.16) shows the sensorgrams depicting the signal response resulting from 
the ochratoxin A present in wine samples. Signal spikes result from interfering 
substances present in wine that affect the refractive index change on the sensor surface. 
A clear increase in signal during the association phase can only be seen with wine 
sample 4 (121 RU), 6 (15 RU) and 9 (50 RU).  
 
All other curves show a negative response or interferences in signal. This is probably 
related to the clean-up procedure of wine samples and the remainder of interfering 
particles in the concentrate, which might indicate that the immunoaffinity (IAC) clean-
up procedure is not removing isolated ochratoxin A from the wine sample but also 
other, possibly interfering, substances. Another possibility is that the solvent (methanol) 
used for ochratoxin A extraction was not completely evaporated when redissolving 
ochratoxin A in HEPES buffer and that the methanol could have an effect on the 
refractive index of the injected sample solution and thus causes the signal spikes. To be 
able to measure ochratoxin A concentration in processed wine samples, the indirect 
competitive assay needs further improvement. 
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3.4.7 Control experiments 
Some control experiments were carried out to determine the binding model of 
multivalent ochratoxin A-BSA and the bivalent antibody. Other control experiments 
involved the investigation of the common mass transfer effect and also the binding 
interaction of both antibodies to the BSA reference surface is investigated. 
3.4.7.1 Multi-valance of the binding interaction 
To establish what type of binding model would fit the interaction; a linked reaction 
experiment is carried out. A fixed concentration of ochratoxin A-BSA analyte is binding 
to immobilized ligand (antibody A) at different flow rates. By aligning the curves at the 
injection stop marker (end of association), the dissociation phase is analysed (Figure 
3.17).  
-40
-30
-20
-10
0
10
20
-8000 -6000 -4000 -2000 0 2000 4000 6000 8000
Time [sec]
R
es
po
ns
e 
[R
U
]
R
es
po
ns
e 
[R
U
]
 
Figure 3.17: Sensorgrams of response unit versus time showing a fixed concentration 
of ochratoxin A-BSA (10 mg L-1) analyte binding to immobilized ochratoxin A-
antibody at two distinct flow rates: 1 μl min-1 (blue) and 5 μl min-1 (red). 
For a 1:1 binding or heterogenous ligand, the dissociation curves should match. As seen 
in Figure 3.17, the dissociation phase at the different flow rates do not match, as the 
faster flow rate yields a dissociation curve above the slower one. This indicates that the 
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binding event is clearly more complex than a 1:1 binding or heterogeneous ligand 
model. The suggested models are bivalent analyte for analytes with two ligand binding 
sites or heterogeneous analyte, when a competing reaction occurs. Here, with ochratoxin 
A-BSA as analyte, a multivalent interaction is assumed, when the antibody is the 
analyte, it is clearly a bivalent interaction as long as the immobilized ligand is 
monovalent. With ochratoxin A-BSA immobilized, the model would fit the 
heterogeneous ligand model, as long as the analyte is monovalent. Multivalent ligands 
behave as separate binding sites, whereas multivalent analytes lead to avidity effects 
which are difficult to analyse. Since both reagents are multivalent, a perfect fit cannot 
be established easily.  
3.4.7.2 Mass transfer control experiment 
When the association rate constant (ka) is greater than 1x106 M-1s-1 then the measured 
rate of binding interaction may reflect the transfer of analyte to the surface rather than 
the reaction rate itself (Chaiken, 1993). The mass transfer control experiment for 
antibody A and B analytes to immobilised ochratoxin A-BSA is depicted in Figure 3.18 
and 3.19. 
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Figure 3.18: Association rate constant ka versus increasing flow rate. Ochratoxin A 
antibodies (antibody A (■) and antibody B (●)) are passed over a sensor surface with 
immobilised ochratoxin A-BSA. The binding interaction is observed at increasing flow 
rates (5, 15 and 75 μl min-1) and the increasing association constant (ka) is related to 
mass transfer. 
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A ka value as high as 1x106 M-1s-1 has not been observed in the presented experiments, 
however, mass transfer limitation are likely. This was identified by varying the flow 
rate, since mass transfer is influenced by flow whereas the reaction rate is flow 
independent. As seen in Figure 3.18 above, the ka value increases slightly with 
increasing flow rate (75 μl min-1). Is mass transport limitation involved, a higher flow 
rate will also decrease the dissociation rate constants (Figure 3.19) until the mass 
transport limitation is slower than the binding kinetics.  
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Figure 3.19: Dissociation rate constant kd versus increasing flow rate. Ochratoxin A 
antibodies (antibody A (■) and antibody B (●)) are passed over a sensor surface with 
immobilised ochratoxin A-BSA. The binding interaction is observed at increasing flow 
rates (5, 15 and 75 μl min-1) and the increasing dissociation constant (kd) is related to 
mass transfer. 
The dissociation rate constant kd decreased significantly at 75 μl min-1 (Figure 3.19). It 
can be assumed that there is minor mass transfer, indicated by the variation in 
association and dissociation rate constant, for both antibodies. However, the variation is 
within the standard deviation in both plots. Therefore, the mass transfer should not limit 
the interaction of the antibody analytes with immobilised ochratoxin A-BSA and the 
observed binding rate as depicted in Figure 3.3 and 3.5 is confirmed as the true, 
unlimited binding rate of the binding interaction. 
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3.4.7.3 BSA cross-reactivity 
BSA cross-reactivity can be easily assessed by monitoring varying antibody 
concentrations on a single flow cell immobilised with BSA. In the following 
experiment, the flow cell response signal that has been reference subtracted from 
sensorgrams in Figure 3.3 is shown in Figure 3.20 for antibody B binding BSA.  
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Figure 3.20: Sensorgram of response unit versus time illustrating the binding of 
antibody B to immobilized BSA (bovine serum albumin). All antibody concentrations 
are displayed from top to bottom ranged from 100, 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.05 
and 0 mg L-1. 
The flow cell response signal that has been reference subtracted from sensorgrams in 
Figure 3.5 is shown in Figure 3.21 for antibody A binding BSA. It seems that there is a 
population of antibodies that show fast kinetics with BSA and dissociation is fast and 
completed right at the beginning of the dissociation phase. 
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Figure 3.21: Sensorgram of response unit versus time illustrating the binding of 
antibody A to immobilized BSA (bovine serum albumin). All antibody concentrations 
are displayed from top to bottom ranged from 100, 50, 20, 10, 5, 2, 1, 0.5, 0.2, 0.1, 0.05 
and 0 mg L-1. 
As seen in Figure 3.20, it seems that antibody B binds with a greater capacity to 
immobilised BSA as the signal response is greater for similar antibody concentrations. 
In Figure 3.21, the beginning of the association appears to be slower than the end of 
association displaying two phase association kinetics which indicates two distinct 
populations of polyclonal antibodies binding BSA. Also, the dissociation of antibody B 
(Figure 3.20) from BSA is fast indicated by an instant drop in signal after end of 
association, whereas antibody A displays slower dissociation kinetics, which are not 
completed right at the start of the dissociation phase. This would indicate that antibody 
A is cross-reacting with BSA to a greater extend than antibody B. 
Antibody B results in the following kinetic and affinity with a chi2 value of 0.9: 
ka = 3.03x105 M-1s-1, kd = 7.49x10-4 s-1 and KA = 4.04x108 M-1, KD 2.47x10-9 M. 
Antibody A results in the following kinetic and affinity with a chi2 value of 9.05 
ka = 2.41 x103 M-1s-1, kd = 6.36x10-4 s-1 and KA = 3.79x106 M-1, KD 2.64x10-7 M. 
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The overall affinity of the antibody A for BSA is actually two magnitudes lower than 
with antibody B as a result of a fast association rate displayed in Figure 3.21. The 
affinity indicates that the antibody A is cross-reacting with BSA with less strength. 
3.5 Concluding remarks 
The binding interaction analysis using Biacore shows several advantages compared with 
standard immunoassay techniques, such as the real-time, high throughput monitoring of 
association and dissociation rates and also the sensitivity of the detection. However, the 
standard immunoassay could be optimised further.  
In this work, antibody A had shown better sensitivity in the competitive assay (Figure 
3.12) it was used when monitoring a number of standard ochratoxin A concentrations in 
a competitive format to establish a standard curve that can be used alongside wine 
analysis. Figure 3.14 and 3.15 confirms the linear dependency of ochratoxin A 
concentration and response signal and illustrates the dynamic range of the binding assay 
of 0.1 μg L-1 to 10 mg L-1 with a sensitivity of below 0.1 μg L-1. The sensitivity of this 
assay was directly compared to a multi analyte biosensor for mycotoxins by van der 
Gaag et al. [2003], who produced calibration curves for the mycotoxins, zearalenone, 
aflatoxin B1, and Ochratoxin A. The detection limit for all mycotoxins was between 0.1 
to 0.4 µg L-1. The indirect competitive binding assay for ochratoxin A was similar to 
this work, except for using a non-commercial monoclonal antibody and having an 
ochratoxin A-derivative immobilised on the sensor surface. The assay results in a 
detection limit of 0.1 μg L-1 ochratoxin A, which is in about the same range presented 
here.  
Deoxynivalenol (DON) sensing from wheat extracts by SPR-based immunoassays has 
been reported by Schnerr et al. [2002], who used a similar indirect competitive assay 
using polyclonal antibodies as described in this work, resulting in a working range 
between 0.13 and 10.0 mg L-1 of DON and a detection limit of 2.5 μg L-1. Another SPR-
based inhibition assay was developed for deoxynivalenol, using monoclonal antibodies 
as recognition elements. The assay was based on the competition for antibody binding 
between the immobilized deoxynivalenol conjugate on the sensor and the free 
deoxynivalenol molecules in the test solution. The working range of the assay was 
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between 2.5 and 30 µg L-1 [Tudos et al., 2003]. Polyclonal antibodies were used in a 
surface plasmon resonance-based immunoassay for aflatoxin B1, resulting in a linear 
range of 3- 98 µg L-1 [Daly et al., 2000]. Alternatively, Thompson and Maragos 
[Maragos & Thompson, 1999] designed a fibre-optic immunosensor that has the 
potential for screening corn for fumonisins with a detection limit of 10 µg L-1. Optical 
waveguide lightmode spectroscopy (OWLS) has been applied for aflatoxin B1 and 
ochratoxin A determination using monoclonal antibodies in both direct and indirect 
competitive binding format. The sensitivity of the competitive assay ranged between 0.5 
– 10 μg L-1 for both aflatoxin B1 and ochratoxin A. 
This shows that few SPR-based immunosensors have been tried for ochratoxin A 
analysis, but a view were developed for deoxynivalenol showing good sensitivity of 
about 2.5 µg L-1. Other sensors were based on fibre-optic or OWLS technology, 
showing less sensitivity as compared to SPR immunosensors. The work presented here 
shows that SPR could be a sensitive technique as an alternative method for ochratoxin A 
analysis in wine, which shows the required sensitivity and applicability for multiple 
sample analysis. However, the equipment and maintenance is costly and rquires trained 
personell, thus a cheap, disposable sensor platform has an advantage. 
The antibodies analysed with SPR technology were examined to be chosen for the 
electrochemical immunosensor and should show sufficiently high affinity and 
sensitivity in an indirect detection format. Taking the influence of BSA cross-reactivity 
into account, antibody B showed higher affinity for ochratoxin A, whereas antibody A 
displayed better sensitivity of the assay. After careful consideration, antibody A was 
chosen as recognition element for the electrochemical immunosensor development. One 
reason is that sensitivity of the assay has priority over affinity, especially since the 
difference in affinity is minor and antibody A shows high affinity by itself. Secondly, an 
indirect binding assay should not involve the immunogen to avoid further cross-
reactivity and as the immunogen for antibody B was ochratoxin A-BSA conjugate and 
for antibody A the immunogen was a peptide mimicking the conjugate, the latter 
antibody A was suited better for the application even though Figure 3.20 and 3.21 
indicate that polyclonal antibody A involves a population of antibodies recognizing 
BSA non-specifically. 
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CHAPTER 4 : SCREEN PRINTED ELECTRODE 
BASED IMMUNOSENSOR FOR OCHRATOXIN A 
4.1 Introduction 
Bioanalytical assays such as immunoassays, which use specific antigen-antibody 
interaction, are commonly applied in many fields including biological and medical 
research, e.g. testing for environmental pollutants such as pesticides, in clinical drug 
tests, tumour markers, or food toxins. Immunoassays combined with electrochemical 
methods have been proven to be sensitive analytical tools obtaining detection limits 
down to 10-15 M and offer reduced instrumentation costs compared to their optical 
counterparts.  
 
Warsinke et al. [2000] already showed electrochemical immunoassays as promising 
alternatives to existing immunochemical tests for their use in opaque or optically dense 
matrices and the application of potentiometric, capacitive and amperometric transducers 
for direct and indirect electrochemical immunoassays. Amperometric transducers are 
preferred due to their fast detection, broad linear range and low detection limit. 
Competitive and non-competitive amperometric immunoassays have been developed 
with redox compounds or enzymes as labels. Amperometric screen-printed electrode 
sensors based on a sensitive immunoassay format represent a promising tool for the 
specific and sensitive analysis of ochratoxin A. The performance and reproducibility of 
an electrochemical immunosensor depend mainly on the communication of detection 
system and transducer and also on the immobilisation procedure involved.  
 
In this work the development of a disposable immunosensor on screen-printed gold 
electrodes for the analysis of ochratoxin A (OTA) contamination in wine samples is 
presented.  
 
To date, there is no known immunosensor applying screen-printed gold electrodes and 
using the indirect competitive immunoassay format for the detection of ochratoxin A in 
wine. Previous work using a screen-printed electrode sensor for ochratoxin A analysis 
has been conducted using a carbon working electrode [Alarcon et al., 2006] as well as a 
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sample clean-up. In this paper, however, we report the first use of screen-printed gold 
electrodes (SPGE) as an attractive alternative to the common carbon electrode. Major 
difficulties in the immunosensor development are primarily related to immobilising 
biomolecules that remain biologically active and secondly to generate a sensitive signal 
free of interferences arising due to complex sample matrices [Corgier et al., 2005].  
Interferences arising from wine are generally due to its polyphenols, which are easily 
oxidised on the working electrode [Avramescu et al., 2001].  
 
To tackle the problem arising from a complex sample matrix such as wine, the electrode 
surface was modified with a polyanionic reagent to diminish possible non-specific 
interaction and interference from wine components. This technique also allows for 
simple dilution of the sample prior to measurement instead of elaborative sample clean-
up and pre-concentration procedures. The assay format is an indirect system, using 
immobilised ochratoxin A-BSA conjugate, a specific ochratoxin A antibody and a HRP-
labelled anti-IgG antibody. The electrochemical detection involves chronoamperometry 
and uses a TMB/H2O2 substrate catalysed by horseradish peroxidase that has been 
widely used for screen printed immunosensors [Butler et al., 2006; Connely et al., 2006 
and Crew et al., 2007].  
 
The sensor was characterised using cyclic voltammetry and optimised resulting in a 
sensitive biosensor for ochratoxin A utilizing screen-printing technology with 
amperometric detection. The performance of the immunosensor for ochratoxin A 
standard solutions and real wine samples was cross-examined in relation to a standard 
enzyme immunoassay test kit (Ridascreen®) and HPLC analysis [European Standard, 
2006]. 
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The procedure for ochratoxin A determination in wine using the proposed screen-
printed immunosensor is considered to be economical and has a high potential for 
automation and miniaturisation. The suggested immunosensor design is illustrated in 
Figure 4.1. 
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Figure 4.1: The immunosensor procedure proposed for ochratoxin A analysis using 
immunoaffinity purification of wine samples, transfer of the sample extract to the 
immunoassay-modified screen-printed gold electrode and measurement using 
chronoamperometry. 
This (Figure 4.1) displays the immunosensor design for ochratoxin A in wine samples. 
The first step shows the immunoaffinity chromatography of wine samples using affinity 
extraction columns such as OchraTestTM and collection of concentrated ochratoxin A 
extract in buffer. The concentrated samples were transferred to the immunoassay 
modified electrode surface of the screen-printed gold electrode and upon addition of 
reactant, an amperometric signal change (current, I) can be observed over time.  
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4.2 Experimental 
Anti-ochratoxin A antibodies were purchased from Acris GmbH (Germany). Secondary 
antibody (rabbit IgG-HRP) was from Dako (DakoCytomation, Denmark). The 3,3′,5,5′-
tetramethylbenzidine (TMB) solution containing hydrogen peroxide (H2O2) was 
purchased from Europa Bioproducts Ltd. (UK). Hydroquinone, polyvinylalcohol 
(PVA), polyvinylpolypyrrolidone (PVPP), polyethylene glycol (PEG), dextran (MW 
10,000), 30 % hydrogen peroxide solution, 5% Nafion solution,  and di-sodium 
phosphate and sodiumhydrogen phosphate as well as ochratoxin A-BSA conjugate and 
ochratoxin A was purchased from Sigma Aldrich Ltd. (UK). Sodium chloride, 
chloroacetic acid, sodium hydroxide and hydrochloride acid and potassium chloride 
were obtained from Fluka (UK). N-ethyl-N’-(3-dimethylaminopropyl)-carbodiimide 
(EDC), N-hydroxysuccinimide (NHS) and 0.1 M ethanolamine was from Biacore AB 
(Uppsala, Sweden).  
 
Phosphate buffered saline, pH 7.4, containing KCl, was prepared according to the 
following recipe: NaH2PO4 (2.96 g), Na2HPO4 (11.5 g) and NaCl (8.4 g) are dissolved 
in 1L H2O. The pH was adjusted to 7.4, followed by 1:2 dilution with 0.2 M KCl in 
H2O, yielding a final concentration of 50 mM PBS, pH 7.4, containing 0.1 M KCl. 
 
Screen printing gold ink R-464 (DPM-78) was purchased from Ercon Inc. (USA). 
Electrodag graphite ink (Electrodag 423 SS) and silver/silver chloride ink (Electrodag 
6037 SS) is from Acheson Industries Inc. (USA). The insulating ink (242-SB) is an 
epoxy-based protective coating ink obtained from Agment ESL (Reading, UK). Melinex 
sheets were obtained from Cadillacprinting Ltd. (Swindon, UK). The edge connector 
with ribbon data cable (DG41U) was purchased from Maplin Electronics Ltd. (Milton 
Keynes, UK). Wine samples were chosen from distinct origins and grape species and all 
purchased from local stores in the lower to middle price range. Synthetic wine was 
kindly provided by Mariluz Rodriguez, prepared at the University of Valladolid, Spain, 
according to “Estacion Enologica of Rioja” (see also Appendix 1). 
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4.3 Methods 
A DEK 248 screen-printing system (produced by DEK, UK) was used to fabricate the 
electrodes. Cyclic voltammetry experiments and chronoamperometry studies were 
performed using a Galvanostat/Potentiostat from Autolab (EcoChemie, Utrecht, 
Netherlands). A PC equipped with data acquisition and treatment software (GPES3) was 
used to record the signal generated in the electrochemical cell and received via the 
potentiostat. 
4.3.1 Fabrication of screen printed electrodes 
Stainless steel screens with a screen mesh size of 200 counts per inch were used to print 
the electrodes. The DEK 248 parameters were adapted according to the standard 
operating procedure summarised in Table 4.1. 
Table 4.1: Screen printer DEK 248 parameters for screen printing electrodes onto a 
polyester substrate using imaged screens. 
Parameter Action 
Menu Default 
Menu name Default 
Print Mode Double Squeegee 
Print gap 2.6 cm 
Deposits 1 (Carbon ink), 2 (Ag/AgCl and 
Forward speed 66 mm s-1 
Reverse speed 66 mm s-1 
Inspection rate 0 
Alignment rate 0 
Front limit 54 mm 
Rear limit 420 cm 
Hop-over 26 mm 
Separation speed 10% 
Table-In delay 0 sec 
Squeegee delay 0 sec 
Hop-over delay 0 sec 
Squeegee pressure 4 psi 
Chapter 4: Screen printed electrode based immunosensor 
148 
The protocol in Table 4.1 was used to prepare the screen-printed electrodes (Figure 4.2) 
consisting of a gold working electrode (1.3 mm2 planar area), carbon counter electrode 
and Ag/AgCl reference electrode. The screen-printed electrodes were mass fabricated 
in-house by a multi-stage screen-printing process using a DEK model 248 machine 
(DEK, Weymouth, UK). The electrodes were printed onto 250 µm thick Melinex ST725 
polyester sheet obtained from Cadillac Plastic (Swindon, UK).  
Working Electrode
Au
Counter Electrode
Carbon Reference Electrode
Ag/AgCl
Conducting track
Carbon
10 mm
49 mm
Edge connector contacts
Insulating layer (blue)
 
Figure 4.2: Three-electrode design of screen printed gold electrodes fabricated in-house 
at Cranfield University, 2006. 
At first, the conducting basal tracks were printed using graphite based ink in one single 
deposit and dried in an oven at 100°C for 15 minutes. In the second step, a double 
deposit of silver/silver chloride in silver paste was printed onto one of the terminal basal 
tracks and dried in an oven at 100°C for 15 minutes. For screen-printed gold electrode 
construction, the centre terminal basal track was re-printed with one deposit of gold ink 
at an increased carriage speed of 66 mm s-1 and then dried at 100 for 15 minutes. In the 
last step, the basal tracks were insulated with a protective coating ink leaving a defined 
circular shaped area (3.2 mm2) for the electrical contact in measurements. The 
insulation layer was cured at 100oC for 1 hour in order to stabilise the epoxy resin.  The 
sheets were left thereafter to dry in a drying cabinet at room temperature overnight. 
About 100 electrodes are printed per sheet at a time; and can be cut into individual 
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electrodes. Prior to use, the screen printed electrodes are treated at 120°C for 30 minutes 
and then cooled to room temperature under nitrogen atmosphere. In the following, the 
screen printed gold electrodes are generally abbreviated as SPGE, screen printed carbon 
electrodes as SPCE. 
4.3.2 Electrochemical noise of screen printed electrodes 
Electrochemical noise refers to naturally occurring fluctuations in potential and current 
flow. Electrochemical noise (EN) monitoring can be further subdivided into 
electrochemical potential noise (EPN) measurements and electrochemical current noise 
(ECN) measurements. Electrochemical noise measurements to date have been 
performed entirely on the subject of corrosion [Hickling et al., 1998; Eden, 2000]. The 
noise impact of the electrode material can be determined using a zero resistance 
ammeter (ZRA). A ZRA is a current to voltage converter that produces a voltage output 
proportional to the current flowing between its two input electrodes at zero internal 
resistance. The ZRA system used in this work has been manufactured by Capsis Ltd. 
[Oxford, UK] and generally used to detect localized corrosion mechanisms in real time. 
From the three-electrode design of the screen printed electrodes, the counter and 
working electrode were connected to a ZRA and assumed as two ‘identical’ working 
electrodes during this measurement. In this context the gold microelectrodes introduced 
in Chapter 1 (Section 1.8.6) are implemented into the study as comparison to screen 
printed electrodes. The gold (Au) microelectrode comprised also a three-electrode 
design, which consists entirely of gold electrodes; one can be modified with Ag/AgCl as 
reference electrode. The SPCE has been produced in-house in the same design as the 
SPGEs and compared to an industrially manufactured SPCE (Dupont Ltd., UK) of 
similar design. In the case of SPCE and gold microelectrodes, the assumption of 
connecting ‘identical’ working electrodes is valid; however, the SPGE was connected 
assuming Au and Carbon electrode to be ‘identical’ working electrodes and was thus 
expected to show different noise patterns due to their dissimilar materials. 
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4.3.3 Voltammetric studies 
The screen-printed electrodes were inserted applying a ‘push-fit’ action via their carbon 
basal track into a 34-way edge connector connected via a ribbon data cable. Each basal 
track is connected via a single pin and the copper outlets of the ribbon cable were 
manually soldered to crocodile clamps that were connected to a ‘3-copper core (non-
plated) individually screened cable’ leading towards the PC-controlled Autolab 
potentiostat/galvanostat that is run by the software package type GPES 3 (Eco Chemie 
B.V., NL). Up to four electrodes can be fitted and monitored simultaneously; here, three 
electrodes were attached simultaneously for triplicate measurement.  
4.3.3.1 Cyclic voltammetry 
From the Autolab software, the option cyclic voltammetry (CV) was selected from the 
menu and parameters set as describe below. The cyclic voltammogram was monitored 
applying a start potential of -0.8 V, first vertex potential of 1.0 V and second vertex 
potential of -0.2 V. The step potential was 0.0027 V and CV was performed at a scan 
rate of 50 mV s-1 for three cycles.  
4.3.3.2 Cyclic voltammetric studies of TMB 
Hydroquinone and 3,3′,5,5′-tetramethylbenzidine (TMB) were examined with cyclic 
voltammetry to characterise their redox reaction on SPGEs. A solution of 20 μl TMB at 
a concentration of 0.1 μg L-1 in H2O and 0.1 μg L-1 Hydroquinone in H2O deposited 
(liquid/spot) onto a bare SPGE. TMB has been extensively used as colorimetric 
substrate for the assay of horseradish peroxidase (HRP). According to the manufacturer, 
the TMB solution (Europa Bioproducts Ltd.) is optimized with respect to TMB and 
hydrogen peroxide concentrations and yields a linear response with the concentrations 
of HRP usually employed in immunologic assays. It also contains stabilisers. 
The possibility of using SPGEs as sensors with the ready-made TMB solution was 
investigated by cyclic voltammetry. All voltammorgams were recorded in electrolyte 
buffer, since a constant concentration of chloride ions is needed in order to stabilise the 
Ag/AgCl reference electrode. Cyclic voltammetry parameters were set to a start 
potential of -0.8 V, first vertex potential of 1.0 V and second vertex potential of -0.2 V 
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and step potential was 0.0027 V. Varying scan rates were monitored for 25; 50; 75; 100; 
150; 200; and 400 mV s-1 over three cycles. When comparing TMB to 50 mM PBS, pH 
7.4 containing 0.1M KCl, the scan rate was set to 50 mV s-1.  
4.3.3.3 Redox peak characterisation 
Horanyi et al. [1983] observed that chloride ions actively participate in the electro-
oxidation of gold by voltammetric characterisation of a gold working electrode with 
chloride containing electrolyte. To conduct the voltammetric characterisation of the 
SPGE, a voltage sweep (start potential of -0.8 V, first vertex potential of 1.0 V and 
second vertex potential of -0.2 V, scan rate of 50 mV s-1, three cycles) was applied to 
the working electrode (Au) and the current response monitored using 20 µl 0.1 M KCl 
deposited on the SPGE and SPCE. 
4.3.3.4 Redox peak (interference) investigation 
Interference studies were performed, by depositing 10 µl of Nafion solution (Nafion 
perfluorinated ion-exchange resin 5 wt%, Aldrich, UK) onto the electrode area of a 
SPGE and depositing 5 µl to the reference electrode area only, respectively. The Nafion 
solution was incubated on SPGE at room temperature for one hour. The SPGE was 
washed in water and 10 µl 0.1 M PBS, pH 7.4 containing 0.1 M KCl was added to the 
whole electrode surface for a blank reading. To determine the characteristics of Nafion 
in combination with TMB, 10 µl TMB solution was added subsequentially. The Nafion-
modified SPGE were characterised using cyclic voltammetry at a potential range 
between −0.2 and 0.8 V at a scan rate of 50 mV s-1 over three cycles. 
4.3.3.5 Voltammetric studies of ochratoxin A–BSA adsorption 
A volume of 20 μl ochratoxin A-BSA (100 mg L-1) has been left to adsorb for 8 hours 
on the gold working electrode (room temperature, humidity chamber). As comparison, 
20 μl ochratoxin A-BSA (100 mg L-1) has been deposited onto the gold working 
electrode of another SPGE just prior to measurement. Voltammetric characterisation of 
adsorbed and non-adsorbed ochratoxin A-BSA was performed immediately by cyclic 
votammetry at a scan rate of 100 mV s-1 over three cycles. Both electrodes were 
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measured simultaneously. The peak shift upon protein adsorption compared to the 
cyclic voltammogram obtained from freshly applied ochratoxin A-BSA solution was 
compared. 
4.3.3.6 Voltammetric studies of wine samples 
Cyclic voltammetry was used to observe the electrochemical behaviour of wines and 
assess possible interferences regarding the sensor sensitivity. For this purpose, 
voltammograms were recorded for different wine solutions using the same three-
electrode configuration as described. These solutions were 10-fold dilutions in 0.1M 
phosphate buffer pH 7.4 of either kind of wine solution and synthetic wine as control. 
Synthetic wine is prepared solving 32 organic compounds usually found in the 
headspace (volume left at the top of a filled container (e.g. bottle) before sealing) of 
wines in 12 % ethanol as summarised in Appendix 1. The potential was scanned 
between −0.2 and 0.8 V at a scan rate of 50 mV s-1 for three cycles.  A random red wine 
sample was analysed using cyclic voltammetry to assess the interferences arising from 
polypohenols during the amperometric measurement. The red wine (sparkling 
Lambrusco) was treated prior to measurement by bubbling with N2 to remove any 
bubbles. A volume of 20 μl was deposited onto a bare SPGE and a cyclic 
voltammogram recorded at a potential range between −0.2 and 0.8 V at a scan rate of 50 
mV s-1 over three cycles. In comparison, a 1:10 sample dilution (0.1M phosphate buffer 
pH 7.4, 0.1 M KCl) was monitored and also a 1:10 diluted sample pre-treated with a 
saturating concentration of PVPP (Polyvinylpolypyrrolidone). 
4.3.4 Amperometry 
Prior to use, the SPGEs were baked at 100°C for 30 minutes to remove any particles 
from the surface, then each SPGE was cleaned with distilled water using a spray flask 
and dried under N2.  
4.3.4.1 Amperometric studies of TMB/H2O2 (HRP) 
The amperometric investigation was performed by a) stepamperometry to determine the 
optimal potential of TMB solution and b) chronoamperometric investigation of 
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subsequent addition of hydrogen peroxide and TMB followed by HRP enzyme. First, 
stepamperometry was performed to assess the optimal working potential for TMB on 
SPGE. For this, 20 μl TMB solution was deposited on the SPGE area and a step-wise 
potential (-600; -400; -200; -100; 0; +100; +200; +400; +600 mV) was applied for 100 
seconds per step. The current response was monitored in comparison to a SPGE with 
electrolyte buffer. The stable current at 50 seconds of each step potential was plotted 
versus the applied electrochemical potential.  
 
Secondly, chronoamperometry was used to evaluate the potential of screen-printed 
electrodes as sensors using TMB. The potential was set constant to -150 mV. Pre-
anodization was performed by applying a potential at +1 V versus Ag/AgCl for 10 s in 
10 μl electrolyte solution (pH 7.4 PBS containing 0.1M KCl). The preanodization 
procedure can not only make the screen-printed electrodes more electroactive towards 
TMB oxidation but also provide low susceptibility to electrode fouling [Prasad et al., 
2006]. Dissolution of gold is observed at potentials above +0.9 V. The pre-anodization 
is followed by an equilibration period (E = -150 mV) of 10 seconds. The measurement 
starts at time zero where the electrolyte solution is monitored as baseline. At time 100 
seconds, 10 μl of 3 % H2O2 was deposited on the electrodes in such a manner that the 
liquid area was covering all electrodes, then another 10 μl of TMB solution at time 300 
seconds  was added and the change in current monitored for another 300 seconds. 
 
In another experiment the baseline current is monitored for 100 seconds, then 20 μl of a 
TMB/H2O2 mix (15 μl TMB, 5 μl H2O2) was added and compared to the addition of 
TMB/ H2O2/ HRP mix (15 μl TMB, 5 μl 3% H2O2 and 1 μl 1:10 dilution HRP in PBS, 
pH 6.5). The current change was monitored for another 100 seconds.  
 
The electrochemical reaction follows the equation:  
               HRP 
H2O2 + TMBH2     2H+ + ½O2 + TMBOx  Equation XI 
 
        E appl > E0 
TMBOx     TMBRed +2e-    Equation XII 
 
Chapter 4: Screen printed electrode based immunosensor 
154 
Care has been taken that the measurement is performed at an acid pH wherein the 
enzymatic product, yellow diimine, is stable and yields 2 electrons by TMB oxidation. 
The TMB solution, according to the manufacturer, is dissolved in citric acid buffer, pH 
3.3 (Europa Bioproducts Ltd., UK) 
4.3.4.2 Chronoamperometric characterisation of ochratoxin A-BSA 
The SPGE was treated by liquid/spot deposition with a volume of 20 µl per SPGE at a 
range of ochratoxin A-BSA concentrations (0.5 – 100 mg L-1 in 0.1 M PBS, pH 7.4), 
which were adsorbed for 2 hours. All incubations were performed at 37˚C in a humidity 
chamber. After washing off unbound excess by PBST followed by H2O, the surface was 
blocked with 1 % PVA for one hour. A saturating anti-ochratoxin A antibody 
concentration of 20 µl 20 mg L-1 was incubated for one hour. Secondary antibody 
(rabbit-IgG-HRP) was added at a dilution of 1:2000 (0.5 mg L-1) for another hour. The 
reaction layer of the described immunosensor is illustrated in Figure 4.3. 
 
H2O2 + TMB(H2) TMBOx + 2H+ + ½O2
+
-
BSA BSA BSA
HRP
diffusion
TMBox + 2H+ +2e-
Eappl > E0’
CE
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Gold WE
 
Figure 4.3: Immunoassay layer on SPGE showing HRP catalysed reaction of H2O2 and 
TMB at a gold working electrode with a set potential. 
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The measurement was performed at a constant potential of -150 mV in 50 mM PBS, pH 
7.4, containing 0.1 M KCl for a time frame of 100 seconds (baseline current). Upon the 
addition of TMB/H2O2 solution a decrease in current is proportional to the HRP 
catalysis rate, which, in return, is directly proportional to the varying amount of 
ochratoxin A-BSA adsorbed on the surface. 
 4.3.4.3 Chronoamperometric characterisation of anti-ochratoxin A antibody 
A SPGE was modified with a saturating concentration of 10 mg L-1 ochratoxin A-BSA 
(20 µl per sensor SPGE) by adsorption for 2 hours. All incubations were performed at 
37˚C in a humidity chamber. After washing off unbound excess by PBST followed by 
H2O, the surface was blocked with 1 % PVA for one hour. The optimal anti-ochratoxin 
A antibody concentration was investigated using a dynamic range of 1-100 mg L-1 
antibody applied by liquid/spot deposition of 20 µl per SPGE for one hour. Secondary 
antibody (rabbit-IgG-HRP) was added at a dilution of 1/2000 (0.5 mg L-1) for another 
hour. The measurement was performed at a constant potential of -150 mV in 50 mM 
PBS, pH 7.4, containing 0.1 M KCl over 100 seconds (baseline current). TMB/H2O2 
solution (heated to 37˚C, 80 µl/ SPGE) was then added and the current monitored for 
another 100 seconds. The baseline current was subtracted from the signal current and 
plotted against the ochratoxin A-BSA concentration. Upon the addition of TMB/H2O2 
solution a decrease in current is proportional to the HRP catalysis rate, which, in return, 
is directly proportional to the varying anti-ochratoxin A antibody concentrations bound 
to the fixed amount adsorbed ochratoxin A-BSA. 
4.3.4.4 Ochratoxin A biosensor development 
An indirect immunoassay format had been investigated prior to the biosensor 
development on solid phase supports and showed a limit of detection (LOD) of 1 μg L-1 
ochratoxin A in phosphate buffer, pH 7.4 (Chapter 2). Thus, an indirect detection format 
was chosen for the electrochemical immunosensor. 
 
The immunosensor has been initially optimised with respect to coating and operating 
pH, ochratoxin A-BSA and ochratoxin A antibody concentration as well as range of 
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ochratoxin A standard concentrations and HRP/TMB/H2O2 loading. The final protocol 
resumes with the drop deposition of  20µl 10 mg L-1 ochratoxin A-BSA conjugate in 50 
mM PBS, pH 7.4 onto the gold surface of the working electrode. The droplet was 
adsorbed for two hours. Non-covalent immobilisation was chosen as the gold surface 
allows for easy adsorption of biomolecules as a result of hydrophobic and thiol–gold 
interactions [Horisberger & Vauth, 1984]. After washing off unbound excess by PBST 
followed by PBS, the entire SPGE electrode area was blocked by dipping the electrode 
into 1% PVA solution for one hour. Specific ochratoxin A antibody (20 µl of 10 mg L-1 
in 0.1 M PBS, pH 7.4) was added to 10 μl ochratoxin A competitor of different 
concentrations, mixed briefly and deposited to the gold surface. Binding interaction was 
allowed for two hours and unbound material washed off. Then, the horseradish 
peroxidase (HRP)–labeled secondary antibody (0.5 mg L-1 in 0.1 M PBS, pH 7.4) was 
added for one hour. All incubations were performed at 37ºC in a humidity chamber. The 
amount of bound ochratoxin A antibody is determined in an indirect detection format, 
thus the signal is inversely proportional to the ochratoxin A sample concentration. 
Chronoamperometry was monitored at a set potential of -150 mV. The electrodes were 
equilibrated to stabilise the background current for 10 seconds at -150 mV. The 
measurement starts at time zero where the electrolyte buffer is monitored as baseline for 
50 seconds. The TMB reaction solution is added to the electrode area in excess (50 μl). 
The current-time response is monitored for another 250 seconds (total measurement 
time per electrode is 300 seconds).  
4.3.4.5 Surface modification of SPGE 
Carboxymethylated dextran (CMD) was prepared according to the literature 
[Hermanson, 1996; Surugiu et al., 2001]. The procedure adds 1 ml of 40 mg ml-1 
dextran to a solution consisting of 1 M chloroacetic acid in 3 M NaOH. The mixture 
was allowed to react while stirring for 2 hours at room temperature. The reaction was 
stopped by adding 4 mg NaH2PO4 per ml of dextran solution and the pH was adjusted to 
neutral with HCl. The excess of reactants was removed by dialysis towards 0.1 M PBS, 
pH 7.4 at room temperature for 24 hours. 
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The gold working electrode of each SPGE was modified by adsorbing a volume of 3 µl 
of carboxymethylated dextran (CMD) solution to the bare gold surface. The SPGE was 
then air-dried at room temperature. To protect the carbon counter electrode and 
Ag/AgCl reference electrode, a 2 µl droplet of 6 % D-(+) Trehalose-dihydrate in 10 % 
Gelantine was deposited onto each electrode track.  
 
The CMD-modified gold working electrode was activated by liquid/spot deposition 
using 5 µl of a 1:2 mixture of 0.05 M NHS and 0.2 M EDC. Then, a solution of 20 µl 10 
mg L-1 ochratoxin A-BSA conjugate in 0.1 M PBS, pH 7.4 was added and left to 
incubate for two hours at 37˚C in a humidity chamber. The SPGE were washed using 
PBST followed by PBS. The activated carboxymethylated dextran was blocked by 
depositing of 2.5 µl 0.1 M ethanolamine, pH 8.5, onto the gold working electrode and 
incubating at 37˚C for 30 minutes. Another blocking step of 1 % PVA was introduced 
covering the entire electrode area for 30 minutes. After washing off excess biomaterial, 
20 µl ochratoxin A antibody was premixed with distinct ochratoxin A concentrations 
and added to the electrode surface. Subsequent steps using the secondary antibody and 
detection with HRP/TMB/H2O2 was performed as described above in Section 4.3.4.4. 
4.3.4.6 Sample preparation and analysis 
The three-electrode screen printed electrode assembly, was subjected to electrolyte 
buffer (10 μl) containing 0.1 M KCl for baseline establishment. The amperometric 
measurement procedure was initiated at +1 V pre-anodization and the electrochemical 
response was allowed to equilibrate for 10 s, after which the TMB/H2O2 solution was 
deposited on the working electrode which was set at a potential of -150 mV versus the 
Ag/AgCl reference. The change in response was monitored after TMB/H2O2 addition 
for 200 seconds.  
 
The wine samples used for the sensor analysis were diluted 1:2 in carbonate buffer 
containing PEG (5% NaHCO3 + 1% PEG, pH 8.3) to stabilise the pH at 7-8. A volume 
of 10 μl of each dilution was pre-mixed (1:2 dilution) with 10 μl of a fixed 
concentration of 5 μg L-1 (1:200 dilution) antibody A and deposited onto the 
immunosensor surface. Standard curves were prepared with every assay. 
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Sensor performance was compared against a standard ochratoxin A immunoassay test 
method based on a commercially available colorimetric test kit (Ridascreen, UK) and 
the initially in-house developed indirect competitive immunoassays. Samples were 
tested in accordance with the supplied protocol and the absorbance was measured at 450 
nm. 
The official method recommended for ochratoxin A determination in beer and wines is 
based on HPLC. This method is the European Standard (prEN 14133) with the reference 
number EN 14133:2003/AC and the document title “Foodstuffs - Determination of 
ochratoxin A in wine and beer - HPLC method with immunoaffinity column clean-up”, 
published in 2006. This protocol comprises quantification using HPLC with 
fluorescence detection and immunoaffinity chromatography for sample clean-up and 
pre-concentration in accordance with the work published by Visconti et al. [1999]. 
 
Wine (5 ml) was added to 5 ml of diluting solution (1% polyethylene glycol (PEG) + 
5% NaHCO3, pH 8.3) and mixed vigorously. The Ochratest™ immunoaffinity column 
was connected to a pumpstand and 10 ml diluted sample solution was added to the 
column reservoir, whereas the solution was passed through the column at a flow rate of 
1-2 drops/second using a syringe. The column was washed using 5 ml washing solution 
(2.5% NaCl + 0.5% NaHCO3) and then dried. Ochratoxin A was eluted by passing 2 
mL methanol, at a flow rate of 1 drop/second, trough the column and the eluate was 
evaporated to dryness at 50°C under Nitrogen. The eluate was re-dissolved immediately 
in HPLC mobile phase, Water/acetonitrile/glacial acetic acid (51:47:2), pH 3.2, for 
HPLC analysis. 
 
HPLC was performed according to a modified method published by Visconti et al. 
[1999]. Fifty microlitre re-dissolved eluate (equivalent to 0.5 ml wine) was injected via 
an autoinjector loop injection system over a RP-C18 column. The mobile phase 
consisted of a mixture of acetonitrile/water/acetic acid (51:47:2) eluted at a flow-rate of 
1 ml min-1 and a fluorescence signal was monitored over an acquisition time of 15 
minutes (Exitation 333 nm, Emission 460 nm). Quantification of ochratoxin A was 
performed by measuring peak areas at ochratoxin A retention time and comparing them 
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with the standard curve. A standard curve was produced from ochratoxin A 
concentrations 0; 0.001; 0.01; 0.1; 1; and 10 mg L-1 dissolved in HPLC mobile phase. 
4.3.4.7 Microelectrode arrays –preliminary characterisation- 
Microelectrodes composed of a 5x5 microelectrode array with a size of 20 μm and a 
separation distance of 200 μm were prepated at the Tyndall Institute for sensor research 
(Cork, Ir). Preliminary characterisation of the microelectrodes was conducted using 
TMB solution containing hydrogen peroxide as a representative electroactive species. 
TMB and hydrogen peroxide were tested on the AuME using cyclic voltammetry by 
adding 10 µl of the mixed solution to the electrode array area. Cyclic voltammetry 
parameters were set to a start potential of -0.8 V, first vertex potential of 1.0 V and 
second vertex potential of -0.2 V. The step potential was 0.0027 V. Varying scan rates 
were monitored for 25; 50; 75; 100; 150; 200; and 400 and mV s-1. When comparing 
TMB to 0.1 M PBS, containing 0.1M KCl, the scan rate was set to 50 mV s-1.  
 
The amperometric investigation was performed by a) step amperometry to determine 
the optimal potential of TMB solution b) chronoamperometric investigation of 
subsequent addition of hydrogen peroxide and TMB followed by HRP (horse radish 
peroxidase). A volume of 10 μl TMB solution was deposited on the gold microelectrode 
area and a step-potential (-600; -400; -200; -100; 0; +100; +200; +400; +600 mV) was 
applied for 100 seconds per steps. The current response was monitored in comparison to 
a SPGE with electrolyte buffer. The stable current at 50 seconds of each step potential 
was plotted versus the electrochemical potential.  
 
Chronoamperometric measurement was performed at a potential of +150 mV. The 
measurement starts at time zero where 10 μl electrolyte solution (pH 7.4 PBS containing 
0.1M KCl) was deposited onto the gold microelectrode and the current monitored as 
baseline. At about 50 seconds, 10 μl of TMB solution was added and the change in 
current observed over time for 200 seconds.  
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4.3.4.8 Preliminary direct immunosensor 
Protein A (20 µl; 5 mg L-1) 0.1 M PBS, pH 7.4 was applied to the SPGE by drop 
deposition onto the gold working electrode and adsorbed for one hour. The ochratoxin 
A antibody was incubated at a dilution of 1:200 (5 mg L-1) with protein A modified for 
1 hour. After washing off unbound excess by PBST followed by PBS, the entire SPGE 
electrode area was blocked by dipping the electrode into 1% PVA solution for one hour. 
Ochratoxin A antibody (5 µl; 1:10 dilution in 0.1 M PBS, pH 7.4) was added to 5 μl 
ochratoxin A competitor of varying concentrations, mixed briefly and deposited to the 
gold surface. Binding interaction was allowed for two hours and unbound material 
washed off. All incubations were performed at 37ºC in a humidity chamber. The 
amount of bound ochratoxin A-HRP is determined in direct detection format, thus the 
signal is directly proportional to the ochratoxin A sample concentration. 
Chronoamperometry was monitored at a set potential of -150 mV. The electrodes were 
equilibrated to stabilise the background current for 10 seconds at -150 mV. The 
measurement starts at time zero where the electrolyte buffer is monitored as baseline for 
50 seconds. The TMB reaction solution is added to the electrode area in excess (50 μl). 
The current response is monitored over time. 
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4.4 Results and discussion 
4.4.1 Electrode fabrication and configuration 
The picture (Plate 4.1) documents the produced electrode designs connected via an edge 
connector and ribbon data cable to a static potentiostat (Autolab, Eco Chemie BV, NL). 
 
Plate 4.1: Illustration of the screen printed gold electrode (SPGE) with working 
electrode (WE), counter electrode (CE) and reference electrode (RE) connected via a 1-
outlet edge connector (insert) with ribbon data cable to a potentiostat (Autolab). Three 
electrodes can be fitted into the 3-outlet edge connector for simultaneous multiple 
measurements.  
 
This instrumental setup was applied throughout this work unless stated otherwise. 
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4.4.2 Economical aspects of screen printed electrode-based sensor  
The described ochratoxin A biosensor has several advantages over the reference 
immunoassay method such as the simplicity of the procedure and the equipment, as well 
as the short time required for one assay and its production costs. The cost of gold ink is 
compared to carbon ink more expensive, e.g. 50 g E4464 gold ink costs an equivalent of 
£746.640 ($1,473.65*). However, the overall cost of each sensor is comparably cost-
effective and cheaper compared to commercially available sensors. In Table 4.2, a 
number of commercial available screen printed gold electrodes are summarised and 
their cost compared to the in-house manufactured SPGEs. 
Table 4.2: End-user prices of screen printed gold electrodes per piece (valid 2007). 
Source Screen printed electrode type Price per SPGE [£ ]* 
Cranfield University 
–produced in-house- 
WE Au , CE Carbon, RE Ag/AgCl 
Carbon basal track 0.4 
Florence Sensors Three electrode design Au working electrode 
1,2 (≥ 400) 
1.4 (80 to 380) 
2.0 (20 to 60) 
DropSens Sensors 
Three electrode design 
Au working electrode 
220AT&220BT 
1,2 (Ink AT) 
1,2 (Ink BT) 
 
BVT Technologies WE Au, CE Au, RE Ag/AgCl Silver basal track 
1.35 (250) 
0.67 (>250) 
* Prices in Euro converted to GBP according to 1 EUR = 0.678997 £, and 1$ = 0.506 £ 
The cost for one electrode of the in-house produced SPGE design (assuming 100 SPE 
per sheet and 20 sheets per 50 g ink), is about 40 pence, which is still 1.5 - 3 times less 
than the commercially available screen printed gold electrodes from e.g. BVT 
technologies [Brno, CR]. However, the production costs for the in-house produced 
electrodes do not include the cost for personell, which should be taken into account. 
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4.4.3 Electrochemical noise of screen printed electrodes 
Upon establishment of an electrochemical cell potential between two working electrode, 
a galvanic currents arises due to the surface condition and local chemistry differences 
between the two. The cell potential depends on the potentials of the electrodes involved, 
thus the SPGE displays a cell potential established from carbon (counter electrode) and 
gold (working electrode). SPCE displays a cell potential from carbon (counter 
electrode) and carbon (working electrode) and ME from gold (counter electrode) and 
gold (working electrode).  Connection of the electrodes to the zero resistance ammeter 
(ZRA), the potential noise is observed over time. The cell potential establishment with 
time after connection of the electrodes is dependent on the electrode material and its 
influence on the cell potential. Figure 4.4 depicts the characteristic cell potential 
patterns for all screen printed electrodes and a gold microelectrode. 
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Figure 4.4: Electrochemical potential [mV] illustrated versus time [seconds]. Curves 
display the potential noise of the cell potential [mV] for SPGE (black), SPCE (green), 
SPCE-Dupont (blue) and gold microelectrode AuME (red).  
As Figure 4.4 shows, the noise of the electrochemical potential is different for the 
combination of working and counter electrode (WE-CE) that are Au-C (SPGE) and C-C 
(SPCE) and Au-Au (ME) electrodes. The ‘dimeric’ electrode (WE-CE) design, in the 
case of AuME and SPCE results in a decrease of potential within the first 150-200 
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seconds, whereas with SPGE a potential increase is observed. It can also be seen that 
the AuME reaches its cell potential plateau already after 50-100 seconds, thus indicating 
less potential noise, which agrees with the micro-manufacturing process and thus 
thinner and more even layer of gold. It was also observed, that the in-house produced 
carbon electrode (SPCE) takes the longest to reach its cell potential plateau (up to 300 
seconds). Summarising, the AuME showed the lowest potential noise (13.6 mV), 
whereas the SPCE showed the highest. SPGE (in-house, 146.2 mV) and SPCE (Ind., 
36.2 mV) showed mirrored curve patterns which is due to the fact that the SPGE is a 
non-identical electrode setup, causing a shift in cell potential dependant on the Au 
electrode potential. The potential differences between SPCE (79.2 mV) and SPCE (Ind), 
was about 40 mV due to the slight differences of the local chemistry and surface 
conditions. Practically, the screen printed electrodes used in this work need to be 
connected in electrolyte 150 +/-50 seconds prior to the measurement to let the cell reach 
its potential plateau, otherwise, the measurement will be compromised by the increase 
or decrease in potential during the first 150 seconds. The noise of the electrochemical 
current was also monitored for the screen printed electrodes and the microelectrode and 
depended on the cell potential. The current noise is depicted in Figure 4.5. 
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Figure 4.5: Electrochemical current [μA] depicted as columns comparing the current 
noise for screen-printed gold (SPGE), carbon (SPCE), carbon (SPCE-Dupont) and gold 
(Au) microelectrodes. The current noise was determined as an average value of an 
alternating current signal over 600 seconds. 
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The presence of current noise indicates that there existed a potential difference between 
two working electrodes, as seen in Figure 4.5. A range of 3 – 10 nA as current noise 
value is acceptable for this application. Whereas the SPGE displayed a higher average 
current noise over time, it showed the least standard deviation. This indicates that due to 
the dissimilarity of gold-carbon electrode (SPGE) and its resulting electrochemical cell 
potential a higher noise current is observed over time than for carbon-carbon electrodes 
(SPCE).  
 
However, observing the standard deviation of average current, the SPGE design shows 
the lowest alternation in current compared to SPCEs and is similar to the standard 
deviation displayed by the gold microelectrode. The microelectrode displayed negative 
current noise values in contrast to the screen printed electrodes, which arises due to the 
gold-gold connection and direction of current flow. An increase in background current 
indicates the formation of redox active groups, thus, the SPGE seem to be more redox 
active than the SPCEs.  
4.4.4 Choice of electroactive species 3,3′,5,5′-tetramethylbenzidine  
There are a number of possible substances that can be used as electrochemical mediator 
for horseradish peroxidase catalysed reactions [Volpe et al., 1998]. Here, we investigate 
two possible substances, 3,3′,5,5′-tetramethylbenzidine (TMB) and hydroquinone to 
establish their electrochemical behavior at a screen printed gold working electrode 
polarized at -150 mV versus Ag/AgCl (Figure 4.6).  
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Figure 4.6: Current versus electrochemical potential shows the cyclic voltammograms 
of TMB (black) and hydroquinone (red) on bare screen-printed gold elctrodes (SPGE). 
The cyclic voltammograms were monitored separately upon addition of 20 μl TMB and 
hydroquinone at a scan rate of 50 mV s-1.  
Figure 4.6 shows that hydroquinone is displaying one oxidation peak at +0.4 V, TMB a 
peak shoulder consisting of two oxidation peaks at +0.29 V and +0.55 V, in addition to 
that, TMB also shows a reduction peak at -0.25 V, whereas hydroquinone does not 
show any change in current on the negative scan, indicating the oxidation of 
Hydroquinone is not reversible.   
 
TMB is the reagent of choice for the detection with H2O2 catalysed by HRP as the first 
oxidation peak and reduction peak occur at a potential which is suitable, since 
interferences are common above potentials of +0.4 V. Peak currents for the TMB 
oxidation peaks are comparable less than the hydroquinone peak current. Hydroquinone 
oxidation occurs at a potential that is too high and thus might be subject to interferences 
such as polyphenols.  
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4.4.5 Cyclic voltammetric studies of TMB 
The dependence of peak current (ip) on scan rate (v) for the oxidation of TMB was 
investigated for the SPGE. There was a gradual increase in the ip with respect to the 
increase in v. Figure 4.7 displays the increase in peak current and peak shift with 
increasing scan rate. 
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Figure 4.7: Current versus electrochemical potential shows the cyclic voltammograms 
(CV) of 20 μl TMB solution on SPGE at different scan rates [v]. From inner to outer 
cyclic voltammogram the scan rate is 25; 50; 75; 100; 150; 200; and 400 mV s-1. 
Figure 4.7 shows all cyclic voltammograms for all scan rates that display the 
characteristic TMB double shoulder on the positive scan, which are considered to result 
from the TMB itself illustrating two 1-electron oxidation steps. One reduction peak on 
the negative scan is illustrating a 2-electron reduction step.The TMB peaks are most 
profound at scan rates in the range of 25 -75 mV s-1. 
 
 
The anodic peak currents for both TMB peaks on the positive scan and the cathodic 
peak current were further evaluated by plotting the peak current versus the square root 
of the scan rate as shown in Figure 4.8. 
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Figure 4.8: Anodic peak currents [μA] versus square root of scan rate √v [√(V s-1)] 
obtained from cyclic voltammograms on bare SPGE with increasing scan rate. Linear 
relationship of anodic peak current pa,1 (□) and pa,2 (■) as well as the cathodic peak 
current pc (●) of TMB with the scan rate v. 
Seen in Figure 4.8, shows that the anodic and cathodic peak currents (ipa and ipc) display 
a linear dependence proportional to the square root of scan rate (√ Vs-1). This confirms 
that the redox reaction is a typical surface-controlled (quasi-reversible) process and thus 
that the electrochemical oxidation of TMB is a diffusion-controlled electron transfer 
process. In contrast, a non-linear relationship would indicate an adsorption depended 
redox reaction.  
 
 
The peak-to-peak separation was also evaluated by plotting the separation potential (E) 
versus the scan rate. Figure 4.9 shows that with increasing scan rate the peak-to-peak 
separation increases accordingly. 
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Figure 4.9: Linear relationship of peak separation [mV] versus scan rate v obtained 
from cyclic voltammograms for anodic peaks pa,1 [■] and pa, 2 [●] of TMB on a bare 
SPGE. 
The peak-to-peak separation is seen in Figure 4.9. The lower the peak-to-peak 
separation, the lower the mass transfer influence on the diffusion controlled redox 
reaction of TMB. Thus, the smallest peak-to-peak separation of 25 mV was found for 
both TMB pa,1 and pa,2 at a scan rate in the range of 50 to 100mV s-1 which indicates a 
fast electron transfer rate. Therefore, the median scan rate of 50 mV s-1 was assigned as 
standard scan rate for future measurements. 
 
 
Cyclic voltammetry was also used to investigate the electrochemical behaviour of TMB 
with SPGE, compared to PBS buffer, pH 7.4 containing 0.1M KCl, and plain DI water 
using a scan rate of 50 mV s−1, as displayed in Figure 4.10. 
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Figure 4.10: Cyclic voltammograms of H2O (blue); 0.1 M PBS, pH7.4, containing 
0.1M KCl (red); and TMB solution (black) on bare SPGE recorded at a scan rate of  50 
mV s−1. 
The cyclic voltammograms in Figure 4.10 show that the peak for the oxidation of TMB 
on the bare screen-printed gold electrodes corresponds to +0.29 V and +0.55 V. The 
reduction peak is observed at -0.25 V. The peak observed scanning 0.1 M PBS 
containing 0.1 M KCl at +0.11 V and -0.12 V may be caused by the high salt 
concentration (Cl- ion) on the SPGE surface; hence, exceedingly high Cl- ions can cause 
interferences in potential with certain electrochemical cells [Skoog & Leary, 1992]. 
4.4.6 Identification and characterisation of KCl peak 
The first assumption from the occurrence of the redox peak at +0.11 V and -0.12 V was 
that  characteristic element of cyclic voltammetry on gold electrodes is a set of peaks 
associated with the formation and dissolution of a surface oxide layer at about 1.6 V and 
0.2 V, respectively [Norouzi et al., 2006]. Chloride adsorption on noble metal 
electrodes has been mentioned in the literature, but the first direct observation of 
chloride adsorption on gold was made by Horanyi et a1. [1983]. 
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The effect of adsorbed Cl- ion on the current of the cylic voltammogram can be seen 
directly. However, current changes should mainly take place at the potential regions of 
the oxidation and reduction of gold. This can be seen as anodic wave on positive scan 
0.8-1.1 V and on negative scan 0.8-0.6 V. In this work, however, no peak currents were 
observed at these potentials.  
 
To confirm that the peaks at +0.11 V and -0.12 V are caused by Cl- ions, a cyclic 
voltammogram was monitored of bare SPGE in 0.1 M KCl (Figure 4.12, A). This 
experiment was also performed on a carbon screen printed electrode (SPCE) to 
investigate whether this peak is only displayed on gold screen printed electrodes 
(SPGE) shown in Figure 4.11. 
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Figure 4.11: Cyclic voltammograms of 0.1 M KCl on bare SPGE (red) compared to 
bare SPCE (black) and of 0.1 M KCl on SPCE (red). Scan rate is 50 mV s−1. 
The cyclic voltammograms (Figure 4.11) established that the occurring redox peaks 
must be arising as a result of the KCl electrolyte. It furthermore has to be mentioned 
that, when compared to a similarly designed carbon screen printed electrode (SPCE), 
these redox peaks did not occur. Moreover, the SPCE did not show any change in 
current upon change of applied potential when subjected to 0.1 M KCl electrolyte, 
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except for a slight anodic peak at 0.78 V. The Ag/AgCl reference electrode provides a 
stable potential through the reaction: 
 
 AgCl(s) ? e- + Ag(s) + Cl-      Equation XIII 
 
However, for AgCl in aqueous solution there is also the solution/deposition equilibrium 
reaction: 
 
 AgCl(s)?Ag+ + Cl-       Equation XIV 
 
During cyclic voltammetry with a KCl solution, Cl- is consumed during the oxidation 
(positive scan), which disturbs the equilibrium and causes the dissolution of AgCl. 
During the reduction half cycle, Ag+ is deposited on the working electrode (gold), 
which also causes the dissolution of AgCl. So during the entire cycle, AgCl is being 
dissolved. Eventually all of the AgCl is dissolved, and the reference electrode is no 
longer able to provide a stable potential [Cao et al., 2005]. Concluding, that the ion 
transfer from the Ag/AgCl electrode to the electrolyte is the main cause of the 
interferences observed and can result in the eventual failure of the electrode [Nolan et 
al., 1997]. 
4.4.7 Interference control 
To avoid the KCl peak for clearer measurements, since it partially overlaps with the 
measurement potential at -150 mV, the reference electrode needs to be stabilised. This 
is done by coating the reference electrode with a conductive layer that is non-permeable 
for silver or chloride ions and thus, will prevent electrode fouling of the reference 
electrodes. Such material could be Nafion (anion-exchange polymer) or modified 
polyurethane (redoxpolymer) and the procedure is described by Nolan et al. [1997].  
 
In the following experiment the effect of Nafion on bare screen printed electrodes was 
characterised using cyclic voltammetry. Nafion deposition on the reference electrode 
alone was compared with whole SPGE deposition as shown in Figure 4.12. 
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Figure 4.12: Cyclic voltammograms of Nafion-modified bare SPGE. Nafion-modified 
reference electrode is shown in black; whole (3-electrode) modified SPGE is shown in 
red. The cyclic voltammogram was recorded in 0.1 M PBS, pH7.4, containing 0.1 M 
KCl at a scan rate of 50 mV s−1. 
It is shown in Figure 4.12 that the re-occurring peaks characerised earlier to arise due to 
Cl- ions in the electrolyte buffer, are still prominent with the Nafion coating of the 
electrode surface. In this experiment it could be furthermore established that the Nafion 
solution used causes some background noise at about +0.48 - 0.57 V on the positive 
scan and +0.23 – 0.4 V on the negative scan. The noise was more prominent when the 
whole 3-electrode design of the SPGE was treated with Nafion compared to the 
reference electrode only.  
 
To establish if this interference would overlap with the monitoring of TMB, the SPGE 
with Nafion-modified reference electrode was subjected to TMB. The monitored cylic 
voltammograms are shown in Figure 4.13. 
Chapter 4: Screen printed electrode based immunosensor 
174 
-30
-25
-20
-15
-10
-5
0
5
10
15
20
25
-1 -0.75 -0.5 -0.25 0 0.25 0.5 0.75 1 1.25
E [V]
C
ur
re
nt
 [ μ
A]
415 mV, 6.1 uA
547 mV, 7.7 uA
 
Figure 4.13: Cyclic voltammograms of Nafion-modified reference electrode on bare 
SPGE with 20 μl added TMB solution compared to 0.1 M PBS, pH7.4, containing 0.1M 
KCl. Nafion-modified reference electrode in 0.1 M PBS is shown in black and with 
TMB is shown in red. 
Figure 4.13 shows that the TMB oxidation and its occurring double shoulder on the 
positive scan is unaffected by the background current that arises through the Nafion 
modification. The increase in background charging current, when using chemically 
modified electrodes, has been observed by Wang and Golden [1989], who also observed 
a significant improvement in the magnitude and sharpness of redox peaks. They 
furthermore stated that the increased background current does not affect analytical 
measurements commonly done by a) differential-pulse voltammetry or b) fixed-
potential amperometry and that c) the cyclic voltammetric peak potentials are not 
affected. The latter statement is verified by the occurrence of Cl-ion peaks in the same 
spot on both the positive and the negative scan. The fixed potential of -150 mV is also 
unaffected by the Nafion modification which shows no increased noise at that potential. 
Conclusively, one can say that Nafion-modification can be safely used on SPGE with 
TMB as mediator without any added interferences at a potential of -150 mV. However, 
the advantages of Nafion-modification are questionable since the initial effort to 
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stabilise the reference electrode by a conducting polymer such as Nafion, which is non-
permeable for silver or chloride ions was (Figure 4.12 and 4.13) unsuccessful. 
Furthermore, even though the Nafion polymer is a conductive ion-exchange resin and 
commonly used as preconcentration agent, it appears that the resulting peak currents for 
the TMB oxidation dropped on average 30 % compared to the ones determined in 
Figure 4.10. This can be explained by the nature of the Nafion ion exchange medium is 
to attract specifically ions of positive charge, whereas TMB, before it gets oxidised at 
the electrode, is not attracted by the ion exchange medium and therefore fails to 
accumulate on the electrode surface. Thus, the decrease in peak current can be 
explained by the creation of a diffusion barrier caused by the thickness of the nafion 
film, which affects the flux of TMB from the bulk solution to the electrode surface. 
Since the Nafion modification could not be related to any significant improvement of 
interference reduction or measurement sensitivity, the use of Nafion-modified screen 
printed gold electrodes using TMB as mediator was excluded from further experiments. 
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4.4.8 Potential selection for amperometric studies with TMB 
The optimum working electrode potential for TMB was selected using step 
amperometry. A 20 μl solution of 100 mg L-1 TMB in electrolyte buffer was deposited 
on a bare SPGE and the potential increased step-wise (100 seconds/step). Each signal 
point was recorded at time 50 seconds of each step potential (Figure 4.14). 
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Figure 4.14: Current [μA] versus step potential [mV] illustrates step-amperometry of 
20 μl TMB solution on bare SPGE. The current was recorded over a hundred seconds 
for each step potential (-600 to +600 mV). 
This (Figure 4.14) displays the current response to each potential step. The current 
increases more significantly within the negative potential range, where it is displayed in 
negative values. Within the positive potential range >0 V to + 400 mV the current 
change in proportion to potential increase is less than at negative potentials. The highest 
signal: noise ratio was observed at -200 to + 200 mV as the current background (0.05 M 
PBS, 0.1 M KCl, pH 7.4) was near zero. The low background current is optimal for 
enzymatic activity determination when a small amount of catalysis product (TMBox) 
needs to be measured in the presence of high concentrations of H2O2 substrate [Volpe et 
al., 1998; Badea et al., 2004]. 
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The effect of applied potential on the current response is summarised in Table 4.3.  
Table 4.3: Effect of applied potential on the current response on SPGE with TMB. 
Step potential [mV] Signal current [μA] Background current [μA] 
-600 -4.42 -3.090 
-400 -3.23 -1.640 
-200 -2.31 -0.290 
-100 -0.21 -0.022 
0 0.03 -0.005 
100 0.09 -0.004 
200 0.17 -0.009 
400 0.21 -0.002 
600 1.03 -0.008 
Based upon these findings and taking into account the interferences from phenolic 
compounds specifically at positive potentials and less in the range of 0-100 mV, a 
potential of -150 mV was selected as a working potential for the chronoamperometric 
detection of TMB. Thus, the proposed immunosensor monitors the change in reduction 
current over time.  
4.4.9 Cyclic voltammetry of ochratoxin A –BSA adsorption 
Ochratoxin A-BSA diluted in PBS, pH 7.4 containing 0.1 M KCl, was deposited onto a 
SPGE and compared to a SPGE modified with adsorbed ochratoxin A-BSA (Figure 
4.15). 
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Figure 4.15: Cyclic voltammogram of ochratoxin A-BSA (0.1 mg L-1) on SPGE at a 
scan rate of 50 mV s-1. Addition of 20 μl ochratoxin A-BSA solution (red) added prior 
to measurement and after overnight adsorption of ochratoxin A-BSA (black). 
As shown in Figure 4.15, a redox peak is observed at potentials +154 mV and -189 mV 
due to the Cl- presence in the electrolyte buffer.  The anodic peak potential is shifted 
upon ochratoxin–BSA adsorption to 231 mV and the cathodic peak potential to -298 
mV, which displays a shift of 77 and 109 mV respectively and is clearly related to the 
gold surface modification. Due to the presence of protein, the peaks on the positive and 
negative scans shift towards higher potentials, which is more prominently increased 
upon protein adsorption. The adsorbed protein layer also influences the current, 
particularly, the anodic current, which is increased on average about 2 µA, a sign of 
increased background interference, also a result of the adsorbed protein layer. The 
observed redox peaks have been identified as adsorbed ions on the gold surface that 
have an effect on the current. Is the gold surface exposed to protein (which can adsorb 
on the electrode) such as ochratoxin A-BSA, any surface redox process should become 
strongly inhibited. In fact, the inhibition of the surface process causes significant change 
in the currents at the potential region, and as a consequence the profound changes in the 
shape of CVs take place [Norouzi et al., 2006]. 
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Cyclic voltammograms obtained for the oxidation of TMB on ‘indirect immunoassay’-
modified SPGE to one without addition of TMB (Figure 4.16). 
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Figure 4.16: Cyclic voltammograms of 20 μl TMB solution (red) and the control 50 
mM PBS, pH 7.4, 0.1 M KCl (black) on SPGE at a scan rate of 50 mV s-1. 
The Cl- peaks are observed in Figure 4.16 in both instances, which can be explained by 
the equilibration of the SPGE prior to measurement in 50 mM PBS, pH 7.4, containing 
0.1 M KCl. Compared to the CV behaviour observed on a bare SPGE (+ 0.11 V; -0.12 
V), the ‘indirect immunoassay’-modified SPGE exhibited a significant shift in Cl- peak 
potential to +0.16 and -0.22 which corresponds to a shift of about 50 and 100 mV 
respectively. This potential shift was already observed when investigating the 
adsorption of ochratoxin A-BSA and can be readily explained by the increased protein 
layer attached to the gold surface. The positive shift in the oxidation potential also 
reflects the slower electron transfer reaction [Liu et al., 2002].  
 
The peak-to-peak separation was further investigated with adsorbed ochratoxin A-BSA 
on SPGE with increasing scan rates (Figure 4.17). 
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Figure 4.17: Plot of scan rate versus peak separation for anodic peak [■] and cathodic 
peak [●] of ochratoxin A-BSA (50 mM PBS, pH 7.4 in 0.1 M KCl adsorbed on SPGE at 
a scan rate of 50 mV s-1. 
Figure 4.17 displays peak-to-peak separations of 80, 82, 55, and 25 mV at 25, 50, 100, 
150, and 200 mV s-1 respectively, thus substantially higher than those observed on bare 
SPGEs; this again indicates a slower electron transfer rate. 
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4.4.10 Electrochemical characterisation of wine 
For this study cyclic voltammograms were monitored on bare SPGE with a red wine 
sample and compared to synthetic wine control as illustrated in Figure 4.18.  
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Figure 4.18: Cyclic voltammograms of 20 μl red wine sample diluted in 0.1 M PBS, pH 
7.4 containing 0.1 M KCl (red) compared to synthetic wine (black) and monitored on a 
bare SPGE at a scan rate of 50 mV s-1. 
This (Figure 4.18) shows the CV of red wine whicg exhibits anoxidation process 
between the potentials +0.5 and +0.8 V, indicated by the broadened peak shoulder. This 
observation was also made by Parra et al. [2004] who observed peaks at 0.45 V and 
0.87 V using an unmodified carbon paste electrode (CPE) versus Ag/AgCl. According 
to previously published works by Kilmartin et al. [2001 and 2002] these peaks are 
related to the polyphenolic content of red wine. In particular, the peak at 0.45 V has 
been assigned to polyphenols containing an ortho-diphenol (cathechol) group. In 
addition to that, no major peak was observed for red wine in the area of the potential 
selected for TMB determination (-150 mV). In this work, we also observe a distinct 
peak for the red wine sample at +0.16 V and -0.2 V, previously marked as a response to 
the Cl--Ion in KCl electrolyte (+0.11 and -0.11 V) interacting with the SPGE surface. 
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Since the red wine was 10 fold diluted in electrolyte buffer; this peak was much more 
developed and the increase in oxidation current was about 5 µA and reduction current 
about 3.5 µA. Synthetic wine does not display a polyphenol peak (+0.5 and +0.8 V) as it 
contains much less polyphenols (Appendix A). 
4.4.11 Wine interference study on SPGE 
Red wine should generate the most electrochemical interferences as it contains more 
polyphenols than white wine. The effect of dilution and the treatment with PVPP is 
examined in comparison. PVPP is commonly used in wine fining and known to 
complex with phenolic and polyphenolic components in wine and also attracts low 
molecular weight catechins [Morris & Main, 1995]. Using cyclic voltammetry, the 
electrochemical behaviour of a red wine sample was investigated in the presence of 
PVPP (Figure 4.19). 
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Figure 4.19: Cyclic voltammograms of a red wine sample (black), 1:10 diluted red 
wine sample (red) and 1:10 diluted red wine sample treated with PVPP (blue) on SPGE 
at a scan rate of 50 mV s-1. Dilution buffer was 5% Na2CO3, 1%PEG, pH 8.3. 
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The cyclic voltammogram of red wine exhibits an oxidation peak between the potentials 
+ 0.4 and + 0.8 V, indicated by the broadened peak shoulder. According to previously 
published works by Kilmartin et al. [2001 and 2002] these peaks are related to the 
polyphenolic content of red wine. In particular, the peak at around 0.45 V has been 
assigned to polyphenols containing an ortho-diphenol (cathecol) group. The cyclic 
voltammograms confirm that wine does not cause much interference at a working 
potential of -150 mV with a peak current of 0.69 μA. The diluted wine sample shows a 
50% reduced background current, which is also observed with the PVPP treated sample. 
As expected, PVPP removed phenolic compounds from the sample solution, which is 
depicted in the cyclic voltammogram as a sharp reduction in the peak area +400 to +800 
mV. However, the background current observed at -150 mV is the same range for the 
wine sample with and without PVPP addition. Therefore, it was found it unnecessary to 
treat the diluted wine samples with PVPP prior to detection. It had also been observed 
that the clean-up and pre-concentration procedure did not make a significant difference 
regarding interferences at a working potential of -150 mV and presumed a simple 
dilution of the sample as sufficient. 
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4.4.12 Chronoamperometric studies of TMB/ H2O2/HRP system 
The mediator TMB and HRP substrate H2O2 were studied using chronoamperometry to 
characterise the resulting current as an effect of subsequent addition of H2O2 and TMB 
as illustrated in Figure 4.20. 
 
Figure 4.20: Chronoamperometry of current [μA] versus time [sec] illustrates the 
current response upon the addition of H2O2 and then TMB when applying zero potential 
(black) compared to applying a potential at -150 mV (red). 
Figure 4.20 shows that the current decreases sharply upon addition of H2O2 and 
stabilises within 50-100 seconds. At potential zero, there is barely an electrochemical 
net conversion of reactant visible, but the spontaneous reduction of H2O2 that probably 
resulted from remaining charges of the previously applied conditioning potential of the 
electrode. However, at an applied potential of -150 mV, where the negative potential 
causes the reduction of H2O2, the sharp decrease (‘spike’) in current, confirms the intial 
reduction of H2O2 at the electrode surface. Upon addition of TMB, there is another 
sharp decrease of current that stabilises within 50 seconds indicating the initial 
oxidation of TMB (by reducing further H2O2) at the electrode surface. At potential -150 
mV, the current spike is followed by a constant increase in current, illustrating the 
Chapter 4: Screen printed electrode based immunosensor 
185 
diffusion of TMB molecules from the bulk solution to the electrode surface. At zero 
potential, the current-time curve is showing different characteristics such as the steady 
increase indicates an ongoing diffusion of TMB to the electrode surface. This can be 
explained by the non-electrochemically induced reduction of H2O2 at zero potential; 
thus, the net concentration of H2O2 is higher at the point of TMB addition than the 
decreased concentration (reduced H2O2) caused by the application of -150 mV potential. 
Therefore, the reaction shows a steady current increase caused by the reaction of TMB 
with H2O2. The addition of TMB results in its oxidation by H2O2 and subsequent 
reduction at the gold electrode releasing further electrons. 
 
Overall, one can conclude, that at a set potential of -150mV, the reaction rate H2O2 
alone on the gold working electrode is highest within 100 seconds from the point of 
deposition, after that the reaction rate is growing steadily slower, which can be also 
observed past the deposition of TMB.  
 
To maximise signal sensitivity, TMB and H2O2 should be deposited together in a 
freshly mixed solution, to maximise the concentration of initial H2O2 and TMB at the 
start of the reaction (redox reaction taking place in the bulk solution), whereas the 
resulting current is entirely depended on the diffusion rate of oxidised TMB to the 
electrode surface. One also needs to take into account, that upon addition of the 
H2O2/TMB solution, the reaction rate will be at its steepest slope within the first 100 
seconds. 
 
This reaction can be catalysed by the presence of a redox enzyme such as horseradish 
peroxidase. After the establishment of a baseline at an applied potential of -150 mV, a 
mix of TMB and H2O2 with and without enzyme is deposited onto the SPGE and the 
decrease in current observed (Figure 4.21). 
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Figure 4.21: Chronoamperometry of current [μA] versus time [sec] illustrates the 
current response upon the addition of TMB and H2O2 (black) in comparison to the 
addition of TMB/H2O2/HRP (red) at an applied potential of -150 mV. 
From Figure 4.21 it becomes clear that even with the addition of a low concentration of 
enzyme, there is a visible change in current, which decreases even further as a result of 
the catalysed reduction of H2O2. The resulting electrons were shuttled to the electrode 
via TMB. The higher the concentration of enzyme, the more the decrease in current is to 
be expected. Therefore, using a redox enzyme such as HRP as label in the immunoassay 
setup will result in a direct signal response with enzyme concentration, which, in turn, is 
depended on antibody concentration bound to immobilised ochratoxin A-BSA. This 
format allows for non-competitive and competitive detection of analyte. In Figures 4.20 
and 4.21, one can clearly observe the electrolytic process as the current spikes as a 
result of electroactive species being transformed at the electrode surface. Over time, the 
current shows a diffusion profile according to the Cottrell equation as electroactive 
species diffuse from the bulk solution to the electrode surface in order to react. 
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4.4.13 Optimal ochratoxin A-BSA concentration 
In immunosensor development, the direct immunoassay format with transducer-
immobilised antibodies has been traditionally used. However, the stability of the sensor 
relies on the quality of the immobilisation technique. Thus, an indirect competitive 
assay with a stable conjugate of the antigen bound to the sensor surface has been proven 
to produce more stable and reproducible sensors [Bier et al., 1994]. 
 
An indirect assay was developed on the sensor by establishing the optimal ochratoxin 
A-BSA concentration to be adsorbed onto the gold surface. This was determined by 
immobilising varying concentrations of ochratoxin A-BSA onto the SPGE. The amount 
of adsorbed ochratoxin A-BSA is determined via anti-ochratoxin A antibody and 
secondary HRP-labelled antibody. Change in current was observed over time at a 
potential of -150 mV as seen in Figure 4.22. 
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Figure 4.22: Chronoamperometry of current [μA] versus time [sec] illustrates the 
current response upon the addition of TMB and H2O2 to the immunosensor surface 
(non-competitive immunoassay-modified SPGE). The change in current at an applied 
potential of -150 mV was monitored over time. The grey arrow depicts increasing 
adsorbed ochratoxin A-BSA concentration (black) [0.1; 0.5; 1; 2; 5; 10; and 100 mg L-1 
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ochratoxin A-BSA] with decreasing current compared to the negative control BSA 
(red). 
The amount of adsorbed ochratoxin A-BSA is directly proportional to the decrease in 
current observed with increasing HRP catalysis. Upon addition of TMB/H2O2 (Figure 
4.22), an instant decrease in current can be observed, which stabilise within 50 seconds.  
 
The degree of current decrease changes with increasing ochratoxin A-BSA 
concentration towards negative current values as expected. The current [µA] was then 
plotted versus immobilised ochratoxin A-BSA concentration (Figure 4.23). 
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Figure 4.23: Current -[μA] versus immobilised ochratoxin A-BSA (■) concentration 
illustrates the current response with increasing ochratoxin A-BSA adsorbed to the 
SPGE. 
From Figure 4.23, it was established that the current did decrease with increasing 
ochratoxin A–BSA concentration in the current range of -0.8 to -3.7 µA, depicting the 
dynamic concentration range of adsorbed ochratoxin A-BSA. Saturation was not 
reached at the maximum applied concentration of 100 mg L-1 ochratoxin A-BSA. 
Therefore, a saturation concentration and current could not be established. The lowest 
adsorbed concentration showing a distinguishable signal (10 % above the blank value 
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I0= -0.84 µA) is approximately 0.5-1 mg L-1 ochratoxin A-BSA with an optimal coating 
concentration at I50 of about 2-10 mg L-1.  
4.4.14 Optimal antibody concentration 
The optimal antibody concentration was determined by immobilising a fixed amount of 
ochratoxin A-BSA (10 mg L-1) and incubating with distinct concentrations of antibody 
in the range of 1-50 mg L-1 (equivalent of dilutions from stock of 1/1000 to 1/20). Again, 
the amount of bound antibody was determined via a secondary HRP-labelled antibody 
and directly proportional to the decrease in current observed with increasing HRP 
catalysis. Figure 4.24 depicts a plot of current versus antibody concentration. 
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Figure 4.24: Current -[μA] versus immobilised anti-ochratoxin A antibody (■) 
concentration illustrates the current response with increasing antibody concentration 
bound to a fixed concentration of adsorbed ochratoxin A-BSA. 
It can be seen from Figure 4.24, that at 50 mg L-1 antibody concentration, saturation of 
adsorbed ochratoxin A-BSA binding sites was not yet reached. This was expected since 
a similar range of concentrations was used as when establishing the optimal ochratoxin 
A-BSA concentration. It was established that the lowest antibody concentration 
considered to show a distinguishable signal (considered 10 % above the blank value I0 = 
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-0.17 µA) is approximately 1-2 mg L-1 antibody (equivalent to a dilution of 1/1000 to 
1/500). It was also observed that the range of current decreasing with increasing antibody 
concentration was low, between -0.1 to -1.1 µA, requiring a much higher antibody 
concentration to reach saturation of adsorbed ochratoxin A-BSA. The optimal antibody 
concentration determined at I50 for this assay was about 15 mg L-1. 
4.4.15 Indirect competitive ochratoxin A immunosensor 
The developed indirect competitive immunoassay was transferred onto the screen 
printed gold electrode. A range of ochratoxin A standard concentrations was applied to 
establish a calibration curve. A mixture of TMB and H2O2 was added to the 
immunoassay on the sensor surface and the change in current was observed over time 
for different ochratoxin A competitor concentrations at a potential of -150 mV (Figure 
4.25).  
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Figure 4.25: Chronoamperometry of current [μA] versus time [sec] illustrates the 
current response upon the addition of TMB and H2O2 to the immunosensor surface 
(indirect competitive immunoassay-modified SPGE). The change in current at an 
applied potential of -150 mV was monitored over time. The grey arrow depicts the 
increasing ochratoxin A competitor concentration (black) [0.00001; 0.0001; 0.001; 0.01; 
0.1; 1; and 10 mg L-1 ochratoxin A] inversely proportional to the current response. The 
negative control is 0.1 M PBS, pH 7.4 (red). 
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With increasing ochratoxin A competitor concentration, the less antibody is bound to 
the surface, thus, the less resulting decrease in current (Figure 4.25). Therefore, the 
decrease in current is inversely proportional to the ochratoxin A competitor 
concentrations. The degree of current increase changes with increasing ochratoxin A 
competitor concentration is inversely proportional to the non-competitive approach. The 
more ochratoxin A competitor, the less antibody binds to the ochratoxin A-BSA 
modified SPGE. The less antibody binds, the less secondary antibody binds and thus 
less HRP is bound to the SPGE, which results in a less negative (therefore increasing) 
current.  The current [µA] is then plotted versus ochratoxin A competitor concentration 
(Figure 4.26). 
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Figure 4.26: Competitive response curve of current -[μA] versus ochratoxin A (■) 
competitor concentration illustrating the current response with increasing ochratoxin A 
[µg L-1] applied with fixed antibody and immobilised ochratoxin A-BSA concentration 
on SPGE monitored using the Autolab potentiostat. Standards are prepared in PBS, pH 
7.4. 
As Figure 4.26 shows, the range of ochratoxin A concentration reached from 1 ng L-1 to 
10 μg L-1 displaying a dynamic range that covers the permissible concentration of about 
2 µg L-1. The plot shows linearity in the range from 10-1000 ng L-1 ochratoxin A with a 
detection limit of < 100 ng L-1 ochratoxin A and a standard deviation of 6 %. 
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4.4.16 Biosensor optimisation through surface modification 
It has been discussed that significant improvement to sensor performance can be 
achieved by incorporation of new printed materials or support surfaces. Surface-
modification (e.g. new ligands, polymers and nanostructure materials) can enhance the 
reproducibility and sensitivity of screen-printed based sensors [Renedo et al., 2007]. In 
this work, a polymer was implemented into the sensor. The gold electrode was modified 
with carboxymethylated dextran (CMD), a carboxy-group functionalised dextran 
polymer mainly known in SPR measurements [Lofas & Johnsson, 1990]. This 
calibration graph for ochratoxin A determination (Figure 4.26) is being further 
improved by modifying the SPGE surface with CMD to enable the covalent attachment 
of ochratoxin A-BSA. The electrochemical characteristics of carboxymethylated 
dextran were initially characterised using cyclic voltammetry on a bare SPGE (Figure 
4.27). 
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Figure 4.27: Cyclic voltammograms of current [μA] versus potential [V] of CMD-
modified SPGE illustrating adsorbed carboxymethylated dextran (CMD) (red) 
compared to bare SPGE in 0.1 M PBS, pH 7.4 containing 0.1 M KCl at a scan rate of 50 
mV s-1. 
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As shown in Figure 4.27, no significant oxidation or reduction peak was monitored for 
CMD on SPGE versus Ag/AgCl. The catalytic current did not decrease as opposed to a 
study by Pallarola et al. [2006] who observed a decrease in catalytic current with CMD 
modified gold electrodes suggesting that the CMD may hinder the access of the redox 
couple to the electrode surface. The high molecular weight dextran used in this work 
has a much looser and flexible structure and should not hinder the access to the 
electrode surface. The observed increased background current (0.5-1.5 µA compared to 
electrolyte buffer background) arose probably due to surface charges through carboxy 
groups present in the carboxymethylated dextran as suggested for other poly-anionic 
surfaces (e.g. Nafion). CMD surface modification is presumed to increase stability of 
the active surface and decrease non-specific binding of protein and interfering wine 
components. Subsequentially, ochratoxin A-BSA was immobilised covalently to the 
carboxymethylated surface via carbodiimide coupling (Figure 4.28). 
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Figure 4.28: Competitive response curve of current -[μA] versus ochratoxin A (■) 
concentration illustrating the current response with increasing ochratoxin A competitor 
[µg L-1] concentration on CMD-modified SPGE monitored using the Autolab  
potentiostat. Standards are prepared in PBS, pH 7.4. The curve was fitted using a four 
parameter fit. 
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As Figure 4.28 shows, the range of concentration reached from 10 ng L-1 to 100 µg L-1 
displaying a dynamic range, covering lower concentrations of interest and also covering 
the aim of detection of about 2 µg L-1.  
 
The plot shows linearity in the range from 0.1-10 µg L-1 with a detection limit of 10 ng 
L-1 and a standard deviation in the range of 8 %. This covalent immunosensor 
construction is about 10 times more sensitive than the immunosensor using adsorbed 
ochratoxin A-BSA, which can be partially explained by the increase in surface charges 
(surface activity) and also trough the decrease in non-specific binding through covalent 
coupling of biomolecules. 
 
Despite its relatively narrow linear range (0.1-10 µg L-1), the biosensor described in this 
work appears suitable for on-site applications of wine sample contamination displaying 
a detection limit of 10 ng L-1.  
 
 
 
4.4.17 Analysis of ochratoxin A in wine samples 
The signal current monitored for the wine samples was baseline substracted and a 1:2 
dilution of sample and a sample volume of 10 μl taken into account.  
 
The calculated values for ochratoxin A contamination are listed in Table 4.4, as seen 
below. The results of the wine analysis are compared with two further immunoassay-
based methods, the previously developed indirect competitive immunoassay and a 
commercial directly competitive immunoassay kit. 
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Table 4.4: Comparison of sensor and standard immunoassay test kit results for 
measurement of ochratoxin A in wine samples. 
Wine sample 
Immuno- 
sensor 
HPLC 
 
Immuno-
assay kit 
 Clean-up 
 1:2 
dilution 
IAC IAC 
White wine Ochratoxin A [ug L-1] 
Canti Catarratto Chardonnay, Italy-Sicily 2005 1.763 1.337 0.398 
Canti-Chardonnay Pinot Grigio, Italy 2005 (1) 0.748 1.629 0.411 
Canti Catarratto Chardonnay, Italy-Sicily 2005 1.752 1.338 0.410 
Bordeaux, France 2005 1.253 0.998 0.405 
Soave, Italy-Verona 2005 1.232 1.094 0.409 
Pinot Grigio, Italy 2005 0.720 0.813 0.385 
Canti-Chardonnay Pinot Grigio, Italy 2005 (2) 0.563 0.020 0.397 
Canti-Chardonnay Pinot Grigio, Italy 2005 (3) 0.763 0.536 0.392 
Soave Classico, Italy 2005 0.854 1.260 0.392 
Red wine Ochratoxin A [ug L-1] 
France, 2001 0.152 0.572 0.389 
Canti, Italy, 2006 * 0.379 0.4 
Cabernet Sauvignon, Chile, 2005 0.285 0.439 0.328 
Italy, 2006 0.182 0.556 * 
Bordeaux, France, 2005 0.155 0.321 0.375 
Cru,S 0.176 0.138 0.403 
Mon,France, 2005 * 0.213 0.379 
South Africa, 2006 * 0.354 0.314 
unknown origin * 0.722 0.396 
Lambrusco,Italy,2005 sat PVPP 0.512 / / 
Lambrusco,Italy,2005 0.2% PVPP 0.523 / / 
-*- depicts a signal below the detection limit and -/-depicts a sample not included in that 
method 
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The wine sample analysis suggested that more interference were observed with red wine 
than with white wine samples, possibly due to increased polyphenols in red wines. Also, 
the data monitored with the immunosensor and HPLC suggest that there is more 
ochratoxin A contamination in white wines than in red, which is generally not published 
in the literature as it is well established that red wines contain more ochratoxin A than 
white ones. On an overall note, the sensor data correlated best with the HPLC data, even 
though the sample pre-treatment differs substantially. Also, it can be observed that the 
standard deviation of the immunoassay kit compared to the sensor and HPLC data is, 
especially with white wine samples, very high. The wine analysis showed good results 
corresponding with HPLC data, however, not with the immunoassay data.  
4.4.18 Microelectrode immunosensor 
The trend in biosensor design moves towards miniaturisation since it saves materials 
and can improve performance. Microfabrication technology is a great tool for 
miniaturisation applying novel techniques such as photolithography or electron-beam-
lithography as well as chemical and electrochemical etching to produce reactive 
surfaces. High density immobilisation and the use of polymer materials enables 
integration of core components like sampling, reaction, sensing, transduction and data 
processing into one entity (lab-on-a-chip).  
 
In this work, the use of gold microelectrode arrays was described as a means of 
improving immunosensor performance by increasing the current density on the sensor 
area and thus producing an accumulative signal response. This is achieved by using 
microelectrode arrays. Also, the microelectrode design allows for a different diffusion 
profile and thus electrochemical kinetics and also for much lower samples volumes to 
be used. The indirect immunosensor format that has been proven to work on SPGE is 
transferred to the gold microelectrodes. The microelctrode array prepared at Tyndall is 
composed of a gold reference and counter electrode that can be modified further and a 
working electrode made of an array of 5x5 microelectrodes with a size of 20 μm and a 
separation distance of 200 μm (as seen Figure 1.7). 
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The microelectrodes were characterised using cyclic voltammetry by monitoring the 
dependence of peak current (ip) with scan rate (v) for the oxidation of TMB (Figure 
4.29). 
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Figure 4.29: Current versus electrochemical potential shows the cyclic voltammograms 
(CV) of 10 μl TMB solution on SPGE at different scan rates [v]. From inner to outer 
cyclic voltammogram the scan rate is 25; 50; 75; 100; 150; 200; and 400 mV s-1. 
Figure 4.29 shows cyclic voltammograms for all scan rates that display the 
characteristic TMB double shoulder on the positive scan, which are considered to result 
from the TMB itself illustrating two 1-electron oxidation steps. One reduction peak on 
the negative scan is illustrating a single 2-electron reduction step. There was a gradual 
increase in peak current ip with respect to the increase in v. It was also observed that the 
cyclic voltammogram shows interferences as the current seems to be oscillating while 
scanning the potential. 
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The anodic peak currents for both TMB peaks on the positive scan and the cathodic 
peak current were further evaluated by plotting the anodic peak current versus the 
square root of the scan rate as shown in Figure 4.30. 
y = 0.1986x + 0.9086
R2 = 0.9706
R2 = 0.9971
0
0.5
1
1.5
2
2.5
0.16 0.22 0.27 0.32 0.39 0.45 0.63
square root of scan rate √v [√(V s-1)] 
an
od
ic
 p
ea
k 
cu
rr
en
t  
[ μA
]
 
Figure 4.30: Anodic peak currents [μA] versus square root of scan rate √v [√(V s-1)] 
obtained from cyclic voltammograms on bare gold microelectrodes with increasing scan 
rate.  
Figure 4.30 shows that the anodic peak current (ipa) display a more non-linear 
relationship to the square root of scan rate (√ Vs-1). This indicates that the redox 
reaction of TMB on gold microelectrodes is more adsorption depended redox reaction 
and less diffusion-controlled electron transfer process as shown for SPGE (Figure 4.8). 
This could mean that the different diffusion patterns (radial versus linear diffusion) on 
microelectrodes influence the redox reaction of TMB or that due to lower sample 
volumes on microelectrodes, capillary forces prevent mixing and distribution of analyte 
(TMB) over the electrode surface and thus limit diffusion. 
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Cyclic voltammetry was also used to investigate the electrochemical behaviour of the 
gold microelectrodes with PBS buffer, pH 7.4 containing 0.1M KCl, and H2O using a 
scan rate of 50 mV s−1 (Figure 4.31). 
-7
3
13
23
33
43
53
-1 -0.75 -0.5 -0.25 0 0.25 0.5 0.75 1 1.25
E [V]
C
ur
re
nt
 [ μ
A]
 
Figure 4.31: Cyclic voltammograms of H2O (blue); 0.1 M PBS, pH7.4, containing 
0.1M KCl (red); and TMB solution (black and seen as insert) on bare gold 
microelectrodes recorded at a scan rate of 50 mV s−1.  
The cyclic voltammograms in Figure 4.31 also show a peak for the oxidation of TMB 
and there are no distinctive peaks for H2O or 0.1 M PBS containing 0.1 M KCl, 
although the latter shows a high increase in current at potentials larger than 750 mV, 
which indicates possible interferences. The lack of a peak caused by the high salt 
concentration (Cl- ion) that had been observed on the SPGE surface (Figure 4.11) is not 
observed with the gold microelectrodes. Nevertheless, this could be a result of the 
different reference electrode used with the microelectrodes. Whereas SPGE used gold 
working electrode versus Ag/AgCl reference electrode, the microelectrodes have a gold 
working and also gold reference electrode. This might cause instability in the current 
response, possibly the increased current response for PBS at > 750 mV and also the 
slight oscillation in current signal observed in Figure 4.29. 
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The optimum working electrode potential for TMB on the gold microelectrodes was 
determined using step amperometry depositing 10 μl TMB solution on a bare gold 
microelectrode and increasing the electrode potential step-wise (100 seconds/step). Each 
signal point was recorded at time 50 seconds of each step potential (Figure 4.32). 
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Figure 4.32: Current [μA] versus step potential [mV] illustrates step-amperometry of 
20 μl TMB solution on bare gold microelectrodes. The current was recorded for each 
step potential (-600 to +600 mV) over a hundred seconds. 
Figure 4.32 displays the current response to each potential step. Here, the current 
increases more significantly within the positive potential range between >100 mV to + 
400 mV, whereas the current change at negative potentials is small and close to zero 
ampere. Therefore, a potential working potential of +150mV was chosen, since more 
positive potentials might result in interferences. 
 
When performing chronoamperometry, the change in current (I) is monitored as a 
function of time (t). At applied positive potentials, in contrast to negative working 
electrode potentials, the current ‘spikes’ towards more positive current values with a 
‘reverse’ decay towards more negative values as the diffusion-controlled current 
‘decays’ towards zero ampere upon addition of an electroactive. The indirect 
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immunoassay format that has been used for the SPGE immunosensor development in 
Section 4.4.15 was transferred to the gold microelectrode and a small range of 
ochratoxin A competitor concentrations (1-50 mg L-1) was determined to obtain a 
preliminary standard curve. Chronoamperometry on gold microelectrodes is shown in 
Figure 4.33. 
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Figure 4.33: Chronoamperometry of current [μA] versus time [sec] illustrates the 
current response upon the addition of TMB and H2O2 to the immunosensor surface 
(indirect competitive immunoassay-modified gold microelectrode). The change in 
current at an applied potential of +150 mV was monitored over time. Increasing 
ochratoxin A competitor concentrations [6; 12; and 50 mg L-1 ochratoxin A] are shown 
in black and negative control is 0.1 M PBS, pH 7.4 (red). 
Figure 4.33 shows a current change over time that does not decay towards zero and is 
not corresponding to the Cottrell equation (Equation V) but shows a peak-shaped 
current increase followed by a decrease over time. It is also peculiar that the current 
seem to be increasing in proportion to the ochratoxin A competitor concentration 
instead of being inversely proportional. This indicates that the indirect competitive 
binding assay for ochratoxin A on the gold microelectrodes does need further 
characterisation of the microelectrodes and adaptation of the assay. It has also been 
observed that 50% of the received microelectrodes had faulty connections (as tested 
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with a voltameter) and as a result did not show a current signal at all. The peculiar shape 
of the current response upon addition of TMB/H2O2 could be a result of misconnection 
of the microelectrodes working, counter and reference electrode. 
4.4.19 Preliminary direct competitive ochratoxin A immunosensor 
To establish, if the direct immunoassay would work on the SPGE, a preliminary 
experiment was executed, where ochratoxin A antibody was immobilised on the SPGE 
surface via protein A. The ochratoxin A-HRP conjugate that had shown a low binding 
ability for the antibody in biospecific interaction analysis (Biacore) was employed for 
the competitive assay with ochratoxin A standards. Figure 4.34 shows the current 
response for a direct competitive assay on SPGE using the ochratoxin A-HRP conjugate 
with ochratoxin A standards. 
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Figure 4.34: Competitive response curve of current -[μA] versus ochratoxin A (■) 
concentration illustrating the current response with increasing ochratoxin A competitor 
[µg L-1] concentration on SPGE modified with protein A bound antibody. Standards are 
prepared in PBS, pH 7.4. The curve was fitted using a four parameter fit. 
Figure 4.34 shows the range of concentration reached from 100 ng L-1 to 10 mg L-1 aim 
of detection of about 2 µg L-1 ochratoxin A. The plot shows linearity in the range from 
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0.1-100 µg L-1 with a lowest detectable concentration of 100 ng L-1 ochratoxin A 
standard. The graph indicates that concentrations below 100 ng L-1 could be measured 
sensitively and that the limit of detection is much lower. These data show that the direct 
format can be used on the SPGE and that the ochratoxin A-HRP conjugate does respond 
in an electrochemical assay when competing with ochratoxin A standards. These results 
can be a promising alternative to the indirect immunosensor assay.  
 
4.5 Conclusions 
Cost-effective, disposable and sensitive sensors for ochratoxin A were produced by 
screen-printing. The initial immunosensor with ochratoxin A-BSA-adsorbed SPGEs 
reached a detection limit of less than 100 ng L-1. Further improvement was achieved 
when covalently immobilising ochratoxin A-BSA, and decreasing the detection limit to 
10 ng L-1. Furthermore, the direct immunoassay format showed promosing results 
indicating a detection limit below 100 ng L-1. This level of detection corresponds with 
the lowest level of wine contamination with ochratoxin A in Europe (0.01 – 7 μg L-1) 
and outreaches the permissible limit of ochratoxin A in wine and grape containing 
drinks set by the European Comission ( 2 μg L-1) as well as the desired limit of 
detection suggested by the GoodFood requirements. 
 
Furthermore, each measurement takes about 200 seconds, where up to three electrodes 
as multiple measurement, can be monitored at the same time. The construction of each 
immunoassay modified electrode takes a minimum of 5 hours, including the covalent 
surface modification with carboxymethylated dextran, since the CMD-modified SPGEs 
can be produced in advance.  
The screen-printed immunosensor was optimised for wine analysis, the electrochemical 
interferences due to phenol compounds being tackled. The solution to this problem 
offered in this work in order to perform accurate determinations with biosensors 
consisted in polarising the working electrode at -150 mV versus reference Ag/AgCl. 
The developed immunosensor in the indirect format using non-modified SPGE resulted 
in a detection limit of 100 ng L-1, whereas using CMD modification of the SPGE a 
detection limit of 10 ng L-1. The non-modified SPGE method performed comparable to 
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a previously reported electrochemical immunosensor run with standard OTA solutions 
by Alarcon et al. [2006], who used monoclonal antibodies in both a direct and indirect 
format to determine ochratoxin A in wheat. The standard curve data of the 
electrochemical immunoassay resulted in a detection limit of 60 and 100 ng L−1 for the 
direct and indirect assay format, respectively. Alarcon et al. [2004] initially had used 
commercially available polyclonal antibodies (Biogenesis Ltd.) in a similar assay, 
which had a detection limit of 180 ng L-1. The authors stated that the use of a 
monoclonal antibody had improved the assay performance. However, in this assay, the 
detection limit of 100 ng L-1 was reached using polyclonal antibodies in an indirect 
detection format and was improved by modifying the sensor surface with 
carboxymethylated dextran (CMD), thereby exhibiting superior sensitivity. 
 
Another ochratoxin A immunosensor was presented by Prieto-Simón et al. [2008], who 
compared polyclonal to monoclonal antibodies and also the effect of the enzyme label 
by studying HRP and AP-labelled secondary antibodies in an indirect assay format. 
They also reported better sensitivity using monoclonal antibodies confirming the 
statement by Alarcon et al. [2006] and the superior use of HRP-labels in 
electrochemical assays a electroactive interferences present in spiked wine samples did 
not affect HRP-labelled immunosensors, but they were likely oxidised at the working 
potential for AP-labelled immunosensors (0.225 V vs Ag/AgCl). The limit of detection 
for the HRP-labelled immunosensor was 700 ng L-1 ochratoxin A (700 ng L-1 using an 
AP-label). The results confirm that using an HRP-label will reduce interferences from 
electrochemical detection in wine. The group also reduced the effect of the wine pH by 
neutralization with buffer and removed polyphenols with PVP, which confirms the 
procedure used in this work, where the wine sample was diluted in carbonate buffered 
containing PEG to neutralize the pH and the wine was pretreated with PVPP to remove 
polyphenols. However, the detection limit of the work presented in this thesis is still 
superior to the achieved detection limit achieved by Prieto-Simón et al. [2008], which 
is, assumingly, entirely due to the CMD-modified SPGE. The modification with CMD 
will enable covalent attachment of the immunoreagents, but also enhance stability as it 
is known that polymers such as dextran or polyions such as PEG are used in protein 
stabilisation [Drago & Gibson, 2001]. 
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The immunosensor in the indirect format using CMD modification of the SPGE 
exhibited superior sensitivity according to the detection limit of 10 ng L-1 and was then 
selected for the experimental work on real samples. 
 
It has been established in Chapter 3 by surface plasmon resonance analysis that the 
ochratoxin A antibody was cross-reacting to a certain extend with BSA. By choosing an 
antibody for the immunosensor development where BSA was not used as immunogen in 
addition to affinity-purifying the antibody with BSA, any non-specific binding of the 
antibody to BSA was diminished. An in-depth literature search resulted in a novel 
aspect that might cause the low reproducibility of the immunoassay. Galtier et al. 
[1981] show that ochratoxin A also binds BSA non-specifically and thus affects the 
performance of the indirect immunosensor assay, since free ochratoxin A in solution 
can be adsorbed onto immobilised BSA-conjugate. This might be the reason for the low 
reproducibility of the SPGE immunosensor standard curve and also for the increase in 
current with ochratoxin A concentration determined with the microelectrodes.  As 
ochratoxin A interacts with BSA, the toxin would also bind to the immobilised 
ochratoxin A-BSA conjugate instead of the antibody when using the indirect 
competitive format. Also, the interaction of ochratoxin A with BSA is depended on the 
ionic strength of the buffer. This explains, why the results obtained with the screen-
printed gold electrode immunosensor were more reproducible than with the 
microelectrodes, as the ochratoxin A standards used for the microelectrode standard 
curve were dissolved in a low ionic strength buffer. To avoid the interaction of 
ochratoxin A with BSA, a high ionic strength buffer can be used throughout the assay. 
However, the better alternative would be to remove BSA from the assay by for instance 
using the direct immunoassay format. 
 
However, further optimisation of the proposed ochratoxin A immunosensor on SPGE 
should be carried out in order to achieve better reproducibility on SPGE. Furthermore, 
the preliminary result of a direct competitive immunosensor for ochratoxin A showed a 
detection limit of 10 ng L-1 and seems a promising alternative in the development of a 
BSA-free affinity sensor for ochratoxin A. 
Chapter 4: Screen printed electrode based immunosensor 
206 
Microelectrode arrays as biosensor platform can monitor multiple analytes 
simultaneously or increase the sensitivity of single analyte analysis as the electrode 
array increases current density (signal). As some mycotoxins can be found alongside in 
the same sample matrix, a single sample deposition can be used to determine several 
mycotoxins quantitatively. Most mycotoxin sensor arrays are based on an immunoassay 
format, while using different transduction methods, whereof most are based on 
fluorescence determination [Prieto-Simón et al., 2007] 
Piermarini et al. [2007] describe the only electrochemical immunosensor array so far for 
the detection of AF B1, by using an indirect competitive immunoassay format on a 96-
screen-printed electrode array format with attached 96-well microplate. The detection 
was carried out using an AP-labelled secondary antibody and 4-nitrophenylphosphate 
by intermittent pulse amperometry an applied potential of +400mV (with a pulse width 
of 1ms and a selected frequency of 50 Hz). AF B1 was detected in spiked corn samples 
at conentrations as low as 30 ng L-1 allowing the measurement of multiple samples, 
replicates and all the corresponding controls at the same time.  
Work on fluorescence sensor arrays for mycotoxins using a competitive immunoassay 
format with fluorescent labelled antibody were carried out comprehensive work on 
fluorescent biosensor arrays for mycotoxins for ochratoxin A [Ngundi et al., 2005], 
DON [Ngundi et al., 2006] and AF B1 [Sapsford et al., 2006] with detection limits of 
ochratoxin A in several cereals ranged from 3.8 to 100 μg kg-1, while in coffee and 
wine, detection limits were 7 and 38 μg kg-1, respectively [Ngundi et al., 2005], 
detection limits of deoxynivalenol ranged from 0.2 μg L-1 in buffer to 50 μg kg-1 in oats, 
and for aflatoxin B1 the detection limit in buffer was 0.3 μg L-1 and increased in real 
samples to 1.5 and 5.1 μg kg-1 (corn) and 0.6 and 1.4 μg kg-1 (nuts). An SPR-based 
biosensor array was developed by van der Gaag et al. [2003] for simultaneous detection 
of DON, AF B1, and zearalenone, but lacked the analysis of real samples and 
interference analysis. 
This shows that the use of microarrays for mycotoxin analysis is still in progress and the 
idea of an electrochemical microelectrode array is novel. The electrochemical sensor 
array [Piermarini et al., 2007] also indicated that it is possible to achieve lower 
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detection limits than with fluorescence based methods. The microelectrode array in this 
work is preliminary used to enhance sensitivity by increased current density of the array 
and will evolve further into multi-mycotoxin analysis. Interference analysis and matrix 
effects of real samples are prioritised. The construction of a standard curve was 
inconclusive as the standard curve resulted in an increasing current in proportion to the 
ochratoxin A competitor concentration instead of being inversely proportional. This 
indicates that the indirect competitive binding assay for ochratoxin A on the gold 
microelectrodes does need further characterisation of the microelectrodes and 
adaptation of the assay.  
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CHAPTER 5 : COMPUTATIONAL MODELLING OF 
PEPTIDE RECEPTORS 
5.1 Introduction 
One of nature's most important talents is evolutionary development of systems capable 
of distinguishing one molecule from another. Molecular recognition is the basis for 
most biological processes, such as ligand-receptor binding, antibody-antigen interaction 
or substrate-enzyme reactions, and is therefore of general interest. 
To date, many analytical methods are based on biomolecular recognition elements, such 
as antibodies, enzymes, and protein or peptide receptors. These methods include 
enzyme assays and immunoassays, biosensors and various (immuno)-affinity separation 
techniques. Although of fundamental importance, these methods sometimes suffer from 
features such as low stability and reproducibility, often as a result of the implemented 
biomolecule. 
Commercially available antibodies for ochratoxin A exist but are an expensive 
commodity. The production of an antibody against a small molecule is particularly 
difficult as small molecular weight molecules do not cause a sufficient immune 
response since they are not recognized as pathogens by the immune system. Antibody 
production can be labour-intensive, time- and cost-consuming, but is especially difficult 
for small molecular weight toxins such as ochratoxin A. The mycotoxin would more 
likely cause an acute toxic response in the boosted animal than the production of 
antibodies.  
Therefore, one often uses carrier proteins linked with small molecular weight haptens to 
boost the immune response. When using toxin-protein conjugates (e.g. ochratoxin A-
BSA) the concentration has to be sufficiently low, so no acute toxic effect is interfering. 
When using carrier proteins, the result is often a polyclonal antibody partly recognising 
the conjugate-structure it was raised against.  
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Also, common methods used in analysis such as high-performance liquid 
chromatography (HPLC), gas chromatography (GC), etc. require constantly new and 
more specific stationary phases for chromatography columns.  
Thus, alternative techniques to produce new (bio)-materials for separation chemistry are 
therefore of great interest and value.  
Peptides show advantages over other receptors, as they are known to be more stable 
under a wider range of physicochemical contiditions (ionic strength, pH, temperature) 
and generally easy to synthesize. 
Usually, a combinatorial approach is applied where millions of possible molecules from 
a library are screened to identify in vitro the best candidates for synthesis. The screening 
procedure is based on an existing library that might not contain the optimal ligand, since 
the produced molecular library is only containing a finite number of possibilities. The 
best fit (hit) can only be chosen from that confined set of molecules, which depends on 
the make of the library. Hence, the size of a combinatorial library is not decisive, but 
rather the need for more diversity within the library for a given task or problem. 
Therefore, a method that can screen for an infinite number of variants of peptide 
receptors, specific for ochratoxin A, is required.  
 
Computational modelling can be applied for the design of peptide receptors derived 
from 20 standard amino acid monomers that can be combined in any possible way to 
built peptides displaying various lengths (dimer, trimer, oligomer, etc.) and variations 
into a library. From that virtual library, peptide combinations are screened for hits 
according to the binding energy of the interaction calculated by computational 
modelling algorithms. Computational modelling is a powerful tool to simulate highly 
specific molecular interactions cost- and time-efficiently without the need for animal 
recourses or bench space. Virtual peptide sequence screening showed promising results 
with previous designed biomimetics for small molecular weight ligands 
[Subrahmanyam et al., 2001; Chianella et al., 2002]. This work presents the design of a 
peptide receptor for a specific template molecule (i.e. ochratoxin A) using computer 
simulation technology. 
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5.2 Experimental 
Molecular modelling was carried out on a Silicon Graphics (SGI) workstation running 
IRIX 6.6 operating system. The workstation was configured with two 195 MHz reduced 
instruction set processors, 712 MB memory and 12 GB fixed drive. This system was 
used to execute the software SYBYL 6.9.1 (Tripos Associates Inc., US). 
5.3 Methods 
Computational modelling was performed to obtain a suitable peptide receptor for the 
template ochratoxin A. Molecular modelling procedure was performed as follows: 
 
(1) Ochratoxin A structure was drawn manually using SYBYL drawing tools. 
(2) Energy minimisation generates a set of atomic coordinates which correspond to a 
minimum of energy to enhance the molecule geometry of ochratoxin A. 
(3) Simulated annealing searches for conformations with energies lower than the 
minimum of energy found by energy minimization. 
(4) LeapFrog tool designs peptide ligands for ochratoxin A by repeatedly making 
small structural changes and evaluating the binding energy E (kcal mol-1). 
(5) FlexiDock simulates receptor-ligand docking of LeapFrog derived sequences and 
their analogues. 
5.3.1 Drawing tools 
The ochratoxin molecule was drawn according to the SYBYL tutorial ‘small molecule 
sketching’ [Sybyl Tutorial Pages, 1999] and imported into the SYBYL program 
Hydrogen atoms were added subsequently to the entire ochratoxin A structure. 
5.3.2 Energy minimisation 
The minimization tool was used to refine the molecular model of ochratoxin A. All 
minimisation simulations were performed using MAXIMIN2 applying the Powell 
method. This was conducted following the SYBYL protocol shown in Figure 5.1. 
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Figure 5.1: Setup of minimization via the SYBYL menu bar. 
The Energy tool was approached via: 
Compute >>> Minimise >>> Modify >>> Energy Dialog box 
Free energy determinations should be performed with an all-atom force field that treats 
the aqueous environment via an explicit solvent model. The TRIPOS force field was 
applied for energy calculations, the utilised charges were Gasteiger-Hückel charges. The 
dielectric constant, which defines the screening effect on electrostatic interactions and 
can vary from 1 (in vacuo) to 80 (in water), is set to corresponded water conditions. A 
‘Gradient’ with a cut-off value of 0.001 kcal mol-1 at a maximum of 1,000 iterations 
was used as summarised in Table 5.1. 
Table 5.1: Parameters used for energy minimization. 
Parameter Value 
Force field TRIPOS 
Charges Gasteiger-Hückel 
Dielectric constant 80  
Termination: Gradient cut-off 0.001 kcal mol-1 
Iterations 1000 
The minimisation output consists of a report of energy, gradient, etc. for each step. The 
changes in molecular structure can be visualized during interactive minimisation, which 
is completed when the gradient reduces to the cut-off point. 
Chapter 5: Computational modelling of peptide receptors 
212 
5.3.3 Simulated annealing 
In simulated annealing, as in genetic algorithms, there is a fitness function that defines a 
fitness landscape. Simulated annealing also adds the concept of ‘temperature’, which 
gradually decreases over time. At each step of the algorithm, the solution mutates 
(which is equivalent to moving to an adjacent point of the fitness landscape). The fitness 
of the new solution is then compared to the fitness of the previous solution; if it is 
higher, the new solution is kept. Otherwise, the algorithm makes a decision whether to 
keep or discard it based on temperature. If the temperature is high, as it is initially, even 
changes that cause significant decreases in fitness may be kept and used as the basis for 
the next round of the algorithm, but as temperature decreases, the algorithm becomes 
more and more inclined to only accept fitness-increasing changes. Finally, the 
temperature reaches zero and the system ‘freezes’; whatever configuration it is in at that 
point becomes the solution. Simulated annealing is often used for engineering design 
applications such as determining the physical layout of components on a computer chip 
[Kirkpatrick et al., 1983]. 
 
The simulated annealing tool surmounts energetic barriers in a search for conformations 
with energies lower than the local minimum energy by simulating motions at a very 
high temperature, where nearly all conformations are energetically accessible. This is 
followed by slowly cooling down to room temperature or below. The molecule settles 
into a natural conformation at that temperature. This was executed following the 
SYBYL protocol as shown in Figure 5.2. 
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Figure 5.2: Setup of annealing via the SYBYL menu bar. 
Parameters used to anneal the ochratoxin A structure were set according to Table 5.2. 
The simulated annealing setup tool was approached via: 
Compute>>>Dynamics>>>Simulated Annealing dialog box 
Table 5.2: Parameters used for simulated annealing. 
Parameter Value 
RUN 10 cycles 
Heat molecule at 700 K for 1000 fs 
Anneal Molecule to 200K for 1000 fs 
The annealing function followed a second minimization step for further structure 
optimization as described in Section 5.3.2. 
5.3.4 Ligand design using LeapFrog 
LeapFrog was used to screen a database of amino acid monomers for their interacton 
with the ochratoxin A template. Interactions predominantly take place through 
hydrogen-bonding and van der Waals electrostatic interactions. LeapFrog performs an 
evaluation of ligands (here: single and combined amino acid monomers) based on their 
binding score. Calculations are based on an electrostatic screening process, where 
LeapFrog is repetitively trying novel ligands in different positions (starting points) of 
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the ochratoxin A template. Depending on the calculated ochratoxin A energy, the 
program is adding suitable ligands to a binding score list. This procedure followed the 
SYBYL protocol. The LeapFrog Start-up tool was approached via: 
Options >>> Tailor >>> Subject >>> LeapFrog 
Parameters used in LeapFrog were set according to Table 5.3. 
Table 5.3: Parameters used for LeapFrog. 
Parameter Value 
Mode DREAM  
Move frequencies Begin with 1000 
Input Data Peptide 
Start with cavity molecule in M1 ON 
Calculate site points for: ALL Atoms 
Box described by: Corners 
Starting ligands None from database 
 
 
The program was applied in DREAM mode for 100,000 to 1,000,000 iterations, 
respectively. When using a starting ligand from database, LeapFrog was started with 
1,000 iterations to begin with, and then modified by adding ‘active hydrogens to the 
ligand’s structure for binding interaction localization.  
To obtain peptide ligands, designed from only amino acid monomers, the input data was 
set on ‘peptide’. The program performed its calculations within a prescribed box, where 
the template molecule and the novel ligands are inserted to. Box dimensions (X; Y; Z) 
entered for a Leapfrog run is given in Table 5.4. 
Table 5.4: LeapFrog electrostatic screening box dimensions. 
X -6 8 
Y -8 12 
Z -11 6 
Selecting ‘Tailor’ in the LeapFrog start-up, the appearing window was set as default 
except for the category ‘Relative move frequencies’. The ‘Join’ parameter allows for 
construction of novel molecules by combining several fragments into one molecule 
[Boehm, 1995].  
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The ‘Bridge’ move was set to zero, since a software problem was isolated to that part by 
Richard Day [1999], who observed that as the amino acids were refined and joined from 
previous iterations, old results were not being removed and eventually all the memory 
of both system and virtual were being consumed. The ‘Bridge’ move was therefore 
turned off and the number of iterations doubled to allow larger fragments to grow. To 
enhance that feature, the ‘Join’ move, which joins different fragments together, was also 
increased.  Further parameters of this category are shown in Table 5.5. 
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Table 5.5: Summary of relative move frequencies. 
Parameter Description Default Modified value
Join Joining of different fragments 2 6 
Fuse Fuses fragments 0 0 
New New ligand is started by aligning fragments 5 5 
Fly Alternative minimum energy ligand orientations 2 2 
Twist Conventional minimizing 2 2 
Refine Improves newly found ligand 2 2 
Bridge Considers all fragments as bridges 2 0 
Complement  Chooses moiety complementary to a cavity group as a ligand 2 2 
Save Saves ligands that match requirements 2 2 
Weed Discards the worst ligands except the top 10 0 0 
Crossover Generates best hybridizations among similar molecules 0 0 
Prune Can delete moieties of a known ligand on the basis of their energy with the receptor 0 0 
The LeapFrog results for the binding scores from each run are listed. The ligands given 
the highest binding score (lowest binding energy) were assumed to represent the best 
fitting peptide ligands for ochratoxin A. The virtual peptide library database is generally 
stored as SLN-file. SYBYL Line Notion (SLN) is an ASCII language used to represent 
chemical structures, including common organic molecules, macromolecules, polymers, 
and combinatorial libraries. SLN is also used to express substructural (2D) queries [Ash 
et al., 1997].  
5.3.5 Receptor-ligand docking using FlexiDock 
FlexiDock is a genetic algorithm for receptor-ligand docking. It is designed to dock a 
number of ligands into a receptor molecule cavity such as an enzyme macromolecule. In 
this application, FlexiDock is used to dock a number of LeapFrog designed peptide 
receptors around the ligand molecule ochratoxin A.  
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Effectively, the terms ligand and receptor are reversed in that context. The following 
docking protocol is adapted from the Tripos Bookshelf 7.2 FlexiDockTM Manual.  
FlexiDock allows to "recycle" a molecular (ochratoxin A ligand) definition so that a 
variety of peptide receptor molecules can be investigated at once. A selection of lead 
sequences of the virtual database of peptide receptors designed from LeapFrog is 
assembled in one database file. Then, the ochratoxin A ligand file is loaded and 
prepared as follows: 
? Empty the binding pocket: remove any existing ligand. 
? Check all atom types (energy calculations are based on atom types, therefore it is 
important to verify that these have been assigned correctly by SYBYL) 
? Removal off all water molecules (deletion of crystal water), keeping only those 
that may contribute to the interactions between the ligand and receptor. 
? Adding hydrogens and charges (AMBER charges for ochratoxin A and 
Gasteiger-Hückel charges for the peptide receptors) 
? Definition of ochratoxin A table bonds 
? Mark the hydrogen bonding sites 
? Pre-position the ligand in a virtual cavity 
For each peptide receptor: 
? Load the molecule into a second molecule area and prepare it.  
? Add all hydrogens.  
? Compute atomic charges. 
? Define the ochratoxin A table bonds ( to simply define all ligand bonds as 
ochratoxin A table)  
? Mark the hydrogen bonding sites.  
? Manually position the peptide receptor in the ochratoxin A cavity.  
Run FlexiDock on the entire set: 
Compute >>> FlexiDock >>> Run Existing Input Files... 
The results of the FlexiDock run are stored in the SYBYL database (e.g.: file.mdb). The 
resulting spreadsheet includes a column; titled ‘Energy’ and containing the FlexiDock 
score for the saved solution.  
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5.4 Results and Discussion 
5.4.1 Minimisation and annealing 
The ochratoxin A structure (Figure 5.3) was drawn from the scratch using SYBYL 
‘DRAW’. In this context the ochratoxin A structure is referred to as template or as 
ligand, whereas the derived peptide structures are referred to as receptors. 
 
Figure 5.3: Minimised and annealed structure of the ochratoxin A template (shown in 
stick and ball). 
The ochratoxin A structure was minimised, annealed and then minimised again before 
running the de novo design tool LeapFrog. Table 5.6 summarises the results of a 
minimization procedure for ochratoxin A, before as well as after annealing. 
Table 5.6: Minimisation of ochratoxin A structure.  
Energy contribution Energy [kcal mol-1] 
Bond stretching energy 0.526 
Angle bending energy 2.233 
Torsional energy 5.551 
Out of plane bending energy 0.053 
1-4 van der Waals energy 4.167 
Van der Waals energy -4.004 
1-4 electrostatic energy -7.855 
Electrostatic energy -5.239 
Ochratoxin  A energy [kcal mol-1] -4.569 
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The various energy contributions that make up the overall molecular energy of 
ochratoxin A are listed in Table 5.6. The energies were obtained by minimising the 
structure (Figure 5.3) of ochratoxin A. The total energy outcome of the minimised 
ochratoxin A structure was -4.569 kcal mol-1. Minimisation was followed by annealing 
and another step of minimisation to for further optimisation of the ochratoxin A 
structure. The values for the energy minimisation before and after annealing vary 
considerably; the energy of the molecule is increased after annealing. 
5.4.2 Leapfrog assisted design using ochratoxin A  
The de novo design of ligands was performed using LeapFrog, where the ochratoxin A 
template is initially subjected to a procedure called electrostatic screening (Figure 5.4). 
LeapFrog proposed novel peptide structures after about 1,000,000 iterations of trial. 
 
Figure 5.4: Electrostatic screening of the ochratoxin A template (seen in purple). 
Coloured dots are depicting the sites of interaction tried by the LeapFrog tool.  
LeapFrog stored its best scoring results in a spreadsheet for further evaluation. The 
binding score, assumed to be directly related to the ochratoxin A binding energy of the 
binding interaction, was shown in kcal mol-1. 
 
A LeapFrog run was setup according to the protocol in Section 5.3.4. The binding 
energy of every single amino acid with ochratoxin A was assessed and should indicate 
the characteristics of each amino acid monomer in relation to ochratoxin A interaction.  
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The binding energies and corresponding polarity of each applied amino acid is shown in 
Table 5.7. The lowest binding energy is ascending which describes the binding energy 
for the most likely binding interaction with ochratoxin A.  
Table 5.7: Binding energies for all 21 amino acids with ochratoxin A. 
No. Amino acid Polarity Binding energy [kcal mol-1] 
1 Phenylalanine (Phe) Apolar -33.52 
2 Proline (Pro) Apolar -32.10 
3 Valine (Val) Apolar -30.93 
4 Isoleucine (Ile) Apolar -30.37 
5 Leucine (Leu) Apolar -28.94 
6 Cysteine (Cys) Polar (non-charged) -28.67 
7 Tyrosine (Tyr) Polar (non-charged) -27.29 
8 Methionine (Met) Apolar -26.33 
9 Threonine (Thr) Polar (non-charged) -25.55 
10 Tryptophan (Trp) Apolar -22.71 
11 Alanine (Ala) Apolar -21.87 
12 Glutamate (Glu) Polar (negatively charged) -20.63 
13 Aspartate (Asp) Polar (negatively charged) -19.86 
14 Asparagine (Asn) Polar (non-charged) -13.27 
15 Lysine (Lys) Polar (positively charged) -11.72 
16 Histidine (His) Polar (positively charged) -10.06 
17 Glutamine (Gln) Polar (non-charged) -6.43 
18 Arginine (Arg) Polar (positively charged) -5.65 
19 Serine (Ser) Polar (non-charged) -5.23 
20 Glycine (Gly) Polar (non-charged) -1.89 
As listed in Table 5.7, the five best scoring amino acids interacting with ochratoxin A 
have an apolar side chain and exhibit a hydrophobic character (Phe; Pro; Val: Ile;Leu). 
The highest binding score was seen with Phenylalanine that contains a water-insoluble 
aromatic ring, which is insofar interesting, since the ochratoxin A structure contains an 
L-β-phenylalanine moiety as well.  
The second best binding score showed Proline (cyclic amino acid) and followed by 
Valine, Leucine and Isoleucine that have all aliphatic acyclic residual groups (Figure 
5.5).  
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Figure 5.5: Ochratoxin A template (seen in purple) interacting with distinct amino acids 
(from left to right: isoleucine, valine, glycine, methionine, lysine and tryptophan). 
The lowest binding scores were obtained by polar (charged and non-charged) amino 
acids (Figure 5.5) that are relatively hydrophilic due to the polar functional groups in 
their side chains. The lowest binding score showed Glycine, which has as side chain a 
hydrogen atom that has no effect on the hydrophilic character of the amino acid. These 
findings confirm the hydrophobicity of ochratoxin A and the likelihood of establishing 
hydrophobic interactions. 
5.4.3 De novo designed peptides 
The de novo design of peptide receptors was facilitated using LeapFrog in DREAM- 
mode, by directly proposing new lead compounds by trying all 20 amino acids listed in 
Table 5.7. The best interacting peptide sequences regarding binding energy and H-
binding are shown in Table 5.8. 
Table 5.8: Binding energy and corresponding H-bonds highest scoring peptide 
sequences interacting with ochratoxin A generated from LeapFrog. 
No. Peptide Sequence H- 
bonds 
Binding energy 
[kcal mol-1] 
1 Tripeptide Ile-Gly-Ala 4 -44.55 
2 Tetrapeptide  Ile-Gly-Ala-Pro 3 -44.54 
3 Tetrapeptide  Ile-Gly-Ala-Gly 5 -40.05 
4 Tetrapeptide Ile-Gly-Ala-Cys 5 -38.56 
5 Pentapeptide  Ile-Gly-Ala-Pro-Ala 5 -37.47 
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As shown in Table 5.8, the highest scoring peptide sequence was a tripeptide, which 
formed three H-bonds with ochratoxin A. This peptide contains two apolar (Ile and Ala) 
and one non-charged polar amino acid, which can act as spacer. The second best 
sequence was a tetrapeptide which differed in just one amino acid from the lead 
compound, which is Proline, another apolar amino acid.  
The main assumption made from the results is that mainly apolar or non-charged amino 
acids are combined to a peptide sequence that is able to interact with ochratoxin A. This 
confirms the data obtained with single amino acid monomers shown in Table 5.7, which 
indicated high binding affinities for apolar amino acid monomers. Therefore, the 
interactions of the peptide sequence with ochratoxin A is most likely based on 
hydrophobic interactions. Interestingly, the number of hydrogen bonds does not seem to 
be directly proportional to the binding score.  
The two highest scoring peptides interacting with ochratoxin A are shown in Figure 5.6.  
 
 
Figure 5.6: Left: Ochratoxin A with tripeptide (from left to right: Ile-Gly-Ala) linked 
via 4 H-bonds. Binding energy: -44.55 kcal mol-1. Right: ochratoxin A with tetrapeptide 
(from top to bottom: Ile-Gly-Ala-Pro) linked via 3 H-bonds Binding energy: -44.54 kcal 
mol-1. 
Ochratoxin A 
Ochratoxin A 
Tetrapeptide 
Tripeptide 
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Figure 5.6 shows that the tripeptide (left) is mainly building H-bonds with the L-β-
phenylalanine moiety of ochratoxin A. Alanine is building 2 H-bonds and Isoleucine 
one H-bond with the L-β-phenylalanine moiety, whereas Isoleucine establishes another 
H-bond with the OH-residue of the 3,4-dihydro-3-methyl-isocoumarin part of 
ochratoxin  A. Glycine doesn’t seem to interact at all and is probably used as a spacer 
monomer for stabilisation. This is confirmed in the tetrapeptide structure in Figure 5.6 
(right), where both Alanine and Proline establishing one H-bond each with the L-β-
phenylalanine moiety and Isoleucine one with the OH-residue of the isocoumarin 
moiety.  
Therefore, the main interaction of the peptides seems to be localised on the L-β-
phenylalanine part of ochratoxin A based on hydrophobic interaction of mainly apolar 
amino acids. The sequence Ile-Gly-Ala was repeated throughout the first five lead 
compounds and was involved in the majority of H-bond interactions with ochratoxin A 
(Table 5.8). The termini of the tetramer and pentamer sequences differed in one or two 
amino acids such as Glycine, Cystein or Proline with Alanine, which established a fifth 
H-bond with ochratoxin A (Table 5.8). 
5.4.4 De novo peptide design using a starting molecule 
To optimize specificity of the binding interaction, lead sequences were implemented in 
the electrostatic screening process to give LeapFrog a starting point of existing H-bond-
based interactions, from where it could expand the given peptide receptors with further 
amino acid monomers to obtain a longer, more specific sequence (lower binding 
energy).  
 
LeapFrog was setup with the tripeptide and tetrapeptide chosen from Table 5.8 as 
starting molecules around the ochratoxin A template. Table 5.9 below shows the results 
of LeapFrog run applying starting molecules. 
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Table 5.9: Binding energy and corresponding H-bonds of lead peptide sequences 
interacting with ochratoxin A generated from LeapFrog using starting ligands. 
No. Starting ligand Resulting 
Peptide 
H-bonds Binding energy [kcal mol-1] 
1 Ile-Gly-Ala Ile-Ser-Pro 4 -38.34 
2 Ile-Gly-Ala-Pro Ile-Ser-Gly 4 -35.56 
Only the two highest scoring peptide sequences are shown in Table 5.9. The resulting 
lead sequences were both tripeptides, which each formed 4 hydrogen-bonds with 
ochratoxin A. One tripeptide contained two apolar (Ile and Pro) and one non-charged 
polar (Serine) amino acid. The other sequence differed from the first one in just one 
amino acid that is a Glycine instead of the Proline. Again, mainly apolar or non-charged 
amino acids were combined to a peptide sequence.  
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The two lead peptides, interacting with ochratoxin A, are shown in Figure 5.7.  
 
Figure 5.7: Peptide interaction with ochratoxin A, applying a starting ligand. Left: 
Ochratoxin A with tripeptide (from left to right: Pro-Ser-Ile) linked via 4 H-bonds. 
Binding energy: -38.34 kcal mol-1. Right: Ochratoxin A with tripeptide (from left to 
right: Gly-Ser-Ile) linked via 4 H-bonds. Binding energy: -35.56 kcal mol-1. 
Figure 5.7 shows that one tripeptide (left) is building hydrogen bonds with ochratoxin  
A mainly via the amino acids Serine and Isoleucine. The residual OH-group and the 
NH-group of ochratoxin A’s phenylalanine moiety are part of the hydrogen-bonding. 
The same functional groups of ochratoxin A are interacting with the amino acids of the 
second tripeptide, which are Isoleucine, Serine, and Glycine. The hydrogen-bonding of 
this modelling experiment, using starting molecules, seemed to distribute the 
interactions between the de novo designed receptor and ochratoxin A over the entire 
structure.  
 
However, the resulting lead sequences shown in Table 5.9 are both very short sequences 
(tripeptides) with a higher binding energy than the initially obtained sequences (Table 
5.8) when no starting molecule was used. Therefore, the approach of using a starting 
ligand to enhance specificity of the peptides was discarded. 
Tripeptide 
Ochratoxin A
Tripeptide 
Ochratotxin A 
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5.4.5 Screening the peptide receptor library 
To obtain longer peptide sequences and thus higher specificity (lower binding energy), 
the ‘Tailor’ option in the LeapFrog start-up was modified in the category ‘Relative 
move frequencies’ in its ‘join’ and ‘bridge’ parameters (see Section 5.3.4, Table 5.5). 
The ‘Tailor’ option allows LeapFrog to combine amino acids into short peptide 
sequences of 3-6 amino acids in length. By increasing the parameter ‘join’ and setting 
the ‘bridge’ function to zero, LeapFrog should increase the length of peptide fragments 
to be joined. High scoring peptide sequences interacting with the ochratoxin A template 
are shown in Table 5.10.  
Table 5.10: Binding energies for the highest scoring peptide sequences. 
No. Amino acid  sequence Binding energy [kcal mol-1] 
1 Pro-Ser-Ile-Val-Glu -46.45 
2 Ile-Gly-Ala -44.55 
3 Ile-Gly-Ala-Pro -44.54 
4 Cys-Ser-Ile-Val-Glu -42.13 
5 Ile-Gly-Ala-Pro-Ala -37.47 
6 Cys-Gly-Pro-Ala-Gly-Ile -31.85 
7 Ser-Pro-Ala-Gly-Ile -31.56 
The highest scoring peptide sequences contained repetitively the amino acids 
Isoleucine, Glycine, Alanine and Proline as well as Valine and Glutamate. The 
introduction of Proline, Valine and Leucine in the peptide sequences was expected since 
those amino acid monomers resulted in high binding scores when modelling the amino 
acid monomer interactions with ochratoxin A. Alanine and Glutamate had shown 
medium binding interaction and Glycine has the highest binding energy and therefore 
the lowest binding score (Table 5.7) and is possibly not involved in any hydrogen 
bonding. The majority of these amino acids are apolar, which means they are difficult to 
dissolve in aqueous solution.  
5.4.6 Docking simulation for lead sequence selection 
By modelling the dynamics of the peptide-ochratoxin A interaction, the flexibility of the 
modelled sequences binding to ochratoxin A is characterised. High scoring peptides 
designed with LeapFrog were screened using FlexiDock, which assumes high flexibility 
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of the peptide around ochratoxin A. The simulation was performed using selected 
peptides and manually modified sequence analogues containing negatively charged 
amino acids such as Aspartate and Glutamate, as well as positively charged Lysine and 
polar (non-charged) Serine that were introduced at random positions into the sequences 
to improve hydrophilicity.  
 
The final peptide design from FlexiDock contained a LeapFrog-derived peptide 
sequence and was terminally functionalized with a Cysteine residue to facilitate 
immobilisation procedures in binding assays. The final peptide sequences screened by 
Flexidock and corresponding binding energies are shown in Table 5.11. 
Table 5.11: List of 11 highest ranking peptides screened with FlexiDock shown in 
descending order 
No. Peptide sequence Binding 
energy 
[kcal mol-1] 
Acidic (-1) 
/basic(+1) 
rating 
1 Gly-Pro-Ser-Ile-Val-Glu-Cys -17.24 -1 
2 Pro-Ser-Ile-Val-Glu-Pro-Ser-Ile-Val-Glu-Cys -16.72 -1 -1 
3 Ser-Pro-Ala-Gly-Ile -16.07 / 
4 Cys-Ser-Ile-Val-Glu-Asp-Gly-Lys -14.90 -1+1 
5 Cys-Gln-Ile-Val-Glu-Pro-Gln-Ile-Val-Glu -14.63 -1 -1 
6 Cys-Phe-Asp-Pro-Ala-Gly-Ile-Lys -14.25 -1 +1 
7 Cys-Phe-Asp-Ala-Pro-Ala-Gly-Ile-Lys -13.08 -1 +1 
8 Pro-Ser-Ile-Val-Glu -12.48 -1 
9 Gly-Pro-Ala-Gly-Ile-Asp-Gly-Pro-Ala-
Gly-Ile-Arg-Cys 
-11.81 -1 
10 Gly-Ser-Pro-Ala-Gly-Ile-Gly -11.78 / 
11 Cys-Gly-Pro-Ala-Gly-Ile -8.72 / 
The binding energy values in Table 5.11 are similar to LeapFrog generated energy 
values in that large, negative binding energy is indicating a high score. However, these 
values are not identical to what would be obtained using the Tripos force field because 
different force field terms are used and a site-point matching score was included in the 
FlexiDock calculation. Table 5.11 lists the sequences that showed the lowest binding 
energy resulting from docking simulations with FlexiDock. Reoccurring sequences can 
be found in the highest scoring peptides such as the sequences Cys-Gly-Pro-Ala-Gly-Ile 
(6), Ser-Pro-Ala-Gly-Ile (7), and Pro-Ser-Ile-Val-Glu (1) derived from Table 5.10. 
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Other short sequences such as Pro-Ala-Gly-Ile (Table 5.8) have been implemented into 
several peptides. 
 
Relating hydrogen bonding to binding energy, it was shown that corresponding to the 
chemical environment the strength of hydrogen bonds can vary from 2 kJ/mol (0.5 
kcal/mol) to 15 kJ/mol (3.6 kcal/mol), in extreme cases up to 42 kJ/mol (10 kcal/mol). 
Hence, an average value may not always be representative, especially in multiple 
hydrogen bonded systems [Boehm et al., 1996]. The designed peptides are multiple 
hydrogen-bonded systems of an average of 4-5 hydrogen bonds per peptide receptor 
molecule. Thus, assuming a number of  4-5 H-bonds should result in a range of average 
binding energies of  2 to 14.4 kcal/mol for 4 H-bonds and 2.5-18 kcal/mol for 5 H-
bonds. The displayed binding energies in Table 5.11 vary between 8 and 18 kcal/mol 
which is within the theoretical range. Therefore, all of the listed peptide receptors are 
within the acceptable range of binding energies and can be considered as lead peptide to 
be synthesized. Considering solubility and ease of synthesis [Patel, 2005] as well as 
probability of binding interaction in an in vitro environment [Tame, 1999], two peptide 
sequences were chosen for synthesis (Figure 5.8).  
 
Figure 5.8: Final result of de novo designed peptide sequences shown interacting with 
ochratoxin A. The 13-mer peptide (A, left) and the octapeptide (B, right) sequence are 
seen as space-filled, ochratoxin A as stick & ball structures. 
A B 
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A 13-mer peptide with the sequence NH2-Gly-Pro-Ala-Gly-Ile-Asp-Gly-Pro-Ala-Gly-
Ile-Arg-Cys-COOH (Figure 5.8, A), which was derived from the basic sequence 
[PAGI] (Table 5.8), combined into a dimeric molecule that is separated by negatively 
charged Aspartate and Glycine, where the latter was also incorporated as N-terminal 
cap. The C-terminal end of the sequence was modified by positively charged Arginine 
and Cysteine for immobilisation purposes. The second peptide is an octapeptide with 
the sequence COOH-Cys-Ser-Ile-Val-Glu-Asp-Gly-Leu-NH2 (Figure 5.8, B) with an 
introduced negatively charged amino acid Aspartate and a C-terminal Cysteine residue. 
The sequence of the octamer (Table 5.11) was further modified post-simulation by 
using Leucine instead of Lysine as N-terminal amino acid was chosen with the intent to 
avoid an accumulation of basic pH at the peptide’s N-terminal end. The molecular 
weight of the peptides was determined by mass spectroscopy. The 13-mer peptide 
(Appendix 2) has an average molecular mass of 1183.47 and the octapeptide (Appendix 
3) of 856.64 m/z. 
 
Table 5.11 also lists a simplified acidity/basic rating, since the pH is an important issue 
for the charge of the peptide in solution. Changes in the pH value can cause the 
protonation or deprotonation of the interaction partners and result in different 
interaction patterns [Krovat et al., 2005]. A rule of thumb in determining peptide pH is 
the following: Arg, Lys, His and N-terminal -NH2 all contribute to the basic pH of a 
peptide. Asp, Glu and a C-terminal COOH-(carboxy) group contribute to the peptide’s 
acidity. Assigning +1 values to basic residues (including CONH2) and -1 values to 
acidic residues (including C-COOH) within the peptide will yield an overall acidic/basic 
rating [Globalpeptide, 2007]. The overall acidic/basic rating is described in Table 5.11 
for all high scoring peptide sequences derived from FlexiDock. One lead sequence 
selection criteria was to adjust the peptide pH as closely to the sample pH it is destined 
for. Since the sample matrix is wine in this study, the pH has to be considered. Table 
wines generally have a pH between 3.3 and 3.7 [Pandell, 1999], therefore, a slightly 
acidic or neutral peptide structure is favourable since it would be probably more stable 
in acidic solution.  
A critical issue is the multi-factorial dependence of docking results. Much effort has 
been devoted to investigate how and to what extend, the outcome and accuracy of a 
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docking approach is influenced by different parameters. Aside from docking simulation 
algorithm and scoring function, binding-site definitions (electrostatic screening) are 
decisive [Schulz-Gasch & Stahl, 2005]. Also the nature of the molecular target, the 
properties of the binding site as well as (bio)-molecule flexibility were found to 
influence docking reliability [Kontoyianni et al., 2004]. Using FlexiDock tool, to 
simulate docking of a binding site “around” a ligand as opposed to modeling a ligand 
“into” a binding pocket, one can only assume that this might have a vast influence on 
docking results. Furthermore, both the molecular template and receptor structure (i.e. 
molecular weight) and the manual binding-site definition via the selection of hydrogen-
bonds are defining parameters that can influence the outcome of the docking results. 
Therefore this is a biased docking solution toward formation of hydrogen bonds by 
marking H-bond donor and acceptor sites on the peptide receptor and ochratoxin A. 
As our peptide synthesis facilities were outdated we opted to use outside facilitate to 
synthesise the peptides. The peptide structures were chemically synthesized by The 
Medical Research Council (MRC) at Imperial College, London. The synthesized 
peptides were then subjected to in vitro affinity characterisation with ochratoxin A to 
establish the suitability of the peptide sequences as recognition layer in the proposed 
biosensor application. 
5.5 Concluding Remarks 
The initial argument of the approach to simulate nature’s evolution to de novo design a 
receptor for a small molecular weight toxin still holds up. The advantages of designing a 
receptor for ochratoxin A in silico, and therefore being able to neither use animal 
resources nor being directly subjected to ochratoxin A is advanteous. However, one has 
to review if such an attempt is possible with today’s technology. This work’s results 
illustrate the design and synthesis of a small peptide receptor for ochratoxin A using de 
novo design software. 
In the process, it was confirmed that the de novo design tool LeapFrog can be used to 
produce a virtual library of peptide receptors for ochratoxin A and also screen this 
library using binding energy algorithms to produce a hit-list of lead peptide sequences. 
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From the hit-list, a manual selection of a lead sequence was necessary, being subject to 
correct interpretation of parameters such as H-bonds being part of the interaction. First 
of all, it has to be mentioned that LeapFrog can be used for the design of relatively 
small peptide receptors for small molecular weight ligands even though its primarily 
application is the design of molecules into binding pockets of macromolecules like 
enzymes. However, the lack of background information sources (published literature on 
the software) supplied with LeapFrog was decimating the possibilities of modifying 
binding interaction parameters for applications like the peptide receptor design for small 
molecules. Also, the screening of the LeapFrog-generated library was limited by the 
lack of structure-activity/ -function simulations.  
 
The applied program FlexiDock, part of the LeapFrog software, can be used for a rough 
simulation of receptor-ligand docking. However, the application is based on simple 
parameters and one cannot be sure that it simulates the ‘real’ nature of the molecular 
interactions, for example the simulation is subject to selecting the interaction sites for 
H-bonding manually. In addition to that, the manual extension of the peptide sequence 
with charged amino acids or with a Cysteine-tag might have an effect on the affinity of 
the interaction, since it is well known that the interchange of only one charge in an 
amino acid sequence can have an immense effect on the activity of the molecule, which 
is not sufficiently characterised using FlexiDock simulations.  
Modelling parameters are of critical importance in determining the types of 
intermolecular forces that underly ligand-receptor interaction. The three major types of 
parameters that were initially suggested are electronic, hydrophobic, and steric in nature 
[Hansch et al., 1964 & Hansch, 1969]. Extensive studies using electronic parameters 
reveal that electronic attributes of molecules are closely related to their chemical 
reactivities and biological activities.  
Thus, molecular interactions have an impact on the receptor-ligand interaction and 
therefore the affinity of the complex formation and dissociation. It is crucial to 
determine those parameters carefully to completely understand the extensiveness of 
molecular interactions and thus being able to simulate the structure-activity function in 
silico. Therefore, one cannot presume a 100% accurate result using FlexiDock. The 
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binding affinity of the interaction is to be confirmed in vitro using solid-state peptide 
assays and real-time monitoring of the binding interaction with the SPR biosensor 
Biacore.  
Generally, the de novo design of biomolecules, particularly receptors for small ligands, 
using computational modelling is still a sporadic discipline. De novo design software 
problems are approached from different points of view, with different methods and 
different purposes: such as the optimal estimation of binding energies by either QSAR, 
empirical energy functions or free energy calculations based on molecular dynamics 
simulations and relative energies versus absolute enthalpies calculations in the 
determination of binding affinity.  
The specific purpose of the ideal computational model should be a systematic 
generation and high throughput screen of large molecule libraries for the establishment 
of inter- and intra-molecular interaction parameters, kinetics and affinity and structure-
activity relationships. In the absence of such conglomeration, the state of the art in de 
novo drug design and binding interaction prediction can be summarized by saying that 
we are still at the stage of exploration and data collection.  
 
So far computer-assisted molecular design (CAMD) cannot substitute for a clear 
understanding of the biological system being studied. Ideally, one would have 3-
dimensional structural information for the peptide receptor and the ochratoxin A-
receptor complex from X-ray diffraction or NMR. Ongoing research in receptor design 
and structure-function studies as well as the introduction of small molecular weight 
templates are well underway and molecular dynamics simulation techniques will guide 
computational chemists to real predictions of binding affinities of receptor-ligand 
interactions without them having to synthesize the molecule. 
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CHAPTER 6 : SURFACE PLASMON RESONANCE 
ANALYSIS OF PEPTIDE RECEPTORS 
6.1 Introduction 
Computational modelling simulates the chemicophysical behaviour of molecular 
structures using quantum equations and classical physics by generating and representing 
them numerically. The technique has been successfully used to gain a selection of 
synthetic receptors based on peptide molecules (Chapter 5). The peptide receptor design 
for small molecular weight toxins such as ochratoxin A is a completely new approach. 
To assess the binding interaction of the newly designed peptides with ochratoxin A in 
vitro, binding interaction analysis was performed using solid phase assays and a surface 
plasmon resonance-based technique (Biacore). Sensors using surface plasmon 
resonance (SPR) for binding interaction studies have been reviewed by Homola et al. 
[1999]. The SPR biosensor Biacore has been successfully applied for multiple-
mycotoxin analysis and was described by van der Gaag et al. [2003]. In this work, the 
peptides were initially characterised on solid phase assays to assess whether they show 
any binding for ochratoxin A in vitro. An extended study was performed using the SPR 
(Biacore) technique to investigate kinetic and affinity of the binding interaction. 
6.2 Experimental 
The ochratoxin A-BSA conjugate, N-Succinimidyl 3-(2-pyridyldithio) propionate 
(SPDP) and cysteine was purchased from Sigma Aldrich Ltd. (UK). Acetate buffer and 
Glycine was from Fluka (UK). The CM5 sensor chips, HEPES buffered saline (HBS-
EP), 1M ethanolamine-HCl, EDC (N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide) 
and NHS (N-hydroxysuccinimide) as well as the BIAcore 3000™ instrument used for 
the analysis were from BIAcore AB (GE Healthcare, Uppsala, Sweden). The ready-
made TMB (3,3´,5,5´-tetramentylbenzidine) solution was from Europa Bioproducts Ltd. 
(UK). Peptides have been synthesized and analysed with mass spectroscopy by the 
Medical Research Council (MRC) at Imperial College, London.  
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6.3 Methods 
6.3.1 Solid phase binding assay of peptide-ochratoxin A interaction 
This assay formats involve the immobilisation of the peptide receptor molecule. The 
immobilisation of small molecules, such as the peptide receptors presented here, is more 
cumbersome since small peptides do not offer as many potential attachment sites. 
Therefore, the optimal immobilisation technique has to be characterised. Generally, it is 
recommended to covalently immobilise peptides via reactive amines-, thiol- or 
carboxyl-groups and using site-directed immobilisation technique is considered to 
enhance the orientation of peptides [Hermanson, 1992]. Therefore, two immobilisation 
strategies were employed to test the initial binding of the peptides. One is based on the 
common amine coupling approach that couples primary and secondary amine groups to 
carboxy groups. Thiol coupling specifically targets the terminal cysteine-tag (sulfhydryl 
group) attached to each synthetic peptide and allows site-directed attachment. 
 
The peptide binding assay is performed in a direct binding format; with the peptide 
being immobilised and using the ochratoxin A-HRP conjugate as label as the peptides 
are not labelled themselves. The activity of the ochratoxin A-HRP conjugate has been 
confirmed in Chapter 2 (Section 2.48) and its specificity, even though very low affinity 
has been shown applying biospecific interaction analysis in Chapter 3 (Section 3.4.3.3). 
Both peptides were coupled to secondary amine (R2NH)-activated polystyrene wells of 
a micro titre plate. Amine coupling was performed using NHS and EDC as linker and 
the thiol coupling using SPDP, a heterobifunctional cross-linking reagent with amine 
and sulfhydryl reactivity. Tiol coupling was used to investigate whether site-directed 
immobilisation would result in better sensitivity.  
 
Amine coupling was performed by incubating 100 μg ml-1 of each peptide solution in 10 
mM carbonate buffer pH 9.6 on the NH-plate for 30 minutes. Then, 200 mM EDC and 
50 mM NHS was added to the peptide and further incubated for one hour. The plates 
were washed using PBST and blocked using 0.1 M ethanolamine for 30 minutes. A 
range of ochratoxin A-HRP dilutions was added to the immobilised peptides and 
incubated for 2 hours. All incubations were performed at room temperature. The zero 
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reference was determined with HRP alone. The detection was performed with the 
chromogen TMB in ready-made solution containing hydrogen peroxide. The absorbance 
was read after 20 minutes at 450 nm.  
 
Thiol coupling was performed via the immobilisation of 1.5 mg ml-1 SPDP in phosphate 
buffer (PBS) pH 7.4 incubated 30 minutes at room temperature. The peptides were 
added at 100 μg ml-1 in a phosphate buffer pH 8.0 and incubated for another two hours 
at room temperature. The plates were washed using PBST and blocked for one hour 
using 1 mg ml-1 cysteine in 1 M NaCl and 0.1 M sodium acetate, pH 4.0. The binding 
was determined by adding varying ochratoxin A-HRP conjugate dilutions in phosphate 
buffer pH 7.4 to the immobilised peptides and incubate for 1.5 hours. The zero 
reference was determined with HRP alone. The detection was performed, after washing 
the microtitre plates using PBST, with the chromogen TMB in ready-made solution 
containing hydrogenperoxide. The absorbance was read after 20 minutes at 450 nm.  
6.3.2 Bioanalysis of peptide-ochratoxin A interaction using Biacore 
The binding interaction analysis of the peptide receptor with ochratoxin A was carried 
out on a CM5 (carboxymethylated dextran) sensor chip at 25 °C. HBS-EP (0.01 M 
HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% Surfactant P20) was used as 
running and dilution buffer. Peptides (100 mg L-1 in 10 mM acetate buffer, pH 4.5) were 
immobilised using N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) and N-
hydroxysuccinimide (NHS), applying amine coupling. The injection volume was 75 μl 
at a flow rate of 5 μl per minute for 15 minutes. Ochratoxin A-BSA (10 mg L-1 in 10 
mM acetate buffer, pH 4.5) was immobilised using amine coupling at an injection 
volume of 35 μl at a flow rate of 5 μl per minute. As reference, BSA was immobilised. 
Every flow cell of a sensor chip was immobilised separately. Non-bound binding sites 
were subsequently deactivated by injecting 35 μl 1M ethanolamine-HCl, pH 8.5 for 7 
minutes. Un-conjugated BSA was injected as zero concentration. Binding interaction 
analysis was executed at a flow rate of 5 μl min-1 and an injection volume of 60 μl 
ochratoxin A-BSA (in HBS-EP, pH 7.4) with an equivalent dissociation time. 
Dissociation was observed in running buffer without regeneration reagents. The kinetic 
Chapter 6: Surface plasmon resonance analysis of peptide receptors 
236 
parameters of the binding reactions were determined using BIAevaluation 3.2 software 
[Karlsson et al., 1994]. 
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6.4 Results and Discussion 
An octapeptide with the sequence CSIVEDGL and a 13-mer peptide with the sequence 
GPAGIDGPAGIRC have been successfully synthesised. In the following the 
implementation of the peptides into binding assays is presented. 
6.4.1 Solid phase binding assay of peptide-ochratoxin A interaction 
The peptide binding assay was performed to get a quick yes/no answer whether the 
peptides bind to ochratoxin A in vitro. For that study, both peptides were separately 
immobilised to the solid-phase support and subjected to varying concentrations of the 
ochratoxin A-HRP conjugate in a direct (non-competitive) binding format. Two 
immobilisation techniques were employed to investigate the optimal conditions for 
peptide immobilisation. Figure 6.1 shows both immobilisation techniques for the 
octapeptide as a plot of absorbance signal versus ochratoxin A-HRP dilution. 
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Figure 6.1: Plot of absorbance at 450 nm versus ochratoxin A–HRP conjugate (stock 
concentration of 1.9 mg ml-1) using immobilised octapeptide CSIVEDGL via amine 
coupling (■) and site-directed thiol coupling (●). Standard deviation of the multiple 
measurements is depicted as error bars. The curves are fitted with a four parameter fit. 
As depicted in Figure 6.1, an increase in absorbance with increasing conjugate 
concentration is observed for both amine and thiol coupling of the octapeptide. It can 
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also be seen that thiol coupling results in a higher signal when using lower conjugate 
concentrations, whereby the signal displaying amine coupling is increasing slower but 
shows a higher signal/noise ratio. At conjugate concentration higher than 1/10 dilution, 
the resulting signal for both immobilisation techniques is similar and a difference in 
coupling method is not visible. The same strategy was employed for the 13-mer peptide 
and the results depicting the immobilisation strategies are shown in Figure 6.2. 
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Figure 6.2: Plot of absorbance at 450 nm versus ochratoxin A–HRP conjugate (stock 
concentration of 1.9 mg ml-1) using immobilised 13-mer GPAGIDGPAGIRC via amine 
coupling (■) and site-directed thiol coupling (●). Standard deviation of the multiple 
measurements is depicted as error bars. The curves are fitted with a four parameter fit. 
In Figure 6.2, the thiol-coupled 13-mer peptide demonstrates an increase in signal with 
increasing conjugate concentration, whereas the amine coupling does not show a 
significant signal. This might indicate that the amine coupling restricts the binding 
ability of the 13-mer peptide. The plot also indicates that the binding rate should be 
lower for the 13-mer peptide than for the octapeptide. Regarding the coupling strategies, 
for the octapeptide, both coupling strategies seem to work, assuming sufficient 
flexibility around the peptide’s structure to perform a binding event with ochratoxin A. 
The results in Figure 6.1 and 6.2 suggest that both peptides bind, however with different 
strength, to ochratoxin A.  
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6.4.2 Peptide immobilisation level on CM5 
When having a small ligand immobilised and using a large analyte the amount to be 
immobilised need to be reduced in order to avoid steric crowding effects on the surface 
[Biacore Handbook, 2007]. Therefore, the binding level response for small molecular 
weight peptides, as employed here, is expected to be relatively small. The 
conformatation of the peptides on the CM5 chip will be different to the immobilisation 
on microtitre plate supports, since covalent attachment to surface carboxy groups will 
take place through amine and amino groups in different positions on the peptides 
(Figure 6.3). The ligands and their immobilisation level (RU) are shown in Table 6.1. 
Table 6.1: Ligands immobilised to CM5 chips and their immobilisation response. 
Ligand Immobilisation level Analyte 
Octapeptide CSIVEDGL 251 RU Ochratoxin A-BSA 
13-mer peptide GPAGIDGPAGIRC 227 RU Ochratoxin A-BSA 
The net surface plasmon resonance signal for immobilised peptides was about 251 RU 
(octapeptide) and 227 RU (13-mer peptide) after completion of the chip regeneration 
cycle, which corresponds to 251 pg/mm2 (octapeptide) and 227 pg/mm2 (13-mer 
peptide) that is 30 and 19 fmol/mm2, respectively. Even though the immobilisation 
response was low for both peptides, the calculated immobilisation level is still high in 
relation to the molecular weight of both peptides. 
6.4.3 Immobilised peptide interaction with ochratoxin A-BSA  
The binding interaction of immobilised peptides with ochratoxin A is studied in a flow 
system to confirm the results obtained on a static micro titre plate system in Section 
6.4.1. For that purpose, both peptides were immobilised onto the sensor chip surface 
using amine coupling, since the approproiate reagents for sulfuhydryl coupling, were at 
that point of time not available. Using ochratoxin A-BSA as analyte, one has to observe 
that the binding interaction model does not follow a simple 1:1 stoichiometry, but a 1:3 
to 1:6 binding as 3-6 mol ochratoxin A is bound per mol BSA. A saturating 
concentration of 100 mg L-1 ochratoxin A-BSA conjugate was injected over both 
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immobilised peptides and the association and dissociation monitored in real-time as 
seen in Figure 6.3.  
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Figure 6.3: Sensorgrams displaying 100 mg L-1 ochratoxin A-BSA binding to 
immobilised peptides a) 13-mer GPAGIDGPAGIRC in blue and b) CSIVEDGL is 
shown in red; and 100 mg L-1 BSA binding to c) 13-mer in dark grey and d) octapeptide 
in light grey. 
Figure 6.3 shows that both 13-mer and octapeptide bind the high concentration of 
ochratoxin A-BSA conjugate and showed no unspecific binding to the reference analyte 
BSA. Fast on and off-rates for the both peptides were observed as the baseline was 
reached almost immediately after the end of analyte injection. Weak affinity can be 
advantageous as there is the no need for a regeneration step, which improve the stability 
of the peptides. Weak affinity interactions have been first recognised by Ohlson et al. 
[1988], who defined weak affinity within the range of KA 102-104 M-1 (or dissociation 
constant > 104 M). To establish the maximum response the theoretical binding 
capacities were calculated according to the equation [Biacore Handbook, 2007]: 
Rmax  = (MW(analyte) / MW(ligand)) * R(ligand) * S   Equation XV 
According to the equation Rmax is the theoretical binding capacity; MW describes the 
molecular weight of the analyte and ligand, whereas R describes the immobilisation 
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level of the ligand and S the stoichiometry of the interaction. Applying equation XV, the 
theoretical binding capacity was 6742 RU for a 1:3 and 3432 RU for a 1:6 binding 
model when applying the immobilised octapeptide (CSIVEDGL). The theoretical 
binding capacity was 4298 RU for a 1:3 and 2188 RU for a 1:6 binding model with the 
immobilised 13-mer peptide (GPAGIDGPAGIRC). The true binding capacity for the 
octapeptide was observed at 21 RU and for 13-mer at 25 RU. This could be primarily 
due to assuming the wrong stoichiometry of the interaction as this can vary in the range 
of 1:3 - 1:6 molecular ratios. To establish the affinity of the interaction, increasing 
ochratoxin A-BSA concentrations were injected over both peptide surfaces (Figure 6.4). 
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Figure 6.4: Sensorgrams show the binding interaction of immobilised synthetic octamer 
CSIVEDGL (A) and 13-mer GPAGIDGPAGIRC (B) peptide with decreasing 
ochratoxin A-BSA analyte concentration (from top to bottom: 100, 1, 0.1, 0.01 mg L-1). 
The zero reference is shown in grey. The sensograms were trimmed by removing the 
signal spikes occurring at injection start and stop.  
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It is depicted in Figure 6.4 that the off-rates for both peptides are rapid and baseline was 
reached almost immediately after the end of analyte injection indicating weak affinity 
interactions. Also, the sensorgrams for the octapeptide (Figure 6.4, A) and 13-mer 
peptide (Figure 6.4, B) show quite similar curve shapes and binding response indicating 
a similar binding stoichiometry. In Figure 6.4 the sensorgrams are showing a bulk 
refractive index (RI) change of about 20 RU that is probably due to steric hindrance of 
the ochratoxin A-BSA analyte binding to the peptide layer. The blank sensorgram (un-
conjugated BSA) is shown in grey and has been subtracted from the signal curves to 
eliminate the RI when fitting the curves. Kinetic assessment is not possible for these 
sensorgrams as Rmax (maximum binding capacity) is not reached and the concentration 
range is too small. Also, the binding soichiometry is unknown which makes choosing a 
fitting model more difficult. Preliminary results, fitting the curves with a 1:1 binding fit  
gives the binding strength of the peptides displayed as equilibrium dissociation constant 
KD. The 13-mer (GPAGIDGPAGIRC) peptide exhibited a binding strength to 
ochratoxin A with a KA of 6.34 x 104 M-1 and the octapeptide (CSIVEDGL) peptide 
resulted in a similar KA of 8.45 x 104 M-1. In contrast, ochratoxin A-specific antibody 
showed relatively high affinity and slow off-rates indicated by a KD of 3x10-6 M 
(Biogenesis) and KD of 3.38x10-9 M (Acris) (Chapter 3, Section 3.4.4) when 
immobilised and subjected to the same ochratoxin A-BSA concentrations.  
The resulting affinity of the novel peptide receptors is corresponding to the binding 
energy calculated by computational modelling. The 13-mer sensorgram indicates faster 
on and off-rates corresponding to higher binding energy (lower binding score) in 
comparison to the octapeptide. This was confirmed for both the LeapFrog peptide 
library design of short peptide sequences and when modelling the dynamics of the 
binding interaction using FlexiDock. The binding energies for the short peptide 
sequences as illustrated in Chapter 5 (Table 5.9, No. 4 and 3) correspond to the final 
sequences as highlighted in Table 5.10 (No. 4 and 9) and to the binding affinities 
obtained using surface plasmon resonance. 
 
The results strongly suggests that weak affinity interactions are involved in the peptide 
binding interactions with ochratoxin A as there is the no need for a regeneration step. 
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The analysis can be performed in an isocratic buffer environment enhancing the stability 
of the biomolecules and improving the life-time of the receptor surface. 
6.4.4 Immobilised ochratoxin A-BSA interaction with peptides 
The binding interaction was further characterised by the immobilisation of ochratoxin 
A-BSA conjugate. This assay format allows both peptide analytes more conformational 
flexibility when binding immobilised ochratoxin A-BSA. At a MW of 67211-68422 g 
mol-1 depending upon the ratio of ochratoxin A (403.81 g mol-1) per mol BSA (MW 
66000 g mol-1), the net surface plasmon resonance signal for immobilised ochratoxin A-
BSA, was about 6460 resonance units after completion of the chip regeneration cycle, 
which corresponds to 6.5 ng/mm2 (95-96 fmol/mm2). Figure 6.5 displays the binding of 
the octapeptide (CSIVEDGL) analyte to immobilised ochratoxin A-BSA.  
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Figure 6.5: Sensorgram (resonance units versus time) showing the octapeptide 
CSIVEDGL (red) binding immobilised ochratoxin A-BSA and the reference BSA 
(blue). 
Figure 6.5 shows a sharp increase in resonance units during the association phase and 
the distinct dissociation phase compared to the references cell, it can be assumed that 
the octapeptide CSIVEDGL (100 mg L-1) binds immobilised ochratoxin A-BSA, but not 
to the BSA reference. The binding response achieved when using the peptide as analyte 
is much higher than for the immobilised octapeptide, which is a result of the higher 
flexibility of the octapeptide in solution. The sensorgram also shows high bulk 
refractive index (RI) indicated by the spike in resonance units at injection start and stop. 
The RI is about 160 RU for the octapeptide, probably a result of the low flow rate. 
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Subtracting the RI from the resonance units at the end of association, a binding capacity 
was 58 RU for the octapeptide. The theoretical maximum binding capacity was 
calculated at 80 RU. The interaction shows very high on and off-rates for the 
octapeptide indicating steady state affinity and weak affinity interactions.  
 
The same binding assay was performed using the 13-mer peptide and Figure 6.6 
displays the binding of the 13-mer peptide (GPAGIDGPAGIRC) to immobilised 
ochratoxin A-BSA.  
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Figure 6.6: Sensorgram (resonance units versus time) showing the 13-mer peptide 
GPAGIDGPAGIRC (green) binding immobilised ochratoxin A-BSA and the reference 
BSA (blue). 
Figure 6.6 shows that the 13-mer peptide binds to immobilised ochratoxin A-BSA in 
comparison to the reference cell (BSA). The sensorgram also indicates a weaker affinity 
to ochratoxin A-BSA a higher off-rate than the octapeptide. The bulk refractive index 
change (RI) is also high at about 125 RU. The binding capacity of 100 mg L-1 13-mer 
peptide was calculated at about 27 RU and the theoretical binding capacity was 
calculated at 113 RU. This shows that it requires much higher concentrations of the 13-
mer to reach the maximum binding response than the octapeptide. 
 
Fitting the curves using 1:1 binding stoichiometry resulted kinetic data with a high chi2 
and were not statistically valid. This indicates that the binding interaction of 
immobilised ochratoxin A-BSA conjugate with the peptide analytes is more complex 
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than a simple 1:1 or 1:2 binding event and cannot be fitted using the present kinetic 
models supplied in the BIAcore software. 
 
However, the interactions of both peptide receptors correlate in their on and off-rates 
and binding response to the binding energy obtained by computational modelling. The 
GPAGIDGPAGIRC shows clearly faster on and off-rates, when injected in the flow, 
which corresponds to less negative binding energy (lower binding score). This 
confirmed both the computational modelling results shown in Table 5.8 and 5.9 and the 
results obtained for binding interaction analysis of immobilised peptides (Section 6.4.3). 
 
Van der Gaag and co-workers [2003] describe a competitive binding assay for 
ochratoxin A using a monoclonal antibody and having an ochratoxin A-derivative 
immobilised on the sensor surface. The assay results in a sensitivity value of 0.1 μg L-1. 
The assay described above is non-competitive, however, a binding capacity of 27 RU 
(13-mer peptide) and 58 RU (octapeptide) at a concentration of 100 mg L-1 is very low 
and the sensitivity of the assay is therefore predicted to be much less than the work 
proposed by van der Gaag et al. [2003]. 
6.5 Concluding remarks 
A synthetic peptide receptor for ochratoxin A was designed using an innovative 
computational approach. The initial argument of the approach to simulate nature’s 
evolution by de novo designing a receptor for a small molecular weight toxin was 
investigated using biospecific interaction analysis. The artificial peptide receptor was 
binding to ochratoxin A when observing the binding interaction in vitro using solid-
phase assays and the surface plasmon resonance biosensor. The peptide receptors 
showed both weak affinity indicated by fast on and off-rates and no need for surface 
regeneration. The 13-mer showed faster on and off-rates when immobilised and when 
used as analyte on immobilised ochratoxin A. The sensorgams correlate well with the in 
silico data obtained with both Leapfrog and FlexiDock. It is anticipated that the peptide 
receptor can be used in receptor binding assays and affinity sensors. Low cost, time-
saving and high-throughput screening procedures prior to in vitro testing illustrate one 
major advantage of de novo designed peptides towards antibodies. 
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According to the literature, peptide receptors have been used as receptors and studied by 
SPR, although in all cases peptide selection was either from a peptide phage library or 
artificial peptide library using combinatorial analysis. There is no publication record of 
an artificial peptide that has been custom-designed for a target molecule using 
computational modelling; hence this work is representing a completely new approach.  
 
Peptides as ochratoxin A receptors have been recently prepared [Giraudi et al., 2007], 
where a hexapeptide library was produced by combinatorial synthesis. The 
identification of a suitable peptide sequence binding ochratoxin A has been performed 
through a displacement assay on peptide-modified microtitre plates by determination of 
the flourescence of free ochratoxin A, thereby comparing fluorescence of total to free 
ochratoxin A and being able to calculated peptide-bound ochratoxin A. Affinity was 
determined through a Scatchard plot as KA = 3.4×104M−1. 
 
The sequence Ser-Asn-Leu-His-Pro-Lys does not correspond in more than one amino 
acid each to the peptide sequences for ochratoxin A designed here by computational 
modelling. The octapeptide (Cys-Ser-Ile-Val-Glu-Asp-Gly-Leu) has serine in common 
and the 13-mer (Gly-Pro-Ala-Gly-Ile-Asp-Gly-Pro-Ala-Gly-Ile-Arg-Cys) the proline. It 
is also interesting to see the similarity of the remaining amino acids, where the 
hexapeptide contains neutral asparagine; both octamer and 13-mer contain aspartate, 
which is negatively charged. Also, where the hexapeptide contains leucine, both 
octapeptide and 13-mer contain isoleucine, which are both neutral. So, there are certain 
similarities in the amino acid sequences.  
 
In this work, the affinity was determined by SPR in a similar format, where the peptides 
are immobilised and binding directly to ochratoxin A-BSA, however, without the 
displacement with free ochratoxin A (which would be a useful future experiment). 
Affinity of the octamer was determined at KA = 8.45 x 104 M-1 and of the 13-mer at KA 
= 6.34 x 104 M-1. Comparing to the hexapeptide obtained from the library, the affinity 
has the same order of magnitude at about 2-3 fold increased affinity shown by the 
octapeptide and 13-mer peptide produced in this work. This shows that the 
computational approach for peptide selection shows corresponding results to 
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combinatorial selection in terms of affinity of the lead peptide binding to ochratoxin A. 
By circumventing the effort of preparing a peptide library and the cumbersome and 
timely process of lead sequence selection, computational modelling has a great 
advantage towards conventional methods. 
 
Giraudi et al. [2007] is using the selected hexapeptide to develop a solid phase 
extraction method for ochratoxin A in wine and several different wine samples spiked 
with ochratoxin A at 2 and 4 μg L−1 levels showed recovery of 94.7% and 98.4%. Here, 
the peptide is intended as recognition element in a sensor setting. Detection limits for 
ochratoxin A in wine were not established yet, but binding of the ochratoxin A 
conjugate showed that sensitivity could be reached for concentrations around 10 μg L−1. 
This shows that even if the peptide receptor, upon assay optimisation, should not show 
the required sensitivity for sensor development, it is comparable in its sensitivity to be 
used as receptor in solid phase extraction. 
 
Giraudi et al. [2007] also cross-referenced a paper by Sbobini et al. [2001] that states 
that a range of affnities between 104 and 106 M−1 is typical for biomacromolecules 
binding to coumarinic structures (as in ochratoxin A). However, the developed peptides 
in this work and Giraudi et al. [2007] to not count as macromolecules and therefore 
show completely different binding properties to ochratoxin A. 
 
Other work involving peptide selection and SPR analysis was done by Gaus and Hall 
[2003], who selected short peptide sequences from a library to distinguish between 
normal and oxidised LDL (low density lipoprotein). Here, the peptides were 
immobilised to a SAM-modified gold surface via carbodiimide coupling as also 
presented in this work and the binding compared for a number of peptides. This work 
shows that carbodiimide coupling of peptides can be used in binding analysis and that 
thiol coupling is not necessary to get sufficient binding for distinguishing affinity. 
 
Also, the use of peptide phage libaries was presented by Soycut et al. [2008] for the 
selection of phage clones displaying peptides that recognize staphylococcal enterotoxin 
B (SEB). The affinity of the phage clones was determined by SPR where clones were 
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allowed to bind to the SEB immobilized on the sensor surface. However, the binding 
constant of the lead peptide was determined at KA = 4.2×105 M−1 with isothermal 
titration calorimetry (ITC).  
The affinity of the SEB peptide was in the same range as described by Giraudi et al. 
[2007] for ochratoxin A and the affinities established for the peptides in this work. This 
might indicate peptide recognition is generally showing weak affinity characteristics, 
which is also supported by the fact that peptide in vivo are predominantly involved in a 
number of biochemical processes, such as signal transduction (e.g. europeptides), 
etabolism (e.g. hormones), cell growth (e.g. Ras-protein, p53), and imune defense (e.g. 
MHC-receptors) [Schmuck, 2001] often displaying weak affinity characteristics. 
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CHAPTER 7 : CONCLUSIONS 
This thesis has demonstrated the applicability of screen-printed gold electrodes in the 
construction of an amperometric affinity sensor for ochratoxin A. The developed and 
evaluated immunosensor was validated successfully against standard methods used for 
ochratoxin A analysis in wine samples. All experimental stages of the biosensor 
development were implemented into the final biosensor demonstrating the capability of 
sensitive ochratoxin A determination.  
 
• The first stage of the biosensor development involved the characterisation of the 
antibody recognition elements using enzyme immunoassays (ELISA). 
Ochratoxin A antibodies were purchased and investigated. This work resulted in 
the establishment of a limit of detection of 1 µg L-1 ochratoxin A. 
 
• Optimal microtitre plate assay parameters were established at a coating 
concentration of 750 µg L-1 ochratoxin A-BSA and an ochratoxin A antibody 
concentration of 500 µg L-1 applying a optimal coating time of ochratoxin A-
BSA for 4 hours at room temperature. Casein blocking was used in the coating 
buffer and an incubation time of ochratoxin A-antibody of 4 hours at an optimal 
incubation temperature of 4°C was established. 
 
• A preliminary affinity value of the interaction of immobilised ochratoxin A-BSA 
with a range of antibody concentrations could be established on solid-phase 
immunoassay (without steady-state equilibrium). The affinity constant KA was 
estimated 1.66x1011 M-1. 
 
• The results of the enzyme immunoassay work have been compared to another 
indirect immunoassay for ochratoxin A published by Alarcon et al. [2004] using 
the same BSA-purified ochratoxin A antibody. The results obtained for this 
thesis show comparably better reproducibility and sensitivity (1 µg L-1). A direct 
immunoassay was presented by Alarcon et al. [2004] showing a five times lower 
LOD as compared to this work. 
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• Biospecific interaction analysis was used for monitoring binding interaction, 
kinetic rates and cross-reactivity towards BSA. Affinity data were obtained and 
compared to the solid phase immunoassay data. The binding interaction analysis 
resulted in antibody B showing higher affinity for ochratoxin A (KA = 9.84x1011 
M-1 and KD = 1.02x10-12 M), whereas antibody A (KA = 2.55x1011 M-1 and KD = 
3.92x10-12) displayed better sensitivity of the assay and antibody A was chosen 
as recognition element for the electrochemical immunosensor development. In 
comparison, the affinity value obtained on the solid-phase immunoassay for 
antibody B (1.66x1011 M-1) is within the same order of magnitude and suggests 
that the method to gain the functional affinity analysis, according to Loomans et 
al. [1995] using the Beatty formula [Beatty et al., 1987], is valid. 
 
• Screen-printed gold electrode sensors were mass-produced (200 electrodes per 
sheet, >20 sheets per batch) by screen-printing applying thick film technology. 
The screen-printed electrodes provided a cost-effective way to obtain disposable 
sensor that show good sensitivity. 
 
• The initial immunosensor using ochratoxin A-BSA adsorbed to SPGEs in an 
indirect immunosensor format showed a detection limit of <100 ng L-1. Further 
improvement was achieved when covalently immobilising ochratoxin A-BSA by 
modifying SPGE with CMD thus decreasing the detection limit to 10 ng L-1.  
 
• Each measurement took about 200 seconds, where up to three electrodes can be 
monitored simulataneously. The final construction of each immunoassay-
modified electrode takes a minimum of 5 hours (including the covalent surface 
modification with carboxymethylated dextran.  
 
• The screen-printed immunosensor was optimised for wine analysis in terms of 
the electrochemical interferences arising from phenolic compounds. This was 
done by polarising the working electrode at -150 mV versus reference Ag/AgCl. 
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• The proposed sensor is resulting in a better sensitivity compared to another 
ochratoxin A immunosensors for wheat analysis [Alarcon et al., 2006]. The 
group presented an electrochemical biosensor for ochratoxin A in wheat with the 
lowest detection limit for an indirect assay at 0.9 (±0.1) μg L−1. In this work, 
detection limits of 9-90 times lower than that using a similar, though improved 
(CMD-modified SPGE), approach is shown.  
 
• A microelectrode array format as an alternative transducer for the immunosensor 
was investigated. Preliminary characterisations of the gold microelectrodes prior 
to microelectrode-immunosensor development were performed and evaluated. 
The resulting standard curve was inconclusive and a LOD for ochratoxin A on 
microelectrodes could not be established. It has also been observed that 50 % of 
the received microelectrodes had faulty connections (as tested with a 
voltammeter) and as a result did not show a current signal at all. The peculiar 
shape of the current response upon addition of TMB/H2O2 could be a result of 
misconnection of the microelectrodes working, counter and reference electrode. 
 
• Furthermore, an initial direct competitive immunosensor format for ochratoxin 
A showed a detection limit of <100 ng L-1 and seems a promising alternative in 
the development of a BSA-free affinity sensor for ochratoxin A. 
 
• The amperometric screen-printed immunosensor demonstrated good correlation 
with HPLC results, but less with an immunoassay test kit. 
 
• This work also involved the parallel execution of the computational design of 
peptide receptors for ochratoxin A and the consecutive characterisation of 
peptide recognition elements using binding assays as well as their possible 
implementation into an affinity sensor for ochratoxin A. This work’s results 
illustrate the design and synthesis of a small peptide receptor for ochratoxin A 
using de novo design software.  
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• It was confirmed that the de novo design tool LeapFrog can be used to produce a 
virtual library of peptide receptors for ochratoxin A and also screen this library 
using binding energy algorithms to produce a hit-list of lead peptide sequences. 
The applied program FlexiDock, part of the LeapFrog software, can be used for 
a rough simulation of receptor-ligand docking. The manual extension of the 
peptide sequence with charged amino acids or with a Cysteine-tag can not be 
sufficiently characterised using FlexiDock simulations.  
 
• Two lead peptide sequences were selected from the computational hit list and 
synthesised. The sequences are a 13-mer (GPAGIDGPAGIRC) and an 
octapeptide (CSIVEDGL). 
 
• The binding of the peptides to ochratoxin A was confirmed in vitro using solid-
state peptide assays and real-time monitoring of the binding interaction with the 
SPR biosensor Biacore. The peptide receptors showed both weak affinity 
indicated by fast on and off-rates and no need for surface regeneration. The 13-
mer showed faster on and off-rates when immobilised and when used as analyte 
on immobilised ochratoxin A as compared to the octapeptide. Preliminary 
affinity values indicate a binding strength of the 13-mer (GPAGIDGPAGIRC) 
peptide to ochratoxin A with a KA of 6.34 x 104 M-1 and the octapeptide 
(CSIVEDGL) peptide resulted in a similar KA of 8.45 x 104 M-1. The sensorgams 
correlate well with the in silico data obtained with both Leapfrog and FlexiDock. 
It is anticipated that the peptide receptor can be used in receptor binding assays 
and affinity sensors. Low cost, time-saving and high-throughput screening 
procedures prior to in vitro testing illustrate one major advantage of de novo 
designed peptides towards antibodies. 
 
Conclusively, the thesis reports the development of an affinity sensor that can be 
applied for ochratoxin A for determination in wine samples. The sensor elements 
provide sufficient specificity and sensitivity, like the antibody recognition element, 
while being time and cost-effectiveness through using disposable screen-printed 
electrodes.  
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Upon further improvisation in terms of reproducibility and signal variance, the proposed 
biosensor could be used to monitor ochratoxin A contamination on-site the wine yard 
and thus prevent wine samples that are above the EC permissible limit to reach the 
consumer.  
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CHAPTER 8 : FUTURE WORK AND ALTERNATIVE 
APPROACHES 
• Enzyme immunoassays for ochratoxin A antibody characterisation could be 
further improved in its sensitivity by choosing a monoclonal antibody for assay 
development to increase specificity for ochratoxin A and to avoid cross-
interaction with the BSA-conjugate of ochratoxin A. A monoclonal antibody for 
ochratoxin A can be acquired from Abcam Plc. (UK) since August, 2005. 
According to the manufacturer, no cross-reactivity towards ochratoxin B or BSA 
can be observed. The product was not available at the time of this assay 
development and it was not feasible to implement a novel antibody at such a late 
stage of the sensor development. The antibody available at that point of time was 
a polyclonal antibody from Acris GmbH (Germany) that did not use the BSA-
conjugate of the toxin as immunogen. Suggested future work involves the 
analysis of the antibody from Acris GmbH by enzyme immunoassays in the 
same way as the antibody from Biogenesis Ltd. to compare with the Biacore 
results. 
 
• Furthermore, the direct competitive enzyme immunoassay format needs to be 
further explored as it displays a simpler binding interaction approach. Therefore, 
an ochratoxin A-HRP conjugate needs to be obtained. A conjugate with 
preferably a 1:1 molar ratio of ochratoxin A to HRP would be optimal, which 
can be achieved by refining the conjugation method.  
 
• Sample pre-treatment and purification has to be more extensively investigated 
such as the recovery rates when using immunoaffinity columns for ochratoxin A 
extraction and furthermore the effect of the wine components and wine pH on 
the assay performance (also when using diluted samples).  
 
• The binding interaction analysis using Biacore that was performed consecutively 
of the enzyme immunoassay analysis needs to be improved in its experimental 
setup to gain accurate kinetic data. For the various binding formats the Rmax 
value (maximum binding capacity) has to be determined by saturating the ligand 
bound to the sensor surface with higher analyte concentrations. For kinetic 
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measurements, another chip with low surface capacity should be prepared 
 
• The Rmax value is to be compared with the theoretical value to examine 
whether the stoichiometry is correct. The linked reaction experiment should be 
performed for all binding interaction formats to confirm the stoichiometry and 
binding model. The binding analysis should be simplified so that a 1:1 binding 
can be measured on the sensor surface. 
 
• For the wine analysis using the binding interaction analysis, the competitive 
assay has to be optimised for a wider range of ochratoxin A standards. The 
sensitivity and the dynamic range can be positively influenced by using a 
monoclonal antibody for ochratoxin A. Thus, the competitive assay on the 
sensor chip can be used for sensitive detection of ochratoxin A.  
 
• The immunosensor in this work could be improved in various ways. Work has 
been initiated to transfer the immunosensor approach to a handheld device for 
field-analysis. In this context, the stability of the sensor has to be optimised. It 
was observed that after several days of storage at 4°C, the ochratoxin A 
immunosensor showed less bioactivity, being subjected to activity loss of the 
protein components involved. Consequently, all the measurements with the 
biosensors were done within a day of the assay construction. Thus, the 
components of the immunosensor have to be stabilised further. However, the 
bare screen-printed gold electrodes are stable for several months when storing 
under dry, inert conditions such as under nitrogen atmosphere. CMD-modified 
sensors are stable under storage of either N2 or in phosphate buffer, pH 7.4 at 
4°C for several weeks. 
 
• Furthermore, CMD-modified SPGE described in 4.4.16 has to be improved as 
the carboxymethylated dextran (CMD) is currently adsorbed to the gold surface. 
By coupling the CMD covalently to the surface, the sensitivity of the assay can 
be significantly enhanced. This can be achieved by following the protocol of 
Masson et al. [2004], which was derived from the initial protocol for 
carboxymethylated dextran modification of gold surfaces in SPR measurements 
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[Lofas & Johnsson, 1990]. The protocol is described in brief: The gold surface is 
incubated overnight with 0.005 M 11-mercaptoundecanol (80:20 Ethanol:H2O) 
to form a self-assembled monolayer (SAM). The SAM is incubated with 0.6 M 
epichlorohydrin in 1:1 diglyme and 0.4 M NaOH for 4 hours and then washed 
with water, ethanol, and water. The surface is then incubated with 0.3 g/ml 
dextran (500 kDa) in aqueous solution and 0.1 M NaOH. The dextran polymer is 
then modified to carboxymethylated dextran with bromoacetic acid in 2 M 
NaOH for another 16 hours and washed again with water, ethanol, and water. To 
confirm the presence of linked carboxymethylated dextran, the surface can be 
characterized using FTIR (Fourier Transform Infrared Spectroscopy). 
 
• As the trend in biosensors moves towards homogenous and label-free detection 
an alternative approach for ochratoxin A detection using screen printed 
electrodes is suggested as follows. The literature describes the monitoring of 
ochratoxin A oxidation [Calcutt et al., 2001] which has been performed on 
glassy carbon electrodes vs Ag/AgCl [Oliviera et al., 2007]. Calcutt et al. [2001] 
monitored the oxidation of ochratoxin A on screen printed gold electrodes 
versus Ag/AgCl using cyclic voltammetry by observing the oxidation peak with 
decreasing ochratoxin A concentration. Using the same approach, cyclic 
voltammograms were obtained in this work illustrating decreasing ochratoxin A 
concentrations on SPGE. The CV shows a peak on the positive scan at about 
+1.0 V, but no proportional decrease in peak current or a significant peak shift 
was observed when varying the ochratoxin A concentration. Since the 
ochratoxin A oxidation potential is fairly high, a mediator might be introduced 
into the detection, which would be reduced upon oxidation of ochratoxin A and 
in turn reduced at the electrode producing a current that can be monitored 
sensitively via chronoamperometry.  
 
• The development of an ochratoxin A immunosensor on microelectrodes requires 
further characterisation of the microelectrodes and adaptation of the assay, 
which involves the optimal coating and binding concentrations of all reagents 
involved and the reduction of faulty connections of the microelectrode 
components. 
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• Computational modelling can be further optimised for instance by the choice of 
applied force field as well as the simulated solvent environment. In this work the 
Tripos force field had been selected for molecular modelling. An alternative is 
the application of protein force fields such as CHARMM22 that has been 
specifically applied for the modelling of peptides by MacKerell [1998].  As an 
alternative to LeapFrog, other de novo design programs such as LUDI [Böhm, 
1992] can be applied for the peptide design task. Another improvement would 
be the better choice of receptor-ligand interaction simulation software. A 
suggestion would be either AutoDock 3.0 [Morris et al., 1998] or FlexX/FlexE 
featured by Tripos Inc., which adds the ability to consider protein structural 
variability in docking calculations. For refinement one could use a dynamics 
package like AMBER 7 to refine docked complexes or QSAR, which is a 
toxicity-modelling algorithm based on Quantitative Structure-Activity 
Relationships (QSAR), neuronal networks, or artificial intelligence concepts 
[Selassie, 2003]. A new approach named Quasar (Quasi-atomistic receptor 
modelling) combines receptor modelling and QSAR technique based on a 
genetic algorithm by mapping an unknown or hypothetical receptor (such as the 
peptide receptor) in 3D and quantitatively calculating the affinity of small 
molecules binding to it [Vedani et al., 2000; Vedani and Dobler, 2002].  
 
• It is known from the literature that small peptides such as trimers or tetramers 
are very well able of interacting with relatively strong affinity via H-bonds and 
electrostatic interactions. Smaller peptides have a more defined structure and 
physicochemical properties. The longer the peptide, the more distinct properties 
affecting the interaction and thus it occurs that smaller peptides often illustrate 
higher binding affinities [Schmuck, 2005]. LeapFrog parameters can be 
manipulated to design small, soluble peptides by choosing only from a set of 
hydrophilic amino acid monomers for synthetic peptide library construction. In 
addition to that, using Cysteine as a fixed starting molecule, will introduce it into 
every peptide sequence, however at random position. 
 
• 3-dimensional structural information for the peptide receptor and the ochratoxin 
A-receptor complex provided by X-ray diffraction or NMR can give a better 
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inside into the binding interaction and the complex formation. Ongoing research 
in receptor design and structure-function studies as well as the introduction of 
small molecular weight templates are well underway and molecular dynamics 
simulation techniques will guide computational chemists to real predictions of 
binding affinities of receptor-ligand interactions without them having to 
synthesise the molecule. 
 
• The synthesised peptides obtained from LeapFrog were analysed in vivo using 
binding interaction analysis. Further work should examine the suitability of the 
novel receptors as sensing layer in diagnostic binding assays and sensors. The 
specificity of the peptide interaction has to be further examined for cross-
reactivity towards ochratoxin A derivatives and wine components in general. 
Also, the peptide receptors have to be validated further against other, random 
peptide sequences. 
 
• Another approach would be the selection of a peptide sequence from the binding 
site of a molecule that is known to bind ochratoxin A such as the enzyme t-RNA 
Synthetase. This, however, is dependent on two issues, 1) if the ochratoxin A 
binding site on this molecule is of linear or non-linear sequence, hence only a 
linear sequence can be easily extracted from the binding site and a non-linear 
one would require more intensive molecular dynamics studies of variants of the 
non-linear sequence, and 2) if the affinity of the extracted peptide sequence to 
ochratoxin A is sufficiently high to demonstrate a detectable binding interaction. 
It is known that ochratoxin A binds to the enzyme t-RNA Synthetase as an 
inhibitor competing with the enzyme substrate phenylalanine. Thus, ochratoxin 
A has an effect on protein biosynthesis; one of its bioactive effects on the 
mammalian system, but is easily replaced when phenylalanine is added. The 
research group around Qinglai et al. [2004] published the development of a 
tRNA-Synthetase microarray for protein analysis. This paper lead to the hereby 
suggested idea of applying this sensor for an ochratoxin A 
inhibition/displacement assay. This would involve the epitope mapping of the t-
RNA-Synthetase binding site for ochratoxin A and also computational 
modelling of the interaction of the enzyme using molecular dynamics studies. 
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The t-RNA-Synthetase displacement biosensor for ochratoxin A could be used 
for ochratoxin A analysis in contaminated samples. An advantage of enzymes is 
that they are more stable in an acidic environment, such as wine, as compared to 
antibodies. However, this idea has not evolved past the drawing board and can 
be merely seen as an alternative needing extensive development and 
optimisation. 
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APPENDICES 
Appendix A: Table of synthetic wine compounds and their concentration according to 
“Estacion Enologica of Rioja” obtained from University of Valladolid, Spain, 2006. 
Component Concentration (mg L-1) 
Isopenthyl Acetate  0.523 
Trans-2- hexenal 0.508 
Ethyl Hexanoate  0.523 
Hexyl Acetate  0.524 
Ethyl Heptanoate  0.521 
1-hexanol 0.492 
Ethyl Octanoate  0.520 
1-heptanol 0.493 
Benzaldehyde  0.630 
Ethyl Pelargonate  0.520 
Linalool 0.517 
1-octanol 0.494 
Isoamile Lactate  0.517 
Phenil Acetate  0.646 
Ethyl Decanoate  0.518 
Butyrolactone  0.672 
Diethyl Succinate  4.156 
Terpineol 2.239 
Citronellol  2.062 
Nellol 3.508 
Acetate-2-phenilethyle  2.479 
Ethyl Dodecanoate  0.556 
Geraniol 3.416 
Guayacol 4.516 
Bencilic Alcohol  4.200 
t-whiskylactone 4.360 
2 –Phenilethanol  4.080 
wiskylactone 4.360 
4-etilguayacol 4.258 
2-Ethylphenol  4.148 
Eugenol 4.264 
4-Ethylphenol 6.080 
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Appendix B: Mass Spectroscopy spectra of the 13-mer peptide 
with the sequence GPAGIDGPAGIRC. The peptide showed one 
major signal at m/z 1183.47 (average molecular mass). 
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Appendix C: Mass Spectroscopy spectra of the octapeptide with the sequence 
CSIVEDGL. The peptide showed a major signal at m/z 856.64 (average molecular 
mass) and some minor signals at 834.39 and 878.24. 
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Appendix 4: Heurich, M., Danielsson, B., Tothill, I.E., (2005). “Affinity Sensor for 
Ochratoxin A using Synthetic Peptide Receptor”, Second world congress on synthetic receptors, 
Salzburg, Austria. 
Affinity Sensor for Ochratoxin A using 
Synthetic Peptide Receptor
M. Heurich*1, B. Danielsson2 and I. E. Tothill1
1Cranfield University, UK; 2Lund University, Sweden
Conclusions
• Low cost, time‐saving and  high‐throughput screening procedures prior to in vitro testing  illustrate the major advantage of de novo designed  peptides towards antibodies. 
• The work shows the potential of using synthetic peptides as sensitive and specific receptors for  detecting  ochratoxin A contamination.
• Further work will examine the suitability of the novel receptors as sensing layer in binding assays and electrochemical sensors.
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Introduction Materials and Methods
Fig. 2. Electrostatic screening procedure of the 
ochratoxin A template (purple) with several 
ligands being tried at distinct positions.
Simulations  are  based  on 
binding  energies  for  the 
interaction  of  amino  acid 
monomers  as  well  as  peptide 
polymers with  the ochratoxin A 
template. 
High  scoring  peptide  sequences 
were  screened  using  a  receptor‐
ligand docking software tool. 
Designed  sequences  were 
synthesised  and  screened  for 
their affinity towards ochratoxin 
A  in  vitro  applying  a  surface 
plasmon  resonance  biosensor 
(BIAcore  3000)  monitoring  the 
binding interaction [1]. 
Mycotoxins  are  widespread  fungal 
contaminants  found  in  many  cereals 
and  other  crops.  There  is  a  growing 
concern  regarding  their  potential  toxic, 
mutagenic,  carcinogenic,  and 
immunosuppressive  effect  on  human 
and animals alike. 
Ochratoxin A (Figure 1)  is produced by 
several  species  of  Aspergillus and 
Penicillium and found in a wide range of 
foods and also beverages such as wine.
Therefore  there  is an  essential need  for 
sensitive,  specific,  reusable,  rapid  and 
easy‐to‐perform diagnostic methods  for 
quantitatively detecting ochratoxin A.
Computational  modeling  was 
performed  on  a  Silicon  Graphics 
Octane  workstation  executing  Sybyl 
6.9.  Peptide  library  design  applied 
molecular  modeling  software  (Figure 
2),  which  uses  the  ochratoxin  A 
structure as template. 
In  this  work  an  artificial  receptor 
specific  for  ochratoxin  A  has  been 
designed  using  computational 
methods.  The  optimal  receptor 
molecule  was  then  synthesised  and 
characterised  for  its  affinity  and 
specificity  for ochratoxin A detection 
using  a  surface  plasmon resonance 
biosensor.
Fig. 1. Ochratoxin A  structure.
Results
The  final  synthetic  peptide  receptors  for  ochratoxin  A    were  modified  manually 
resulting in better solubility and applicability in bioassays. The first de novo designed 
peptide was a 13‐mer ( Figure 4, A)  and the second an octapeptide  (Figure 4, B). Both 
were chemically synthesized for in vitro investigation. 
The octapeptide (Figure 5, right) also recognized ochratoxin A, with dissociation 
constants KD from 100 μM. Association and dissociation  rate  constants  (ka and 
kd)  for both peptides were  rapid  and baseline  signal was  almost  immediately 
reached after  the end of each ochratoxin A  injection, hence no need  for surface 
regeneration.
Both ochratoxin A peptide receptors were characterised in vitro for their affinity 
and kinetics using a surface plasmon resonance‐based biosensor (BIAcore 3000). 
Two  polyclonal  ochratoxin  A  antibodies  were  compared  to  the  synthetic 
peptide receptors. Both antibodies showed high affinity and exhibited  specific 
binding to ochratoxin A, with dissociation constants KD in the range from 7 nM  
and  20  nM.   Association  and  dissociation  rate  constants  (ka and  kd)  for  the 
antibodies were slow, showing a need for regeneration of the sensor surface. 
Affinity and kinetics evaluation of the  two peptides confirmed  that  the 13‐mer 
peptide  (Figure  5,  left)  exhibited  specific  binding  to  ochratoxin  A,  with 
dissociation constants KD in the range from 0.1‐100 μM. 
Peptide  libraries were designed by  computational modeling  (Figure  3)  and  a  list  of 
high scoring peptide sequences produced that were showing high binding interaction 
with  the  ochratoxin A  template.  Selected  peptide  sequences were  further  screened 
using molecular modelling applying docking simulations.
Fig. 4. Final result of de novo designed peptide sequences shown interacting 
with ochratoxin A. The 13-mer peptide (A, left) and the octapeptide (B, right) 
sequence are seen as space-filled, ochratoxin A as stick & ball structures.
Fig. 3. Computational design result. Ochratoxin 
template (shown in purple stick & ball) is shown 
interacting with amino  acid monomers  (stick & ball).
Fig. 5 Sensorgram obtained from BIAcore 3000 showing the binding
interaction of immobilized synthetic 13-mer peptide (left) and octapeptide 
(right) with ochratoxin A (OTA-BSA) at distinct concentrations. The peptide is 
recognizing ochratoxin A  specifically and is showing weak affinity.
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Appendix 5: Heurich, M. and Tothill, I.E. (2006). “Affinity Sensors for Ochratoxin A 
Detection”, 9th World Congress on Biosensors, Toronto, Canada. 
Introduction
Mycotoxins are toxic fungal metabolites that occur in food products, 
such as ochratoxin A which contaminates grapes as a result of mould 
growth. Ochratoxin A may be transferred to grape containing drinks and 
wine due to its high chemical stability. There is an increasing concern for 
human health since ochratoxin A is known to be possibly carcinogenic 
or can be immunosuppressive for the mammalian system. 
Ochratoxin A free beverages are also of economic importance for the 
wine industry. Therefore, a need exists for a sensitive, selective, rapid 
and low-cost measurement of ochratoxin A contents that can be 
implemented on-site in wine yards.
This project focuses on the development of affinity sensors for 
ochratoxin A. Commercially available natural receptors such as 
antibodies and specifically designed and synthesised artificial receptors 
such as peptides are investigated as the sensing layer. 
Artificial peptide receptors were designed using a host of computational 
modeling techniques such as de novo design and receptor-ligand
dynamic simulations.
Enzyme immunoassays were used as developmental tools prior to 
transferring the ochratoxin A assay to the sensor surface.  The 
electrochemical immunosensor for ochratoxin A was developed on an 
Au screen printed electrodes (SPE). 
Future Developments
? Sensitivity of the ochratoxin A SPE assay will be optimised for the determination of real wine samples
? The synthesised peptides for ochratoxin A will be investigated as receptors using the Au SPE sensor
Electrochemical immunosensorSPR biosensor
Kinetic and affinity data were obtained 
using a surface plasmon resonance (SPR) 
biosensor monitoring binding interactions of 
ochratoxin A with an ochratoxin antibody as 
seen in the sensorgram in Fig. 1a.
Peptide Receptor
The peptide receptors were designed 
using computational modelling.
The final synthetic peptide receptors for 
ochratoxin A  were a 13-peptide (Fig.2a)  
and an octapeptide  (Fig.2b). Both were 
chemically synthesized for in vitro 
investigation using a surface plasmon
resonance biosensor.
Fig. 
2a
Fig. 
2b
Affinity constants determined 
applying binding interaction analysis 
for 13-peptide: 
KA [M-1] = 7.40x106,
KD [M] = 1.34x10-7 
and for the octapeptide:
KA [M-1] = 1.49x104, 
KD [M] = 6.69x10-5
Antibody receptor
Plots of resonance units [RU] versus ochratoxin A antibody concentration 
were obtained from the sensorgrams, illustrating the affinity constants in 
Fig.1b and 1c respectively. Two different antibodies (A & B) were 
investigated to select the best antibody. A detection limit of 1 mg L-1 was 
monitored for ochratoxin antibody (A),  compared to 10 mg L-1 for 
antibody (B). 
0 20 40 60 80 100
0
500
1000
1500
2000
2500
3000 Steady State Affinity Fit:
KA [1/M] = 3.15
6 (sd +/- 1.026)
K
D
 [M] = 3.37-7 (sd +/- 9.2-8)
R
es
on
an
ce
 s
ig
na
l [
R
U
]
concentration [µg ml-1]
Fig. 1b
100 200 300 400 500
60
80
100
120
140
160
R
es
po
ns
e 
si
gn
al
 [R
U
]
concentration [µg ml-1]
Steady State Affinity Fit:
KA [1/M] = 3.61
5
KD [M] = 2.77
-6
Fig. 1c
Affinity Sensors for Ochratoxin A Detection
Meike Heurich and Ibtisam E. Tothill
School of Applied Sciences, Cranfield University, Cranfield, 
Bedfordshire, MK43 0AL, UK
Electrochemical properties of 
wine were determined using 
cyclic voltammetry. CV’s were 
taken of synthetic wine and a 
random wine sample (Fig. 5). 
The synthetic wine showed  
distinctive peaks contrary to the 
wine sample. 
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Competitive binding assays for ochratoxin A using ochratoxin
antibodies on Au SPE. Amperometric detection is based on a 
TMB/HRP system.
Ochratoxin A is competing with immobilised ochratoxin A-BSA in 
an indirect binding assay (Fig. 3) and with ochratoxin A-HRP 
conjugate in a direct assay format (Fig. 4). The detection limit of 
the indirect assay resulted in 1 μg L-1 and for the direct assay 
format in 0.1 μg L-1 ochratoxin A. 
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